Citrus Sinensis ID: 007120
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 617 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.964 | 0.7 | 0.487 | 1e-169 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.889 | 0.701 | 0.495 | 1e-166 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.948 | 0.682 | 0.462 | 1e-158 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.967 | 0.704 | 0.473 | 1e-157 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.940 | 0.711 | 0.503 | 1e-155 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.961 | 0.703 | 0.478 | 1e-154 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.949 | 0.703 | 0.456 | 1e-149 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.949 | 0.693 | 0.456 | 1e-145 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.951 | 0.688 | 0.466 | 1e-143 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.941 | 0.690 | 0.433 | 1e-139 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 304/624 (48%), Positives = 407/624 (65%), Gaps = 29/624 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K+ VWVANR P++ S G L I+ + NLV+ QS+ VWS L+ +V++P+V +
Sbjct: 73 KAISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAE 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN VLRD + + WQSFD+P+DTLLP MKLGWD KTG R + SWKS DDPS
Sbjct: 132 LLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF + +E + PE+ +W + YR+GPWNG+RFS P ++P F+F ++ E+
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y+F IT V SR+ ++ + ++R F W + Q+W + P+DQCD Y CG YG C
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQR-FTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDS 310
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SPVC C+KGFKP++ G D S GCVR L+ DGF++ ++KLPD T++ V
Sbjct: 311 NTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVD 370
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + +KEC + CL + +C A+ N+DIRG GSGC W GEL D+R++ GGQD Y+R++A+
Sbjct: 371 RGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAAT 430
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYL-IRKRRRNIAEKT--------------- 408
++ K + KI+ I + LL + I +L RK++R+I +T
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 409 ----ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
+ R +EN DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DG
Sbjct: 491 EVVISSRRHISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDG 548
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QE+AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLD
Sbjct: 549 QEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLD 608
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
S +FD++R + L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY 608
DFG+ R FG DETE NT +VVGTY
Sbjct: 669 DFGMARIFGRDETEANTRKVVGTY 692
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 584 bits (1505), Expect = e-166, Method: Compositional matrix adjust.
Identities = 298/602 (49%), Positives = 398/602 (66%), Gaps = 53/602 (8%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGF---KPKSGGYVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF P++ D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
Query: 367 GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLE 426
++++ +SR+ ++E DLE
Sbjct: 429 ETLQRESSRV---------------------------------SSRKQEEE------DLE 449
Query: 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 486
LP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+AVKRLS+ S QG++E KNE
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNE 509
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ RR LDW +R II
Sbjct: 510 IKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIK 569
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL RT GGDETE NT RVVG
Sbjct: 570 GIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVG 629
Query: 607 TY 608
TY
Sbjct: 630 TY 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 286/618 (46%), Positives = 407/618 (65%), Gaps = 33/618 (5%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQLLDSGNLV 76
VWVANR NP++++ G L I+ NLVL SN VW L++ ++PVV +LL +GN V
Sbjct: 83 VWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFV 141
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAI 136
+RD + D+ Y WQSFDYP+DTLLP MKLG++LKTGL R +TSW+S DDPS G+F + +
Sbjct: 142 MRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKL 201
Query: 137 ERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNK 195
E Q PE + + + +R+GPWNG+RFS P + ++F+ N+ E+ YTF +TN
Sbjct: 202 ETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN 261
Query: 196 AVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRD-QCDTYGLCGAYGICIIGQSPVCQ 254
+ SR+ + Y +R W + + W + P D QCDTY +CG Y C + SPVC
Sbjct: 262 SFYSRLTLISEGYFQR-LTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCN 320
Query: 255 CLKGFKPKSGGYVDR---SQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKE 311
C++GF P++ D+ + GC+R L+ S DGF + ++KLP+ T + V +S+ +KE
Sbjct: 321 CIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKE 379
Query: 312 CREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGG---GQDFYIRMSASEIGA 368
C++ C+ + +C A+ N+DIR GGSGC +W L D+R++ GQD Y+R++A++I
Sbjct: 380 CKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK 439
Query: 369 KGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI----- 423
K + KI+ + + + LL +++ + + KR++ A+ + S Q N++ +
Sbjct: 440 KRNASGKIISLTVGVSVLLLLIM---FCLWKRKQKRAKASAISIANTQRNQNLPMNEMVL 496
Query: 424 -------------DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+LELPL E+ T+ AT+NFS NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 497 SSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVK 556
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK S QG E NEV L ++LQH NLV++LGCCI+G+EK+LIYE++ N SLDS++F +
Sbjct: 557 RLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGK 616
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TRR+ L+W++RF I G ARGLLYLHQDSR RIIHRDLK SN+LLD++M PKISDFG+ R
Sbjct: 617 TRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMAR 676
Query: 591 TFGGDETEGNTNRVVGTY 608
F DETE NT +VVGTY
Sbjct: 677 IFERDETEANTMKVVGTY 694
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 557 bits (1435), Expect = e-157, Method: Compositional matrix adjust.
Identities = 294/621 (47%), Positives = 394/621 (63%), Gaps = 24/621 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTE-------------- 409
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNE 488
Query: 410 --NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
+ + E++ LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 489 LVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668
Query: 588 LVRTFGGDETEGNTNRVVGTY 608
+ R FG +ETE NT RVVGTY
Sbjct: 669 MARIFGREETEANTRRVVGTY 689
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 549 bits (1414), Expect = e-155, Method: Compositional matrix adjust.
Identities = 307/610 (50%), Positives = 407/610 (66%), Gaps = 30/610 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPV----VLQL 69
P VVWVANR NP+ + GFL ++ G+L L + +WS+ S + +L++
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKI 131
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPSP
Sbjct: 132 SCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSP 187
Query: 130 GDFIWAIERQDNPEVVMWKG--SRKFYRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDVE 185
GDF +++ + P++++ K S YR G WNGL F+ AP++ R N +F + F S+ E
Sbjct: 188 GDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQE 247
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +C
Sbjct: 248 VNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304
Query: 246 IIG--QSPVCQCLKGFKPKSGGYVDRSQG---CVRSKPLNYSRQDGFIKFTELKLPDATS 300
I +P C CL+GFKPKSG + S+G CV P N ++D F+KF LKLPD +
Sbjct: 305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364
Query: 301 SW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD Y
Sbjct: 365 SWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVY 424
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQEN 418
IRM ++I KG +VV + A++ VV+ A + + +R + EN R+ +E
Sbjct: 425 IRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKR---YRGENFRKGIEEE 481
Query: 419 EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ 478
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S Q
Sbjct: 482 -----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQ 536
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDW 538
G++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LDW
Sbjct: 537 GVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDW 596
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++E
Sbjct: 597 KKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSE 656
Query: 599 GNTNRVVGTY 608
+TNRVVGTY
Sbjct: 657 SSTNRVVGTY 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1403), Expect = e-154, Method: Compositional matrix adjust.
Identities = 297/621 (47%), Positives = 399/621 (64%), Gaps = 28/621 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN------------- 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLIND 484
Query: 411 ---SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 485 VVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 588 LVRTFGGDETEGNTNRVVGTY 608
+ R FG +ETE NT RVVGTY
Sbjct: 665 MARIFGREETEANTRRVVGTY 685
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 530 bits (1366), Expect = e-149, Method: Compositional matrix adjust.
Identities = 283/620 (45%), Positives = 403/620 (65%), Gaps = 34/620 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNI--VVWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N ++WS +S + P +V L D G
Sbjct: 68 IVWVANRDHPINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLG 127
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SFD+P+DT LP M+LG+ K GL+R +TSWKS DP GD I
Sbjct: 128 NLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLI 184
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ER+ P+++++KG ++R G W G R+S P + IF+ SFV+N+ E+ +T+ +
Sbjct: 185 LRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGV 244
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPV 252
T+ +VI+R ++N+T + R F W + W + VP++QCD Y CG G C S
Sbjct: 245 TDASVITRTMVNETGTMHR-FTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKT 303
Query: 253 --CQCLKGFKPKSGGY---VDRSQGCVRSKPLNY-SRQDGFIKFTELKLPDATSSWVSKS 306
C CL GF+PK + D S GC + K + S +DGF+K +K+PD + + V +
Sbjct: 304 FECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMN 363
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC++ CL+N SC+AY ++ + + G GC W G ++D R + GQDFYIR+
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKE 423
Query: 365 EI------GAKGEPTTKIVVI-VISTAALLAVVLIAGYLIRKRRRNIAEKTENSR----- 412
E+ G G+ +++I +I+ LL V+L ++R+RR++ ++ ++
Sbjct: 424 ELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFC--VVRERRKSNRHRSSSANFAPVP 481
Query: 413 ----ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+ + +D+ + ELPLF+L TI AT+NFS NKLG GGFGPVYKG L + EIA
Sbjct: 482 FDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIA 541
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSLD FIF
Sbjct: 542 VKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIF 601
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +R LDW +R I+ G ARG+LYLHQDSRLRIIHRDLKASN+LLD +M PKISDFG+
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661
Query: 589 VRTFGGDETEGNTNRVVGTY 608
R FGG++ EG T+RVVGT+
Sbjct: 662 ARIFGGNQMEGCTSRVVGTF 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 515 bits (1326), Expect = e-145, Method: Compositional matrix adjust.
Identities = 285/625 (45%), Positives = 406/625 (64%), Gaps = 39/625 (6%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIV--VWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N +WS + +Q P +V +L D G
Sbjct: 71 IVWVANRDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLG 130
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SF++P++TLLP MK G+ ++G++R +TSW+S DP G+
Sbjct: 131 NLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNIT 187
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ IER+ P+++M+KG ++RTG W G R+S P + IF+ SFV+N E+ T+ +
Sbjct: 188 YRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGV 247
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC--IIGQS 250
+ +V +R+V+N+T ++R F WN + W + P D+CD Y CG G C +
Sbjct: 248 LDASVTTRMVLNETGTLQR-FRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEK 306
Query: 251 PVCQCLKGFKPKSGG---YVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
C CL G++PK+ D S GC R K + ++GF K +K+P+ ++ V +
Sbjct: 307 FECSCLPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMN 366
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC + CL+N SC+AY ++ + + G GC W G ++D R + GQDFY+R+ S
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKS 426
Query: 365 EI------GAKGEPTTKIVVIVISTAALLAVVLIA--GYLIRKRRRNIAEKTENSRETD- 415
E+ GA G+ ++V+I+IS A++ ++LI+ YL ++R+R + + + +
Sbjct: 427 ELARWNGNGASGK--KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484
Query: 416 ------------QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
+E ED++ ELPLFEL+TIA AT+NF+ NKLG GGFGPVYKG L +
Sbjct: 485 PSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQN 544
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G EIAVKRLSK S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSL
Sbjct: 545 GMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSL 604
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
D FIF + +R LDW +R II G RG+LYLHQDSRLRIIHRDLKASNVLLD +M PKI
Sbjct: 605 DYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKI 664
Query: 584 SDFGLVRTFGGDETEGNTNRVVGTY 608
+DFGL R FGG++ EG+TNRVVGTY
Sbjct: 665 ADFGLARIFGGNQIEGSTNRVVGTY 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 286/613 (46%), Positives = 381/613 (62%), Gaps = 26/613 (4%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVL 77
VWVANR P+++ G L I+ NLV+ S+ VWS L+ V++ VV +LLD+GN VL
Sbjct: 83 VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141
Query: 78 RDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIE 137
R +S+ + WQSFD+P+DTLLP MKLG D K GL R VTSWKS DPS G F++ +E
Sbjct: 142 RGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLE 201
Query: 138 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELYYTFNITNKA 196
PE + + YR+GPW+GLRFS ++ ++F N E+ YTF +T+
Sbjct: 202 TLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHN 261
Query: 197 VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCL 256
SR+ +N T+ F+W Q W ++ +P+D CD YG+CG Y C + SP C C+
Sbjct: 262 SYSRLTIN-TVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCI 320
Query: 257 KGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKECR 313
KGF+P S D + C R L +D F + +K+P T++ V K + LKEC
Sbjct: 321 KGFQPLSPQDWASGDVTGRCRRKTQLTCG-EDRFFRLMNMKIPATTAAIVDKRIGLKECE 379
Query: 314 EGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEIGAKGEPT 373
E C + +C AY NSDIR GGSGC +W GE D+R++ GQD ++R++A+E G +
Sbjct: 380 EKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 374 TKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTE---NSRETDQENEDQN-------- 422
KI+ ++I + +L + I Y K+++ A T R+ QE N
Sbjct: 440 GKIIGLIIGISLMLVLSFII-YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGR 498
Query: 423 ------IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
DLELPL E T+ AT+NFS +N LG GGFG VYKG L+DGQEIAVKRLS++S
Sbjct: 499 RLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMS 558
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT-L 535
QG E KNEV L ++LQH NLV+LL CCI +EK+LIYE++ N SLDS +F+ T+ +
Sbjct: 559 SQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNK 618
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
L+W RF II G ARGLLYLHQDSR +IIHRDLKASNVLLD++M PKISDFG+ R F D
Sbjct: 619 LNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERD 678
Query: 596 ETEGNTNRVVGTY 608
ETE NT +VVGTY
Sbjct: 679 ETEANTRKVVGTY 691
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 496 bits (1278), Expect = e-139, Method: Compositional matrix adjust.
Identities = 272/627 (43%), Positives = 382/627 (60%), Gaps = 46/627 (7%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVV-LQLLD 71
P VVWVAN+ +PIND+ G + I + GNL +T N +VWS +S V +QL+D
Sbjct: 79 PIQTVVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMD 138
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
SGNL+L+D + W+SF +P D+ +P M LG D +TG ++TSW S DDPS G+
Sbjct: 139 SGNLMLQDNRNNGE--ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGN 196
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSF-VSNDVELYYTF 190
+ I PE+++WK + +R+GPWNG F + +F F +++D + +
Sbjct: 197 YTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISM 256
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N + + ++ + ++ W+ + ++W + P CD YG CG +G C G++
Sbjct: 257 SYANDSFMYHFNLDPEGIIYQK-DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGEN 315
Query: 251 PVCQCLKGFKPKS-----GGYVDRSQGCVRSKPLNYSRQ------------DGFIKFTEL 293
P C+C+KGF PK+ GG + S GC+R PL RQ DGF+K ++
Sbjct: 316 PPCKCVKGFVPKNNTEWNGG--NWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKM 373
Query: 294 KLP-DATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
K+P A S S+ + C + CL+N SC AY G GC +W G+L+DM+ F G
Sbjct: 374 KVPISAERSEASEQV----CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG 425
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G D +IR++ SE+ I VI + AV ++ RK ++ A + S
Sbjct: 426 SGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLA--CRKYKKRPAPAKDRSA 483
Query: 413 E----------TDQENEDQNIDL-ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 461
E +D E+ I L ELPLFE +A +TD+FS+ NKLG+GGFGPVYKG L
Sbjct: 484 ELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKL 543
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
+GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+GEE++L+YE+MP K
Sbjct: 544 PEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKK 603
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
SLD+++FD ++ +LDW RF+I+ G RGLLYLH+DSRL+IIHRDLKASN+LLD+++NP
Sbjct: 604 SLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNP 663
Query: 582 KISDFGLVRTFGGDETEGNTNRVVGTY 608
KISDFGL R F +E E NT RVVGTY
Sbjct: 664 KISDFGLARIFRANEDEANTRRVVGTY 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 617 | ||||||
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.967 | 0.728 | 0.641 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.962 | 0.724 | 0.642 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.967 | 0.714 | 0.620 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.902 | 0.708 | 0.615 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.901 | 0.708 | 0.613 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.962 | 0.704 | 0.611 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.965 | 0.725 | 0.579 | 0.0 | |
| 356514935 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.970 | 0.718 | 0.587 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.956 | 0.724 | 0.580 | 0.0 | |
| 356514913 | 829 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.717 | 0.563 | 0.0 |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/608 (64%), Positives = 468/608 (76%), Gaps = 11/608 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+++YR+GPWNG+ FS P LR NP+F F FV + E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQ+ Y R+R+ WN+ Q+W LY++VPRD CDTY LCGAYG CII
Sbjct: 242 YTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCII 301
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVC+CL+ F PKS +D SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 302 SQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 361
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CLEN SCMAYT ++I+ SGCA+WFG+LID+ P GQ+ YIRM+AS
Sbjct: 362 KTMNLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLIDITQLPAAGQEIYIRMNAS 420
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKT----ENSRETDQENED 420
E V I +S ++L+A Y+ +++ + I + T N E DQ +
Sbjct: 421 ESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKVTLTAFSNREENDQIDSG 480
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K S+ S QG+
Sbjct: 481 PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSRSSGQGI 540
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+
Sbjct: 541 NEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGELLDWSK 600
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGN
Sbjct: 601 RFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGN 660
Query: 601 TNRVVGTY 608
T RVVGTY
Sbjct: 661 TTRVVGTY 668
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/605 (64%), Positives = 469/605 (77%), Gaps = 11/605 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGN VL S +N VVWS+ K Q+ + +
Sbjct: 69 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQS-AMGE 127
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L DSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 128 LQDSGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 187
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NP+F F FV + E+Y
Sbjct: 188 SGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVY 247
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQT Y R+R+ WN+ Q+W LY+ VPRD CDTY LCGAYG CI+
Sbjct: 248 YTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIM 307
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVCQCL+ F P+S +D S+GCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 308 SQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 367
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CL+N SCMAYT ++I+ SGCA+WFG+LID+R F GQ+ YIR++AS
Sbjct: 368 KTMNLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLIDIRQFSAAGQEIYIRLNAS 426
Query: 365 EIGAKGEPTTKIVV-IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI 423
E AK K+ V +S ++L+A Y+ +++ ++I N E DQ +
Sbjct: 427 ESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGG---NREENDQIDSGPKE 483
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K LS+ S QGL E
Sbjct: 484 DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSRSSGQGLNEF 543
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+RF
Sbjct: 544 KNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGKLLDWSKRFS 603
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGNT R
Sbjct: 604 IICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGNTTR 663
Query: 604 VVGTY 608
VVGTY
Sbjct: 664 VVGTY 668
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/624 (62%), Positives = 476/624 (76%), Gaps = 27/624 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S +Y WQSFDYPSDT+LPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+V+WKGS K++R+GPWNG+ FS +LR NP+F F FV N E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTL-YVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
YT+N+ NK++I+R+VMNQT ++R+R+ WN+ +Q+WELY+ VPRD CD Y LCGAYG CI
Sbjct: 242 YTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCI 301
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
I QSPVC+CL+ F PKS ++ SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV
Sbjct: 302 ISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWV 361
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K+MNLKECR CL+N SCMAYT +DI+ SGCA+WFG+LID+R FP GGQ+ YIRM+A
Sbjct: 362 NKTMNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPDGGQEIYIRMNA 420
Query: 364 SEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRN------------------IA 405
SE + I +S ++L+A Y+ ++ + ++
Sbjct: 421 SESSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 406 EKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
EKT +RE DQ + D+ELPLF+ TIA AT+ FS+NNK+GEGGFGPVYKGTL DG
Sbjct: 481 EKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDG 540
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPN+SLD
Sbjct: 541 QEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLD 600
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
SFIFDQTR LLDWS+RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKIS
Sbjct: 601 SFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKIS 660
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY 608
DFGL R GGD+TEGNT RV+GTY
Sbjct: 661 DFGLARMVGGDQTEGNTTRVIGTY 684
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/603 (61%), Positives = 449/603 (74%), Gaps = 46/603 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS GFL I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G+LID+R FP GGQ+ YIRM
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRM---- 429
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
N +E E ++ DQ + +N DL
Sbjct: 430 -------------------------------------NPSESAEMDQQNDQITDGENEDL 452
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 453 ELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKN 512
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 513 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 572
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 573 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 632
Query: 606 GTY 608
GTY
Sbjct: 633 GTY 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/603 (61%), Positives = 448/603 (74%), Gaps = 47/603 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS G L I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+ YIRM+ SE
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPSE 433
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
+E ++ DQ + +N DL
Sbjct: 434 ------------------------------------------SEMDQQNDQITDGENEDL 451
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 452 ELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKN 511
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 512 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 571
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 572 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 631
Query: 606 GTY 608
GTY
Sbjct: 632 GTY 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/608 (61%), Positives = 453/608 (74%), Gaps = 14/608 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQ 68
K+ P +VWVANR NPINDS G L ++ ++VL S +N VVWS+ +K+ +P+ LQ
Sbjct: 65 KNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPI-LQ 123
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRD++DG S WQSFDYP DT+LPGMK+GWDL+ G + R++SWKS DDPS
Sbjct: 124 LLDSGNLVLRDKNDGRS-GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPS 182
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVELY 187
PGDF IER+ NPEVV WKGS+K YR+GPWNG+ FS + ++PNP+F F+FVSN++E+Y
Sbjct: 183 PGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVY 242
Query: 188 YTFNITNKA-VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y FN+ +++ VI+R+V+N T R+ + WN+ TQ+W L VPRD CD YGLCGA CI
Sbjct: 243 YIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCI 302
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
PVCQCL+ FKPKS +D SQGCVR+K L+ + DGFIKF LKLPDAT SWV
Sbjct: 303 FNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWV 362
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K MNLKEC+ CL N SCMAY+N DIRGGGSGCA WFG+L+D+R PGGGQ+ YIRM A
Sbjct: 363 NKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPGGGQELYIRMHA 422
Query: 364 SEIGAK-GEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAE-----KTENSRETDQE 417
SEIG + + KI I + L+ L Y + K + AE +TEN + D
Sbjct: 423 SEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSERTENDWKNDTN 482
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
N Q D+ELPLF + IA+AT+NFS+NNKLGEGGFGPVY+G L DG EIAVKRLS+ S
Sbjct: 483 NGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIAVKRLSRCSG 542
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG E KNEVIL +KLQHRNLVKLLGCC Q EEK+LIYE+MPN+SLD FIFD+T+ LLD
Sbjct: 543 QGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIFDETKGRLLD 602
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
WS+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGL R F D+T
Sbjct: 603 WSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGLARMFVADQT 662
Query: 598 EGNTNRVV 605
EG+T+RV
Sbjct: 663 EGDTSRVT 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/606 (57%), Positives = 436/606 (71%), Gaps = 10/606 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPI D+ L IN GN +L +Q+N V+WS + + VV Q
Sbjct: 67 KNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKASL-VVAQ 125
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D + E Y WQSFDYPSDT LPGMK GWDLK GL R +T+WK++DDPS
Sbjct: 126 LLDSGNLVLRDEKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAWKNWDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
GDF R + PE VMWKG+ ++YR+GPW+G +FS +PS+ N I ++S VSN E Y
Sbjct: 186 SGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVVSNKDEFY 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
T+++ +K++ISR+V+NQTLYVR+R WN+ +Q+W + S++P D CD Y CGA+GIC+
Sbjct: 246 ATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCGAFGICVA 305
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLN--YSRQDGFIKFTELKLPDATSSW 302
GQ+PVC CL GFKPKS ++ +QGCV ++ + +DGF KF+ LK PD SW
Sbjct: 306 GQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKAPDTERSW 365
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
V+ SM L EC+ C EN SC AY N D+RG GSGCA+WFG+L+D+R P GQD YIR++
Sbjct: 366 VNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRLIPNAGQDLYIRLA 425
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE K + K+VVI ++++A +LI ++ +NI E + NE Q
Sbjct: 426 VSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKEIILGIEV--KNNESQQ 483
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D ELPLF+L +IA ATD+FS +NKLGEGGFGPVYKGTL DG E+AVKRLS+ S QGLKE
Sbjct: 484 EDFELPLFDLVSIAQATDHFSDHNKLGEGGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKE 543
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV+L +KLQHRNLVK+LGCCIQ EKLLIYE+M NKSLD F+FD R LLDW +RF
Sbjct: 544 FKNEVMLCAKLQHRNLVKVLGCCIQENEKLLIYEYMANKSLDVFLFDSDRSKLLDWPKRF 603
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+II ARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGL R GGD+ EG T
Sbjct: 604 YIINRIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGKTR 663
Query: 603 RVVGTY 608
RVVGTY
Sbjct: 664 RVVGTY 669
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514935|ref|XP_003526157.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/614 (58%), Positives = 446/614 (72%), Gaps = 15/614 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P VVWVANR NPINDS G L +N TGN VL ++V ++ K+ Q PV + L
Sbjct: 84 KNIPIQTVVWVANRENPINDSSGILTLNNTGNFVLAQNESLVWYTNNSHKQAQNPVAV-L 142
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLV+R++ + + E Y WQSFDYPSDTLLPGMKLGWDL+TGL+RR+T+WKS DDPSP
Sbjct: 143 LDSGNLVIRNDGETNPEAYLWQSFDYPSDTLLPGMKLGWDLRTGLDRRLTAWKSPDDPSP 202
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYY 188
GD +E PE + KG++K YR GPWNGL FS P LR N IF F+F SN E YY
Sbjct: 203 GDVYRDLELYSYPEFYIMKGTKKVYRFGPWNGLYFSGVPDLRNNTIFGFNFFSNKEESYY 262
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
F+ TN V+SRIVMN++ + R ++W + Q+W +Y+ +P+D CDTYGLCG YG C+
Sbjct: 263 IFSPTND-VMSRIVMNESTTIYR-YVWVEDDQNWRIYTSLPKDFCDTYGLCGVYGNCMTT 320
Query: 249 QSPVCQCLKGFKPKS-GGYVDR--SQGCVRSKPLNYSRQ--DGFIKFTELKLPDATSSWV 303
Q+ VCQCLKGF PKS +V SQGCVR+KPL+ + DGF+K+ LK+PD +W+
Sbjct: 321 QTQVCQCLKGFSPKSPEAWVSSGWSQGCVRNKPLSCKDKLTDGFVKYEGLKVPDTRHTWL 380
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+S+ L+EC+ CL N SCMAYTNSDIRG GSGC MWFG+LID++ GQD YIRM A
Sbjct: 381 DESIGLEECKVKCLNNCSCMAYTNSDIRGAGSGCVMWFGDLIDIKQLQTAGQDLYIRMPA 440
Query: 364 SEIGAKGEPTTKIVVIVISTAAL-LAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE+ + K I ST A V+L++ Y I + RRN A K+ T+ ++E
Sbjct: 441 SELESVYRHKKKTTTIAASTTAAICGVLLLSSYFICRIRRNNAGKSL----TEYDSEKDM 496
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
DL++ LF+L TI AT++FS+ NK+GEGGFGPVYKG LVDGQEIAVK LS+ S QG+ E
Sbjct: 497 DDLDIQLFDLPTITTATNDFSMENKIGEGGFGPVYKGILVDGQEIAVKTLSRSSWQGVTE 556
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
NEV L +KLQHRNLVKLLGCCIQG+EK+LIYE+M N SLDSFIFD +R LL W Q+F
Sbjct: 557 FINEVKLIAKLQHRNLVKLLGCCIQGQEKMLIYEYMANGSLDSFIFDDKKRKLLKWPQQF 616
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
HIICG ARGL+YLHQDSRLRIIHRDLKASNVLLD++ +PKISDFG+ RTFGGD+ EGNT+
Sbjct: 617 HIICGIARGLMYLHQDSRLRIIHRDLKASNVLLDENSSPKISDFGMARTFGGDQFEGNTS 676
Query: 603 RVVGTYCGTKAFLY 616
RVVGT CG A Y
Sbjct: 677 RVVGT-CGYMAPEY 689
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/605 (58%), Positives = 439/605 (72%), Gaps = 15/605 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL+FSA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQFSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGTY 608
VVGTY
Sbjct: 659 VVGTY 663
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514913|ref|XP_003526146.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/618 (56%), Positives = 445/618 (72%), Gaps = 23/618 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P VVWVANR P+ D+ L+I GNLVL +++N V WS + + P+ LQL
Sbjct: 65 KNIPVKTVVWVANRDYPLKDNSTKLIITNDGNLVLLTKNNKVQWSTNTTTKASRPI-LQL 123
Query: 70 LDSGNLVLRDEHDGD-----------SETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRV 118
L++GNLVLR++++ + + + WQSFDYPSDTLLPGMKLGW KTGL RRV
Sbjct: 124 LNTGNLVLRNDNEDNKNNNKSSNNNNEDRFLWQSFDYPSDTLLPGMKLGWYRKTGLNRRV 183
Query: 119 TSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-----SLRPNP 173
+WK++DDPSPG+F W I NPE+V+WKGS K++R+GPWNG+RFS L +P
Sbjct: 184 IAWKNWDDPSPGNFSWGITFDSNPEMVLWKGSFKYHRSGPWNGIRFSGAFGGSNRLSTHP 243
Query: 174 IFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQC 233
+F + ++ND E+YY++++TNK+VIS +VMNQTL R+R IW +W L+ PRD C
Sbjct: 244 LFVYKLINNDDEVYYSYSLTNKSVISIVVMNQTLLRRQRNIWIPENGTWRLFQTAPRDIC 303
Query: 234 DTYGLCGAYGICIIGQSPVCQCLKGFKPKSGGYVDRSQGCVRSKP--LNYSRQDGFIKFT 291
DTY CG+Y C++ SPVCQCL+GFKPKS ++ QGCVRS+P +DGF KF
Sbjct: 304 DTYNPCGSYANCMVDSSPVCQCLEGFKPKSLDTME--QGCVRSEPWSCKVEGRDGFRKFV 361
Query: 292 ELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFP 351
LK PD T SW++KSM L+EC+ C EN SC AY N DIRG GSGC++WFG+LID++
Sbjct: 362 GLKFPDTTHSWINKSMTLEECKVKCWENCSCTAYANLDIRGAGSGCSIWFGDLIDLKVVS 421
Query: 352 GGGQDFYIRMSASEIGAKGEPTTK-IVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTEN 410
GQ YIRM+ S+ AK K +++I ++ V+L+A + KR+R E+ +
Sbjct: 422 QSGQYLYIRMADSQTDAKDAHKKKELLLIGTIVPPIVLVILLAIFYSYKRKRKYEEENVS 481
Query: 411 SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+ D E Q +ELPLF+LAT+ NAT+NFS +NKLG+GGFGPVYKG L GQEIAVK
Sbjct: 482 VVKKD-EAGGQEHSMELPLFDLATLVNATNNFSTDNKLGQGGFGPVYKGVLAGGQEIAVK 540
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLS+ S QGL E KNEVIL +KLQHRNLVK+LGCCI+ EEK+L+YE+MPNKSLDSF+FD
Sbjct: 541 RLSRSSGQGLTEFKNEVILCAKLQHRNLVKVLGCCIEEEEKMLLYEYMPNKSLDSFLFDS 600
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
T+ +LDWS+RFHI+C TARGLLYLHQDSRLRIIHRDLKASN+LLD ++NPKISDFGL R
Sbjct: 601 TKSKILDWSKRFHILCATARGLLYLHQDSRLRIIHRDLKASNILLDNNLNPKISDFGLAR 660
Query: 591 TFGGDETEGNTNRVVGTY 608
GGD+ EGNTNRVVGTY
Sbjct: 661 MCGGDQIEGNTNRVVGTY 678
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 617 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.560 | 0.441 | 0.452 | 1.1e-159 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.938 | 0.710 | 0.504 | 4.5e-153 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.643 | 0.468 | 0.407 | 2.5e-149 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.640 | 0.468 | 0.405 | 2.2e-148 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.296 | 0.215 | 0.704 | 2.3e-129 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.948 | 0.704 | 0.436 | 5.7e-123 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.930 | 0.713 | 0.436 | 1.8e-119 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.936 | 0.714 | 0.423 | 2.6e-118 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.931 | 0.714 | 0.422 | 1.1e-117 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.936 | 0.710 | 0.417 | 2.3e-117 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 1.1e-159, Sum P(2) = 1.1e-159
Identities = 163/360 (45%), Positives = 236/360 (65%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGFKPKSG-GYV--DRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF K+ +V D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1493 (530.6 bits), Expect = 4.5e-153, P = 4.5e-153
Identities = 308/611 (50%), Positives = 411/611 (67%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAY-----LSKEVQTPVVLQ 68
P VVWVANR NP+ + GFL ++ G+L L + +WS+ SK P+ L+
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPL-LK 130
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
+ SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPS
Sbjct: 131 ISCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186
Query: 129 PGDFIWAIERQDNPEVVMWK-GSRKF-YRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDV 184
PGDF +++ + P++++ K G + YR G WNGL F+ AP++ R N +F + F S+
Sbjct: 187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246
Query: 185 ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGI 244
E+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +
Sbjct: 247 EVNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAV 303
Query: 245 CIIGQ--SPVCQCLKGFKPKSGGY--VDR-SQGCVRSKPLNYSRQDGFIKFTELKLPDAT 299
C I +P C CL+GFKPKSG + R + GCV P N ++D F+KF LKLPD +
Sbjct: 304 CGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTS 363
Query: 300 SSW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDF 357
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD
Sbjct: 364 WSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDV 423
Query: 358 YIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQE 417
YIRM ++I KG ++V +V+ + +AVVL+ + +++ + EN R+ +E
Sbjct: 424 YIRMGFAKIEFKGR---EVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEE 480
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S
Sbjct: 481 E-----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSG 535
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LD
Sbjct: 536 QGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELD 595
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
W +R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++
Sbjct: 596 WKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQS 655
Query: 598 EGNTNRVVGTY 608
E +TNRVVGTY
Sbjct: 656 ESSTNRVVGTY 666
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 2.5e-149, Sum P(2) = 2.5e-149
Identities = 165/405 (40%), Positives = 240/405 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKT 408
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQT 473
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 2.2e-148, Sum P(2) = 2.2e-148
Identities = 165/407 (40%), Positives = 244/407 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPN 471
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 683 (245.5 bits), Expect = 2.3e-129, Sum P(2) = 2.3e-129
Identities = 129/183 (70%), Positives = 152/183 (83%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP+F L IA AT++F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSLD F+FD+T++ L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+ R FGG++ E NT RVV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 606 GTY 608
GTY
Sbjct: 693 GTY 695
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
Identities = 272/623 (43%), Positives = 373/623 (59%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL-QLLD 71
P VVWVAN +PINDS G + I+K GNLV+ V WS + V +LL+
Sbjct: 67 PVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLN 126
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLVL + E W+SF++P + LP M L D KTG ++ SWKS DPSPG
Sbjct: 127 TGNLVLLGTTNTGDEI-LWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGR 185
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRF-SAPSL--RPNPIFSFSFVSNDVELYY 188
+ + PE+V+WK +R+GPWNG F P++ R N +F + +S+D
Sbjct: 186 YSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELT-LSSDNRGSV 243
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII- 247
+ + ++ +++ V +R WN A Q W+ + VP +CDTY CG + C
Sbjct: 244 SMSYAGNTLLYHFLLDSEGSVFQRD-WNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFN 302
Query: 248 -GQSPVCQCLKGFKPKSGGYVDR---SQGCVRSKPLNY--------SRQ-DGFIKFTELK 294
G +P C C++GFKP+S + +QGCVR PL SR+ DGF++ ++K
Sbjct: 303 PGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMK 362
Query: 295 LPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354
+P N ++C E CL+N SC AY+ G GC +W G L+DM++F G G
Sbjct: 363 VPHNPQR---SGANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTG 415
Query: 355 QDFYIRMSASEIGAKGEPTTKIVVIVISTAALLA-VVLIAGYLIRKRR-RNIAEKTENSR 412
FYIR++ SE + + I V ++ A L A V++A + I K R +N + N R
Sbjct: 416 VVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNER 475
Query: 413 ETDQENEDQNIDL-------ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ D L ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G
Sbjct: 476 MEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGL 535
Query: 466 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
+IAVKRLS+ S QG++E NEV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD+
Sbjct: 536 DIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDA 595
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
++FD ++ LLDW RF+II G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 596 YLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISD 655
Query: 586 FGLVRTFGGDETEGNTNRVVGTY 608
FGL R F G+E E +T RVVGTY
Sbjct: 656 FGLARIFQGNEDEVSTVRVVGTY 678
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1176 (419.0 bits), Expect = 1.8e-119, P = 1.8e-119
Identities = 265/607 (43%), Positives = 369/607 (60%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
P VVWVANR P+ DS +L I+ +G+L+L + + VWS+ ++ + +L DSG
Sbjct: 70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFS-SSGCRAELSDSG 128
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NL + D SE WQSFD+ DTLL L ++L T +R +TSWKS+ DPSPGDF+
Sbjct: 129 NLKVIDNV---SERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFL 185
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL--YYTF 190
I Q + + +GS ++R+GPW RF+ P + + F+ + DV Y T+
Sbjct: 186 GQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFT-LHQDVNGSGYLTY 244
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+SRI + ++ ++ WELY + P+ CD YG CG +G+C++ S
Sbjct: 245 -FQRDYKLSRITLTSEGSIK---MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPS 300
Query: 251 PVCQCLKGFKPKSGGYVDRSQ---GCVRSKPL----NYSRQDG--FIKFTELKLPDATSS 301
P+C+C +GF PKS R GCVR L N + +D F + +K PD
Sbjct: 301 PMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE- 359
Query: 302 WVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRM 361
+ S+N +EC + C+ N SC+A+ I+G GC +W +L+D F G+ IR+
Sbjct: 360 -FASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLVWNQDLMDAVQFSATGELLSIRL 414
Query: 362 SASEI-GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENED 420
+ SE+ G K + T IV ++S + + A + R R +IA ++++ + D + +D
Sbjct: 415 ARSELDGNKRKKT--IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQD 472
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
L F++ TI NAT+NFS++NKLG+GGFG VYKG L DG+EIAVKRLS S QG
Sbjct: 473 VP---GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGK 529
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+E NE++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSLD+F+FD +R +DW +
Sbjct: 530 EEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPK 589
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF II G ARGLLYLH DSRLR+IHRDLK SN+LLD+ MNPKISDFGL R + G E + N
Sbjct: 590 RFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 649
Query: 601 TNRVVGT 607
T RVVGT
Sbjct: 650 TRRVVGT 656
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
Identities = 261/617 (42%), Positives = 365/617 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K P VVWVANR P+ DS L I+ G+L+L ++++ VVWS +L
Sbjct: 65 KGIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIG-ETFASNGSRAEL 123
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
D+GNLV+ D + G + W+SF++ DT+LP L ++L TG +R +TSWKS DPSP
Sbjct: 124 TDNGNLVVIDNNSGRT---LWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSP 180
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYY 188
GDF I Q + +GS+ ++R+GPW RF+ P + FS + D
Sbjct: 181 GDFTVQITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFS-LQQDTNGSG 239
Query: 189 TFNITNKAV-ISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
+F + +S I++ ++ I+ WEL + P + CD YG CG +GIC++
Sbjct: 240 SFTYFERNFKLSYIMITSEGSLK---IFQHNGMDWELNFEAPENSCDIYGFCGPFGICVM 296
Query: 248 GQSPVCQCLKGFKPKS------GGYVDRSQGCVRSKPL------NYSRQDGFIKFTELKL 295
P C+C KGF PKS G + D GCVR L N +GF +K
Sbjct: 297 SVPPKCKCFKGFVPKSIEEWKRGNWTD---GCVRHTELHCQGNTNGKTVNGFYHVANIKP 353
Query: 296 PDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQ 355
PD + ++ + C + CL N SC+A+ + G GC MW +L+D F GG+
Sbjct: 354 PDFYE--FASFVDAEGCYQICLHNCSCLAFAYIN----GIGCLMWNQDLMDAVQFSAGGE 407
Query: 356 DFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGY-LIR-KRRRNIAEKTEN--S 411
IR+++SE+G G KI+V I + +L ++ A + +R K + ++ K S
Sbjct: 408 ILSIRLASSELG--GNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIAS 465
Query: 412 RET-DQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+E + + E Q++ L FE+ TI ATDNFS++NKLG+GGFG VYKG L DG+EIAVK
Sbjct: 466 KEAWNNDLEPQDVS-GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 524
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLS S QG +E NE++L SKLQH+NLV++LGCCI+GEE+LL+YEF+ NKSLD+F+FD
Sbjct: 525 RLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDS 584
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+R +DW +RF+II G ARGL YLH+DS LR+IHRDLK SN+LLD+ MNPKISDFGL R
Sbjct: 585 RKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLAR 644
Query: 591 TFGGDETEGNTNRVVGT 607
+ G E + NT RV GT
Sbjct: 645 MYQGTEYQDNTRRVAGT 661
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 260/615 (42%), Positives = 358/615 (58%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K P VVWVANR P+ S L I+ G+L+L V+WS A+ S +
Sbjct: 62 KKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHA--- 118
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LLD+GN V+ D+ G+ WQSF++ +T+LP L +D G +R +T+WKS D
Sbjct: 119 -ELLDTGNFVVIDDVSGNK---LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSD 174
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVE 185
PSPG+F I Q + ++ +GS ++R GPW RFS S + + + FS V +
Sbjct: 175 PSPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAA 234
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+F+ + + + T + + +W+ +W+L+ +P + CD YG CG YG+C
Sbjct: 235 GTGSFSYSTLRNYNLSYVTLTPEGKMKILWDDGN-NWKLHLSLPENPCDLYGRCGPYGLC 293
Query: 246 IIGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQ----------DGFIKFTE 292
+ P C+CLKGF PKS G + + GCVR L+ + D F + T+
Sbjct: 294 VRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTD 353
Query: 293 LKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
+K PD + +N ++C +GCL N SC A+ G GC +W GEL D F
Sbjct: 354 VKTPDLHQ--FASFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFLS 407
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G+ +IR+++SE+ G KI+V + ++ +++ A ++ + R + +N
Sbjct: 408 SGEFLFIRLASSELA--GSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGF 465
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
E Q+ N FE+ TI AT+NFS +NKLG+GGFGPVYKG LVDG+EI VKRL
Sbjct: 466 ER-QDVSGVNF------FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRL 518
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEFM NKSLD FIFD
Sbjct: 519 ASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCL 578
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LDW +RF+II G ARGLLYLH+DSRLR+IHRDLK SN+LLD MNPKISDFGL R F
Sbjct: 579 KFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMF 638
Query: 593 GGDETEGNTNRVVGT 607
G + + NT RVVGT
Sbjct: 639 QGTQYQDNTRRVVGT 653
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 259/621 (41%), Positives = 369/621 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K+ P VVWVANR P+ ++ L IN G+L+L + VVWS + S E++
Sbjct: 66 KNITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNELRA--- 122
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LL++GNLVL D G SE W+SF++ DT+L + +D+ +R ++SWK+ D
Sbjct: 123 -ELLENGNLVLID---GVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTD 178
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDV- 184
PSPG+F+ + Q P+ + +GSR ++R GPW +RF+ P + + + F +S DV
Sbjct: 179 PSPGEFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFD-ISQDVA 237
Query: 185 ----ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCG 240
L Y+ N +S + ++ IWN + W + P CD Y CG
Sbjct: 238 AGTGSLTYSLERRNSN-LSYTTLTSAGSLK--IIWNNGS-GWVTDLEAPVSSCDVYNTCG 293
Query: 241 AYGICIIGQSPVCQCLKGFKPKSGGYVDRSQ---GCVR----SKPLNYSRQ------DGF 287
+G+CI P C+CLKGF PKS ++ GC+R S +N S D F
Sbjct: 294 PFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIF 353
Query: 288 IKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347
+K PD ++S +N ++C++ CL N SC A++ + GC +W EL+D+
Sbjct: 354 DIVANVKPPDFYE-YLSL-INEEDCQQRCLGNCSCTAFSYIE----QIGCLVWNRELVDV 407
Query: 348 RDFPGGGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEK 407
F GG+ IR+++SE+ G KI+V I + ++ +++ A Y + + +
Sbjct: 408 MQFVAGGETLSIRLASSELA--GSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDS 465
Query: 408 TENSRETDQEN-EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
ET Q+ +Q ++ F++ TI T+NFS+ NKLG+GGFGPVYKG L DG+E
Sbjct: 466 NPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKE 525
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF 526
IA+KRLS S QGL+E NE+IL SKLQHRNLV+LLGCCI+GEEKLLIYEFM NKSL++F
Sbjct: 526 IAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTF 585
Query: 527 IFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586
IFD T++ LDW +RF II G A GLLYLH+DS LR++HRD+K SN+LLD++MNPKISDF
Sbjct: 586 IFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDF 645
Query: 587 GLVRTFGGDETEGNTNRVVGT 607
GL R F G + + NT RVVGT
Sbjct: 646 GLARMFQGTQHQANTRRVVGT 666
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000369 | hypothetical protein (820 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 617 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 8e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-18 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 62/160 (38%), Positives = 83/160 (51%), Gaps = 11/160 (6%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E ++ E+M L S++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ +++ KISDFGL R D+
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-41
Identities = 47/111 (42%), Positives = 71/111 (63%), Gaps = 2/111 (1%)
Query: 154 YRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRR 212
+R+GPWNG+RFS P ++ + ++F N+ E+YYT+ +TN ++ SR+ ++ + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER- 59
Query: 213 FIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263
F W +Q W L+ P+DQCD YG CG YG C + SP C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 8e-41
Identities = 62/154 (40%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKGTL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E +++ E+MP L ++ R L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N L+ +++ KISDFGL R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 57/156 (36%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 446 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500
KLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L + +HRDL A N L+ +D+ KISDFGL R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 59/162 (36%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 495
+ KLGEG FG VYKGTL ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+LLG C QGE ++ E+MP L F+ + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
+HRDL A N L+ +++ KISDFGL R D+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY 157
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 5e-37
Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 14/171 (8%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 566 RDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
RDLK N+LLD D K++DFGL + D++ T GT A++
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK------TIVGTPAYM 160
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+L+ + L+ E+ L ++ +R L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
IIHRDLK N+LLD++ KI+DFGL + ++ + T+ GT ++
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK------SSSSLTTFVGTPWYM 165
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 57/112 (50%), Positives = 70/112 (62%), Gaps = 6/112 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANRLNP+ DS L++ GNLVL + VVWS+ + + V L D GNLV
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSS-NTSGKGSGCVAVLQDDGNLV 62
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L D +S WQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 63 LYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L ++ L+ E+ L + + R + D ++ + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEAR--FYLRQILSALEYLHS-- 115
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
I+HRDLK N+LLD+D + K++DFGL R + + T+ GT ++
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL-------DPGEKLTTFVGTPEYM 163
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 29/181 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LG G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 498 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICGTAR 550
+V+ G E+ L I+ E++ SL S + ++F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL YLH I+HRD+K +N+L+D D K++DFG + G ET T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 607 T 607
T
Sbjct: 166 T 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/167 (35%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I K+G+GGFG VYK G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G ++ +E ++ EF SL + T +T L SQ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQT-LTESQIAYVCKELLKGLEYLHS--- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRD+KA+N+LL D K+ DFGL N +VGT
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 31/180 (17%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 497
N+ + + +G G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 498 LVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFH------IICGTA- 549
+VK +G I+ + L I E+ N SL I ++F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 550 --RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+GL YLH+ +IHRD+KA+N+L +D K++DFG+ + + VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 19/190 (10%)
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE 482
+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
+ NE+++ +H N+V + G+E ++ E+M SL I Q + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE----P 116
Query: 543 HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
I +C +GL YLH +IHRD+K+ N+LL +D + K++DFG F T+
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKE 169
Query: 600 NTNR--VVGT 607
+ R VVGT
Sbjct: 170 KSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 8e-24
Identities = 35/65 (53%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 283 RQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342
DGF++ +KLPD T++ V +S+ LKEC + CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 343 ELIDM 347
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/157 (34%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 446 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 499
+LGEG FG V L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 500 KLLGCC--IQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
K G C G LI E++P+ SL ++ + LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
YL R IHRDL A N+L++ + KISDFGL +
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I KLGEG +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G + + ++ E+ S+ S I T +TL + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTL-TEEEIAAILYQTLKGLEYLHS--- 117
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA N+LL+++ K++DFG+ T N V+GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 4/149 (2%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C GE +I E M SL +F+ + L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N+L+ +D+ K++DFGL R
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (251), Expect = 4e-23
Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 496
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKL L+ E++ SL+ + R+ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
IIHRD+K N+LLD+D K+ DFGL + + + + T GT ++
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 494
D+F +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++KL Q EE L + E+ PN L +I + LD L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-------- 605
YLH IIHRDLK N+LLD+DM+ KI+DFG + + + +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 606 ------GTYCGTKAFL 615
++ GT ++
Sbjct: 174 KNRRRFASFVGTAEYV 189
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 494
+ ++GEG +G VYK G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L + +++E+M + L + + SQ + GL
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLH + I+HRD+K SN+L++ D K++DFGL R + + TNRV+
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 1e-22
Identities = 59/158 (37%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 496
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL I E KL L++E+ + L ++ R L + I+ RGL Y
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
H RI+HRDLK N+L+++D K++DFGL R FG
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----TLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ + LI + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
R++HRDL A NVL+ + KI+DFGL + DE E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 57/172 (33%), Positives = 79/172 (45%), Gaps = 24/172 (13%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 500
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 501 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L Q EEKL L+ E+ P L S + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L II+RDLK N+LLD D + K++DFGL + + T+CGT
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL------SSEGSRTNTFCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 448 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIICG 547
LLG C + + +++E++ + L F+ D+T ++ LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +HRDL A N L+ + + KISDFGL R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+ I ++G+G FG VY DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-------TLLDWSQRFHIICGTAR 550
++K + + ++ E+ L I Q + +LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L YLH SR +I+HRD+K N+ L + K+ DFG+ + T VVGT
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-22
Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 278 PLNYSR---QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGG 334
PLN DGF+K ++KLPD ++ +++L+ECRE CL N SC AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 335 SGCAMWFGELIDMRDFPGGGQDFYIR 360
GC +W G L ++R GG Y+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL--LDWSQRFHIICGTA 549
G C +G+ ++++E+M + L+ F + L SQ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G++YL + +HRDL N L+ D+ KI DFG+ R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
+ LG+G G VYK G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-----RG 551
+VK G + E ++ E+M SL + + + + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L YLH IIHRD+K SN+L++ KI+DFG+ + + T N VGT
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 17/156 (10%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 499
K+GEG +G VYK + G+ +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KLL + L++EFM + L I + R+ L S + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
I+HRDLK N+L++ + K++DFGL R+FG
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C + E ++ E+M SL F+ + L Q + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N+L+ +++ KI+DFGL R DE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + ++I E+M N SLD F+ + Q ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
L S + +HRDL A N+L++ ++ K+SDFGL R E T
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 52/146 (35%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C+Q + ++ E +P SL +F+ + ++ L + + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRDL A N L+ ++ KISDFG+ R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 49/144 (34%), Positives = 78/144 (54%), Gaps = 8/144 (5%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G GQ++AVK L K + E + + L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 508 GEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
G ++ E+M SL ++ ++R R ++ +Q+ G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVR 590
DL A NVL+ +D+ K+SDFGL +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 446 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFG+ R G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 61/162 (37%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 448 LGEGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 497
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLL 553
+VKLLG C+ E + +I E M L S++ D LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 554 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVR 590
YL Q + IHRDL A N L+ D D KI DFGL R
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 57/153 (37%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+Q LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D K++DFGL R FG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 442 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 495
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHI 544
N++KL+G C + ++I FM + L SF+ + L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
A G+ YL S IHRDL A N +L +DM ++DFGL + + GD
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLLY 554
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH +I+HRD+K+ N+ LD N KI D G+ + + NT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 447 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+LGEG FG V+ L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL---LDWSQRFHIICGT 548
G C +G L+++E+M + L+ F I L Q I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + L +HRDL N L+ Q + KI DFG+ R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 20/165 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP+ L ++ + + LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
R++HRDL A NVL+ + KI+DFGL R GDE E N +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 36/159 (22%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 502 LGCCIQGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGTA 549
LG + E+ L I+ E +P SL + I TR+ LL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
GL YLH +HRD+K +N+L+D + K++DFG+
Sbjct: 114 -GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 441 NFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQ 494
N + +LGEG FG V+ L Q+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHI 544
H ++VK G C++G+ ++++E+M + L+ F+ + R L SQ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + +HRDL N L+ +++ KI DFG+ R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 5e-18
Identities = 39/80 (48%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP + S L + GNLV+ S VVWS+ + V VL LLD GNLV
Sbjct: 43 VVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS-NTTRVNGNYVLVLLDDGNLV 100
Query: 77 LRDEHDGDSETYFWQSFDYP 96
L D + WQSFDYP
Sbjct: 101 LYD----SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG V+ G ++ +++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L G C + L++EFM + L ++ + +R + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +IHRDL A N L+ ++ K+SDFG+ R
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 5/155 (3%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E M SL ++ R L Q + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
DL A NVL+ ++ K++DFGL R D E
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 447 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIIC 546
LLG + + +I+ + + L F+ D+T ++ L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ +L S ++H+DL NVL+ +N KISD GL R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 9/175 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
D++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VK + G+E L+ ++ SL + R LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYC 609
+ + IHRD+KA N+LL +D + KI+DFG+ + GGD T VGT C
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 499
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L++EFM L+ I D + +L + + T RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
I+HRDLK +N+L+ D K++DFGL R+FG
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 8/156 (5%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 498
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V+L I E KL L++E+M +K L ++ R LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ R++HRDLK N+L+++ K++DFGL R FG
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 25/185 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-Q 494
+ T F + +GEG +G VYK GQ +A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 495 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------ 542
H N+ G I+ +++L L+ E S+ + + L +R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG+ D T G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
Query: 603 RVVGT 607
+GT
Sbjct: 172 TFIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 59/156 (37%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 448 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 498
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 499 VKLLGCCIQGEEK--LLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLY 554
VK GCC + K LI E++P SL ++ LL ++Q+ IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
LH IHRDL A NVLLD D KI DFGL +
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 37/79 (46%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP++DS L + GNLVL VVWS+ + VL LLD GNLV
Sbjct: 42 VVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS-NTTGANGNYVLVLLDDGNLV 99
Query: 77 LRDEHDGDSETYFWQSFDY 95
+ D + WQSFDY
Sbjct: 100 IYD----SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 498
+++ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 499 VKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V G +KL I E+ SL I+ TR L + Q ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
IHRD+K +N+LL +D + K++DFG
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 30/182 (16%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 500
+G+G FG V++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF----------------HI 544
LLG C G+ L++E+M L+ F+ ++ R S
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 545 IC---GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGN 600
+C A G+ YL S + +HRDL N L+ ++M KI+DFGL R + D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 601 TN 602
N
Sbjct: 190 EN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 48/157 (30%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 447 KLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 501
KLG+G FG V +G +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLH 556
G + + + E P SL + TL D++ + A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R IHRDL A N+LL D KI DFGL+R
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C + +I EFM +L ++ + R ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
IHRDL A N L+ ++ K++DFGL R GD
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 493
+ I ++GEG G V+K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR--FHIICGTARG 551
QH +VKLL G +L+ E+MP+ L + D+ R L + + ++ +G
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDE-ERPLPEAQVKSYMRMLL---KG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ Y+H I+HRDLK +N+L+ D KI+DFGL R F +E +++V
Sbjct: 112 VAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 52/149 (34%), Positives = 84/149 (56%), Gaps = 11/149 (7%)
Query: 448 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 502
+G+G FG VY GTL+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
G C+ E L++ +M + L +FI +T + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +HRDL A N +LD+ K++DFGL R
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 10/157 (6%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+VKLL I E KL L++EF+ ++ L F+ D + + + + +GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L++ + K++DFGL R FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
Q + ++ E +P SF+ + ++ L Q A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 567 DLKASNVLLDQDMNPKISDFGLVR 590
DL A N L+ ++ KISDFG+ R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G VYK + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRF-HIICGTARGLLYLHQDS 559
+ L++EF+ K +DS L+ + + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D++ K++DFGL R FG
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 24/172 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D ++ LGEG FG V K V +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ + +L F+ D R +Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + ARG+ +L + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 20/150 (13%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQR---FHIICGTARGLLYLHQ 557
GC ++ +E L I+ E+MP S+ + + L + R I+ G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ I+HRD+K +N+L D N K+ DFG
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/153 (35%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK G A K + SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V L E KL I EF +LDS I + R L Q ++ L +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGL-TEPQIRYVCRQMLEALNF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
LH ++IHRDLKA N+LL D + K++DFG
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/156 (34%), Positives = 80/156 (51%), Gaps = 24/156 (15%)
Query: 448 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 503 GCCIQ-GEEKL-LIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
G C G L L+ E++P SL ++ D R+ LL SQ IC +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQ----IC---KGMEY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L R +HRDL N+L++ + KI DFGL +
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 490
NF I K+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTA 549
+L H N++K L I+ E ++ E L I + ++ L+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L ++H RI+HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 27/186 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 490
++ I KLGEG FG VYK + G+ +A+K++ +E+ L+E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 491 SKLQHRNLVKLLGCCI-----QGEEKLLIYEFMPNKSLD-SFIFDQTRRTLLDWSQRFHI 544
KL+H N+V L+ + ++ +Y P D S + + L I
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL----TESQI 117
Query: 545 ICGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
C + G+ YLH++ I+HRD+KA+N+L+D KI+DFGL R + G
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 602 NRVVGT 607
GT
Sbjct: 175 GGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 23/172 (13%)
Query: 448 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 507 QGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+ + E +P SL + + +T++ ++++ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHD--- 126
Query: 561 LRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+I+HRD+K NVL++ KISDFG + G N T+ GT
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------INPCTETFTGT 172
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 53/151 (35%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 500
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDS 559
LLG I ++ E M +L +F+ +TR R L+ Q A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+++HRDL A N+L+ +D K+SDFGL R
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 448 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 500
LG G FG V+ KG +G E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E +I E+ L F+ ++ + L Q+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S R +HRDL A N L+ K+S L + E
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L I + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
R++HRDL A NVL+ + KI+DFGL + G DE E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILF 490
D+ ++ LG G FG VY+G D E +AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIIC 546
SK H+N+V+L+G + + ++ E M L SF+ + R + L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVR 590
A+G YL ++ IHRD+ A N LL KI+DFG+ R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 447 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 500
+LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF--------------DQTRRTLLDWSQRFHIIC 546
LLG Q + +++E++ L F+ D T ++ LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +H+DL A N+L+ + ++ KISD GL R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 498
++GEG +G VYK L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 499 VKLLGCC--IQGEEKL---LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
V+LL C + + +L L++E + ++ L +++ + + L ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+LH RI+HRDLK N+L+ D KI+DFGL R +
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 19/155 (12%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 496
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 497 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+ LG EE L I+ E++P S+ S + R + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H I+HRDLKA N+L+D D KISDFG+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 497
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTARG 551
+V+ LG + + + E++P S+ LL+ F + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
L YLH IIHRD+K +N+L+D KISDFG+ + + TN
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + +H N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 53/181 (29%), Positives = 100/181 (55%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KNE 486
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ +L++ N+V L + G+E ++ E++ SL D T +D +Q +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 51/161 (31%), Positives = 88/161 (54%), Gaps = 12/161 (7%)
Query: 444 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 498
I +G G FG V +G L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L G + ++I EFM N +LDSF+ + + T++ Q ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
S + +HRDL A N+L++ ++ K+SDFGL R D ++
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G FG V+ G ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ ++ E+M N L +++ + R+ L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
RDL A N L+ +D K+SDFGL R D+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLY 554
+L Q E +I E+M N SL F+ T L+D + + A G+ +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ R IHRDL+A+N+L+ + + KI+DFGL R +E
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 22/166 (13%)
Query: 444 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----------IFDQTRRT--LLDWSQRFHI 544
+VK G C G+ ++++E+M + L+ F + Q R+ L SQ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + +HRDL N L+ ++ KI DFG+ R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L + E +I E+M SL F+ D+ + LL F A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R IHRDL+A+NVL+ + + KI+DFGL R +E
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F++ +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG 587
IHRD+KA+N+LL ++ + K++DFG
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T G+++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L I TR ++ Q + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+IHRD+K+ ++LL D K+SDFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 54/161 (33%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP L ++ + R LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R++HRDL A NVL+ + KI+DFGL R DETE
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 32/161 (19%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 499
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHIICGTA 549
+ LG C+ + EF+P S+ S + F + + +LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G+ YLH + ++HRD+K +NV+L + K+ DFG R
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 14/155 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 502
+G G FG V++G L + G++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--QRFHIICGTARGLLYLHQDSR 560
G + + ++I E+M N +LD ++ D ++S Q ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
+ +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + + I +LG+G FG VYK + G A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLY 554
+VKLLG + ++ EF P ++D+ + + R + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQY 125
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH ++IIHRDLKA NVLL D + K++DFG+
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 493
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI------------FDQTRRTLLDWSQR 541
H +++KL G C Q LLI E+ SL SF+ D R + +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 542 FHIIC---------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +RG+ YL + ++++HRDL A NVL+ + KISDFGL R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 499
+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + +E ++E+M +L + D+ + S II +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH--- 116
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ HRDLK N+L+ KI+DFGL R
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 57/173 (32%), Positives = 78/173 (45%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 492
+N S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+V LLG C G L+I E+ L +F+ + R + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNT 601
+ +L + IHRDL A NVLL KI DFGL R D +GN
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 59/170 (34%), Positives = 86/170 (50%), Gaps = 35/170 (20%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHR 496
F N++GEG +G VY+ G+ +A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF------DQTRRTLLD-------WSQRFH 543
N+V+L E + K LDS IF +Q +LLD SQ
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++ RGL YLH++ IIHRDLK SN+LL KI+DFGL RT+G
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 497
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFD----------QTRRTLLDWSQRF 542
++ LL + + S + F + + ++ + L D ++
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+ RGL YLH +IHRDLK SN+L++ + + KI DFGL R DE E
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 447 KLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKELKNEVILF 490
KLGEG FG V+ DGQ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL---------DWSQR 541
S+L++ N+++LLG C+ + +I E+M N L+ F+ + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
++ A G+ YL + L +HRDL N L+ KI+DFG+ R + GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 25/169 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 490
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--------QRF 542
+ ++V+LLG G+ L++ E M L S++ ++RR + + Q+F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 543 HIICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 29/155 (18%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSF-----IFDQ--TRR---TLLDWSQRFHIICGTARGL 552
G + E+ + E+ +L+ I D+ R LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
YLH I+HRD+K +N+ LD + K+ DFG
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E+M SL F+ + L Q + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
DL+A+N+L+ +++ K++DFGL R +E
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 499
+G+G FG V K V DG+ + K + ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 500 KLLGCCIQGEEKLL-IY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLH 556
+ I + L I E+ L I + R ++ + I+ L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 557 --QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
D ++HRDLK +N+ LD + N K+ DFGL + G D + T VGT
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQH 495
I +G G FG V G L + G+ +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLY 554
N++ L G + + +++ E+M N SLD+F+ + T++ Q ++ G A G+ Y
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
L S + +HRDL A N+L++ ++ K+SDFGL R D T R
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 22/170 (12%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 498 LVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIIC 546
+++L+G C+Q E ++I FM + L SF+ D L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMT 119
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
A G+ YL S IHRDL A N +L+++MN ++DFGL + + GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 9e-14
Identities = 50/181 (27%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 499
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + E+M SLD + + R + I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+ +IIHRD+K SN+L++ K+ DFG+ N + T+ GT +++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--------VNSLAKTFVGTSSYM 166
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 6/159 (3%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
++ + KLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L + E ++ E+M SL F+ D R L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ IHRDL+++N+L+ + KI+DFGL R +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 496
+F + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
LV L Q EE + L+ + + L + + + +F IC L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYL 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
H IIHRD+K N+LLD+ + I+DF + D T + GT ++
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT----STSGTPGYM 166
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 490
+L+ + + F + +G G +G VYKG V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 491 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF 542
K HRN+ G I ++ L+ EF S+ + + L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG+ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 603 RVVGT 607
+GT
Sbjct: 180 TFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 17/162 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
D + K+GEG +G VYK V + IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L + E++L L++E++ K +DS D + L + + I+ RG+
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSP-DFAKNPRLIKTYLYQIL----RGI 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFG 593
Y H R++HRDLK N+L+D+ N K++DFGL R FG
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 15/168 (8%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVI 488
IA + D ++++ L EG FG ++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRF 542
L L H+N++ +L CI+ E ++Y +M +L F + + L Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H+ A G+ YLH + +IH+D+ A N ++D+++ KI+D L R
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQH 495
N + + I +LG+G FG VYK + +A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG-TARGLLY 554
N+VKLL ++ EF ++D+ + + R L + + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTE--PQIRVVCKQTLEALNY 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH++ +IIHRDLKA N+L D + K++DFG+
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 15/174 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 500
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 501 LLGCCIQ------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC-GTARGLL 553
G I+ ++ L+ EF S+ I + TL + + IC RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAYICREILRGLS 125
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G N +GT
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/183 (33%), Positives = 86/183 (46%), Gaps = 36/183 (19%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 497
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGL 552
LV L C Q E+ + + E+ L I F + R F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-------AVFYAAC-VVLGL 114
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTK 612
YLH++ +I++RDLK N+LLD + KI+DFGL + E G +R T+CGT
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDR-TSTFCGTP 165
Query: 613 AFL 615
FL
Sbjct: 166 EFL 168
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
++ + +++ E+ P +L +I + +LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 562 RIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
I+HRDLK N+LLD+ M KI DFG+ + ++ VVGT C
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPC 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 493
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARG 551
H +VK ++ + +I E+ + LD + T +TL + +Q G
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCEWFIQLLLG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ Y+HQ RI+HRDLKA N+ L ++ KI DFG+ R G
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 11/173 (6%)
Query: 441 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F + KLG+G +G VYK L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH 556
++ + G + ++ E+ P L I + +R L+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ +I+HRDLK++N+LL + KI D G+ + + +GT
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPH 166
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 5e-13
Identities = 48/181 (26%), Positives = 97/181 (53%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG 178
Query: 607 T 607
T
Sbjct: 179 T 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRT--LLDWSQRFHIICGTA 549
G C L E+ P+ +L F+ F T L Q H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK 500
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 501 LLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI-ICGTARGLLYLHQ 557
G C + LI EF+P+ SL ++ + L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
SR + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 46/151 (30%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
+ ++KL L++E+ ++ L + FD + D + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++HRDLK N+L++++ K++DFGL R FG
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 58/183 (31%), Positives = 91/183 (49%), Gaps = 27/183 (14%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 493
+ I KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 494 -QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+VKLL I+ E IY E+M L + I R +L+ + +I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLL 117
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ L Y+H S +IHRDLK SN+LL+ D K++DFGL R+ + E N V+ Y
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYV 173
Query: 610 GTK 612
T+
Sbjct: 174 ATR 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V+ G ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
C Q + ++ EFM N L +++ + ++ LL Q +C G+ YL ++S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD---VC---EGMEYLERNS- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ K+SDFG+ R DE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V G ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C + ++ E+M N L +++ + +R SQ + G+ YL + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
HRDL A N L+D K+SDFGL R DE
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K L I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 27/160 (16%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 501
+GEG +G V K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRFHIICGTARGLLY 554
+ + + L++EF+ + LD + R+ L F I+ RG+ +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL------FQIL----RGIEF 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
H + IIHRD+K N+L+ Q K+ DFG RT
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 44/187 (23%)
Query: 447 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEVI 488
KLGEG FG V+ +V+ Q+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD----------- 537
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 538 --------WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
+S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 590 RT-FGGD 595
R + GD
Sbjct: 186 RNLYAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 31/176 (17%)
Query: 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFI---------FDQTRRTLLDWSQ 540
N++KL+G ++ K ++I FM + L +F+ F +TL+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
RF I A G+ YL S IHRDL A N +L+++M ++DFGL + + GD
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 490
D + LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTR--RTLL 536
+ +H+N++ LLG C Q +I E+ +L F+ FD T+ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGL R
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V T G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ G+E ++ EF+ +L D T ++ Q + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 566 RDLKASNVLLDQDMNPKISDFGL 588
RD+K+ ++LL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/148 (33%), Positives = 77/148 (52%), Gaps = 16/148 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG VY V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--IC-GTARGLLYLHQDS 559
GC ++ L+ E+ + D I + ++ L Q I IC G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAYLHSHE 135
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG 587
R IHRD+KA N+LL + K++DFG
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G G ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 508 GEEKLLIY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ L I E+M SL ++ ++R R++L + YL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 566 RDLKASNVLLDQDMNPKISDFGLVR 590
RDL A NVL+ +D K+SDFGL +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRT----LLDWSQRFHIICGTARGLLY 554
KL + E +I EFM SL F+ D+ + L+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ Q + IHRDL+A+N+L+ + KI+DFGL R +E
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-12
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 282 SRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMW 340
D F++ KLP S V +L+EC CL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 341 -FGELIDMRDFPGGGQDFYIR 360
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 34/176 (19%)
Query: 451 GGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
G +G V+ K T G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
QG++ L L+ E++P L S + D+ D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLV------RTFGGDETEGNTNRVVGT 607
IIHRDLK N+L+D + + K++DFGL R ++ E R+VGT
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T+ G+ +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L D T ++ Q + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+IHRD+K+ ++LL D K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLV 499
LG G F Y+ GTL+ +++ R + SEQ ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
++LG + L E+M S+ + + RGL YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN- 122
Query: 560 RLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+IIHRD+K +N+L+D Q + +I+DFG T G GT AF+
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGT--GAGEFQGQLLGTIAFM 175
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 447 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLYLHQDSRLRII 564
+ GEE ++ EF+ +L I QTR ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
HRD+K+ ++LL D K+SDFG D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILF 490
+ + + +GEG +G V T G ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 491 SKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ +H N++ +L + ++ E M D + +T+ D Q F +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--L 112
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGL R
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 47/193 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D F I ++GEG +G VYK D G+ +A+K++ +E+ ++E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKL----------LIYEFMPN-------KSLDSFIFDQTR--- 532
L HRN+V L ++ L L++E+M + L F D +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LL+ GL Y H+ + L HRD+K SN+LL+ K++DFGL R +
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 593 GGDETEGNTNRVV 605
+E+ TN+V+
Sbjct: 167 NSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 497
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI---ICGTARGLL 553
LVKLL Q +E L L E++P + + L + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH L IHRDLK N L+D + K++DFGL
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 446 NKLGEGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 499
+++G G FG V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRRTLLDWSQRFHIICGTARG 551
+ LG CI+ LL+ EF P L +++ + L + C A G
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASG 112
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LL+LHQ IH DL N L D++ KI D+GL
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L + E ++ EFM SL F+ + + L Q + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQ 494
++ ++ +GEG FG VY+G + + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + ++ E P L S++ Q + LD + + L Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L R +HRD+ A NVL+ K+ DFGL R
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 24/189 (12%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 489
L ++ + TD + I +G+G +G VYK T DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 490 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-- 542
S H N+VK G + G + L+ E S+ + + LL QR
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 543 ----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 599 GNTNRVVGT 607
NT+ VGT
Sbjct: 185 RNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG +Y+ +LV +E+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ L+ E+ +L I + + L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I+HRD+K N+ L + K+ DFG+ + G + + T VVGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 24/169 (14%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 484
T+ T+ + +G G FG V + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF- 542
L L+H N++ L I E + + E + D +R + Q F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFL 114
Query: 543 -HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGL R
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 46/179 (25%)
Query: 442 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 495
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD--------------QTRRTLLD---- 537
N+V L+ ++ +K + +FD Q +R +
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTF 592
S + I+ G+ YLH + ++HRDLK +N+L+ + KI D GL R F
Sbjct: 111 KSLLWQILN----GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 56/177 (31%), Positives = 81/177 (45%), Gaps = 25/177 (14%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDS 559
+ ++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTYCGTKAFL 615
RI++RDLK NVLLD N +ISD GL V GG + +G GT ++
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG--------RAGTPGYM 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 9e-12
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH 495
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V G ++ ++ + EF SL I+ T L SQ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H + +HRD+K +N+LL + + K++DFG+
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 44/186 (23%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNL 498
K+G+G FG V+K Q +A+K++ +E+ L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 499 VKLLGCC---IQGEEK-----LLIYEF--------MPNKSLDSFIFDQTRRTLLDWSQRF 542
V L+ C + L++EF + NK++ F + ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMK------ 126
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
++ GL Y+H R +I+HRD+KA+N+L+ +D K++DFGL R F +
Sbjct: 127 MLL----NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 601 -TNRVV 605
TNRVV
Sbjct: 180 YTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC EEK L E+MP S I DQ T ++++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+G+ YLH + I+HRD+K +N+L D N K+ DFG
Sbjct: 116 ---LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/148 (35%), Positives = 80/148 (54%), Gaps = 10/148 (6%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
I +E L ++E+M + L ++ Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591
+HRDLK N+L+ K++DFGL R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 11/178 (6%)
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
++ E++D + D +P + A A+ +++ L G G V+ T GQ V +
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--V 95
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
KI ++G + E +L + H +++++ + G ++ +P+ S D + + R
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L Q I GL YLH RIIHRD+K N+ ++ I D G +
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 12/147 (8%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C G L+ + P SL + + R LD + + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL 588
R++HR+L A N+LL D +I+DFG+
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGV 155
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 18/181 (9%)
Query: 441 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 497 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V Q +L I E+ L I Q R L Q + GL ++
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAF 614
H +I+HRD+K+ N+ L ++ M K+ DFG+ R ++ + T GT +
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL------NDSMELAYTCVGTPYY 168
Query: 615 L 615
L
Sbjct: 169 L 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 501
+++G G FG VY T E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
GC ++ L+ E+ + D + + L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFG 587
+IHRD+KA N+LL + K++DFG
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC E+ L E MP S I DQ T ++++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G+ YLH + I+HRD+K +N+L D N K+ DFG +
Sbjct: 116 ---LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
F+ ++G G FG VY V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ +IHRD+KA N+LL + K++DFG
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 447 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSR 560
G C + LL+ EF P L ++ + L+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
IH DL N LL D+ KI D+GL
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
FS ++G G FG VY V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ +IHRD+KA N+LL + K+ DFG
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+ G ++G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
R IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 26/182 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKL 493
+ ++LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 494 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTA 549
+ +VK G + + E+ SLDS I+ + ++ ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+GL YLH +IIHRD+K SN+LL + K+ DFG+ N + GT+
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--------NSLAGTFT 164
Query: 610 GT 611
GT
Sbjct: 165 GT 166
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 490
A + +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
+ ++V+LLG QG+ L+I E M L S++ + + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 48/168 (28%), Positives = 88/168 (52%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG V+KG Q++ A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E++ S D R D Q ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 447 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
+LG G FG V KG + Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
G C + E +L+ E L+ F+ ++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
+HRDL A NVLL KISDFGL + G D++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 26/176 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVI 488
D + LGEG FG V + D ++ +AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 489 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLL 536
+ + +H+N++ LLG C Q +I E+ +L ++ ++ T+
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 537 DWSQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++ + +I E++ S D LD +Q I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 26/153 (16%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 502
+G G +G VY+G V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLL----YL 555
G ++G +I E+ S+ RTL+ ++++ I R +L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H+ +IHRD+KA+N+L+ N K+ DFG+
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C Q + ++ E + +F+ +T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRDL A N L+ + KISDFG+ R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 36/159 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCI-QGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGT 548
GC + E+ L I+ E+MP S+ +S TR+ L
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL------------- 116
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
G+ YLH + I+HRD+K +N+L D N K+ DFG
Sbjct: 117 -EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 49/176 (27%), Positives = 70/176 (39%), Gaps = 41/176 (23%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELKNEVI 488
KLGEG FG V+ Q+ AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFDQT---------RRT 534
+ S+L N+ +LLG C +I E+M N L+ F T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
LL ++ A G+ YL L +HRDL N L+ ++ KI+DFG+ R
Sbjct: 132 LL------YMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 440 DNFSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLK 481
+ KLGEG FG V+ K +D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRR 533
+ E+ + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-F 592
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG+ R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 593 GGD 595
GD
Sbjct: 182 SGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 490
D ++ LGEG FG V + + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDW 538
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 539 SQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLH 556
I ++ L L++E++ + L ++ D R L F ++ RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAYCH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
Q R++HRDLK N+L+ + K++DFGL R
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 27/178 (15%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLV 499
LG+G FG V KGT + AVK L K + + ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L C Q +++L + E++ L I Q + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-VGTYCGTKAFL 615
II+RDLK NVLLD + + KI+DFG+ + EG V T+CGT ++
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTSTFCGTPDYI 163
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 444 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 484
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+ ++++H N++ L+ ++G+ L+ + M S + D R+ L SQ I
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCI 124
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
+ GL LH+ +HRDL +N+ ++ KI+DFGL R +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
|
Length = 335 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 9e-11
Identities = 65/191 (34%), Positives = 85/191 (44%), Gaps = 49/191 (25%)
Query: 440 DNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 492
D+F LG G FG V +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR- 550
++H LV L G Q + L L+ E++P L F R+ S RF AR
Sbjct: 58 IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPE--PVARF 105
Query: 551 -------GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
L YLH L I++RDLK N+LLD D KI+DFG + R
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK------------R 150
Query: 604 VVG---TYCGT 611
V G T CGT
Sbjct: 151 VKGRTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 447 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + +AVK L + + LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ F+ T + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+HRDL A NVLL KISDFGL + G DE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 34/174 (19%)
Query: 446 NKLGEGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
N++G G G VYK T G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDS-------FIFDQTRRTLLDWSQRFHIICGTARGLL 553
E ++ EFM SL+ F+ D R+ L G+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH R I+HRD+K SN+L++ N KI+DFG+ R +T N VGT
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGT 231
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 378 VIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLEL---PLFELAT 434
I + A L + L+A + R RN E ENED +L+ + + T
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKR------VENEDGTWELQFFDSKVSKSIT 684
Query: 435 IANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
I + + N + G G YKG ++ +G + VK ++ ++ +E+ KL
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
QH N+VKL+G C + LI+E++ K+L + + L W +R I G A+ L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALR 794
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
+LH ++ +L +++D P +
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQ 494
N ++ + ++G G +G VYK + E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V G + E+ + E+ SL I+ T L Q ++ T +GL Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH ++ HRD+K +N+LL + + K++DFG+
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 29/149 (19%)
Query: 461 LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 519 PNKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
P KSL+ F + D Q + LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGD 595
DLK SN+++ D KI DFGL RT G
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 59/174 (33%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +++ L F Q R L+ RF+ A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYA-AEVASAIGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
II+RDLK N+LLD + ++DFGL + G E E T+ T+CGT +L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTS----TFCGTPEYL 163
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 494
+ + + +GEG +G V K G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L + L++E++ L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
H IIHRD+K N+L+ + K+ DFG R
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E+ L L++E++ +K L ++ D + + F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
++HRDLK N+L+++ K++DFGL R
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILF 490
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
++V+LLG +G+ L++ E M + L S++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V + + DG ++ A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQR 541
H N++ LLG C + E+ P +L +F + + L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S + IHRDL A NVL+ +++ KI+DFGL R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 20/152 (13%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 501
+G G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRF--HIICGTARGLLYLH 556
G + + + E M + SLD F +++ + + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
++ L+IIHRD+K SN+LLD++ N K+ DFG+
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGI 154
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 60/185 (32%), Positives = 81/185 (43%), Gaps = 38/185 (20%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFD--------QTRRTLLDWSQRFHIICGTARGL 552
Q + L L+ M L I++ R +Q II G L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG----L 110
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYCG 610
+LHQ RII+RDLK NVLLD D N +ISD GL G +T+G Y G
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--------YAG 159
Query: 611 TKAFL 615
T F+
Sbjct: 160 TPGFM 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 26/172 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 492
++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ +L ++ FD + +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 33/191 (17%)
Query: 441 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 487
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRF---- 542
I+ +L+H N+V+ ++ + ++ + + L + F +L + QRF
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN------SLKEKKQRFTEER 114
Query: 543 --HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+I L YLH++ R I+HRDL +N++L +D I+DFGL + E
Sbjct: 115 IWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESK 169
Query: 601 TNRVVGT--YC 609
VVGT Y
Sbjct: 170 LTSVVGTILYS 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 37/162 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF----------------IFDQTRRTLLDWSQRFHIICGT 548
F P SL+ F I + L D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQI 127
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H IIHRDLK SN+ +++D KI DFGL R
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 440 DNFSIN--NKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSK 492
DN SI LG G FG + +G L +E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L G +G +++ E+M N +LDSF+ + L Q ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGM 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
YL S + +H+ L A VL++ D+ KIS F
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 497
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V LL I +E L L++E++ + L ++ + + F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
Q I+HRDLK N+L+ K++DFGL R
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 23/171 (13%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLD-WSQRFHIICGTARGLLYLHQDSRL 561
+ ++ + ++ E+ L + + D R L D ++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVV-LAFEYLH---NR 112
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYCGT 611
II+RDLK N+LLD + K+ DFG + G +T T+CGT
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--------TFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHR 496
D + K+GEG +G VYK G+ +A+K+ ++ E+G+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 497 N-LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFIFDQTRR---TLLDWSQRFHIIC 546
+V+LL EEK L++E++ + L F+ D R L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTF 592
+G+ + H + ++HRDLK N+L+D+ KI+D GL R F
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQ 494
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FI----FDQTRRTLLD-WSQRFHI---- 544
H N+V + E + +LD ++ + ++L++ Q F
Sbjct: 63 HPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
Query: 545 --ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ G+ +LH + I+HRDLK SN+LL+ KI DFGL R +G
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 19/174 (10%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R+ + RF+ A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
II+RDLK N+LLD + ++DFGL + G E T+ T+CGT +L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTS----TFCGTPEYL 163
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQH 495
D+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 496 RNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
+++L + +++ L + E++P L S++ + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--- 113
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610
L YLH I++RDLK N+LLD++ + K++DFG + D T T CG
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT--------WTLCG 160
Query: 611 TKAFL 615
T +L
Sbjct: 161 TPEYL 165
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 503 GCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQRFHIICGTA 549
G C L E+ P+ +L +F + + L Q H A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ L++E++ +K L ++ D + + F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDLK N+L+++ K++DFGL R
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 25/157 (15%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVK 500
+G G +G V + +++A+K+++ + + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 501 LLGCCI-----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRFHIICGTARGLLY 554
+ + ++YE M + L I ++ +TL D Q F + RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYF--LYQLLRGLKY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+H + ++HRDLK SN+LL+ + + KI DFGL RT
Sbjct: 124 IHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 451 GGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCC 505
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRII 564
+ L+ E++ S I +T L DW++++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRD+K N+L+DQ + K++DFGL R
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 23/149 (15%)
Query: 448 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ + K TLV AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKS----LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ I E ++ M S L + + + F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AF-ILKDVLNALDYIHS 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDF 586
IHR +KAS++LL D +S
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 29/180 (16%)
Query: 447 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVK 500
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ ++ ++ L I Q +LDW F IC L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHV 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
H +I+HRD+K+ N+ L +D K+ DFG+ R +T + T GT +L
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTPYYL 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
CC Q ++L + EF+ L I Q R + RF+ T+ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-GTYCGTKAFL 615
II+RDLK NVLLD + + K++DFG+ + EG N T+CGT ++
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYI 163
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ + +LG G +G V K V G +AVKR+ + ++ Q K L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRFHIICGTARGLL 553
V G + + + E M + SLD F ++D+ D + I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH S+L +IHRD+K SNVL++++ K+ DFG+
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI 150
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + L++E+ + L+ ++ R + + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNC 121
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
IHRD+K N+L+ + K+ DFG R G +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLG- 503
+G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 504 --CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ G+E Y MP D + L + +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IIHRDLK N+ +++D KI DFGL R
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 44/171 (25%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 500
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 501 LLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLL--------------DWSQR 541
L+ C E K+ L++E + DQ RT L D ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
F RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 117 F------LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 33/166 (19%)
Query: 447 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 499
++GEG +G V+K + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 500 KLLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA----- 549
+L C E KL L++E + DQ T LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 550 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 26/155 (16%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ + L ++ E+ L I Q T+L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H+ R++HRD+K+ N+ L Q+ K+ DFG R
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 462 VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
V G +AVK+LS+ ++ K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 520 NKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567
KSL+ F + D Q LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 568 LKASNVLLDQDMNPKISDFGLVRT 591
LK SN+++ D KI DFGL RT
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 19/174 (10%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +F+ L F Q R+ + RF+ A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
I++RDLK N+LLD + ++DFGL + G +++ T T+CGT +L
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTT-----TFCGTPEYL 163
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVK 500
+G G FG V+ T DG+ +A+K++ + ++ +ELK + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 501 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLL 553
L EE ++ E M L I + D + F I+ RGL
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVFLYQIL----RGLK 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
YLH I+HRD+K N+L++ + KI DFGL R DE++ T VV Y
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKL 501
K+GEG F V K + G+ A+K + K + L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 502 LGCCIQGEEK--LLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ + L++E M D +++ + R+ L + + + L ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+ I HRD+K N+L+ D K++DFG R
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 28/65 (43%), Positives = 37/65 (56%), Gaps = 13/65 (20%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVG 606
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR-------- 159
Query: 607 TYCGT 611
T+CGT
Sbjct: 160 TFCGT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 53/187 (28%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVKL- 501
LG+G FG V L E +K LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 502 --------LGCCIQGEEKLL-IYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFH---I 544
L C Q +E L + E++ L S FD+ R RF+ I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEI 105
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
ICG L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +
Sbjct: 106 ICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS---- 154
Query: 605 VGTYCGT 611
T+CGT
Sbjct: 155 --TFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 54/178 (30%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISE------QGLKELKNEVILF 490
+ +G G +G V +D G+++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL--DSF-IFDQTRRTLLDWSQRFHIICG 547
+H N++ + P + D + + D L S HII
Sbjct: 59 RHFKHDNIIAIRDI------------LRPPGADFKDVYVVMD------LMESDLHHIIHS 100
Query: 548 TA---------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H + +IHRDLK SN+L+++D +I DFG+ R
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E L L++E++ + L ++ L+ + RGL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
I+HRDLK N+L+++ K++DFGL R
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
D+F + +G G FG V+ LV GQ A+K L K +K +N++
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51
Query: 496 RN---------LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
R+ +VKL Q EE L L+ E+MP L + + + + + RF+I
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYI- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
A +L L +L IHRD+K N+L+D D + K++DFGL
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLL 536
++H N++ LL F P +SL+ F ++ T + L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
D +F +I RGL Y+H IIHRDLK SN+ +++D KI DFGL R
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNLV 499
++G G FG V + +A VK L + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-DQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ LG C++ LL++E+ L S++ +Q R + C A G+ ++H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +H DL N L D+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 49/194 (25%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 493
+F + LG G FG V +KGT G+ A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTR---RTLLDWSQRFHIICGTA 549
H +V ++ C Q E ++ + EF+ L F R R D ++ +H A
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH-----A 125
Query: 550 RGLL---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV-----RTFGGDETEGNT 601
+L YLH II+RDLK N+LLD + K++DFG RTF
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--------- 173
Query: 602 NRVVGTYCGTKAFL 615
T CGT +L
Sbjct: 174 -----TLCGTPEYL 182
|
Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 44/169 (26%)
Query: 448 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 505 CIQGEEKLLIYE--FMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTA------ 549
+YE L + T + ++ + G
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 550 -------RGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVR 590
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGL R
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 29/168 (17%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 490
+ + +LG+G +G V T + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 491 SKLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--- 544
H+N+ L I +L +YE + L I ++ + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
I GL Y+H + ++HRDLK N+L++ D KI DFGL R F
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L E+ A+K L K + + + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
CC Q +++L + E++ L I Q R + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTL-ALMFLHRHG-- 116
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTYCGTKAFL 615
+I+RDLK N+LLD + + K++DFG+ + EG T+CGT ++
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYI 163
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 34/157 (21%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFSKLQHRNLV 499
+G G FG V LV G A+K+L K SE KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL Q E L LI E++P + D+F ++TR F+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR---------FYI----AET 110
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 448 LGEGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
LG+G F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G C+ G+E +++ E++ SLD+++ + + L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 560 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGL 588
+ H ++ A NVLL + NP K+SD G+
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 448 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
L+ M L I++ R L + + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL 588
I++RD+K NVLLD N ++SD GL
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 58/174 (33%), Positives = 89/174 (51%), Gaps = 26/174 (14%)
Query: 448 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHRNL 498
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
VKL Q E KL LI +F+ L + + + T D +F++ A L +LH
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYL-AELALALDHLH- 115
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L II+RDLK N+LLD++ + K++DFGL + E+ + + ++CGT
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAY-SFCGT 161
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 25/64 (39%), Positives = 39/64 (60%), Gaps = 9/64 (14%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + T+CGT
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMK---TFCGT 158
Query: 612 KAFL 615
+L
Sbjct: 159 PEYL 162
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 441 NFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + ++ + T + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYI----AEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+L L +L II+RD+K N+LLD + + ++DFGL + F +E E ++CGT
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-----AYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 58/177 (32%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K I + + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQD 558
C Q +E L + EF+ L I D+ R L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
II+RDLK NV+LD+D + KI+DFG+ + E NR T+CGT ++
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNR-ASTFCGTPDYI 163
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLLDWSQRFHIICGTAR 550
F P S+++F ++ T + L D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
GL Y+H IIHRDLK SNV +++D +I DFGL R DE G
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ EFM SLD ++ + +L I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
RD+K SN+L++ K+ DFG+ N + TY GT A++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYM 160
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 448 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLV 499
LG+GG+G V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR--TLLDWSQRFHIICGTARGLLYLHQ 557
L+ G + LI E++ L F R ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
II+RDLK N+LLD + K++DFGL + + T V T+CGT
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGT--VTHTFCGT 163
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 58/183 (31%), Positives = 82/183 (44%), Gaps = 37/183 (20%)
Query: 448 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLV 499
LG+G FG V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 500 KLLGCCIQGEEKLL-IYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLL 553
L C Q +E L + E++ L I FD R T IICG L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQ 110
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYCGTK 612
+LH I++RDLK N+LLD D + KI+DFG+ + GD T T+CGT
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTC----TFCGTP 160
Query: 613 AFL 615
++
Sbjct: 161 DYI 163
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
+ +D + I +G+G +G V+K +G + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 495 HRNLVKLLGC-----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------H 543
H N+VK G G++ L+ E S+ + + L +R +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAY 128
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
I+ GL +LH + + IHRD+K +N+LL + K+ DFG+ NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 604 VVGT 607
VGT
Sbjct: 185 -VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 15/124 (12%)
Query: 459 GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
GTLV + + L +E+ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 519 ----PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
N L ++ + L+ +I+ G RGL YLHQ+ IHR++KAS++L
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 575 LDQD 578
+ D
Sbjct: 134 ISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 20/184 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + + + R Q I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+L L +L II+RD+K N+LLD + + ++DFGL + F DE E + +CGT
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-----FCGT 169
Query: 612 KAFL 615
++
Sbjct: 170 IEYM 173
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R L+ RF+ A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
I++RDLK N+LLD + ++DFGL + E G T+ T+CGT +L
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTS----TFCGTPEYL 163
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 32/156 (20%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHR--NLV 499
+G G G VYK G +AVK++ + + +E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-------HIICGTARGL 552
K G I + + E M S D+ LL Q + + L
Sbjct: 78 KCYGYFITDSDVFICMELM------STCLDK----LLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YL + +IHRD+K SN+LLD N K+ DFG+
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI 161
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 31/159 (19%)
Query: 448 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRF------HIICGTARG 551
F P+ SLD F F T L ++ ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L Y+H IIHRDLK N+ +++D KI DFGL R
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 27/176 (15%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G G V K GT++ + + + S + +Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + EFM SLD +L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
RI+HRD+K SN+L++ K+ DFG+ N + T+ GT ++
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--------INSIADTFVGTSTYM 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 22/176 (12%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKL 501
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 502 LGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+GE+ LL + F L + +Q + L + +Q A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK- 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
I+HRDLK NV L + K+ D G+ R N + T GT ++
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVL------ENQCDMASTLIGTPYYM 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRV 604
++RDLK N+LLD + +ISD GL V+ G+ G V
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 46/148 (31%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
RI++RDLK N+LLD + +ISD GL
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 440 DNFSINNKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
D + ++LG+G +G VYK G + +EI RL + E ++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+V G + E+M SLD + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L ++ IIHRD+K +NVL++ + K+ DFG+
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 30/195 (15%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
E++ N+ + E+E++ ID ++ + ++ + N +G G FG VY+ +D
Sbjct: 39 ERSHNNNAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 466 E-IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLL----IYE 516
E +A+K++ + + +EL ++ L H N++ L C + EK + + E
Sbjct: 92 EKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 517 FMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
F+P +K + + + L + +C R L Y+H I HRDLK N+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNL 201
Query: 574 LLDQDMNP-KISDFG 587
L+D + + K+ DFG
Sbjct: 202 LIDPNTHTLKLCDFG 216
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 496
LG+G F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+LVKL G C++ +E +++ E++ LD F+ + L W + + A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLVRTFGGDE 596
+++H ++ N+L+ + K+SD G+ T E
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 21/175 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSR 560
C Q +L L+ E++ L Q +R L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
II+RDLK NVLLD D + K++D+G+ + G G+T T+CGT ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---PGDTT---STFCGTPNYI 163
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
++F+ LG G FG V T + +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG---TARG 551
H V L G L+ EF+ +F+ RR ++RF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RR-----NKRFPNDVGCFYAAQI 140
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+L L I++RDLK N+LLD+D K++DFG +
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 26/67 (38%), Positives = 40/67 (59%), Gaps = 9/67 (13%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G T R T+
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTR---TF 161
Query: 609 CGTKAFL 615
CGT ++
Sbjct: 162 CGTPDYI 168
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHII 545
+V L + LI EF+P L D+F D TR F++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR---------FYM- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
A +L + +L IHRD+K N+L+D+ + K+SDFGL F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q E KL LI +++ + + ++ R + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFY----SGEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+L L +L I++RD+K N+LLD + + ++DFGL + F +E E ++CGT
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-----SFCGT 169
Query: 612 KAFL 615
++
Sbjct: 170 IEYM 173
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 447 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLV 499
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYL 555
L Q E L L+ ++ P L + Q + L + RF+ ++ L YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H L I++RDLK N+LL + + +SDF L
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDL 149
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 39/181 (21%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 497
+ I +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD--WSQR-------------- 541
+V + C G+ +Y MP +I T ++LL W +
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 542 ----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
FH IC T Y+H S+ ++HRDLK N+LL I D+G +E
Sbjct: 115 FLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 598 E 598
+
Sbjct: 169 D 169
|
Length = 932 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 24/65 (36%), Positives = 39/65 (60%), Gaps = 11/65 (16%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGTYCG 610
L YLH +++RD+K N++LD+D + KI+DFGL + EG ++ + T+CG
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCG 157
Query: 611 TKAFL 615
T +L
Sbjct: 158 TPEYL 162
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 50/161 (31%), Positives = 68/161 (42%), Gaps = 40/161 (24%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQHRNLVK 500
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 501 LL-------GCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L C+ G+ K IY FD+ R I CG
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----AAEITCG 114
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L LH R RI++RDLK N+LLD + +ISD GL
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 17/117 (14%)
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQD 558
L C Q E +L + EF+ L Q +R L + RF+ I L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEIS---LALNFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
II+RDLK NVLLD + + K++D+G+ + G+T T+CGT ++
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GDTT---STFCGTPNYI 163
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 57/221 (25%), Positives = 84/221 (38%), Gaps = 76/221 (34%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL---SKISEQG--LKELKNEVI 488
D + LG G FG V + + ++ +AVK L + SE + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---I 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLI------------------YEFMPNKS-------- 522
L H N+V LLG C + L++ F P ++
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 523 ---------LDS-----------FIFDQTRRTLL------DWSQRF----HIICGT---A 549
LDS FI D++ + + + +I + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 27/66 (40%), Positives = 40/66 (60%), Gaps = 11/66 (16%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-RVVGTYC 609
L YLH +I++RDLK N++LD+D + KI+DFGL + EG T+ + T+C
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFC 156
Query: 610 GTKAFL 615
GT +L
Sbjct: 157 GTPEYL 162
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 492
DN LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEF 517
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 26/65 (40%), Positives = 39/65 (60%), Gaps = 8/65 (12%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610
L YLH + +++RDLK N++LD+D + KI+DFGL + D G T + T+CG
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMK---TFCG 158
Query: 611 TKAFL 615
T +L
Sbjct: 159 TPEYL 163
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 26/67 (38%), Positives = 40/67 (59%), Gaps = 9/67 (13%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A GL +LH II+RDLK NV+LD + + KI+DFG+ + + +G T + T+
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTK---TF 161
Query: 609 CGTKAFL 615
CGT ++
Sbjct: 162 CGTPDYI 168
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 501
+G+G FG VY+ D + I A+K LSK KE+ + +++ + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L Q + L L+ ++M L F Q + +F+I A +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
I++RDLK N+LLD + + DFGL + N+ T+CGT +L
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGL------SKANLTDNKTTNTFCGTTEYL 163
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 14/148 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ + CG L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
RI++RDLK N+LLD + +ISD GL
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
R L Y+H + + HRDLK N+L + D KI DFGL R
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLD----SFIFDQTRRT 534
+L+NE++ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 535 LLDWS------QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
DW Q I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 589 VRTF 592
F
Sbjct: 314 AMPF 317
|
Length = 501 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G+G FG V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q EKL L+ F+ L + FD +R RF+ TA L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR-------ARFY----TAELLCALEN 108
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+ +I+RDLK N+LLD + + DFGL + D+ + N T+CGT +L
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN------TFCGTPEYL 160
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 46/183 (25%), Positives = 88/183 (48%), Gaps = 26/183 (14%)
Query: 419 EDQNIDLELPLFE-----LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL 472
+++NID L +E + + +++ + +G G FG V Q++ A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 473 SKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF 526
SK S+ + +++ F+ + V L C Q ++ L ++ E+MP L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 527 I--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
+ +D + W++ + TA +L L + +IHRD+K N+LLD+ + K++
Sbjct: 134 MSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 585 DFG 587
DFG
Sbjct: 185 DFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRT-----LLDWSQRFHIICGTARGLLYLHQD 558
+ ++ L++++ + F + + L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 18/175 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 492
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L+ N+V+L + + L++E++ L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ H++ I+HRD+K N+L+ + K+ DFG R + + N V T
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 44/188 (23%), Positives = 72/188 (38%), Gaps = 19/188 (10%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATD----NFSINNKLGEGGFGPVYKGTL- 461
+ D+E+ D+ E + ++ ++I + L G G V+ T
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH 114
Query: 462 --VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
+++ VK ++ G K E+ + + HR ++ L+ K + MP
Sbjct: 115 GDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAY---RWKSTVCMVMP 166
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579
D F + R L Q I L YLH IIHRD+K N+ LD+
Sbjct: 167 KYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPE 222
Query: 580 NPKISDFG 587
N + DFG
Sbjct: 223 NAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 448 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 494
LG G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H+++V L G C++ E +++ EF+ LD F+ ++ +L +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 555 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGL 588
L +D L +H ++ N+LL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + +++P + S + + RF+I A L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYI----AELTLAIESVHKMGF 122
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTF 592
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q ++ L + +++P + S IF++ RF+I A +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------ARFYI----AELTCAIES 116
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 44/172 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE--------- 486
+ F I + G FG VY G + + AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 487 ---VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDW 538
V L+ LQ N V L+ E++ + S + FD+ +
Sbjct: 64 PFIVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDE------EM 105
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ++ I A L YLH+ IIHRDLK N+L+ + + K++DFGL +
Sbjct: 106 AVKY--ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL YL + + +I+HRD+K SN+L++ K+ DFG+ G + N VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V K I ++L + + ++N++I ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + + +R + + I RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ + +I+HRD+K SN+L++ K+ DFG+ G + N VGT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-----LHQD 558
+ ++ L++++ + F + + + + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ 465
D+F + KLGEG FG VYK +LV+ Q
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQ 157
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLGC 504
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E++ ++LD + ++ I A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 565 HRDLKASNVLLDQDMNPKISDFG 587
H DL N+L+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 17/142 (11%)
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTL 535
++ + ++ E +F + + + L C Q E +L + E++ L Q +R L
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 93
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FG 593
+ RF+ + L YLH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
Query: 594 GDETEGNTNRVVGTYCGTKAFL 615
GD T T+CGT ++
Sbjct: 150 GDTTS--------TFCGTPNYI 163
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 50/161 (31%), Positives = 67/161 (41%), Gaps = 31/161 (19%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL---- 555
C C+ Y F L SFI D L + H + A Y
Sbjct: 56 CPFIVCMS-------YAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 556 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
H +R +++RDLK +N+LLD+ + +ISD GL F
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 13/132 (9%)
Query: 464 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 519
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 576
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 577 QDMNPKISDFGL 588
+ K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 6/51 (11%)
Query: 543 HIICGT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+IC + A+G+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 22/42 (52%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
ARG+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 49/162 (30%), Positives = 67/162 (41%), Gaps = 33/162 (20%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL--- 555
C C + Y F P+K FI D L + H + Y
Sbjct: 56 CPFIVC-------MTYAFHTPDKL--CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 556 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
H +R +++RDLK +N+LLD+ + +ISD GL F
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 617 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.98 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.89 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.87 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.87 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.86 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.85 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.84 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.84 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.78 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.75 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.58 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.51 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.35 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.33 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.33 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.32 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.18 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.0 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.99 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.39 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.34 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.19 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.06 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.55 | |
| PLN02236 | 344 | choline kinase | 96.51 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.28 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.99 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.91 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.97 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.82 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.72 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.01 Aligned_cols=188 Identities=48% Similarity=0.777 Sum_probs=166.5
Q ss_pred CCCchhHHhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEE
Q 007120 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (617)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (617)
..+.|++.++..+|++|+..+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988764332156799999999999999999999999
Q ss_pred EeCC-eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 506 IQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 506 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875443 78999999999999999999999988899999999999999999999999
Q ss_pred ecCCceeeCCCCccccccee-eeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRV-VGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~-~gt~~y~ape~~ 616 (617)
|||||+......... ... .||++|++||++
T Consensus 220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYA 250 (361)
T ss_pred CccCcccCCccccce--eeecCCCCccCChhhh
Confidence 999997764312221 112 799999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=293.31 Aligned_cols=169 Identities=29% Similarity=0.487 Sum_probs=150.7
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..+|.+.+.||+|+|++||+|+++. +.+||||.+.+. .....+.+..|+.+|+.|+|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4578888999999999999999865 789999999764 5566778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC------CCeEEeecCCc
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGLV 589 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~------~~~ki~DFGla 589 (617)
|||.+|+|.+||+. ...+++.....++.|+|.||++||+.+ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999965 335899999999999999999999998 9999999999999765 46899999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|.+.... ...+.+|++-|||||++
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~ 186 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVI 186 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHH
Confidence 9996443 34568899999999976
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=288.59 Aligned_cols=172 Identities=35% Similarity=0.567 Sum_probs=147.9
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-eEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 517 (617)
.+.+.+.||+|+||+||+|.+.+...||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 444556799999999999999655559999997632 222679999999999999999999999999988 79999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~~~~ 596 (617)
+++|+|.++|+.. ....+++..+++|+.|||+||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45679999999999999999999999863 99999999999999998 99999999999875432
Q ss_pred cccccceeeeeccccCccCCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~~ 617 (617)
...+...||+.|||||+|.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred --ccccCCCCCccccChhhhc
Confidence 2233368999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=275.68 Aligned_cols=170 Identities=26% Similarity=0.397 Sum_probs=145.1
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch-------hhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
..+.|.+.+.||+|+||.|-+|.-+ +|+.||||++.+... .......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999864 599999999975211 12233579999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeec
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 586 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DF 586 (617)
..||||||+++|+|-+++-. .+.+.+..-..++.|++.|+.|||++| |+||||||+||||..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999843 344566666789999999999999998 9999999999999765 78999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||||..+.. ..+.+.+||+.|.|||++
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl 350 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVL 350 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhhe
Confidence 999998633 346778999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=278.49 Aligned_cols=171 Identities=32% Similarity=0.518 Sum_probs=148.4
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHc--cCCCCCccceEEEEEeCC----eEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFS--KLQHRNLVKLLGCCIQGE----EKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~ 512 (617)
.+..++.++||+|+||.||||.+. ++.||||++.. +....|++|-.+.+ .++|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 445667789999999999999994 59999999964 45667777777665 468999999999977666 789
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
||+||.++|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999994 45689999999999999999999975 3568999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
|||..+........+-..+||..|||||+++
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLE 391 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLE 391 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHh
Confidence 9999998776665555588999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=269.51 Aligned_cols=171 Identities=28% Similarity=0.381 Sum_probs=150.3
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|+++++||+|+||+||.++.++ ++.+|+|.+++. .....+..++|..+|.+++||+||+++-.+++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45689999999999999999999766 788999999763 33467789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+||+.||.|...|.. ...+++....-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.--
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999843 445777777778899999999999998 9999999999999999999999999999654
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+. ..+.+.+||+.|||||++
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil 197 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEIL 197 (357)
T ss_pred cCC--CccccccCCccccChHHH
Confidence 332 235568999999999975
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=279.91 Aligned_cols=170 Identities=28% Similarity=0.417 Sum_probs=154.7
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..|...+.||+|+|.++|+++. ..|+.||+|.+.+ .+....+...+|+++-+.|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999997 6699999999976 34456778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|+|++++|..++. +++.+++.++..++.||+.||.|||+.+ |||||||..|+||++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5677999999999999999999999987 999999999999999999999999999999766
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
++. ..+.+||+-|+|||++.
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLN 191 (592)
T ss_pred ccc--cceecCCCcccChhHhc
Confidence 544 34689999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=263.56 Aligned_cols=168 Identities=28% Similarity=0.335 Sum_probs=147.3
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-eEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 517 (617)
+++..+.||+|..|+|||++++. ++.+|+|.+.. ..+...+++.+|++++++.+||+||+++|.|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 45566899999999999999865 77899999843 34556788999999999999999999999999998 59999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|.+|+|++++... +.+++...-+|+.+|++||.|||+. .+||||||||+||||++.|.+||+|||.++.+-+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999543 5589999999999999999999973 24999999999999999999999999999998654
Q ss_pred ccccceeeeeccccCccCCC
Q 007120 598 EGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~~ 617 (617)
.-++.+||..|||||-++
T Consensus 233 --~a~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERIS 250 (364)
T ss_pred --hcccccccccccChhhhc
Confidence 235678999999999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=278.24 Aligned_cols=173 Identities=32% Similarity=0.498 Sum_probs=148.1
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..+.+++.+.||+|.||+|+.|.+.....||||.++.. ....+.|.+|+.+|++|+|+|||+++|+|..+++++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 33455667899999999999999987789999999764 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|+.|+|.+||+. .....+...+.+.++.|||+||+||++++ +|||||+++||||+++..+||+||||||.+..++.
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999976 33556889999999999999999999987 99999999999999999999999999996655544
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
..... ..-...++|||.|
T Consensus 359 ~~~~~-~kfPIkWtAPEa~ 376 (468)
T KOG0197|consen 359 TASEG-GKFPIKWTAPEAL 376 (468)
T ss_pred eecCC-CCCCceecCHHHH
Confidence 32221 2234579999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=268.06 Aligned_cols=171 Identities=29% Similarity=0.404 Sum_probs=147.4
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (617)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.... +....-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35678889999999999999985 458999999987533 34456678999999999999999999999887 67999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+|||+ .+|.-++.. ..-.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMd-hDL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEeccc-chhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999997 578777743 2345889999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.......+++ +-|+.|.|||++
T Consensus 270 ~~~~~~~T~r-VvTLWYRpPELL 291 (560)
T KOG0600|consen 270 PSGSAPYTSR-VVTLWYRPPELL 291 (560)
T ss_pred CCCCcccccc-eEEeeccChHHh
Confidence 7766555654 569999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=249.09 Aligned_cols=168 Identities=29% Similarity=0.361 Sum_probs=150.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|+..+.||.|+||.|.+++.+. |.-+|+|.+++. ...+.+...+|..+|+.+.||++++|.+.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3578889999999999999999765 788999999762 345567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|.|.++|+. ...+++.....++.||+.||+|||+.. |++|||||+|||||.+|.+||+|||+||.+.+
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999965 344788888889999999999999987 99999999999999999999999999999854
Q ss_pred CCcccccceeeeeccccCccCCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
. +-+.+||+.|+|||.++
T Consensus 197 r-----T~TlCGTPeYLAPEii~ 214 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQ 214 (355)
T ss_pred c-----EEEecCCccccChHHhh
Confidence 3 55799999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.16 Aligned_cols=178 Identities=29% Similarity=0.464 Sum_probs=150.9
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
+..+.+....+.||+|+||+||+|+..+ .+.||||.++..... ...+|++|+++++.++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 4455677778999999999999998532 457999999875554 788999999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQT-------R----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~ 577 (617)
++.+||+|||..|+|.+||+... . ..+++..+.+.||.|||.||+||-++. +|||||+++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996421 1 234889999999999999999999886 999999999999999
Q ss_pred CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..|||+||||+|.+-..+.........-...+||||-|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 999999999999987554443333234456789999965
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=252.78 Aligned_cols=169 Identities=24% Similarity=0.351 Sum_probs=143.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
+.|+.+.++|+|+||.|||++.++ |+.||||++.... +...+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778899999999999999876 8999999986532 3334557899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++..-|+++-+ ...-++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998766655432 2334788888999999999999999998 9999999999999999999999999999997432
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. . -+..+.|+.|.|||++
T Consensus 156 d-~-YTDYVATRWYRaPELL 173 (396)
T KOG0593|consen 156 D-N-YTDYVATRWYRAPELL 173 (396)
T ss_pred c-h-hhhhhhhhhccChhhh
Confidence 2 2 2346789999999975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=275.33 Aligned_cols=171 Identities=29% Similarity=0.459 Sum_probs=147.8
Q ss_pred CCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
...++.++||.|.||+|++|+++- ...||||.|+.. .+....+|+.|+.+|.+.+||||++|.|+.....+.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999999853 357999999864 456678999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
.|||+||+|+.||+.. ...+.+.+...|.++||.||+||.+.+ +|||||+++||||+.+..+||+||||+|.+.+
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999763 344899999999999999999999887 99999999999999999999999999999876
Q ss_pred CCcccccceeee--eccccCccCC
Q 007120 595 DETEGNTNRVVG--TYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~g--t~~y~ape~~ 616 (617)
+.....+ +..| ...++|||.|
T Consensus 784 d~~~~yt-t~GGKIPiRWTAPEAI 806 (996)
T KOG0196|consen 784 DPEAAYT-TLGGKIPIRWTAPEAI 806 (996)
T ss_pred CCCcccc-ccCCccceeecChhHh
Confidence 6533222 1222 2578999965
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=241.69 Aligned_cols=169 Identities=33% Similarity=0.486 Sum_probs=145.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|...+.||+|.||.||+|+.. .|+.||||+++.... .......+|+..|+.++|+||+.|++++-..+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778899999999999999964 589999999975322 224567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
||+ .+|...+++ +...+...+...++.++++||+|||++. |+||||||.|+||+++|.+||+|||||+.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 799999965 4456888999999999999999999987 9999999999999999999999999999986544
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
... + ..+-|+.|.|||++
T Consensus 156 ~~~-~-~~V~TRWYRAPELL 173 (318)
T KOG0659|consen 156 RIQ-T-HQVVTRWYRAPELL 173 (318)
T ss_pred ccc-c-cceeeeeccChHHh
Confidence 322 2 23678999999965
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=227.36 Aligned_cols=110 Identities=48% Similarity=0.743 Sum_probs=80.4
Q ss_pred CCceEEEccCCCCCCCC--ceeEEEecCCcEEEEcCCCcEEEee-CCccCc-CCceEEEEecCCCEEEeeCCCCCCCcee
Q 007120 14 PHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSA-YLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYF 89 (617)
Q Consensus 14 ~~t~VW~Anr~~pv~~~--~~~l~l~~~G~L~l~~~~~~~vWst-~~~~~~-~~~~~~~LldsGNlVl~~~~~~~~~~~l 89 (617)
++||||+|||+.|+... ..+|.|..||+|+|.|..++++|++ ++.+.. ....+ +|+|+|||||++.. +.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~-~L~~~GNlvl~d~~----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYL-VLQDDGNLVLYDSS----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEE-EEETTSEEEEEETT----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEE-EEeCCCCEEEEeec----ceEE
Confidence 47999999999999643 3889999999999999999999999 555432 35666 99999999999963 7899
Q ss_pred eeeccCCCcccCCCCcccceeccCCcceEEEeecCCCCC
Q 007120 90 WQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128 (617)
Q Consensus 90 WQSFd~PTDTlLpgq~l~~~~~~g~~~~l~s~~s~~dps 128 (617)
||||||||||+||||+|+.+..++.+..|+||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999987777777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-31 Score=253.04 Aligned_cols=175 Identities=26% Similarity=0.423 Sum_probs=148.7
Q ss_pred CCccccceecccCcccEEEEE-EcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEE-EEeCCe-EEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC-CIQGEE-KLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV 514 (617)
.+|+++++||+|+||+|||++ +.+|..||.|.+.- .+.........|+.+|++|+|||||+++++ +.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 368888999999999999998 46799999998863 455566788999999999999999999994 444444 7899
Q ss_pred EecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|||+..|+|...+... .....+++...++++.|++.||.++|+.- +-.|+||||||.||+|+.+|.+||+||||+|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998643 33567899999999999999999999842 123999999999999999999999999999999
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....+. ....+||+.||+||.+
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i 200 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERI 200 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHH
Confidence 766554 3357899999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=263.84 Aligned_cols=175 Identities=30% Similarity=0.425 Sum_probs=151.9
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecc---cchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (617)
...++|.+++.||+|+|++|++|+... ++++|||++.+ ..+...+....|-..|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345689999999999999999999655 89999999976 2344456677888999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
|+|+||+++|+|.++|.+ ...+++.....++.+|+.||+|||+.+ ||||||||+|||||+||++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999965 355888888899999999999999998 99999999999999999999999999999
Q ss_pred eCCCCcc---------ccc--ceeeeeccccCccCCC
Q 007120 592 FGGDETE---------GNT--NRVVGTYCGTKAFLYD 617 (617)
Q Consensus 592 ~~~~~~~---------~~~--~~~~gt~~y~ape~~~ 617 (617)
+++.+.. ... ...+||-.|.+||++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 9654332 111 4478999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=254.90 Aligned_cols=171 Identities=25% Similarity=0.394 Sum_probs=144.3
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHH--ccCCCCCccceEEEEEeCC----eEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--SKLQHRNLVKLLGCCIQGE----EKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~----~~~ 512 (617)
.++..+.+.||+|+||+||+|.+ .|+.||||++...+ .+.+.+|.++. ..|+|+||+.+++.-..+. .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35788889999999999999999 58899999997533 33455555555 4579999999999865543 478
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
||.+|++.|||.+||. ...++....++++..+|.||+|||- ++++.|.|||||++||||.+++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999993 3568999999999999999999994 578899999999999999999999999999
Q ss_pred CceeeCCCCc--ccccceeeeeccccCccCCC
Q 007120 588 LVRTFGGDET--EGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 588 la~~~~~~~~--~~~~~~~~gt~~y~ape~~~ 617 (617)
||.....+.. ....+..+||-.|||||++|
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd 393 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD 393 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhh
Confidence 9988765533 34566778999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=264.28 Aligned_cols=176 Identities=28% Similarity=0.412 Sum_probs=151.2
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.+.+.+.+.++||+|.||+|..++...+..||||+++.... ....+|.+|+++|.+++|||||+|+|+|..++++++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34566778899999999999999998889999999987544 44589999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|||++|+|.+||....... ++....++|+.|||.||+||.+.+ +|||||+++|||+|.++++||+|||++|.+-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999997643322 466677889999999999999876 999999999999999999999999999977555
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+....+.+-...|||+|-+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESI 711 (807)
T ss_pred CceeeecceeeeeeehhHHHH
Confidence 544444455667889999853
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=265.55 Aligned_cols=177 Identities=29% Similarity=0.416 Sum_probs=146.8
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC--C--cE-EEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEE
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD--G--QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (617)
.++...++..+.++||+|+||+||+|.+.. + .. ||||..+. .......+|.+|+++|+.++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455677777999999999999999754 2 23 89999874 4466788999999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
....++|+|||+|++|+|+++|.+.. ..++..+++.++.++|+||+|||+.+ +|||||+++|||++.+..+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 99999999999999999999996533 35899999999999999999999988 99999999999999999999999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
|||++.-........ ...-...|+|||.++
T Consensus 306 FGLs~~~~~~~~~~~--~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKF--LKKLPIRWLAPETLN 335 (474)
T ss_pred cccccCCcceeeccc--cccCcceecChhhhc
Confidence 999886431111110 112346799999763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=262.39 Aligned_cols=169 Identities=28% Similarity=0.401 Sum_probs=146.9
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchh-hHHHHHHHHHHHccCC-CCCccceEEEEEeCC-eEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 514 (617)
.++|...++||.|.||.||+|+-. .+..||||++++.-.. +.-.-.+|+..|++|+ |||||+|...+.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 467889999999999999999854 4889999999763322 2223468999999998 999999999999988 89999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||||+ .+|.++++++ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99996 7999999764 677999999999999999999999998 99999999999999999999999999998843
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..+-+..+.|+.|.|||++
T Consensus 163 ---kpPYTeYVSTRWYRAPEvL 181 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVL 181 (538)
T ss_pred ---CCCcchhhhcccccchHHh
Confidence 3334567889999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=261.07 Aligned_cols=168 Identities=30% Similarity=0.450 Sum_probs=150.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|.+.+.||+|+||.||||+-+. .+.||+|.+.+. .+...+.+++|++++++++|||||.++.+++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 478888999999999999998655 789999999763 44567789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+.+ +|..+|.. ...+++.....|+.++..||.|||+.+ |+|||+||+||||+..+++|++|||+||.++.+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9986 99999954 455899999999999999999999987 9999999999999999999999999999986543
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ....+.||+-|||||++
T Consensus 155 ~--vltsikGtPlYmAPElv 172 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELV 172 (808)
T ss_pred e--eeeeccCcccccCHHHH
Confidence 2 35568899999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=277.01 Aligned_cols=177 Identities=32% Similarity=0.519 Sum_probs=150.4
Q ss_pred hhcCCccccceecccCcccEEEEEEcC--Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD--GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
...++.++.+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|.|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345677888999999999999999754 33 4999999874 5567889999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
..+|++|||++|+|..||++.. ....+..++.+.++.|||+|+.||+++. +|||||+++||||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997641 1456889999999999999999999987 99999999999999999999999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||||.+-..+......+..-...|||||.|
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl 876 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESL 876 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHH
Confidence 9999976554443333222233689999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=245.75 Aligned_cols=174 Identities=30% Similarity=0.418 Sum_probs=147.5
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--eEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 515 (617)
..++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+.+|.....+ .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999999865 8999999987643333677899999999999999999999855544 688999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~ 594 (617)
||+++|+|.+++..... .+++.....+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999965332 5899999999999999999999988 999999999999999 79999999999998864
Q ss_pred CCc-ccccceeeeeccccCccCCC
Q 007120 595 DET-EGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 595 ~~~-~~~~~~~~gt~~y~ape~~~ 617 (617)
... ........||+-|||||++.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ccccccccccccCCccccCchhhc
Confidence 111 12234578999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=252.14 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=136.4
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
....++|++++.||+|+||.||+++-++ |..+|+|++++. ...+.+..+.|-.+|...++|.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 4466899999999999999999999765 899999999873 345678899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
||||||++||++..+|. +...|+......++.+++.||.-||..+ +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999993 4566888888888899999999999988 99999999999999999999999999964
Q ss_pred e
Q 007120 592 F 592 (617)
Q Consensus 592 ~ 592 (617)
+
T Consensus 291 l 291 (550)
T KOG0605|consen 291 L 291 (550)
T ss_pred h
Confidence 4
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=259.96 Aligned_cols=176 Identities=29% Similarity=0.477 Sum_probs=150.4
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
.+.++..+.+.+.+.||+|+||+||+|.+. ..||||.+.. ...+..+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555667778899999999999999985 4799999975 344578899999999999999999999999998877
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.||+.+|++.+|+.+|+... ..++..+...|+.|||+||.|||.++ |||||||..||+|.+++.|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997644 45888999999999999999999988 9999999999999999999999999987
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.-..-..........|...|||||++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvI 562 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVI 562 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHH
Confidence 65433222233446688999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=254.45 Aligned_cols=173 Identities=24% Similarity=0.393 Sum_probs=149.0
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc----ch-hhHHHHHHHHHHHccCC-CCCccceEEEEEeCC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (617)
...+.|.+.+.||+|+||+|+.|... .+..||||.+.+. .. ...+.+.+|+.++++++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999864 4799999977552 11 23456778999999999 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCC
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGl 588 (617)
..++||||+.+|+|.+++.+ ...+.+.+...++.|++.|++|+|+.+ |+||||||+|||||.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999965 345777888999999999999999988 9999999999999999 9999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
+.... .......+.+||+.|+|||+|.
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~ 194 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLS 194 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhC
Confidence 99874 1122345678999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=230.78 Aligned_cols=173 Identities=29% Similarity=0.374 Sum_probs=149.2
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.+.++|++.+.||+|.||.||.|+.+. +-.||+|.+.+. ..+...++++|+++-+.|+||||+++++++.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 345689999999999999999999754 678999998652 2233567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|++||.+.|.|...|.+.. ...++......++.|+|.||.|+|..+ +|||||||+|+|++..+..||+|||.+..-
T Consensus 99 LilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999997533 344777888899999999999999876 999999999999999999999999999875
Q ss_pred CCCCcccccceeeeeccccCccCCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
+. ..-.+.+||+.|.||||.+
T Consensus 175 p~----~kR~tlcgt~dyl~pEmv~ 195 (281)
T KOG0580|consen 175 PS----NKRKTLCGTLDYLPPEMVE 195 (281)
T ss_pred CC----CCceeeecccccCCHhhcC
Confidence 42 2234688999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=245.73 Aligned_cols=169 Identities=26% Similarity=0.464 Sum_probs=151.7
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.+|++.+.||+|.||+|-+|+. ..|+.||||.+++ .+++..-.+++|+++|+.|+||||+.++.+|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4788889999999999999985 5699999999865 45566778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||..+|.|.+|+.+ ...+++++..+++.||..|+.|+|.+. ++|||||.+|||||.++++||+||||+-.+...
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999954 455899999999999999999999987 999999999999999999999999999887543
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
. ...+.+|++-|.+||.++
T Consensus 207 k---fLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVN 225 (668)
T ss_pred c---HHHHhcCCcccCCccccC
Confidence 3 355688999999999763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=245.76 Aligned_cols=173 Identities=29% Similarity=0.417 Sum_probs=142.7
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch--------------hhHHHHHHHHHHHccCCCCCccce
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------------QGLKELKNEVILFSKLQHRNLVKL 501 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 501 (617)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+..++|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999864 489999999965211 123578899999999999999999
Q ss_pred EEEEEeC--CeEEEEEecCCCCCHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 502 LGCCIQG--EEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 502 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
+.+.-+. +.+|||+|||..|.+... ....+ +...+..+++.++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9997664 468999999999887532 22333 889999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCceeeCCCCc---ccccceeeeeccccCccCC
Q 007120 579 MNPKISDFGLVRTFGGDET---EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 579 ~~~ki~DFGla~~~~~~~~---~~~~~~~~gt~~y~ape~~ 616 (617)
+++||+|||.+........ .....+.+||+.++|||+.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c 287 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELC 287 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhh
Confidence 9999999999987732211 1224457899999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=237.00 Aligned_cols=170 Identities=27% Similarity=0.371 Sum_probs=143.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchh--hHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ--GLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (617)
.+.|+.++.|++|.||.||+|+.+. ++.||+|+++...+. .--.-.+|+.+|.+++|||||.+-.+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4578889999999999999999754 789999999763321 122457899999999999999999887654 46899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|||||+ .+|..++.... ..+...+...++.|+++|++|||... |+||||||+|+|++..|.+||+||||||.++
T Consensus 155 VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999997 68999986533 55778888899999999999999987 9999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... ..+..+-|..|.|||++
T Consensus 229 sp~k--~~T~lVVTLWYRaPELL 249 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELL 249 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHh
Confidence 5432 23457789999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=251.57 Aligned_cols=177 Identities=27% Similarity=0.380 Sum_probs=144.6
Q ss_pred hhcCCccccceecccCcccEEEEEEc------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
...++|++.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+.++..+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34568999999999999999999742 24679999987532 33456789999999999 899999999998764
Q ss_pred C-eEEEEEecCCCCCHHHHHhcCCC-------------------------------------------------------
Q 007120 509 E-EKLLIYEFMPNKSLDSFIFDQTR------------------------------------------------------- 532 (617)
Q Consensus 509 ~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 532 (617)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999999864211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeec
Q 007120 533 ----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608 (617)
Q Consensus 533 ----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~ 608 (617)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 134778889999999999999999987 9999999999999999999999999999775443332233345678
Q ss_pred cccCccCC
Q 007120 609 CGTKAFLY 616 (617)
Q Consensus 609 ~y~ape~~ 616 (617)
.|+|||++
T Consensus 241 ~y~aPE~~ 248 (338)
T cd05102 241 KWMAPESI 248 (338)
T ss_pred cccCcHHh
Confidence 89999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=235.57 Aligned_cols=171 Identities=27% Similarity=0.392 Sum_probs=142.7
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCC-ccceEEEEEeCC------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 509 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 509 (617)
..|...++||+|.||+||+|+.. +|+.||+|++..... ..-....+|+.++++++|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666788999999999999964 488999999875322 12345678999999999999 999999998877
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
..++|+||++ .+|..++...... ..++......++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999996 7999999764432 45677889999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+...-.... ....++|..|.|||++
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvL 192 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVL 192 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHh
Confidence 9987533222 2346789999999964
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=242.88 Aligned_cols=175 Identities=27% Similarity=0.432 Sum_probs=145.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-----------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccc
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 500 (617)
.++|.+.++||+|+||.||++.+.+ +..||||.+... ......+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998532 336999998753 3344567999999999999999999
Q ss_pred eEEEEEeCCeEEEEEecCCCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 007120 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564 (617)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 564 (617)
+++++.+.+..++||||+++++|.+++.... ....+++...+.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 1134688899999999999999999987 99
Q ss_pred ecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 565 HrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||||||+||||++++.+||+|||+++.+.............++..|+|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 9999999999999999999999999876443332223334567889999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=253.11 Aligned_cols=172 Identities=28% Similarity=0.394 Sum_probs=148.0
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (617)
....++|.++++||+|.||+|+++.++. ++.+|||.+++. .....+..+.|.+++... +||.|++|+.++...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3456789999999999999999999865 788999999873 345677788888887766 59999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
+++||||+.||++..+. ....+++....-++..|+.||+|||+++ ||+||||.+|||||.+|++||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954333 3355888888889999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.-.... ..+.+.+||+.|||||.+
T Consensus 517 e~m~~g--~~TsTfCGTpey~aPEil 540 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGTPEFLAPEVL 540 (694)
T ss_pred ccCCCC--CccccccCChhhcChhhh
Confidence 754322 357789999999999976
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=249.04 Aligned_cols=169 Identities=29% Similarity=0.475 Sum_probs=151.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
...|...++||+|+.|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||+++..+..++.++.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 446777789999999999999854 4889999999876666677789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|++|+|.+.+. ...+++.+...|++++++||+|||.++ |||||||.+||||+.++.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999983 345899999999999999999999998 99999999999999999999999999999876665
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. -.+++||+.|||||++
T Consensus 425 K--R~TmVGTPYWMAPEVv 441 (550)
T KOG0578|consen 425 K--RSTMVGTPYWMAPEVV 441 (550)
T ss_pred c--cccccCCCCccchhhh
Confidence 3 3458899999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=236.57 Aligned_cols=175 Identities=26% Similarity=0.368 Sum_probs=151.2
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..+.|++.++||.|..++||+|+. +.+..||||++... .....+++++|+..|+.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346899999999999999999985 55899999998642 3344789999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
.||.+|++.+.++..-.. -+++..+..|.+++++||.|||.++ .||||||+.||||+++|.|||+|||.+-.+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999764333 3889999999999999999999998 999999999999999999999999988776443
Q ss_pred Ccc--cccceeeeeccccCccCC
Q 007120 596 ETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~--~~~~~~~gt~~y~ape~~ 616 (617)
... ...++.+||++|||||++
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred CceeeEeeccccCcccccChHHh
Confidence 322 112567899999999983
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=248.91 Aligned_cols=148 Identities=27% Similarity=0.396 Sum_probs=132.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||++.... ++.||||.+++.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478889999999999999998754 7899999997532 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999954 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=249.71 Aligned_cols=175 Identities=20% Similarity=0.236 Sum_probs=148.6
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
.+....++|++.+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 334456789999999999999999999764 788999998642 2233456889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999999853 23688888999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+..... .......||..|+|||++
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~ 215 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVL 215 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHH
Confidence 98743322 122346799999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=244.82 Aligned_cols=167 Identities=23% Similarity=0.313 Sum_probs=145.9
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+++... ++.||||.+.+. .....+.+.+|+.++++++||||+++++.+.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3578889999999999999999864 789999998652 223456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999854 335788888899999999999999987 99999999999999999999999999998743
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ....||+.|+|||++
T Consensus 171 ~~-----~~~~gt~~y~aPE~~ 187 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVI 187 (329)
T ss_pred Cc-----ceecCChhhcCHHHH
Confidence 22 235799999999976
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=248.61 Aligned_cols=148 Identities=26% Similarity=0.385 Sum_probs=132.8
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 4889999999752 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999854 335889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=245.11 Aligned_cols=168 Identities=24% Similarity=0.314 Sum_probs=145.6
Q ss_pred hcCCccccceecccCcccEEEEEEcC--CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|.... +..||+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578999999999999999998654 368999998642 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999954 335789999999999999999999987 999999999999999999999999999986
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~ 200 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEIL 200 (340)
T ss_pred CCC-----cceecCChhhcCHHHH
Confidence 432 2246799999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-28 Score=238.41 Aligned_cols=165 Identities=29% Similarity=0.410 Sum_probs=133.5
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-----EEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----KLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV 514 (617)
.|+..+++|+|+||.||+|.+.. ++.||||++-...+ .-.+|+++|++++|||||+|+-++..... .-||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999865 68999999854222 22468999999999999999998875432 2489
Q ss_pred EecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCceee
Q 007120 515 YEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla~~~ 592 (617)
||||| .+|..+++... .+..++.....-+..||.+||.|||+.+ |+||||||+|+|+|.+ +.+||+|||.||.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 58888886421 2344666667778999999999999987 9999999999999976 89999999999999
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...+.. ....-|+-|.|||++
T Consensus 177 ~~~epn---iSYicSRyYRaPELi 197 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELI 197 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHH
Confidence 765543 346678999999975
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=203.06 Aligned_cols=109 Identities=50% Similarity=1.141 Sum_probs=104.4
Q ss_pred EEeCCCCCccccC-CCCCCCCceEEEEEecCceeEEEEEecCCceEEEEEEeeecceEEEEEEecCCCcEEEEeeecCCC
Q 007120 154 YRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQ 232 (617)
Q Consensus 154 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~l~~~~~~~~~~~w~~~~~~~~~~ 232 (617)
||+|+|+|..|++ |+|.....+.+.|+.++++.+++|...+.+.+.|++||.+| .+++|.|++..++|.+.|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999 99998888999999999999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCceeeccCCCCcccccCCceeCC
Q 007120 233 CDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263 (617)
Q Consensus 233 C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 263 (617)
||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999888888999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=248.66 Aligned_cols=146 Identities=25% Similarity=0.376 Sum_probs=130.2
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|++.+.||+|+||+||+|+... ++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998754 789999999652 23445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999854 335788888889999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=243.81 Aligned_cols=166 Identities=27% Similarity=0.383 Sum_probs=145.6
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+|+... ++.||||++++.. ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468899999999999999999864 7899999997532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999953 345788899999999999999999987 99999999999999999999999999987643
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
......||+.|+|||++
T Consensus 154 ----~~~~~~gt~~y~aPE~~ 170 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVL 170 (333)
T ss_pred ----ccCCcccCccccChhHh
Confidence 22345689999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=248.01 Aligned_cols=147 Identities=26% Similarity=0.371 Sum_probs=130.7
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++... +++.||||.+.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 4889999998652 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999854 345788888889999999999999987 999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=240.56 Aligned_cols=166 Identities=22% Similarity=0.297 Sum_probs=144.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 48899999986422 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999854 345788999999999999999999987 999999999999999999999999999876432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 155 -----~~~~~gt~~y~aPE~~ 170 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVI 170 (291)
T ss_pred -----cccccCChhhcCHHHH
Confidence 2235689999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=240.54 Aligned_cols=163 Identities=23% Similarity=0.246 Sum_probs=140.0
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||++... +++.||||.+++. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 4889999998752 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccc
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~ 601 (617)
+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99999854 345789999999999999999999987 9999999999999999999999999998643222 123
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....||+.|+|||++
T Consensus 153 ~~~~gt~~y~aPE~~ 167 (323)
T cd05571 153 KTFCGTPEYLAPEVL 167 (323)
T ss_pred cceecCccccChhhh
Confidence 346799999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.91 Aligned_cols=177 Identities=20% Similarity=0.236 Sum_probs=149.8
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEe
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
..++....++|++.+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 33445556899999999999999999999864 788999998642 22334567899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999853 23678888889999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+...... ......||+.|+|||++
T Consensus 188 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l 215 (371)
T cd05622 188 TCMKMNKEGMV-RCDTAVGTPDYISPEVL 215 (371)
T ss_pred ceeEcCcCCcc-cccCcccCccccCHHHH
Confidence 99987543221 22346799999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=235.54 Aligned_cols=169 Identities=28% Similarity=0.340 Sum_probs=144.0
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|+..+.||+|+||.||++... +++.||||.+.+.. ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999874 58999999986422 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998875422 335789999999999999999999987 9999999999999999999999999999864332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||..|+|||++
T Consensus 157 ~---~~~~~g~~~y~aPE~~ 173 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVI 173 (285)
T ss_pred e---ecCCCCCCCccCHhhh
Confidence 2 2235689999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=246.85 Aligned_cols=172 Identities=22% Similarity=0.249 Sum_probs=146.3
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
...++|++.+.||+|+||.||+++... ++.||+|.+++. .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345689999999999999999999754 789999998642 2233456789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999853 23677888889999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ......||+.|+|||++
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~~ 215 (370)
T cd05596 193 DANGMV-RCDTAVGTPDYISPEVL 215 (370)
T ss_pred cCCCcc-cCCCCCCCcCeECHHHh
Confidence 543221 12345699999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=246.44 Aligned_cols=146 Identities=25% Similarity=0.383 Sum_probs=129.8
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|+..+.||+|+||.||+|+... ++.||||.+.+.. ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58888999999999999998754 7889999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999854 235788888889999999999999987 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=240.37 Aligned_cols=171 Identities=22% Similarity=0.276 Sum_probs=147.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++... +++.||||.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999875 4889999999753 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999653 245889999999999999999999987 999999999999999999999999999987544
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~ 175 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVL 175 (330)
T ss_pred Cce-eeecccCCccccCHHHh
Confidence 332 22335689999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=245.70 Aligned_cols=147 Identities=24% Similarity=0.380 Sum_probs=130.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.+|++.+.||+|+||.||+++... ++.||||.+.+.. ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999998754 7899999986522 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999954 345788888889999999999999987 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=239.71 Aligned_cols=171 Identities=23% Similarity=0.279 Sum_probs=146.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++.... ++.||||.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 478899999999999999999754 889999998642 2234556889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 345788899999999999999999987 999999999999999999999999999876543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~ 175 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEIL 175 (331)
T ss_pred CCc-cccceeccccccCHHHH
Confidence 321 12235699999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=239.33 Aligned_cols=163 Identities=24% Similarity=0.261 Sum_probs=140.2
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||++... +++.||||.+.+. .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 4889999998752 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccc
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~ 601 (617)
+|..++.. ...+++.+...++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 99988853 345789999999999999999999987 99999999999999999999999999986432221 22
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....||..|+|||++
T Consensus 153 ~~~~gt~~y~aPE~~ 167 (328)
T cd05593 153 KTFCGTPEYLAPEVL 167 (328)
T ss_pred ccccCCcCccChhhh
Confidence 345699999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=250.82 Aligned_cols=173 Identities=17% Similarity=0.208 Sum_probs=147.8
Q ss_pred CccccceecccCcccEEEEEEcC--CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.|.+.+.||+|+||.||+|.... ++.||+|++..........+++|+.+++.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999998643 5678888776545555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 519 PNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 519 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++|+|.++|... .....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23446889999999999999999999987 99999999999999999999999999998754433
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
........||+.|+|||++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~ 243 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELW 243 (478)
T ss_pred cccccccCCCccccCHhHh
Confidence 2233456799999999976
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=239.60 Aligned_cols=171 Identities=22% Similarity=0.244 Sum_probs=146.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+++... ++.||+|.+.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999754 788999998652 2233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 235788889999999999999999987 999999999999999999999999999887544
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~ 175 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEIL 175 (331)
T ss_pred Cce-eeccccCCcccCCHHHH
Confidence 322 12235699999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=245.72 Aligned_cols=177 Identities=29% Similarity=0.368 Sum_probs=145.6
Q ss_pred hhcCCccccceecccCcccEEEEEE------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
...++|++.+.||+|+||.||+|+. ..+..||||+++.. .....+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455789999999999999999974 22568999998653 233456788999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC--------------------------------------------------------
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (617)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864211
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 533 ----------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 533 ----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 124788999999999999999999987 9999999999999999999999999999875443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.........++..|+|||++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred cccccCCCCCCcceeChhHh
Confidence 32222223456789999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=238.20 Aligned_cols=163 Identities=23% Similarity=0.252 Sum_probs=139.6
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||++... +++.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999875 4889999998752 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccc
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~ 601 (617)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 99988854 345789999999999999999999987 99999999999999999999999999986432221 12
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....||..|+|||++
T Consensus 153 ~~~~gt~~y~aPE~~ 167 (323)
T cd05595 153 KTFCGTPEYLAPEVL 167 (323)
T ss_pred ccccCCcCcCCcccc
Confidence 235689999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=237.24 Aligned_cols=161 Identities=25% Similarity=0.278 Sum_probs=139.1
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||.||++...+ ++.||+|.+++. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999764 789999998652 234456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 999854 335789999999999999999999987 99999999999999999999999999986533222 2334
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
..||+.|+|||++
T Consensus 153 ~~gt~~y~aPE~~ 165 (312)
T cd05585 153 FCGTPEYLAPELL 165 (312)
T ss_pred ccCCcccCCHHHH
Confidence 6799999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=236.46 Aligned_cols=163 Identities=23% Similarity=0.248 Sum_probs=138.8
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||++... +++.||+|.+++. .......+..|+.++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 4889999998752 2234567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 99988843 3458899999999999999999997 55 99999999999999999999999999986533222 1
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (325)
T cd05594 153 MKTFCGTPEYLAPEVL 168 (325)
T ss_pred cccccCCcccCCHHHH
Confidence 2345699999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=237.88 Aligned_cols=171 Identities=20% Similarity=0.244 Sum_probs=145.5
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999865 678999998642 2233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 235788889999999999999999987 999999999999999999999999999876433
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~ 175 (332)
T cd05623 156 GTV-QSSVAVGTPDYISPEIL 175 (332)
T ss_pred Ccc-eecccccCccccCHHHH
Confidence 221 22335699999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=241.27 Aligned_cols=148 Identities=28% Similarity=0.403 Sum_probs=131.8
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++.... ++.||||.+... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999998754 789999998652 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999854 345788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=243.93 Aligned_cols=157 Identities=31% Similarity=0.446 Sum_probs=137.7
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
+.++-||.|+-|.||+|++ .++.||||+++..++ .++.-|++|+||||+.+.|+|.+..-++||||||+.|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3446899999999999999 468999998865332 46778899999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccc
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~ 602 (617)
|...|+. ...+.......+..+||.||.|||.+. |||||||.-||||+.+..|||+|||.++.+....+ .-
T Consensus 199 L~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kM 269 (904)
T KOG4721|consen 199 LYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KM 269 (904)
T ss_pred HHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh---hh
Confidence 9999954 455777888999999999999999987 99999999999999999999999999998865432 22
Q ss_pred eeeeeccccCccCC
Q 007120 603 RVVGTYCGTKAFLY 616 (617)
Q Consensus 603 ~~~gt~~y~ape~~ 616 (617)
..+||..|||||+|
T Consensus 270 SFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVI 283 (904)
T ss_pred hhhhhHhhhCHHHh
Confidence 47899999999987
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=241.49 Aligned_cols=171 Identities=26% Similarity=0.366 Sum_probs=147.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+++.. +++.||||++++. .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 4889999998752 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999643 45889999999999999999999987 999999999999999999999999999877543
Q ss_pred C---------------------------cccccceeeeeccccCccCC
Q 007120 596 E---------------------------TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~---------------------------~~~~~~~~~gt~~y~ape~~ 616 (617)
. .........||..|+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 3 01122345699999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=242.72 Aligned_cols=178 Identities=28% Similarity=0.359 Sum_probs=147.0
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCCccceEEEEEe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 507 (617)
....++|.+.++||+|+||.||+|+... +..||||+++.. .....+.+.+|+.+++++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4456789999999999999999998532 347999999753 3334567999999999996 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCC-------------------------------------------------------
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTR------------------------------------------------------- 532 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 532 (617)
....+|||||+++|+|.++|.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864210
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 533 --------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 533 --------------------------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124778888999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++++.+||+|||+++.+.............++..|+|||.+
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 999999999999999987544332223334567889999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=236.96 Aligned_cols=169 Identities=25% Similarity=0.331 Sum_probs=143.3
Q ss_pred CccccceecccCcccEEEEEEc----CCcEEEEEEeccc----chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (617)
+|++.+.||+|+||.||+++.. .++.||+|.+.+. .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999753 4789999998652 123345688899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 345788999999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...... ......||..|+|||++
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEII 178 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHh
Confidence 6433322 23346799999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=231.88 Aligned_cols=169 Identities=26% Similarity=0.375 Sum_probs=142.8
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999875 47899999986432 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 98 5899888542 335788899999999999999999987 99999999999999999999999999987643222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....+|..|+|||++
T Consensus 159 ~--~~~~~~~~~y~aPE~~ 175 (288)
T cd07871 159 T--YSNEVVTLWYRPPDVL 175 (288)
T ss_pred c--ccCceecccccChHHh
Confidence 1 2235689999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=235.31 Aligned_cols=163 Identities=28% Similarity=0.370 Sum_probs=138.2
Q ss_pred ceecccCcccEEEEEEc----CCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+.||+|+||.||++... .++.||||.+++.. ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 47889999987521 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+.+.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999854 345678888889999999999999987 99999999999999999999999999986533222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||++
T Consensus 156 --~~~~~~gt~~y~aPE~~ 172 (323)
T cd05584 156 --VTHTFCGTIEYMAPEIL 172 (323)
T ss_pred --cccccCCCccccChhhc
Confidence 12335699999999986
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=242.85 Aligned_cols=177 Identities=30% Similarity=0.400 Sum_probs=144.8
Q ss_pred hhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
...++|++.+.||+|+||.||+++.. ++..||||+++.. .....+.+.+|+.+++.+ +|+|||+++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44568899999999999999999742 2357999999753 233456788999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC--------------------------------------------------------
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (617)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999854210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccc
Q 007120 533 -----------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (617)
Q Consensus 533 -----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~ 601 (617)
...+++.+..+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 124788889999999999999999987 999999999999999999999999999876543322222
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....++..|+|||++
T Consensus 272 ~~~~~~~~y~aPE~~ 286 (374)
T cd05106 272 GNARLPVKWMAPESI 286 (374)
T ss_pred cCCCCccceeCHHHh
Confidence 223456789999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=241.62 Aligned_cols=177 Identities=27% Similarity=0.413 Sum_probs=150.7
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
+++..+.++.+..+||-|.||.||.|.++. .-.||||.++. +.-..++|+.|+.+|+.|+|||+|+|+|+|....+.|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344445567777899999999999999976 67899999976 4456899999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||+|||.+|+|.+||++.. +..++....+.|+.||+.||+||...+ +|||||.++|+|+.++..+||+||||+|++
T Consensus 340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999998754 345788888999999999999999877 999999999999999999999999999999
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.++....-.. ..-...|+|||-+
T Consensus 416 tgDTYTAHAG-AKFPIKWTAPEsL 438 (1157)
T KOG4278|consen 416 TGDTYTAHAG-AKFPIKWTAPESL 438 (1157)
T ss_pred cCCceecccC-ccCcccccCcccc
Confidence 8775432111 1123568899864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=242.42 Aligned_cols=168 Identities=25% Similarity=0.365 Sum_probs=148.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.-|++++.||.|+.|.|-.|++. .|+.+|||.+.+. .......+.+|+.+|+-|.|||++++++.+.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999874 5999999999764 2233556889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|-|.++|. +++.+++++..+++.||+.|+.|+|..+ |+||||||+|+|||.+.++||+|||+|-+-.++
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 3566889999999999999999999987 999999999999999999999999999875443
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
. ...+.+|++.|.+||.+
T Consensus 166 k---lLeTSCGSPHYA~PEIV 183 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIV 183 (786)
T ss_pred c---cccccCCCcccCCchhh
Confidence 3 25568899999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=234.12 Aligned_cols=164 Identities=29% Similarity=0.433 Sum_probs=139.4
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
++||+|.||+||-|+++. |+.||||.+.+. .......+++|+.+|.+++||.||.|...|+..+..+.|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 789999999999999754 999999999763 33455789999999999999999999999999999999999996 55
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeecCCceeeCCCCccc
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DFGla~~~~~~~~~~ 599 (617)
..+.+... ....++++....++.||+.||.|||.++ |+|+||||+||||.+. -++||+|||+||++++...
T Consensus 649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 55555442 3445788888889999999999999988 9999999999999653 4799999999999976544
Q ss_pred ccceeeeeccccCccCCC
Q 007120 600 NTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~~ 617 (617)
-..++||+.|+|||++.
T Consensus 723 -RrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLR 739 (888)
T ss_pred -hhhhcCCccccCHHHHh
Confidence 33578999999999863
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=252.07 Aligned_cols=180 Identities=28% Similarity=0.374 Sum_probs=149.4
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcCC-cEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEE-Ee---C
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCC-IQ---G 508 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~---~ 508 (617)
+.....++++.+.|.+|||+.||.|+...+ .++|+|++-..++...+..++|+.+|++|. |+|||.+++.. .. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 344556788889999999999999998776 999999987668888999999999999997 99999999932 21 1
Q ss_pred ---CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 509 ---EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 509 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
-+.+|+||||++|.|-+++..+.... |++.++++|+.++++|+++||... ++|||||||.+||||+.+++.||+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 25689999999999999997654444 899999999999999999999984 7899999999999999999999999
Q ss_pred cCCceeeCCCC-cc-------cccceeeeeccccCccCCC
Q 007120 586 FGLVRTFGGDE-TE-------GNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 586 FGla~~~~~~~-~~-------~~~~~~~gt~~y~ape~~~ 617 (617)
||.|.-..... .. ... ....|+.|.+|||+|
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI-~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEI-EKYTTPQYRSPEMID 228 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHH-HhhCCccccChHHHh
Confidence 99886432211 11 011 134789999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=234.36 Aligned_cols=166 Identities=28% Similarity=0.372 Sum_probs=138.7
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHH---ccCCCCCccceEEEEEeCCeEEEE
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
|++.+.||+|+||.||++... +++.||||.+++.. ....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999875 48899999997532 23345566666554 677899999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988742 35899999999999999999999987 99999999999999999999999999986432
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 154 ~~~--~~~~~~g~~~y~aPE~~ 173 (324)
T cd05589 154 FGD--RTSTFCGTPEFLAPEVL 173 (324)
T ss_pred CCC--cccccccCccccCHhHh
Confidence 221 22346799999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.72 Aligned_cols=168 Identities=24% Similarity=0.284 Sum_probs=141.3
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCC-CccceEEEEEeCCeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 515 (617)
+|++.+.||+|+||.||+|...+ ++.||||.+.+. .....+.+..|..++..++|+ +|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999999765 678999998752 233456788899999999765 5888999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999854 334788999999999999999999987 999999999999999999999999999864222
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||..|+|||++
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~ 173 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEII 173 (324)
T ss_pred CC--ceeeecCCccccChhhh
Confidence 11 23345699999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=231.79 Aligned_cols=170 Identities=28% Similarity=0.370 Sum_probs=142.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 588999999865322 233467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 6787777542 345788889999999999999999987 9999999999999999999999999998754322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......||+.|+|||++
T Consensus 158 ~--~~~~~~~~~~y~aPE~~ 175 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVL 175 (303)
T ss_pred c--cCCCCcccCCCCChHHH
Confidence 2 12235688999999965
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=234.01 Aligned_cols=171 Identities=29% Similarity=0.473 Sum_probs=142.2
Q ss_pred CCccccceecccCcccEEEEEEcC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.+|++.+.||+|+||.||+|++.. +. .||||.++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468899999999999999998643 33 4899998653 334567899999999999999999999999865 5679
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999653 335788999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............++..|++||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~ 183 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESI 183 (316)
T ss_pred CCCcceeccCCccceeecChHHh
Confidence 54433222223356789999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.60 Aligned_cols=169 Identities=24% Similarity=0.285 Sum_probs=146.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+++... +..+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999764 788999988653 33445679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++.+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999954 234788999999999999999999853 39999999999999999999999999998764322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||.+
T Consensus 159 ----~~~~~g~~~y~aPE~~ 174 (331)
T cd06649 159 ----ANSFVGTRSYMSPERL 174 (331)
T ss_pred ----cccCCCCcCcCCHhHh
Confidence 2335689999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=244.92 Aligned_cols=171 Identities=29% Similarity=0.417 Sum_probs=145.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------eEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 512 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 512 (617)
.+...+.||+|+||.||+|+.+ .|+.||||.+.+.. ....+..-+|++++++++|+|||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445579999999999999964 49999999997632 334566789999999999999999999865544 457
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE--cCCC--CeEEeecCC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGL 588 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--~~~~--~~ki~DFGl 588 (617)
+|||||.+|||...|.+..+..-+++.+.+.+..++..||.|||+++ ||||||||.||++ .++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988777788999999999999999999999987 9999999999998 2334 479999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
||.+..++ ......||..|++||+++
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHh
Confidence 99997665 345688999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.52 Aligned_cols=168 Identities=25% Similarity=0.294 Sum_probs=140.7
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+|++.+.||+|+||.||+|.... ++.||||.+++.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999998764 6799999987522 23345567777877776 6899999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998854 234788999999999999999999987 999999999999999999999999999865322
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||+.|+|||++
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~ 173 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEII 173 (323)
T ss_pred CC--ccccCCCChhhcCHHHh
Confidence 21 23345689999999976
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=233.79 Aligned_cols=163 Identities=23% Similarity=0.299 Sum_probs=137.9
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... ++.||+|.+++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 789999998752 223455678888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 999988854 345889999999999999999999987 99999999999999999999999999986432221 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (329)
T cd05618 153 TSTFCGTPNYIAPEIL 168 (329)
T ss_pred cccccCCccccCHHHH
Confidence 2346799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=235.54 Aligned_cols=170 Identities=26% Similarity=0.385 Sum_probs=149.8
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccch---hhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 511 (617)
.....|++.+.||+|.||.||+++.+. |+.+|+|.+++... ...+.+.+|+.+|+++. |||||.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999876 89999999976333 23468999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC----CCeEEeecC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFG 587 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~----~~~ki~DFG 587 (617)
++|||++.+|.|.+.+... . +++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999654 2 899999999999999999999987 9999999999999543 479999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|+.... ......++||+.|+|||++
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl 210 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVL 210 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhh
Confidence 9999876 2235678999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=229.91 Aligned_cols=170 Identities=21% Similarity=0.345 Sum_probs=143.7
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||+++... ++.||||+++.. .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999999864 788999998653 22345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2345788999999999999999999887 9999999999999999999999999999875332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||..|+|||++
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~ 173 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELL 173 (287)
T ss_pred cc-cccccccccccCCcHHH
Confidence 22 22345789999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=220.16 Aligned_cols=169 Identities=25% Similarity=0.373 Sum_probs=145.8
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----c---hhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----S---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
-+.|...+.||.|..+.|-++..+. +++.|+|++... . ....++-+.|+.+|+++ -||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3467777899999999999888654 789999988531 1 12235567899999998 699999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...++|+|.|+.|.|.++|. +.-.+++++..+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999994 4556889999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|..+.+.+. ....+||++|+|||.+
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEti 194 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETI 194 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhhe
Confidence 999976553 4468899999999975
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=233.64 Aligned_cols=163 Identities=23% Similarity=0.298 Sum_probs=138.7
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... ++.||||.+++. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999754 789999999752 223456688999999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999988853 345899999999999999999999987 9999999999999999999999999998532211 12
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (329)
T cd05588 153 TSTFCGTPNYIAPEIL 168 (329)
T ss_pred cccccCCccccCHHHH
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=236.64 Aligned_cols=165 Identities=27% Similarity=0.370 Sum_probs=140.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|+..+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999875 4889999998653 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.... ..++.....++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 2466778889999999999999987 99999999999999999999999999998753321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||++
T Consensus 224 --~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERI 240 (353)
T ss_pred --cccccccCccccCcccc
Confidence 12345799999999976
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=226.03 Aligned_cols=172 Identities=25% Similarity=0.376 Sum_probs=143.4
Q ss_pred cCCccccceecccCcccEEEEEEc----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.. .....+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357888999999999999999863 3568999998753 23445679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999642 245789999999999999999999987 9999999999999999999999999877643
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .......++..|+|||.+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~ 180 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAI 180 (266)
T ss_pred ccch-hcccCCCCceeecCHHHH
Confidence 2211 111123356789999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=238.46 Aligned_cols=165 Identities=19% Similarity=0.254 Sum_probs=140.4
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...+|++.+.||+|+||.||++.... ++.||||... ...+.+|+.++++++|||||++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 44689999999999999999999754 7899999653 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
++. ++|..++.. ...+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+......
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 788888844 235789999999999999999999987 9999999999999999999999999998643222
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||+.|+|||++
T Consensus 237 ~~-~~~~~~gt~~y~aPE~~ 255 (391)
T PHA03212 237 AN-KYYGWAGTIATNAPELL 255 (391)
T ss_pred cc-ccccccCccCCCChhhh
Confidence 11 22345799999999976
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=231.96 Aligned_cols=163 Identities=28% Similarity=0.349 Sum_probs=135.5
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHcc-CCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|...+ ++.||||.++.. .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999754 788999998752 12334455566666654 5899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999998854 235788899999999999999999987 9999999999999999999999999998754322 22
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (316)
T cd05592 153 ASTFCGTPDYIAPEIL 168 (316)
T ss_pred cccccCCccccCHHHH
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=232.31 Aligned_cols=163 Identities=27% Similarity=0.295 Sum_probs=139.3
Q ss_pred ceecccCcccEEEEEE----cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 446 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
+.||+|+||.||++.. ..++.||+|.+.+.. ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 247899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999999854 345899999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||++
T Consensus 154 ~~~~~~g~~~y~aPE~~ 170 (318)
T cd05582 154 KAYSFCGTVEYMAPEVV 170 (318)
T ss_pred ceecccCChhhcCHHHH
Confidence 22345689999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=231.84 Aligned_cols=163 Identities=26% Similarity=0.293 Sum_probs=135.1
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHH-HHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||+||+|... +++.||||.+.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 48899999986521 222344445544 56889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999998854 345788899999999999999999987 9999999999999999999999999998643222 12
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (323)
T cd05575 153 TSTFCGTPEYLAPEVL 168 (323)
T ss_pred cccccCChhhcChhhh
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=245.94 Aligned_cols=178 Identities=20% Similarity=0.273 Sum_probs=148.5
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC---
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 509 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 509 (617)
....++|.+.+.||+|+||+||++... +++.||||.+.. ........+.+|+..+..++|+||+++...+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334569999999999999999999864 589999999864 23445667889999999999999999988775432
Q ss_pred -----eEEEEEecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 510 -----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 510 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3579999999999999986532 2356889999999999999999999987 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+.............||..|+|||++
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 217 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHh
Confidence 999999987544333333456799999999976
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=233.35 Aligned_cols=169 Identities=24% Similarity=0.294 Sum_probs=145.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999864 788999987653 33445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ...+++.....++.+++.||.|||+.. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999954 335788899999999999999999742 39999999999999999999999999998764321
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 159 ----~~~~~~~~~y~aPE~~ 174 (333)
T cd06650 159 ----ANSFVGTRSYMSPERL 174 (333)
T ss_pred ----cccCCCCccccCHHHh
Confidence 2234689999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=227.07 Aligned_cols=174 Identities=29% Similarity=0.460 Sum_probs=145.0
Q ss_pred CCccccceecccCcccEEEEEEc-----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|++.+.||+|+||.||+|... .+..|++|.+... .......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999999852 3578999999753 33445688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 514 IYEFMPNKSLDSFIFDQTR--------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
||||+++++|.+++..... ...+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 234788999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||+++.+.............++..|+|||++
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI 198 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHh
Confidence 9999999999876543322222334467789999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=232.28 Aligned_cols=163 Identities=24% Similarity=0.311 Sum_probs=137.6
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|+... ++.||||.+++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999765 789999998752 223455677888888765 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999988854 335788899999999999999999987 99999999999999999999999999986532222 1
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (321)
T cd05591 153 TTTFCGTPDYIAPEIL 168 (321)
T ss_pred ccccccCccccCHHHH
Confidence 2345689999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=224.40 Aligned_cols=170 Identities=28% Similarity=0.424 Sum_probs=144.3
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEe-----CCeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GEEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 511 (617)
..|...+.||+|+||.|.++.... ++.||||++.. ......+...+|+.+++.++|+||+.+...... -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 345556899999999999998754 89999999974 344567788899999999999999999999865 3457
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
|+|+|+| ..+|...++. ...++......++.|+++||.|+|+.+ |+||||||.|+|++.+...||+||||||.
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 4789988853 344788888889999999999999988 99999999999999999999999999999
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.........+..+-|+.|.|||++
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHH
Confidence 8655334445668889999999964
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=232.32 Aligned_cols=163 Identities=28% Similarity=0.353 Sum_probs=137.8
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... ++.||||.+++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999754 789999998752 223456677888888776 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 999998854 235788999999999999999999987 99999999999999999999999999986432221 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (320)
T cd05590 153 TSTFCGTPDYIAPEIL 168 (320)
T ss_pred ccccccCccccCHHHH
Confidence 3345799999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=226.94 Aligned_cols=169 Identities=28% Similarity=0.345 Sum_probs=143.7
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
+|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999874 47899999986422 2223557889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888643 2345899999999999999999999987 9999999999999999999999999998864332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||..|+|||++
T Consensus 157 ~---~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVV 173 (285)
T ss_pred c---cccccCCCCccCcHHh
Confidence 2 1234689999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=225.29 Aligned_cols=169 Identities=36% Similarity=0.545 Sum_probs=139.6
Q ss_pred ccceecccCcccEEEEEEc-----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 444 INNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+.+.||+|.||.||+|.+. .+..|+||.++.. .....+.|.+|+..+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4579999999999999987 2578999999653 334578999999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++|+|.++|... ....+++..++.|+.|||+||.|||+.+ |+|+||+++||||++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2355899999999999999999999987 99999999999999999999999999998743333
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
............|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~ 177 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVL 177 (259)
T ss_dssp EEESTTSESGGGGS-HHHH
T ss_pred ccccccccccccccccccc
Confidence 2222334567889999964
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=231.79 Aligned_cols=163 Identities=26% Similarity=0.297 Sum_probs=135.4
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHH-HHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++... +++.||||.+.+. ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 4889999998652 2233345555554 57789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 999988853 345789999999999999999999987 99999999999999999999999999986432211 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (325)
T cd05604 153 TTTFCGTPEYLAPEVI 168 (325)
T ss_pred cccccCChhhCCHHHH
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=226.52 Aligned_cols=164 Identities=30% Similarity=0.370 Sum_probs=139.6
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||+||++... +++.||||.+.+.. ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 47899999986522 22346678899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccc
Q 007120 524 DSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602 (617)
Q Consensus 524 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~ 602 (617)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98875422 3346899999999999999999999987 999999999999999999999999999877543322 23
Q ss_pred eeeeeccccCccCC
Q 007120 603 RVVGTYCGTKAFLY 616 (617)
Q Consensus 603 ~~~gt~~y~ape~~ 616 (617)
...||+.|+|||++
T Consensus 156 ~~~g~~~y~aPE~~ 169 (280)
T cd05608 156 GYAGTPGFMAPELL 169 (280)
T ss_pred ccCCCcCccCHHHh
Confidence 35689999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=226.75 Aligned_cols=176 Identities=25% Similarity=0.419 Sum_probs=145.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..++|++.+.||+|+||.||+|.... +..||||.+... ......++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998632 467999988643 22345678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864221 234678889999999999999999987 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+.............++..|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence 999999876543332222223457789999975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=231.93 Aligned_cols=168 Identities=25% Similarity=0.310 Sum_probs=140.7
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (617)
+|+..+.||+|+||.||++... +++.||||.+++. .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 4789999998752 2234456788888888885 577888999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999854 345889999999999999999999987 999999999999999999999999999865332
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||..|+|||++
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEII 173 (323)
T ss_pred Cc--cccCccCCccccCHHHH
Confidence 21 12335689999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=236.31 Aligned_cols=172 Identities=24% Similarity=0.398 Sum_probs=151.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-EEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 515 (617)
++|..+++||+|+||.++..+++. +..+++|++.. ......+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578888999999999999988754 67899998864 334445578899999999999999999999999988 89999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
+|++||+|.+.+.... ...+++...+.++.|++.|+.|||+.. |+|||||+.|||++.+..|||+|||+||.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997644 567899999999999999999999776 999999999999999999999999999999776
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
... .....||+-|+.||++.
T Consensus 160 ~~~--a~tvvGTp~YmcPEil~ 179 (426)
T KOG0589|consen 160 DSL--ASTVVGTPYYMCPEILS 179 (426)
T ss_pred hhh--hheecCCCcccCHHHhC
Confidence 533 44588999999999863
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=233.82 Aligned_cols=169 Identities=24% Similarity=0.390 Sum_probs=139.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (617)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 4889999998642 2234457889999999999999999999986533 479
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 689888843 335889999999999999999999987 999999999999999999999999999875
Q ss_pred CCCCcc-cccceeeeeccccCccCC
Q 007120 593 GGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||..|+|||++
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~ 178 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELC 178 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHH
Confidence 432221 122345689999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=222.45 Aligned_cols=173 Identities=28% Similarity=0.393 Sum_probs=146.7
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|++|.||+|...+++.||||.++... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788899999999999999998778899999987532 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999996533 345799999999999999999999987 99999999999999999999999999998753322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......+..|+|||++
T Consensus 159 ~~-~~~~~~~~~y~aPE~~ 176 (261)
T cd05068 159 EA-REGAKFPIKWTAPEAA 176 (261)
T ss_pred cc-cCCCcCceeccCcccc
Confidence 11 1112234579999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-27 Score=249.02 Aligned_cols=154 Identities=33% Similarity=0.567 Sum_probs=134.2
Q ss_pred ccccceecccCcccEEEEEE-cCC----cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 442 FSINNKLGEGGFGPVYKGTL-VDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~-~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+...++||+|+||+||+|.+ ++| -+||||.+.. ...+...++.+|+.+|.+++||||+||+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457999999999999986 333 3689998865 34456789999999999999999999999998776 88999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
+||+.|.|.+|++. .+..+..+..+.|..|||+||.|||++. ++||||.++||||.+-.++||.|||+|+.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999976 3455788999999999999999999886 999999999999999999999999999999877
Q ss_pred Cccccc
Q 007120 596 ETEGNT 601 (617)
Q Consensus 596 ~~~~~~ 601 (617)
+.+...
T Consensus 852 ~~ey~~ 857 (1177)
T KOG1025|consen 852 EKEYSA 857 (1177)
T ss_pred cccccc
Confidence 765543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=230.68 Aligned_cols=163 Identities=26% Similarity=0.296 Sum_probs=134.4
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHH-HHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
++||+|+||.||+++... ++.||+|.+.+.. ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999754 7899999986522 22234455555 467889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|..++.. ...++......++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888853 344778888889999999999999987 9999999999999999999999999998643222 12
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (321)
T cd05603 153 TSTFCGTPEYLAPEVL 168 (321)
T ss_pred cccccCCcccCCHHHh
Confidence 3346789999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=222.63 Aligned_cols=170 Identities=26% Similarity=0.396 Sum_probs=144.3
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
++|++.+.||+|+||.||++.+.++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 467888999999999999999988889999988642 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999986422 35789999999999999999999987 9999999999999999999999999998764332221
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 158 -~~~~~~~~~y~aPE~~ 173 (256)
T cd05114 158 -SSGAKFPVKWSPPEVF 173 (256)
T ss_pred -cCCCCCchhhCChhhc
Confidence 1223356689999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=229.51 Aligned_cols=163 Identities=27% Similarity=0.332 Sum_probs=136.4
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|+..+ ++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999765 7899999987531 2334556677777765 5999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++.+...++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 999999854 345788999999999999999999987 99999999999999999999999999986432221 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (316)
T cd05619 153 TCTFCGTPDYIAPEIL 168 (316)
T ss_pred eeeecCCccccCHHHH
Confidence 3346789999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=249.57 Aligned_cols=174 Identities=21% Similarity=0.274 Sum_probs=145.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.++||+|+||.||+|.... ++.||||++... .....+.|.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578899999999999999999754 889999998642 2233567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 516 EFMPNKSLDSFIFDQT--------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
||+++++|.+++.... ....+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985321 1233567788999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcc----------------cccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETE----------------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~----------------~~~~~~~gt~~y~ape~~ 616 (617)
+++........ .......||+.|+|||++
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l 203 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence 99987321110 111235699999999975
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=230.75 Aligned_cols=163 Identities=25% Similarity=0.309 Sum_probs=138.5
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... ++.||||.+++. .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 789999999753 223456688999998888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 999988843 345899999999999999999999987 99999999999999999999999999986432211 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 153 TSTFCGTPNYIAPEIL 168 (327)
T ss_pred eecccCCcccCCHHHH
Confidence 2346799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=222.57 Aligned_cols=172 Identities=28% Similarity=0.409 Sum_probs=147.0
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4578899999999999999999888889999998653 234578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986532 345788899999999999999999987 999999999999999999999999999987543322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 160 ~-~~~~~~~~~y~aPE~~ 176 (261)
T cd05072 160 A-REGAKFPIKWTAPEAI 176 (261)
T ss_pred c-cCCCccceecCCHHHh
Confidence 1 2223466789999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=223.22 Aligned_cols=168 Identities=28% Similarity=0.391 Sum_probs=138.5
Q ss_pred ceecccCcccEEEEEEcC---CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4579999886532 234457899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 522 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 234577788889999999999999987 9999999999999999999999999998654333222
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||++
T Consensus 158 ~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 158 TPDQLWVPLRWIAPELV 174 (269)
T ss_pred cCCCcCCcccccCHhHh
Confidence 22334577889999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=224.41 Aligned_cols=168 Identities=27% Similarity=0.382 Sum_probs=136.3
Q ss_pred ceecccCcccEEEEEEcC---CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.||+|+||.||+|...+ ...+++|.+... .......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997644 346888887543 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 522 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999965332 233567788899999999999999987 9999999999999999999999999998654332221
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||++
T Consensus 158 ~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 158 TKDCHAVPLRWLAPELV 174 (269)
T ss_pred ccCCCCCcccccCHHHH
Confidence 12233456789999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=230.04 Aligned_cols=163 Identities=24% Similarity=0.277 Sum_probs=133.5
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHH-HHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+++... ++.||+|.+.+.. ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999764 6789999986522 12233444444 457889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|.+++.. ...+.......++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 999999854 234677788889999999999999987 99999999999999999999999999986532221 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (325)
T cd05602 153 TSTFCGTPEYLAPEVL 168 (325)
T ss_pred cccccCCccccCHHHH
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=221.96 Aligned_cols=173 Identities=28% Similarity=0.426 Sum_probs=145.4
Q ss_pred cCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998743 357999998653 33445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998643 235899999999999999999999987 9999999999999999999999999999885
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~ 180 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAI 180 (266)
T ss_pred ccccceeccCCCCCccccChhhh
Confidence 32222222223356789999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=229.24 Aligned_cols=163 Identities=28% Similarity=0.341 Sum_probs=136.1
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+++... ++.||||.+++.. ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999764 7899999987521 2334556777777765 5899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 999998854 345788899999999999999999987 99999999999999999999999999985422111 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (316)
T cd05620 153 ASTFCGTPDYIAPEIL 168 (316)
T ss_pred eeccCCCcCccCHHHH
Confidence 3346689999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=239.10 Aligned_cols=166 Identities=23% Similarity=0.274 Sum_probs=141.9
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
...|.+.+.||+|+||.||++.... ++.||||... ...+.+|+.++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7889999642 23457899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+. ++|..++... ...+++..++.|+.||++||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 7888888542 335899999999999999999999987 99999999999999999999999999998754433
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
........||..|+|||++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~ 334 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVL 334 (461)
T ss_pred cccccccCCCcCCcCHHHH
Confidence 2223345799999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=225.82 Aligned_cols=160 Identities=17% Similarity=0.262 Sum_probs=136.6
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEEEEEecC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 518 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 518 (617)
..|++|+++.||+|.+ +++.||||.++..... ..+.|.+|+.++++++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5899999999999998 6899999999753222 25778899999999999999999999987 34678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.+++.. ...+++...+.++.+++.||.|||+.. .++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999954 345789999999999999999999742 27899999999999999999999999999764322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
....||..|+|||++
T Consensus 178 ---~~~~~~~~y~aPE~~ 192 (283)
T PHA02988 178 ---FKNVNFMVYFSYKML 192 (283)
T ss_pred ---ccccCcccccCHHHh
Confidence 124578899999986
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=223.86 Aligned_cols=174 Identities=31% Similarity=0.507 Sum_probs=145.7
Q ss_pred CCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
++|++.+.||+|+||.||+|.... ...||+|.+... .......|.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 257999998643 2344567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
++|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999964321 145788999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||+++...............++..|+|||++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI 198 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence 9999999999876443332223345578899999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=224.26 Aligned_cols=175 Identities=28% Similarity=0.481 Sum_probs=147.2
Q ss_pred cCCccccceecccCcccEEEEEEcC------CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|+.++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998643 478999998764333 467899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 512 LLIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
++||||+++++|.+++.... ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996432 1244788999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+++.+.............++..|+|||++
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI 196 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhh
Confidence 999999999876443332222334567889999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=225.28 Aligned_cols=175 Identities=29% Similarity=0.494 Sum_probs=147.5
Q ss_pred cCCccccceecccCcccEEEEEEc------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888899999999999999852 24568999987655566778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 513 LIYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
+||||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2235899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+.............++..|+|||++
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 9999999876543332222334457789999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=238.92 Aligned_cols=166 Identities=27% Similarity=0.415 Sum_probs=139.3
Q ss_pred ccceecccCcccEEEEEEcC-CcEEEEEEec--c--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe--EEEEEe
Q 007120 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS--K--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIYE 516 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 516 (617)
...+||+|+|-+||||.... |.+||--.++ + .++...+.|..|+.+|+.|+|||||+++..+.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 44799999999999998744 6777633222 1 244556889999999999999999999999988765 679999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~~ 595 (617)
.+..|+|..|+.+. ..++.+....|++||++||.|||++. +||||||||.+||+|+. .|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999653 44688899999999999999999985 78999999999999975 579999999999987543
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
. -..++||+.+|||||++
T Consensus 200 ~----aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE 217 (632)
T ss_pred c----cceeccCccccChHHHh
Confidence 3 22478999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=232.59 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=148.6
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.....|.+.+.||+|.|++|..|++.. +..||||.+.+. .......+.+|+++|..|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345678899999999999999999754 899999999763 22334558899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+.+|.+.+||....+ +...+...++.|+..|++|||+++ |||||||++||||+.++++||+|||++-.+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999965433 344777788999999999999998 9999999999999999999999999999986
Q ss_pred CCCcccccceeeeeccccCccCCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
... ...+.+|++.|.|||+++
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~ 227 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFN 227 (596)
T ss_pred ccc---cccccCCCCCccChHhhc
Confidence 333 345678999999999874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=235.71 Aligned_cols=178 Identities=27% Similarity=0.380 Sum_probs=145.6
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCccceEEEEEe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 507 (617)
....++|.+.+.||+|+||.||+|++.+ ++.||||+++... ....+.+.+|+.++.++. |||||+++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3445578888999999999999998632 4689999997532 333457889999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCC-------------------------------------------------------
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTR------------------------------------------------------- 532 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 532 (617)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999964211
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 533 ----------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 533 ----------------------------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
...+++...+.++.||+.||+|||+.+ |+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 124677888999999999999999876 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+++++.+||+|||+++.+.............++..|+|||.+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 99999999999999999976443322222234567889999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=225.10 Aligned_cols=177 Identities=24% Similarity=0.405 Sum_probs=144.5
Q ss_pred hhcCCccccceecccCcccEEEEEEcC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
...++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345689999999999999999997542 4579999886432 233456889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
..++||||+++|+|.+++..... ....++.....++.|++.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964221 234567788899999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+.............++..|+|||++
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHh
Confidence 9999999876443322222223456789999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=222.98 Aligned_cols=173 Identities=29% Similarity=0.479 Sum_probs=149.7
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+..+|++.++||+|+||.||+|...++..+++|.+.........++..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578889999999999999999988899999999775555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+|++++.+||+|||+++.+.....
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996532 345799999999999999999999987 99999999999999999999999999988754322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. ....++..|+|||.+
T Consensus 160 ~~--~~~~~~~~~~~PE~~ 176 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAA 176 (261)
T ss_pred cc--cCCCCceEecCHHHH
Confidence 21 123456789999964
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-27 Score=223.78 Aligned_cols=168 Identities=29% Similarity=0.476 Sum_probs=149.7
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
-|.++++||+|+||.||++.++. |+.||||++.- .....++..|+.+|.+.+.|.+|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 46778899999999999999865 89999999864 3467889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
.|+..+.++. +++++.+.+...++.+.++||+|||... -||||||+-||||+.+|++||+|||.|-.+...- .
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 9999999965 4567899999999999999999999865 7999999999999999999999999999886432 3
Q ss_pred ccceeeeeccccCccCCC
Q 007120 600 NTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~~ 617 (617)
..+++.||+.|||||+++
T Consensus 185 KRNTVIGTPFWMAPEVI~ 202 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIE 202 (502)
T ss_pred hhCccccCcccccHHHHH
Confidence 345688999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=223.88 Aligned_cols=169 Identities=25% Similarity=0.419 Sum_probs=136.2
Q ss_pred CCccccceecccCcccEEEEEEc--CCcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCccceEEEEEe-----
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----- 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 507 (617)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 36789999886422 22234556677666554 79999999999863
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 68999886432 334789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++...... ......||..|+|||++
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~ 181 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVL 181 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHH
Confidence 999875332 23345689999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=231.76 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=144.0
Q ss_pred hcCCccccceecccCcccEEEEEEcC------CcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCccceEEEEEeC-
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG- 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 508 (617)
+.++|++.+.||+|+||.||+|...+ ++.||+|+++... ....+.+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 44579999999999999999997422 4689999986432 33456788899999999 899999999988754
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC--------------------------------------------------------
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (617)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999854221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccc
Q 007120 533 --RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610 (617)
Q Consensus 533 --~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 610 (617)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125789999999999999999999987 999999999999999999999999999987544433333345567789
Q ss_pred cCccCC
Q 007120 611 TKAFLY 616 (617)
Q Consensus 611 ~ape~~ 616 (617)
+|||++
T Consensus 242 ~aPE~~ 247 (337)
T cd05054 242 MAPESI 247 (337)
T ss_pred cCcHHh
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=220.18 Aligned_cols=170 Identities=27% Similarity=0.391 Sum_probs=144.3
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
++|++.+.||+|+||.||+|...++..+|||.+... ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999998877778999988753 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999986432 25899999999999999999999987 9999999999999999999999999998765433211
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|++||++
T Consensus 158 -~~~~~~~~~y~~pe~~ 173 (256)
T cd05113 158 -SVGSKFPVRWSPPEVL 173 (256)
T ss_pred -cCCCccChhhCCHHHH
Confidence 1123356789999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=222.91 Aligned_cols=176 Identities=27% Similarity=0.417 Sum_probs=147.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 510 (617)
..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45688899999999999999999865 688999988653 34456778999999999999999999999877 467
Q ss_pred EEEEEecCCCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653322 56899999999999999999999887 99999999999999999999999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+++.+...+.........++..|+|||++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 9999977544433222234567789999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=221.79 Aligned_cols=171 Identities=27% Similarity=0.411 Sum_probs=141.1
Q ss_pred CCccccceecccCcccEEEEEEcC-Cc----EEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|++.+.||+|+||.||+|.+.. ++ .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788999999999999998743 43 47788775422 234567888999999999999999999875 455789
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999642 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............++..|++||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~ 183 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESI 183 (279)
T ss_pred CCCcccccCCCCCcccccCHHHh
Confidence 44433333445677899999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=223.59 Aligned_cols=175 Identities=27% Similarity=0.373 Sum_probs=147.2
Q ss_pred cCCccccceecccCcccEEEEEEcC-----------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccc
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 500 (617)
.++|++.+.||+|+||.||++...+ +..||+|.+... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998643 245899998753 2345678999999999999999999
Q ss_pred eEEEEEeCCeEEEEEecCCCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQT--------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
+++++..++..++|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996532 1235899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.++.+||+|||+++.+.............++..|+|||++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 99999999999999999876544333333345567889999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=225.00 Aligned_cols=169 Identities=25% Similarity=0.387 Sum_probs=142.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999875 47889999986532 22344678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 984 888887543 345788899999999999999999987 99999999999999999999999999987543322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....+|..|+|||++
T Consensus 160 ~--~~~~~~~~~y~aPE~~ 176 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVL 176 (309)
T ss_pred c--cccccccccccCCHHH
Confidence 1 2234678999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=235.81 Aligned_cols=164 Identities=29% Similarity=0.449 Sum_probs=142.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|+.++.||.|+||.||-|+.. +.+.||||++.- .+......+..|+..|.+++|||+|.+-||+......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5777789999999999999964 478899999863 233345679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
||- |+-.++|.- ..+++.+.++..|+.+.+.||+|||+++ .||||||+-||||++.|.|||+|||.|.+..+
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 995 677777643 3456888899999999999999999998 89999999999999999999999999998754
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.+..+||+.|||||+|
T Consensus 179 ----AnsFvGTPywMAPEVI 194 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVI 194 (948)
T ss_pred ----hhcccCCccccchhHh
Confidence 3457899999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.30 Aligned_cols=166 Identities=25% Similarity=0.389 Sum_probs=138.0
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 5889999987643 334556799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...........
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 345789999999999999999999987 99999999999999999999999999987643221111111
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
...+..|+|||.+
T Consensus 156 ~~~~~~y~aPE~~ 168 (252)
T cd05084 156 KQIPVKWTAPEAL 168 (252)
T ss_pred CCCceeecCchhh
Confidence 1234579999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=224.78 Aligned_cols=177 Identities=27% Similarity=0.417 Sum_probs=146.4
Q ss_pred hhcCCccccceecccCcccEEEEEEc--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 506 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 506 (617)
...++|++.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888899999999999999742 2357999988643 234567899999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcE
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni 573 (617)
.....++||||+++++|.+++..... ...+++.+++.++.||++||.|||+.+ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999965321 235788999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 574 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++++.+||+|||+++.+.............++..|+|||.+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence 9999999999999999987544333223334466789999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=219.00 Aligned_cols=170 Identities=24% Similarity=0.391 Sum_probs=146.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457899999999999999999974 5789999998754444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999853 345789999999999999999999987 99999999999999999999999999997743221
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....|+..|+|||.+
T Consensus 162 ~--~~~~~~~~~y~~PE~~ 178 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVA 178 (267)
T ss_pred c--cCccccCccccCHhHc
Confidence 1 2234688899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=228.29 Aligned_cols=161 Identities=25% Similarity=0.274 Sum_probs=133.1
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccC---CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
||+|+||+||+|+... ++.||||++.+.. ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999998754 8899999986421 12233455566666554 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 999988854 345788999999999999999999987 99999999999999999999999999986433222 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~gt~~y~aPE~~ 168 (330)
T cd05586 153 TNTFCGTTEYLAPEVL 168 (330)
T ss_pred ccCccCCccccCHHHH
Confidence 3346799999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-26 Score=229.33 Aligned_cols=170 Identities=25% Similarity=0.399 Sum_probs=149.5
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..|+..+.||+|+||.||+|.... ++.||+|.+.- ......+.+++|+.++..++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356777899999999999999754 78899999875 3445678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|.+|++.+.|. ....+++....-|+.++..|+.|||+++ .+|||||+.||||.++|.+|++|||++-.+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999984 3444577777788999999999999997 99999999999999999999999999999876655
Q ss_pred ccccceeeeeccccCccCCC
Q 007120 598 EGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~~ 617 (617)
.. .+.+||+.|||||++.
T Consensus 167 rr--~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIK 184 (467)
T ss_pred cc--ccccccccccchhhhc
Confidence 43 5688999999999873
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=226.26 Aligned_cols=163 Identities=27% Similarity=0.325 Sum_probs=138.0
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... ++.||||.+++. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999765 789999998753 223455677888888877 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 999988854 335899999999999999999999987 99999999999999999999999999986422221 2
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 153 ~~~~~g~~~y~aPE~~ 168 (318)
T cd05570 153 TSTFCGTPDYIAPEIL 168 (318)
T ss_pred ccceecCccccCHHHh
Confidence 3345689999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=223.67 Aligned_cols=178 Identities=29% Similarity=0.417 Sum_probs=147.4
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
....++|++.+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4455678889999999999999998643 367999998753 334456788999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
++..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998642 12346889999999999999999999887 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.++.+||+|||+++.+.............++..|+|||.+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence 999999999999999987544332222223456789999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=230.23 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=142.5
Q ss_pred hcCCccccceecccCcccEEEEEE------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC-
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG- 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 508 (617)
..++|++.+.||+|+||.||+|.. ..++.||||.++.. .......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345789999999999999999974 24678999999753 233456788999999999 789999999988654
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC--------------------------------------------------------
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (617)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccccee
Q 007120 533 --------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (617)
Q Consensus 533 --------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 604 (617)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123678888999999999999999987 999999999999999999999999999876443332222334
Q ss_pred eeeccccCccCC
Q 007120 605 VGTYCGTKAFLY 616 (617)
Q Consensus 605 ~gt~~y~ape~~ 616 (617)
.+++.|+|||++
T Consensus 242 ~~~~~y~aPE~~ 253 (343)
T cd05103 242 RLPLKWMAPETI 253 (343)
T ss_pred CCCcceECcHHh
Confidence 466789999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=224.07 Aligned_cols=175 Identities=25% Similarity=0.380 Sum_probs=144.0
Q ss_pred cCCccccceecccCcccEEEEEEcC---------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLL 502 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 502 (617)
.++|++.+.||+|+||.||++...+ ...||||.++.. .......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987632 235899998653 334456799999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcE
Q 007120 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTR---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (617)
Q Consensus 503 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni 573 (617)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854221 124688999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 574 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++++.+||+|||+++.+.............++..|+|||++
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 9999999999999999876433322222334457789999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=223.47 Aligned_cols=173 Identities=29% Similarity=0.436 Sum_probs=143.7
Q ss_pred CccccceecccCcccEEEEEEcC------CcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
+|++.+.||+|+||.||+|...+ ++.||||+++.... ...+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998643 47899999975332 335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985311 1235788899999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+++.+.............+++.|+|||.+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHH
Confidence 999999999977543332223334567899999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.05 Aligned_cols=174 Identities=28% Similarity=0.462 Sum_probs=146.5
Q ss_pred CCccccceecccCcccEEEEEEc------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.+|.+.+.||+|+||.||++... +...+++|.++.......+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999753 245689999876555556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996432 1234789999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+++...............++..|+|||.+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 197 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence 999999999876543332223334567889999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=231.91 Aligned_cols=168 Identities=27% Similarity=0.396 Sum_probs=141.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (617)
+|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 5899999998652 2234567889999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 578777743 345889999999999999999999987 999999999999999999999999999976
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....... .....+|..|+|||++
T Consensus 154 ~~~~~~~-~~~~~~~~~y~aPE~~ 176 (372)
T cd07853 154 EPDESKH-MTQEVVTQYYRAPEIL 176 (372)
T ss_pred ccCcccc-CCCCCcCCCcCCHHHH
Confidence 5433222 2234578899999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=221.28 Aligned_cols=176 Identities=23% Similarity=0.389 Sum_probs=147.0
Q ss_pred hcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..++|++.+.||+|+||.||+|...+ +..||+|.+... ......++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34578889999999999999998753 368999998653 23445678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999999864321 234788999999999999999999887 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+.............+|..|+|||.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHH
Confidence 999999877544332223334567889999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=219.34 Aligned_cols=167 Identities=31% Similarity=0.494 Sum_probs=142.7
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccchhh--HHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
|++.+.||+|+||+||++.... ++.+|+|.+....... .....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677999999999999999866 5689999997643322 224456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|+|||++..+... .
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 9999999996 3445799999999999999999999987 999999999999999999999999999875221 2
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.......+|..|+|||++
T Consensus 153 ~~~~~~~~~~~y~aPE~~ 170 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVL 170 (260)
T ss_dssp SEBSSSSSSGGGSCHHHH
T ss_pred cccccccccccccccccc
Confidence 233446689999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=218.10 Aligned_cols=170 Identities=25% Similarity=0.395 Sum_probs=143.0
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.+|++.+.||+|+||.||++....+..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777789999886422 234578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999986432 35799999999999999999999987 9999999999999999999999999998765332211
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 158 -~~~~~~~~~y~~Pe~~ 173 (256)
T cd05059 158 -SQGTKFPVKWAPPEVF 173 (256)
T ss_pred -cCCCCCCccccCHHHh
Confidence 1122244679999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=220.54 Aligned_cols=172 Identities=26% Similarity=0.447 Sum_probs=142.5
Q ss_pred CCccccceecccCcccEEEEEEc-----CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (617)
++|++.+.||+|+||.||++... ++..||||++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888899999999999999753 4788999999776666677899999999999999999999987543 4678
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 335899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccc-cceeeeeccccCccCC
Q 007120 593 GGDETEGN-TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~-~~~~~gt~~y~ape~~ 616 (617)
........ .....++..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESL 183 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHh
Confidence 54332111 1112234569999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=219.37 Aligned_cols=162 Identities=28% Similarity=0.362 Sum_probs=136.9
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||.||++.... ++.+|+|.+.... ......+..|+.++++++||||+++.+.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998754 8999999986421 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98885432 334789999999999999999999987 99999999999999999999999999988754322 223
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
..||..|+|||++
T Consensus 154 ~~~~~~y~aPE~~ 166 (277)
T cd05607 154 RAGTNGYMAPEIL 166 (277)
T ss_pred cCCCCCccCHHHH
Confidence 4688999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=217.40 Aligned_cols=176 Identities=27% Similarity=0.355 Sum_probs=146.7
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+.+++++.....||+|+||.||+|...+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 4456666666899999999999999654 678999998765556677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~ 593 (617)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999965322212278888899999999999999887 999999999999986 6799999999998764
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....|+..|+|||++
T Consensus 161 ~~~~~--~~~~~~~~~~~aPE~~ 181 (268)
T cd06624 161 GINPC--TETFTGTLQYMAPEVI 181 (268)
T ss_pred cCCCc--cccCCCCccccChhhh
Confidence 33221 2234578899999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=227.60 Aligned_cols=165 Identities=21% Similarity=0.266 Sum_probs=139.6
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
....+|++.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345689999999999999999999764 678999975432 2346899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 688888854 2345899999999999999999999987 999999999999999999999999999864322
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 211 ~~---~~~~~gt~~y~aPE~~ 228 (357)
T PHA03209 211 PA---FLGLAGTVETNAPEVL 228 (357)
T ss_pred cc---cccccccccccCCeec
Confidence 21 2245689999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=218.95 Aligned_cols=167 Identities=22% Similarity=0.349 Sum_probs=135.3
Q ss_pred eecccCcccEEEEEEcCC---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 447 KLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
.||+|+||.||+|...++ ..+++|.++.. .....+.|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999986443 34667766543 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccc
Q 007120 523 LDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (617)
Q Consensus 523 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~ 601 (617)
|.+++..... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999965322 234667778899999999999999887 999999999999999999999999998754322211122
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....++..|+|||++
T Consensus 159 ~~~~~~~~y~aPE~~ 173 (268)
T cd05086 159 DDKCVPLRWLAPELV 173 (268)
T ss_pred cCCcCcccccCchhc
Confidence 235578899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.32 Aligned_cols=170 Identities=25% Similarity=0.425 Sum_probs=147.1
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347888899999999999999875 4789999998765445556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999999854 345789999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.......||..|+|||++
T Consensus 161 -~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred -cccccccCcccccChhhh
Confidence 122345689999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=219.56 Aligned_cols=168 Identities=27% Similarity=0.335 Sum_probs=142.7
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
|+..+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999875 48899999986422 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886432 335899999999999999999999987 99999999999999999999999999987643222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||++
T Consensus 158 ---~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVL 173 (285)
T ss_pred ---ccCCCCCcCccChHHh
Confidence 1234689999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=224.37 Aligned_cols=174 Identities=26% Similarity=0.327 Sum_probs=150.7
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
...+.|+.-++||+|+||+|+-++.+. |+-+|.|++.+ ...+......+|-+++.+++.+.||.|--.+...+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 344678888999999999999998755 88899998865 23455667889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||+..|.+|+|.-.|..... ..+++.....++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999988876544 45888999999999999999999876 999999999999999999999999999998
Q ss_pred CCCCcccccceeeeeccccCccCCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
...+.. ...+||.||||||+++
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQ 359 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHc
Confidence 765543 2237999999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=219.72 Aligned_cols=168 Identities=28% Similarity=0.345 Sum_probs=142.6
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
|+..+.||+|+||.||++... .++.||||.+.... ....+.+..|+.++++++|+|++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 47899999986421 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885422 235789999999999999999999887 99999999999999999999999999987643332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 158 ---~~~~~g~~~y~aPE~~ 173 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVV 173 (285)
T ss_pred ---ccCCCCCccccChHHH
Confidence 1234689999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=217.94 Aligned_cols=172 Identities=26% Similarity=0.447 Sum_probs=138.1
Q ss_pred ccccceecccCcccEEEEEEcCC---cEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------Ce
Q 007120 442 FSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~~---~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 510 (617)
|.+.+.||+|+||.||+|..... ..||+|.++.. .....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34668999999999999997653 26899988652 344567889999999999999999999988543 24
Q ss_pred EEEEEecCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
.++|+||+++|+|.+++... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+.............++..|++||.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 186 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESL 186 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHc
Confidence 99987543321112223456789999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=232.21 Aligned_cols=166 Identities=23% Similarity=0.297 Sum_probs=141.7
Q ss_pred cCCccccceecccCcccEEEEEEcC---CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..+|++.+.||+|+||.||++...+ +..||||.+... +.+.+|+.++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997533 578999988642 23467999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 68888883 3356899999999999999999999987 999999999999999999999999999877544
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
..........||..|+|||++
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~ 259 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELL 259 (392)
T ss_pred cccccccccccccCccCHhHh
Confidence 333333346799999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=216.85 Aligned_cols=150 Identities=29% Similarity=0.336 Sum_probs=132.2
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.+.|++++.||.|.-|+||++++.+ +..+|+|.+.+. ........+.|.++|+.++||.++.|++.+..++..+||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3467788999999999999999976 588999999763 334456778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||||+||+|...++.+. ...++...+..++.+|+.||+|||-.| ||.|||||+||||.++|++-|+||-|+...
T Consensus 156 meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999887654 445777777778999999999999988 999999999999999999999999987643
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=218.74 Aligned_cols=174 Identities=28% Similarity=0.453 Sum_probs=146.3
Q ss_pred CCccccceecccCcccEEEEEEc------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 256799999877666667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCe
Q 007120 514 IYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ 581 (617)
|+||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 134789999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+++.+.............++..|+|||++
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence 99999999876543322222334457789999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=217.25 Aligned_cols=171 Identities=27% Similarity=0.429 Sum_probs=144.4
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.+|++.+.||+|+||.||+|...+ ++.||+|.++.. .....++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788999999999999999754 788999998753 334678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986532 345799999999999999999999987 999999999999999999999999999887543222
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||.+
T Consensus 161 ~-~~~~~~~~~y~aPE~~ 177 (263)
T cd05052 161 A-HAGAKFPIKWTAPESL 177 (263)
T ss_pred c-cCCCCCccccCCHHHh
Confidence 1 1122345679999965
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=220.54 Aligned_cols=173 Identities=31% Similarity=0.426 Sum_probs=142.5
Q ss_pred CccccceecccCcccEEEEEEcC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
+|++.+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998632 3578898886532 3445679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 514 IYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
|+||+++++|.+++.... ....+++...+.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1235789999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||++++.+||+|||+++.+.............++..|+|||.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 99999999999999999876443332222334467789999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=222.23 Aligned_cols=175 Identities=30% Similarity=0.404 Sum_probs=145.7
Q ss_pred hcCCccccceecccCcccEEEEEEc------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (617)
..++|.+.+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999742 24579999987532 34456789999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999996422 234899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+.............++..|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 215 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESI 215 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhh
Confidence 977544322222233467789999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=216.53 Aligned_cols=172 Identities=26% Similarity=0.418 Sum_probs=140.9
Q ss_pred ccccceecccCcccEEEEEEcC----CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-----
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (617)
|++.+.||+|+||.||+|.... +..||||+++.. .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998743 367999998642 33446789999999999999999999999876554
Q ss_pred -EEEEEecCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 511 -KLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
.++|+||+++++|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+.............++..|++||.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhc
Confidence 999987543332222223356789999965
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=255.04 Aligned_cols=160 Identities=24% Similarity=0.430 Sum_probs=134.8
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
..++..+.||+|+||.||+|+. .++..||||+++..... ...|+..+++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999997 46899999998653221 234688899999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.++++. ++|.++.+|+.|||+||+|||+.+..+|+||||||+||+++.++.+++. ||++.....+
T Consensus 766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99999999942 7899999999999999999997655679999999999999999998886 7766554222
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
....||..|+|||++
T Consensus 836 ---~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 836 ---TKCFISSAYVAPETR 850 (968)
T ss_pred ---CCccccccccCcccc
Confidence 123678999999976
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=219.40 Aligned_cols=166 Identities=30% Similarity=0.378 Sum_probs=145.1
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468889999999999999999754 789999998652 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++... ..++...+..++.|++.||.|||+.+ |+|+||+|+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998542 45789999999999999999999987 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|++||.+
T Consensus 155 -----~~~~~~~~~y~aPE~~ 170 (290)
T cd05580 155 -----TYTLCGTPEYLAPEII 170 (290)
T ss_pred -----CCCCCCCccccChhhh
Confidence 2234588899999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=216.82 Aligned_cols=172 Identities=27% Similarity=0.419 Sum_probs=143.1
Q ss_pred CCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.+|++.+.||+|+||.||+|.... ...+|+|.++.. .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998642 347999998653 234456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++... ...+++.+.+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999643 245789999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccc-cceeeeeccccCccCC
Q 007120 595 DETEGN-TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~-~~~~~gt~~y~ape~~ 616 (617)
...... .....++..|++||++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~ 181 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAI 181 (267)
T ss_pred ccceeeecCCCccceeecCHhHh
Confidence 332211 1112235679999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=218.42 Aligned_cols=173 Identities=29% Similarity=0.446 Sum_probs=145.1
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeC------
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------ 508 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 508 (617)
.+.+.|++.+.||+|+||.||+|...+ ++.||+|.+... ......+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 355678888999999999999998754 788999998653 23456788999999998 799999999998763
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999998652 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+..... ......|+..|+|||++
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~ 183 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVI 183 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHh
Confidence 987643222 23346789999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=221.12 Aligned_cols=168 Identities=25% Similarity=0.282 Sum_probs=143.3
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||++.... +..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468889999999999999998754 778899988643 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ..+++.....++.|+++||.|||+.. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999999542 45788999999999999999999742 39999999999999999999999999998763321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||.+
T Consensus 155 ---~~~~~~~~~~~aPE~~ 170 (308)
T cd06615 155 ---ANSFVGTRSYMSPERL 170 (308)
T ss_pred ---cccCCCCcCccChhHh
Confidence 2235688899999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=233.90 Aligned_cols=168 Identities=21% Similarity=0.372 Sum_probs=135.2
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC--------
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 508 (617)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999975 47899999885422 2345799999999999999999886432
Q ss_pred CeEEEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeec
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF 586 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DF 586 (617)
...++||||+++ +|.+++... .....+++.....++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999984 677666432 23456889999999999999999999987 99999999999998665 7999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|+.+..... .....||+.|+|||++
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~ 242 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELM 242 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHh
Confidence 99998754332 2235689999999975
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=216.64 Aligned_cols=171 Identities=26% Similarity=0.403 Sum_probs=142.8
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.++||+|+||.||+|+..+...||+|+++... ...+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688999999999999999998777789999997532 23467899999999999999999999874 45678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999643 2345789999999999999999999987 999999999999999999999999999877543321
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|++||++
T Consensus 159 ~-~~~~~~~~~y~~PE~~ 175 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAA 175 (262)
T ss_pred c-ccCCcccceecCHhHh
Confidence 1 1223466789999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=218.16 Aligned_cols=172 Identities=28% Similarity=0.446 Sum_probs=141.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|++.+.||+|+||.||+|+.. +++ .||+|.++. ......+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888899999999999999853 344 489998864 333456788999999999999999999999975 4567
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998642 345889999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.............++..|++||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESI 183 (279)
T ss_pred ccccceeecCCCccchhhCCHHHh
Confidence 543332222223356789999975
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=218.65 Aligned_cols=159 Identities=23% Similarity=0.290 Sum_probs=132.4
Q ss_pred eecccCcccEEEEEEcC-------------------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccce
Q 007120 447 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 501 (617)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998876444556788999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC--
Q 007120 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 579 (617)
Q Consensus 502 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-- 579 (617)
+++|.+....++||||+++|+|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998542 345789999999999999999999887 99999999999997654
Q ss_pred -----CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 -----NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 -----~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||+++...... ...++..|+|||.+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~ 192 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECV 192 (274)
T ss_pred cCccceeeecCCcccccccccc------ccccCCcccCchhh
Confidence 38999999987653222 13467789999965
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=214.87 Aligned_cols=171 Identities=29% Similarity=0.437 Sum_probs=144.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999874 48899999876421 1234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999854 345788889999999999999999987 9999999999999999999999999998764
Q ss_pred CCCcccc-cceeeeeccccCccCC
Q 007120 594 GDETEGN-TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~-~~~~~gt~~y~ape~~ 616 (617)
....... .....|+..|+|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~ 179 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVI 179 (263)
T ss_pred ccccccccccCCCcCccccCccee
Confidence 3322111 1234578899999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=213.80 Aligned_cols=170 Identities=27% Similarity=0.402 Sum_probs=147.0
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|++|.||++... +++.|++|.+.. ......+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 478999998864 2345567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999753 2356889999999999999999999887 99999999999999999999999999998754432
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....|+..|+|||++
T Consensus 157 ~--~~~~~~~~~y~aPE~~ 173 (256)
T cd08529 157 F--ANTIVGTPYYLSPELC 173 (256)
T ss_pred h--hhccccCccccCHHHh
Confidence 2 2335688899999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=217.58 Aligned_cols=168 Identities=29% Similarity=0.420 Sum_probs=145.5
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999999765 678899998765556677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|..++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 999988754 2345899999999999999999999987 99999999999999999999999999987643221 1
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....+|..|+|||++
T Consensus 160 ~~~~~~~~~y~aPE~~ 175 (282)
T cd06643 160 RDSFIGTPYWMAPEVV 175 (282)
T ss_pred cccccccccccCHhhc
Confidence 2335688999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=217.68 Aligned_cols=171 Identities=30% Similarity=0.417 Sum_probs=148.3
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+.|++.+.||+|+||.||+|.... ++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3578899999999999999999755 789999999776666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999887542 245889999999999999999999987 99999999999999999999999999887543221
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||++
T Consensus 166 --~~~~~~~~~~y~aPE~~ 182 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVV 182 (292)
T ss_pred --ccceecCCccccCceee
Confidence 12345688899999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=217.57 Aligned_cols=170 Identities=29% Similarity=0.441 Sum_probs=143.7
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|++|.||+|+.. +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 4889999998642 223346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888865444466899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||.+
T Consensus 157 ~--~~~~~~~~~y~aPE~~ 173 (285)
T cd07861 157 V--YTHEVVTLWYRAPEVL 173 (285)
T ss_pred c--ccCCcccccccChHHh
Confidence 1 1234568899999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=216.27 Aligned_cols=160 Identities=22% Similarity=0.331 Sum_probs=134.6
Q ss_pred ceecccCcccEEEEEEcC-------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 446 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887654555668899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC-------eEEee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 585 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-------~ki~D 585 (617)
+||||+++++|..++... ...+++..++.++.||++||+|||+.+ |+||||||+||||+.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988542 345889999999999999999999987 999999999999987664 89999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||++..+.... ...++..|+|||.+
T Consensus 156 ~g~~~~~~~~~------~~~~~~~y~aPE~~ 180 (262)
T cd05077 156 PGIPITVLSRQ------ECVERIPWIAPECV 180 (262)
T ss_pred CCCCccccCcc------cccccccccChhhh
Confidence 99998763221 24577889999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=216.43 Aligned_cols=172 Identities=29% Similarity=0.451 Sum_probs=142.5
Q ss_pred CCccccceecccCcccEEEEEEcC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..|++.+.||+|+||.||+|.... + ..||||.++.. ......+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999754 2 36999998753 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998643 345789999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcccc-cceee--eeccccCccCC
Q 007120 595 DETEGN-TNRVV--GTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~-~~~~~--gt~~y~ape~~ 616 (617)
...... ..... .+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAI 183 (269)
T ss_pred CccccccccccCCCcceeecCHhHh
Confidence 332211 11111 13579999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=219.03 Aligned_cols=172 Identities=28% Similarity=0.393 Sum_probs=149.2
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||++... ++..+|+|.++.......+.+..|+.++++++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467899999999999999999975 478999999876556667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999998542 345889999999999999999999987 9999999999999999999999999987654322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......+|..|++||++
T Consensus 158 ~--~~~~~~~~~~y~~PE~~ 175 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVV 175 (280)
T ss_pred c--ccceeecchhhcCHHHH
Confidence 1 12345688999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=216.13 Aligned_cols=163 Identities=25% Similarity=0.316 Sum_probs=140.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778899999999999999864 5789999998653 334456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997553 2578888899999999999999987 9999999999999999999999999998764332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 150 ---~~~~~~~~~y~aPE~~ 165 (279)
T cd06619 150 ---AKTYVGTNAYMAPERI 165 (279)
T ss_pred ---ccCCCCChhhcCceee
Confidence 2235688999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=226.32 Aligned_cols=176 Identities=23% Similarity=0.403 Sum_probs=146.7
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcC---C--cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVD---G--QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~---~--~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
.+..+...+..++||+|.||.||+|...+ | -.||||..+. ......+.|..|..+|++++|||||+|+|.|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 33444556667899999999999998643 2 3589999876 445567889999999999999999999999976
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
.+.+||||.++.|.|.+||.. +...++......++.||..||+|||+.. +|||||+++|||+.+...+||+||||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred cceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 467899999999999999964 4456888999999999999999999986 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
+|-+..+... ...+..-...|||||.++
T Consensus 538 SR~~ed~~yY-kaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 538 SRYLEDDAYY-KASRGKLPIKWMAPESIN 565 (974)
T ss_pred hhhccccchh-hccccccceeecCccccc
Confidence 9998655443 222344557899999764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=221.66 Aligned_cols=175 Identities=29% Similarity=0.417 Sum_probs=143.5
Q ss_pred cCCccccceecccCcccEEEEEEcC--------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
.++|.+.+.||+|+||.||++.... ...+|+|.++.. ......++..|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999997532 346999998753 234456788999999999 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl 575 (617)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235889999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 576 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.++.+||+|||+++.+.............++..|+|||++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence 99999999999999876432222112222345679999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=222.37 Aligned_cols=176 Identities=29% Similarity=0.417 Sum_probs=143.6
Q ss_pred hcCCccccceecccCcccEEEEEEc--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
..++|.+.+.||+|+||.||+++.. ....+|+|.++.. .......+..|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3457888899999999999999752 2457899988753 334566789999999999 69999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
....++||||+++|+|.+++.... ....+++.++..++.||+.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999996532 1235889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++++.+||+|||+++.+.............++..|+|||.+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence 999999999999999876533222212222345679999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=214.88 Aligned_cols=158 Identities=25% Similarity=0.376 Sum_probs=133.6
Q ss_pred ceecccCcccEEEEEEcCCc-----------EEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 446 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5778877643322 6789999999999999999999999988 778999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-------CeEEeecC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 587 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-------~~ki~DFG 587 (617)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999996532 25889999999999999999999887 99999999999999888 79999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+.... ...++..|+|||++
T Consensus 154 ~a~~~~~~~------~~~~~~~y~aPE~~ 176 (259)
T cd05037 154 IPITVLSRE------ERVERIPWIAPECI 176 (259)
T ss_pred ccccccccc------ccccCCCccChhhh
Confidence 999864311 23466789999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=223.68 Aligned_cols=175 Identities=27% Similarity=0.410 Sum_probs=144.0
Q ss_pred cCCccccceecccCcccEEEEEEcC--------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
..+|++.+.||+|+||.||+++... ...||+|.++.. .....+++.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468889999999999999997522 236899988642 334567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl 575 (617)
+..++++||+++|+|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999996432 1234788999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 576 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.++.+||+|||+++.+.............++..|+|||++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence 99999999999999987543322222223345779999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=226.12 Aligned_cols=167 Identities=28% Similarity=0.360 Sum_probs=138.5
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (617)
..++|++.+.||+|+||.||++.... ++.||||.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34789999999999999999998754 889999998642 2344567889999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 5665552 23678888899999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++...... ......||..|+|||++
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~ 194 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVI 194 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhc
Confidence 98754322 12335689999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=216.54 Aligned_cols=171 Identities=28% Similarity=0.458 Sum_probs=141.9
Q ss_pred CCccccceecccCcccEEEEEEcC-Cc----EEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.+|++.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998753 32 58999886543 3445788999999999999999999999987 78899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999643 334899999999999999999999977 9999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............++..|++||.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI 183 (279)
T ss_pred CcccceecCCCcccccccCHHHh
Confidence 44332222222245679999965
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=219.41 Aligned_cols=176 Identities=27% Similarity=0.430 Sum_probs=145.1
Q ss_pred hcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..++|++.+.||+|+||.||++... ++..||+|.+... .....+++.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467889999999999999999864 3578999998653 23445679999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQT-------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~ 571 (617)
.++|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996421 1234788899999999999999999987 999999999
Q ss_pred cEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 572 NVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 572 NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++++.+||+|||+++.+..............+..|+|||++
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI 204 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH
Confidence 999999999999999999876443322112223345679999964
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=218.36 Aligned_cols=178 Identities=26% Similarity=0.388 Sum_probs=147.2
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEE----
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI---- 506 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---- 506 (617)
..+..+.++|++.+.||+|+||.||++.... ++.+|+|.++.. .....++.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4455677899999999999999999998754 789999988652 22345688899999999 6999999999985
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 507 -QGEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 507 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999988642 22345788999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++.+...... .....|+..|+|||++
T Consensus 167 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~ 196 (286)
T cd06638 167 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVI 196 (286)
T ss_pred cCCceeecccCCCc--cccccCCCcccChhhh
Confidence 99999887543221 2335689999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=217.67 Aligned_cols=176 Identities=28% Similarity=0.443 Sum_probs=143.9
Q ss_pred hcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..++|++.+.||+|+||.||+|.+.+ +..|++|.+... .......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998754 467899988643 23445679999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC---CeEE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKI 583 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~ki 583 (617)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 235899999999999999999999987 99999999999998754 6999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+..............+..|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 999999987433222212223345689999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=215.23 Aligned_cols=172 Identities=25% Similarity=0.413 Sum_probs=146.1
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+|+.. +++.||||.++. ........+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 588999998754 22344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||+++++|.+++.... ....++......++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999885422 2345788999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....|+..|+|||++
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~ 178 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERI 178 (267)
T ss_pred hhHH--HhcCCCCccccChhhh
Confidence 3321 2234578899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-25 Score=228.81 Aligned_cols=164 Identities=31% Similarity=0.452 Sum_probs=143.6
Q ss_pred eecccCcccEEEEEEcCC-cEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHH
Q 007120 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (617)
+||+|.||+||-|+..+. ..+|||.+..........+.+|+.+-+.|+|.|||+++|.|.++...-|.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999998664 5799999987677777889999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEEeecCCceeeCCCCcccccc
Q 007120 526 FIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTN 602 (617)
Q Consensus 526 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~~~~~~~~~~~~ 602 (617)
+|+. .-.++ .+.+.-.+..||++||.|||++. |||||||-+||||+ -.|.+||+|||.+|.+.+- ..-+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9964 33344 66777788999999999999987 99999999999996 4789999999999998543 23366
Q ss_pred eeeeeccccCccCCC
Q 007120 603 RVVGTYCGTKAFLYD 617 (617)
Q Consensus 603 ~~~gt~~y~ape~~~ 617 (617)
+..||+.|||||++|
T Consensus 735 TFTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVID 749 (1226)
T ss_pred ccccchhhhChHhhc
Confidence 788999999999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=216.49 Aligned_cols=173 Identities=25% Similarity=0.350 Sum_probs=145.5
Q ss_pred CCccccceecccCcccEEEEEEcC------CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
++|++.+.||+|+||.||+|+... .+.|++|.+...... ...++.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999998642 467999988654333 4678999999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 513 LIYEFMPNKSLDSFIFDQTRR------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999653321 25899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++....... .......++..|+|||++
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~ 190 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAV 190 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhh
Confidence 99986543222 122334577889999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=218.63 Aligned_cols=171 Identities=23% Similarity=0.346 Sum_probs=145.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||++... .+..||+|.++.. .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999986 5889999988642 334457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|..++........+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999999865333346899999999999999999999742 399999999999999999999999999987643222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
....++..|+|||.+
T Consensus 159 ----~~~~~~~~y~aPE~~ 173 (286)
T cd06622 159 ----KTNIGCQSYMAPERI 173 (286)
T ss_pred ----ccCCCccCccCcchh
Confidence 234578899999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=211.87 Aligned_cols=165 Identities=30% Similarity=0.416 Sum_probs=139.2
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (617)
+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3789999999999998888999999987543 333457899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccccee
Q 007120 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (617)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 604 (617)
+++... ...+++..++.++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++......... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 998542 235789999999999999999999987 9999999999999999999999999998654332211 1122
Q ss_pred eeeccccCccCC
Q 007120 605 VGTYCGTKAFLY 616 (617)
Q Consensus 605 ~gt~~y~ape~~ 616 (617)
.++..|+|||++
T Consensus 155 ~~~~~y~aPE~~ 166 (250)
T cd05085 155 QIPIKWTAPEAL 166 (250)
T ss_pred CCcccccCHHHh
Confidence 345779999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-26 Score=213.91 Aligned_cols=169 Identities=28% Similarity=0.430 Sum_probs=142.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEec--ccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++-+.||+|.|+.|++.... .|+.+|+|.+. +......+++.+|+++-+.|+|||||+|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 457888899999999999998764 48888988874 334457889999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DFGla~~~ 592 (617)
|+|.+++|-.-+-. +...++...-+.+.||+++|.|.|..+ |||||+||+|+||.+. --+||+|||+|+.+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999765532 245677888899999999999999998 9999999999999543 35899999999999
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..+. ....+||++||+||++
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVL 184 (355)
T ss_pred CCccc---cccccCCCcccCHHHh
Confidence 73222 3346799999999975
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=219.28 Aligned_cols=170 Identities=25% Similarity=0.455 Sum_probs=147.0
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...+|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4468899999999999999999864 478999999876545556778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999843 34788999999999999999999987 9999999999999999999999999998764433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....|+..|+|||++
T Consensus 171 ~~--~~~~~~~~~y~aPE~~ 188 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVV 188 (296)
T ss_pred cc--cCcccCCccccCHHHH
Confidence 22 1234588899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=213.54 Aligned_cols=168 Identities=33% Similarity=0.483 Sum_probs=144.4
Q ss_pred ceecccCcccEEEEEEcC----CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|+..++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 778999998764332 367899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 521 KSLDSFIFDQTR------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 521 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965421 356899999999999999999999987 99999999999999999999999999998865
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...........++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred ccccccccCCCcCccccCHHHh
Confidence 4322223345578899999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=214.49 Aligned_cols=172 Identities=28% Similarity=0.409 Sum_probs=144.3
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788899999999999999998889999999987533 33567899999999999999999999864 5568999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999986532 345789999999999999999999887 99999999999999999999999999988753322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||++
T Consensus 158 ~~-~~~~~~~~~y~~pe~~ 175 (260)
T cd05067 158 TA-REGAKFPIKWTAPEAI 175 (260)
T ss_pred cc-ccCCcccccccCHHHh
Confidence 11 1123456789999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=218.79 Aligned_cols=170 Identities=25% Similarity=0.453 Sum_probs=147.6
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3468999999999999999999964 589999999876444556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999843 34788999999999999999999987 9999999999999999999999999998865443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|++||++
T Consensus 170 ~~--~~~~~~~~~y~aPE~~ 187 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVV 187 (297)
T ss_pred cC--cCcccCCccccCHHHH
Confidence 22 2234578899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=246.41 Aligned_cols=179 Identities=22% Similarity=0.244 Sum_probs=156.1
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEe
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
..++....++|.++++||+|+||.|..++++. ++.+|+|++++ .......-|+.|-.+|..-+.+-|++|.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45566667899999999999999999999865 78899999987 445566789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
..++|||||||+||+|-.+|.+.. .+++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999995432 5777777778889999999999887 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
.+-.+..+..-. ....+||+.|++||+++
T Consensus 221 sClkm~~dG~V~-s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred hHHhcCCCCcEE-eccccCCCCccCHHHHH
Confidence 998887665433 44578999999999863
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=214.01 Aligned_cols=171 Identities=27% Similarity=0.399 Sum_probs=141.7
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (617)
.+|++.+.||+|+||.||++...+ ++.||||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478889999999999999998754 889999987531 123456788999999999999999999998764 457
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998542 34788888999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......|+..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVI 181 (265)
T ss_pred cccccccccccccCCCCccccChhhh
Confidence 6432111 112334588999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=214.26 Aligned_cols=173 Identities=29% Similarity=0.434 Sum_probs=146.8
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456899999999999999999998888899999987532 3456789999999999999999999999988899999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999996532 345899999999999999999999987 99999999999999999999999999998754322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||.+
T Consensus 159 ~~-~~~~~~~~~y~~PE~~ 176 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAA 176 (261)
T ss_pred hh-hhccCCCccccCHHHh
Confidence 11 1122345679999965
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=213.46 Aligned_cols=166 Identities=28% Similarity=0.406 Sum_probs=140.9
Q ss_pred ceecccCcccEEEEEEcC--C--cEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|++|.||+|.+.. + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998744 2 3699999976544 567789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc-c
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-G 599 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~-~ 599 (617)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999965432 46899999999999999999999987 999999999999999999999999999987543322 1
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||.+
T Consensus 156 ~~~~~~~~~~y~~pE~~ 172 (257)
T cd05040 156 MEEHLKVPFAWCAPESL 172 (257)
T ss_pred cccCCCCCceecCHHHh
Confidence 12234577899999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=212.32 Aligned_cols=167 Identities=29% Similarity=0.431 Sum_probs=144.3
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999986 68899999886532 23557899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999854 234789999999999999999999987 99999999999999999999999999988754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......|+..|++||++
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVI 173 (258)
T ss_pred cc---cccccCCCcceeCHHHh
Confidence 33 12335588899999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=210.98 Aligned_cols=170 Identities=24% Similarity=0.367 Sum_probs=146.5
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|+..+.||+|+||.||.++.. +++.+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999864 4788999987642 345567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999996532 345789999999999999999999987 99999999999999999999999999998754432
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||++
T Consensus 157 --~~~~~~~~~~y~ape~~ 173 (256)
T cd08221 157 --MAETVVGTPYYMSPELC 173 (256)
T ss_pred --cccccCCCccccCHhhc
Confidence 12335688999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=218.11 Aligned_cols=174 Identities=26% Similarity=0.400 Sum_probs=142.8
Q ss_pred cCCccccceecccCcccEEEEEEc-----------------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccc
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 500 (617)
.++|++.+.||+|+||.||++... +...||+|.+... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 1346899998753 3345578999999999999999999
Q ss_pred eEEEEEeCCeEEEEEecCCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
+++++...+..++||||+++++|.+++..... ...+++.+...++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134778899999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~ 615 (617)
||+++++.+||+|||+++.+..........+..++..|++||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 203 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES 203 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence 9999999999999999987644332222223344677999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=210.46 Aligned_cols=170 Identities=23% Similarity=0.355 Sum_probs=145.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
+|++.+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.+++.++|+||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 488999998854 23345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++... ....++....+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988542 3345788999999999999999999987 999999999999999999999999999877543221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||++
T Consensus 157 --~~~~~~~~~~~aPE~~ 172 (255)
T cd08219 157 --ACTYVGTPYYVPPEIW 172 (255)
T ss_pred --cccccCCccccCHHHH
Confidence 2235688899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=212.70 Aligned_cols=174 Identities=26% Similarity=0.368 Sum_probs=142.3
Q ss_pred cCCccccceecccCcccEEEEEEcC-----CcEEEEEEecccch-h-hHHHHHHHHHHHccCCCCCccceEEEEEe-CCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISE-Q-GLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 510 (617)
...|+....||+|.||.||+|.-.+ .+.+|||+++..+. . .....-+|+.+++.|+||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468888999999999999996433 34789999975322 1 12346789999999999999999999887 778
Q ss_pred EEEEEecCCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC----CCeEEe
Q 007120 511 KLLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKIS 584 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~----~~~ki~ 584 (617)
.+|++||.+ .+|.+.++. ..+...++......|+.||+.|+.|||++- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 899999997 578777753 233456888999999999999999999987 9999999999999877 999999
Q ss_pred ecCCceeeCCCCc-ccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDET-EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~-~~~~~~~~gt~~y~ape~~ 616 (617)
|||+||++...-. -...+.++-|+.|.|||++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL 211 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELL 211 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHh
Confidence 9999999864433 2345678889999999975
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=211.89 Aligned_cols=167 Identities=29% Similarity=0.487 Sum_probs=144.3
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.+.||+|+||.||++... ++.||||.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78999999976433 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999996532 235899999999999999999999987 99999999999999999999999999998743221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
....+..|+|||++
T Consensus 158 ----~~~~~~~~~ape~~ 171 (256)
T cd05039 158 ----SGKLPVKWTAPEAL 171 (256)
T ss_pred ----cCCCcccccCchhh
Confidence 22345679999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=211.74 Aligned_cols=172 Identities=27% Similarity=0.433 Sum_probs=147.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||+|... +++.||+|.++. ......+.+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999986 689999998863 22334668899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||+++++|..++... .....+++.+++.++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998643 22455789999999999999999999987 99999999999999999999999999987643
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....++..|+|||++
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~ 178 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERI 178 (267)
T ss_pred CCcc--cceecCCccccCHHHh
Confidence 3221 2234688899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=213.06 Aligned_cols=172 Identities=24% Similarity=0.281 Sum_probs=146.7
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|..+++||+|.||+|-+++-+ .++.+|||++++. .......-..|-++|..-+||.+..|--.+...+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3468999999999999999999864 4889999999862 34456677889999999999999999888999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||..+|.|.-.|. +...+++.....+-.+|..||.|||+.+ ||.||||.+|.|||++|++||+||||+|.-.
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999987773 3445666666668889999999999987 9999999999999999999999999999532
Q ss_pred CCCcccccceeeeeccccCccCCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
.....+.+.+||+.|+|||+++
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred --cccceeccccCChhhcCchhhc
Confidence 2334567789999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=212.47 Aligned_cols=164 Identities=27% Similarity=0.427 Sum_probs=134.4
Q ss_pred eecccCcccEEEEEEc---CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
.||+|+||.||+|.+. ++..||+|.+.... ....+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 34579999986543 334567999999999999999999999885 457899999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc-c
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-T 601 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~-~ 601 (617)
|.+++.. ....+++..+++++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..+..... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999854 2345899999999999999999999987 99999999999999999999999999987654433211 1
Q ss_pred ceeeeeccccCccCC
Q 007120 602 NRVVGTYCGTKAFLY 616 (617)
Q Consensus 602 ~~~~gt~~y~ape~~ 616 (617)
....++..|+|||++
T Consensus 156 ~~~~~~~~y~aPE~~ 170 (257)
T cd05115 156 SAGKWPLKWYAPECI 170 (257)
T ss_pred CCCCCCcccCCHHHH
Confidence 112235789999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=223.52 Aligned_cols=166 Identities=28% Similarity=0.396 Sum_probs=139.4
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC------
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (617)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3568999999999999999999874 47899999986522 23445678899999999999999999987643
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 789988873 234889999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+... .....||..|+|||++
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~ 187 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIM 187 (343)
T ss_pred ceecCCC-----cCCccccccccCchHh
Confidence 9976432 2234689999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=213.30 Aligned_cols=171 Identities=27% Similarity=0.407 Sum_probs=142.7
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.+.||+|+||.||++...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357888899999999999999988888999999875322 3467899999999999999999999875 45678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.... ...+++.++..++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999986532 345789999999999999999999987 999999999999999999999999999887543322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 159 ~-~~~~~~~~~y~aPE~~ 175 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAA 175 (260)
T ss_pred c-ccCCCCCccccChHHH
Confidence 1 1122356689999964
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=217.40 Aligned_cols=170 Identities=26% Similarity=0.471 Sum_probs=147.6
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...+|+..+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345799999999999999999986 4588999999876444556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999998843 34789999999999999999999987 9999999999999999999999999998775443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||++
T Consensus 170 ~~--~~~~~~~~~y~aPE~~ 187 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVV 187 (296)
T ss_pred cc--CCCcCCCccccCcchh
Confidence 22 2234688899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=216.42 Aligned_cols=172 Identities=28% Similarity=0.445 Sum_probs=142.9
Q ss_pred CCccccceecccCcccEEEEEE-----cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (617)
+.|++.+.||+|+||.||++.. ..+..||+|.++... ....+.+.+|+.+++.++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999974 246789999987532 34456899999999999999999999999875 567
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998542 235799999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......++..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHh
Confidence 7543322 112234466789999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=213.09 Aligned_cols=170 Identities=29% Similarity=0.427 Sum_probs=143.5
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+|+..+.||+|+||+||+|...+++.+|||.+.... ......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467789999999999999998788999999886421 22345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999542 34788899999999999999999987 99999999999999999999999999987532
Q ss_pred CCc----ccccceeeeeccccCccCC
Q 007120 595 DET----EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~----~~~~~~~~gt~~y~ape~~ 616 (617)
... ........|+..|+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~ 180 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVI 180 (265)
T ss_pred ccccccccccccccCCCccccChhhh
Confidence 111 1112234588999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=212.30 Aligned_cols=172 Identities=27% Similarity=0.397 Sum_probs=145.0
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34678899999999999999999877888999988753 3345678999999999999999999999887 778999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999996532 345788999999999999999999887 99999999999999999999999999987754322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||++
T Consensus 158 ~~-~~~~~~~~~y~~PE~~ 175 (260)
T cd05073 158 TA-REGAKFPIKWTAPEAI 175 (260)
T ss_pred cc-ccCCcccccccCHhHh
Confidence 21 2223456789999976
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=219.80 Aligned_cols=166 Identities=25% Similarity=0.392 Sum_probs=133.2
Q ss_pred cceecccCcccEEEEEEc---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEEEEecCC
Q 007120 445 NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 519 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 519 (617)
.++||+|+||.||+|... .++.||+|.+... .....+.+|+.++++++||||+++++++.. +...++|+||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 3578999998642 223457789999999999999999999865 456789999986
Q ss_pred CCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE----cCCCCeEEeecCCc
Q 007120 520 NKSLDSFIFDQT------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLV 589 (617)
Q Consensus 520 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~ki~DFGla 589 (617)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57887774321 1235788899999999999999999987 9999999999999 45678999999999
Q ss_pred eeeCCCCcc-cccceeeeeccccCccCC
Q 007120 590 RTFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+.+...... .......||+.|+|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHH
Confidence 987543221 223346789999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=241.65 Aligned_cols=178 Identities=24% Similarity=0.338 Sum_probs=145.1
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeC--Ce
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 510 (617)
....++|++.+.||+|+||.||++.... +..||+|.+.. ........|..|+.+++.|+|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445689999999999999999999755 67889998864 2334567889999999999999999999988653 56
Q ss_pred EEEEEecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceeecccCCCcEEEcC--------
Q 007120 511 KLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQ-------- 577 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~iiHrDlkp~NiLl~~-------- 577 (617)
.+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986432 23468999999999999999999998531 34999999999999964
Q ss_pred ---------CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 ---------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 ---------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...+||+|||+++.+..... .....||+.|+|||++
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELL 213 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHH
Confidence 33589999999998743322 2335689999999975
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=218.91 Aligned_cols=172 Identities=29% Similarity=0.448 Sum_probs=140.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+|.... +. .+++|.++.. .......+.+|+.++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578888999999999999998754 43 4688877643 334566889999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999996432 1235789999999999999999999887 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+++...... ......++..|+|||++
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 195 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL 195 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHH
Confidence 9999999987532111 11122346679999964
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=216.82 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=142.5
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++.... ++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468888999999999999999755 7899999986532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. ...+++.....++.+++.||.|||+.+ |+||||||+||+|+.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999954 245788999999999999999999987 999999999999999999999999998742110
Q ss_pred C-------------cccccceeeeeccccCccCC
Q 007120 596 E-------------TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~-------------~~~~~~~~~gt~~y~ape~~ 616 (617)
. .........++..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhc
Confidence 0 00111224578899999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=216.54 Aligned_cols=171 Identities=27% Similarity=0.429 Sum_probs=139.8
Q ss_pred CCccccceecccCcccEEEEEEcC-C--cEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-G--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~--~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (617)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ......+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 3478888864 2334456789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCe
Q 007120 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ 581 (617)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996432 1235789999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||++....... .......+..|+|||++
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 190 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESL 190 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhh
Confidence 999999987532111 11112235679999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=224.74 Aligned_cols=167 Identities=28% Similarity=0.358 Sum_probs=138.5
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (617)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999864 4789999998752 2334567888999999999999999999886543
Q ss_pred -eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
..++||||+++ +|.+++. ..+++..+..++.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999975 6666663 23788888999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++...... ......||..|+|||++
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~ 190 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVI 190 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHH
Confidence 98764322 12335689999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=213.89 Aligned_cols=172 Identities=26% Similarity=0.417 Sum_probs=146.4
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 46889999987642 2334568899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 22456899999999999999999999987 99999999999999999999999999987754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....|+..|+|||++
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~ 178 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERI 178 (267)
T ss_pred CCcc--cccccCCcCccCHHHh
Confidence 3321 2234588899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=211.16 Aligned_cols=170 Identities=28% Similarity=0.407 Sum_probs=141.4
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
++|.+.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4678889999999999999998777789999886532 33467889999999999999999999875 456789999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999653 2345789999999999999999999887 9999999999999999999999999998774432211
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 160 -~~~~~~~~~y~~Pe~~ 175 (260)
T cd05069 160 -RQGAKFPIKWTAPEAA 175 (260)
T ss_pred -cCCCccchhhCCHHHh
Confidence 1223467789999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.64 Aligned_cols=169 Identities=27% Similarity=0.386 Sum_probs=142.1
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999875 47899999986432 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++... ...+++.....++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 6898888543 335788999999999999999999987 99999999999999999999999999987543222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 160 ~--~~~~~~~~~y~~PE~~ 176 (301)
T cd07873 160 T--YSNEVVTLWYRPPDIL 176 (301)
T ss_pred c--ccccceeecccCcHHH
Confidence 1 2234578899999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=209.74 Aligned_cols=166 Identities=30% Similarity=0.449 Sum_probs=140.3
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (617)
++||+|+||.||++...+++.|++|.++.... ...+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999875333 35678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccccee
Q 007120 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (617)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 604 (617)
+++... ...+++...+.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 235788999999999999999999987 999999999999999999999999999876432222222223
Q ss_pred eeeccccCccCC
Q 007120 605 VGTYCGTKAFLY 616 (617)
Q Consensus 605 ~gt~~y~ape~~ 616 (617)
.++..|+|||++
T Consensus 156 ~~~~~y~~PE~~ 167 (251)
T cd05041 156 QIPIKWTAPEAL 167 (251)
T ss_pred cceeccCChHhh
Confidence 346679999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=224.10 Aligned_cols=167 Identities=27% Similarity=0.353 Sum_probs=138.6
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (617)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999875 4789999998652 233456788999999999999999999987543
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...++||||+++ +|..++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6777663 23788889999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++...... ......||..|+|||++
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~ 197 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVI 197 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHH
Confidence 98764322 12335689999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=210.29 Aligned_cols=171 Identities=24% Similarity=0.433 Sum_probs=148.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||++.... ++.+++|.+........+.+.+|+.++++++||||+++++.+.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4678899999999999999998754 778999998765555678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ...++......++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999998542 245789999999999999999999987 99999999999999999999999999987653321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|++||++
T Consensus 157 ~--~~~~~~~~~y~~Pe~~ 173 (262)
T cd06613 157 K--RKSFIGTPYWMAPEVA 173 (262)
T ss_pred c--cccccCCccccCchhh
Confidence 1 2235678889999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=212.08 Aligned_cols=170 Identities=28% Similarity=0.469 Sum_probs=142.3
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccch---------hhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999874 478999998854211 223578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999954 345788899999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCccc----ccceeeeeccccCccCC
Q 007120 591 TFGGDETEG----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~----~~~~~~gt~~y~ape~~ 616 (617)
.+....... ......|+..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHh
Confidence 875322211 11234578899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=213.82 Aligned_cols=169 Identities=25% Similarity=0.374 Sum_probs=143.6
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999864 8899999886432 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887643 334899999999999999999999987 9999999999999999999999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||.+
T Consensus 155 ~~--~~~~~~~~~~~aPE~~ 172 (286)
T cd07847 155 DD--YTDYVATRWYRAPELL 172 (286)
T ss_pred cc--ccCcccccccCCHHHH
Confidence 21 2234577889999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=212.08 Aligned_cols=173 Identities=27% Similarity=0.443 Sum_probs=143.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|+..+.||+|+||.||+|.... + ..++||.++.. .....+.+..|+.++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999999753 3 37999998653 23445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 245789999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCccccc-ceeeeeccccCccCC
Q 007120 594 GDETEGNT-NRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~-~~~~gt~~y~ape~~ 616 (617)
........ .....+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~ 182 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAI 182 (268)
T ss_pred cccccceeccCCCcCceecCHHHh
Confidence 43322111 111234579999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=217.58 Aligned_cols=172 Identities=30% Similarity=0.509 Sum_probs=140.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-Cc----EEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|+..+.||+|+||.||+|.... +. .||+|.+.... .....++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3467788999999999999998643 43 57888886532 23345789999999999999999999998754 467
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998542 335788999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.............++..|++||++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~ 183 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECI 183 (303)
T ss_pred cCcccccccCCCccccccCCHHHh
Confidence 544333233334467789999975
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=217.86 Aligned_cols=166 Identities=18% Similarity=0.151 Sum_probs=130.0
Q ss_pred HhhcCCccccceecccCcccEEEEEEc--CCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
....++|.+.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+.++++++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345568999999999999999999875 4677899987532 12235679999999999999999853322 2
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeeccc-CCCcEEEcCCCCeEEeecC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NiLl~~~~~~ki~DFG 587 (617)
...+|||||+++++|.. +. .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 21 11 1 1357889999999999987 999999 9999999999999999999
Q ss_pred CceeeCCCCcccc------cceeeeeccccCccCCC
Q 007120 588 LVRTFGGDETEGN------TNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 588 la~~~~~~~~~~~------~~~~~gt~~y~ape~~~ 617 (617)
+|+.+........ .....+++.|++||++.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9998754432222 23567889999999874
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=212.59 Aligned_cols=170 Identities=28% Similarity=0.389 Sum_probs=142.9
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc----------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
+|...+.||+|+||.||+|... +++.||||.++... ....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 48899999875311 112356889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45788999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...............|+..|++||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred ccccccccccccccccCCccccCHHHh
Confidence 876433222223345688899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=215.36 Aligned_cols=168 Identities=32% Similarity=0.448 Sum_probs=142.5
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccch-----hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+|++.+.||+|+||.||+|... +++.||||.++.... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 488999999875322 2345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999995422 36899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....++..|+|||.+
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELL 174 (298)
T ss_pred CCcc--ccccccceeeeCHHHH
Confidence 3221 2223467889999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=193.48 Aligned_cols=168 Identities=27% Similarity=0.396 Sum_probs=139.5
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|...++||+|.||+||+|+..+ .+.||+|++... ++..-....+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667899999999999998655 788999998642 222345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|. .+|..|.... ...++......++.|+++||.+.|+++ +.||||||+|.||+.+|..|++|||+|+.++-.-.
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 6888887542 445888888999999999999999987 99999999999999999999999999998853321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
- ....+-|..|.+|.++
T Consensus 157 c--ysaevvtlwyrppdvl 173 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVL 173 (292)
T ss_pred e--eeceeeeeeccCccee
Confidence 1 1234568899999864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=210.24 Aligned_cols=163 Identities=28% Similarity=0.397 Sum_probs=134.7
Q ss_pred eecccCcccEEEEEEc---CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
.||+|+||.||+|.+. ++..+|+|+++.. .....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 4688999998643 2334678999999999999999999999885 45678999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc-
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN- 600 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~- 600 (617)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999853 235789999999999999999999987 99999999999999999999999999998754433211
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||.+
T Consensus 155 ~~~~~~~~~y~aPE~~ 170 (257)
T cd05116 155 KTHGKWPVKWYAPECM 170 (257)
T ss_pred cCCCCCCccccCHhHh
Confidence 1122345789999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=210.32 Aligned_cols=171 Identities=29% Similarity=0.410 Sum_probs=141.8
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (617)
.+|+..+.||+|+||.||++.... +..|++|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478888999999999999998754 889999988642 123456788999999999999999999998763 567
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999854 234788999999999999999999887 99999999999999999999999999987
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......++..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVI 181 (266)
T ss_pred cccccccCCccccCCccccccCHHHh
Confidence 6432211 112234588899999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=212.73 Aligned_cols=169 Identities=29% Similarity=0.413 Sum_probs=145.5
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.||+|... +++.|+||++.... ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 58899999987533 33456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986432 55899999999999999999999987 99999999999999999999999999998754332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. ......|+..|+|||++
T Consensus 155 ~-~~~~~~~~~~y~aPE~~ 172 (286)
T cd07832 155 R-LYSHQVATRWYRAPELL 172 (286)
T ss_pred C-ccccccCcccccCceee
Confidence 1 12235688899999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=212.70 Aligned_cols=171 Identities=23% Similarity=0.360 Sum_probs=141.5
Q ss_pred cCCccccceecccCcccEEEEEEcCC----cEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34688889999999999999986442 468999886543 4456789999999999999999999999875 55789
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999542 235799999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....++..|+|||.+
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~ 180 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESI 180 (270)
T ss_pred ccccee-cCCCCccccccChhhh
Confidence 543221 1223345689999975
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=214.47 Aligned_cols=168 Identities=26% Similarity=0.419 Sum_probs=135.0
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCccceEEEEEeC-----C
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E 509 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 509 (617)
+|++.+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999999764 7899999886421 11223455677666655 799999999998653 3
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999998 58888885432 344789999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+..... .....||..|+|||++
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~ 179 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVL 179 (288)
T ss_pred ccccCccc---CCCccccccccCchHh
Confidence 98753222 2235688999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=217.26 Aligned_cols=167 Identities=28% Similarity=0.431 Sum_probs=143.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444468999999999999874 478999999876555566778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.. ..+++.+...++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+.....
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999998843 34788999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......|+..|+|||++
T Consensus 174 ~~~~~~~~~~y~aPE~~ 190 (292)
T cd06658 174 KRKSLVGTPYWMAPEVI 190 (292)
T ss_pred cCceeecCccccCHHHH
Confidence 12345689999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=236.46 Aligned_cols=169 Identities=25% Similarity=0.337 Sum_probs=145.2
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|.+.++||+|+||.||+|... .++.||||+++.. .......+..|+.+++.++||||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357899999999999999999986 4889999998652 233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++.. ...+++...+.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999999854 234788889999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccC
Q 007120 595 DETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~ 615 (617)
.... .....+|..|++||.
T Consensus 157 ~~~~--~~~~~~t~~~~~pe~ 175 (669)
T cd05610 157 RELN--MMDILTTPSMAKPKN 175 (669)
T ss_pred Cccc--ccccccCccccCccc
Confidence 3322 234568888888873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=213.06 Aligned_cols=160 Identities=24% Similarity=0.380 Sum_probs=135.4
Q ss_pred ceecccCcccEEEEEEcC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+.||+|+||.||+|.... ..+|++|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 234888888665555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC--------eEEeecCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLV 589 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--------~ki~DFGla 589 (617)
+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996532 35789999999999999999999987 999999999999987765 699999998
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ....++..|+|||++
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~ 176 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECI 176 (258)
T ss_pred cccCCc------hhccccCCccCchhc
Confidence 765432 234578899999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=215.64 Aligned_cols=169 Identities=28% Similarity=0.393 Sum_probs=144.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||+|...+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 7899999886422 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|..+... ...+++..+..++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 234799999999999999999999987 9999999999999999999999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||++
T Consensus 155 ~~--~~~~~~~~~y~aPE~~ 172 (286)
T cd07846 155 EV--YTDYVATRWYRAPELL 172 (286)
T ss_pred cc--cCcccceeeccCcHHh
Confidence 21 2234578999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=212.98 Aligned_cols=171 Identities=29% Similarity=0.359 Sum_probs=141.5
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568999999999999999999875 48899999986532 223346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6777776432 234678888889999999999999987 999999999999999999999999999875432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....++..|+|||++
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~ 175 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVL 175 (291)
T ss_pred CCC--CCCccccccccCCcee
Confidence 221 1234578899999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=213.60 Aligned_cols=181 Identities=30% Similarity=0.427 Sum_probs=149.7
Q ss_pred hhHHhHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566677889999999999999999999975 47899999986532 2345678899999998 89999999999876
Q ss_pred CC-----eEEEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCe
Q 007120 508 GE-----EKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (617)
Q Consensus 508 ~~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ 581 (617)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999988542 22346889999999999999999999887 9999999999999999999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+++.+...... .....|+..|+|||++
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~ 200 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVI 200 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhh
Confidence 99999999876543322 1234688899999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=212.28 Aligned_cols=171 Identities=25% Similarity=0.326 Sum_probs=139.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHH-HccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||++... +++.||||+++... ......+..|+.. ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 48999999986532 2233445555554 677799999999999999999999999
Q ss_pred cCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|++ ++|.+++... .....+++..+..++.||+.||+|||++. +++||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 7888887542 23356899999999999999999999861 3999999999999999999999999999876432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||++
T Consensus 158 ~~---~~~~~~~~~y~aPE~~ 175 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERI 175 (283)
T ss_pred cc---cccccCCccccChhhc
Confidence 21 1234578899999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=216.05 Aligned_cols=165 Identities=26% Similarity=0.398 Sum_probs=132.7
Q ss_pred ceecccCcccEEEEEEcC---CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 520 (617)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 589999999999999754 4689999886532 23467889999999999999999999864 456789999987
Q ss_pred CCHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE----cCCCCeEEeecCCce
Q 007120 521 KSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (617)
Q Consensus 521 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~ki~DFGla~ 590 (617)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4777776421 12235788999999999999999999987 9999999999999 567799999999999
Q ss_pred eeCCCCcc-cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHh
Confidence 87543321 223346789999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=209.00 Aligned_cols=165 Identities=26% Similarity=0.413 Sum_probs=139.3
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeEEEEEecC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFM 518 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 518 (617)
++|++.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. ++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999874 788999988642 235678999999999999999999998654 45789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 9999999986532 345789999999999999999999987 99999999999999999999999999987643221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
...++..|+|||++
T Consensus 158 ----~~~~~~~y~aPE~~ 171 (256)
T cd05082 158 ----TGKLPVKWTAPEAL 171 (256)
T ss_pred ----CCccceeecCHHHH
Confidence 23345689999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=209.04 Aligned_cols=174 Identities=28% Similarity=0.451 Sum_probs=148.8
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|... ++..+++|++... .......+.+|+.+++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999865 4788999998642 233567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++........+++.....++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965433356899999999999999999999987 99999999999999999999999999987754433
Q ss_pred cc--ccceeeeeccccCccCC
Q 007120 598 EG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~--~~~~~~gt~~y~ape~~ 616 (617)
.. ......|+..|++||++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~ 178 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVM 178 (267)
T ss_pred ccccccccccCChhhcChHHH
Confidence 21 22345688999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=210.86 Aligned_cols=170 Identities=25% Similarity=0.438 Sum_probs=143.4
Q ss_pred CccccceecccCcccEEEEEE-cCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
+|+..+.||+|+||.||++.. .+++.||+|.++... ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 458899999986422 1235688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~ 592 (617)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999854 235788999999999999999999987 99999999999998776 5999999999887
Q ss_pred CCCCcc--cccceeeeeccccCccCC
Q 007120 593 GGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||..|+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~ 180 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVL 180 (268)
T ss_pred ccccccCCccccccccccceeCHhHh
Confidence 543221 112235688999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=206.83 Aligned_cols=170 Identities=25% Similarity=0.354 Sum_probs=143.3
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 516 (617)
+|++.+.||+|++|.||++.... ++.||+|++... .....+.+.+|+.++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999998754 788999998642 23445678999999999999999999998764 446789999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999653 2345899999999999999999999987 9999999999999999999999999999874332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......++..|+|||++
T Consensus 157 ~--~~~~~~~~~~y~aPE~~ 174 (257)
T cd08223 157 D--MASTLIGTPYYMSPELF 174 (257)
T ss_pred C--ccccccCCcCccChhHh
Confidence 2 22345688999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=208.19 Aligned_cols=170 Identities=28% Similarity=0.445 Sum_probs=146.0
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|+..+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 578999999875333 3678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999854 334788899999999999999999987 99999999999999999999999999998754332
Q ss_pred ccc--cceeeeeccccCccCC
Q 007120 598 EGN--TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~--~~~~~gt~~y~ape~~ 616 (617)
... .....++..|++||++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred cccccccCCcCCcCccChhhc
Confidence 211 1235578899999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=211.63 Aligned_cols=170 Identities=29% Similarity=0.449 Sum_probs=143.6
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
+|++.+.||+|++|.||+|+.. +++.||||.++.... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999985 488999999875322 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
+ ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 8 488888865444456899999999999999999999987 999999999999999999999999999876432221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....+|..|++||++
T Consensus 157 --~~~~~~~~~y~~PE~~ 172 (284)
T cd07836 157 --FSNEVVTLWYRAPDVL 172 (284)
T ss_pred --cccccccccccChHHh
Confidence 1224578899999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=208.66 Aligned_cols=169 Identities=28% Similarity=0.469 Sum_probs=147.2
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|...+ ++.+++|.++.... .+++.+|+.++++++|+||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999865 78999999875322 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999854 2346899999999999999999999987 99999999999999999999999999998754321
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......++..|+|||++
T Consensus 155 --~~~~~~~~~~y~~PE~~ 171 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVI 171 (256)
T ss_pred --ccccccCCccccCHHHH
Confidence 12234578899999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=216.19 Aligned_cols=169 Identities=18% Similarity=0.206 Sum_probs=138.2
Q ss_pred ccceeccc--CcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 444 INNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 444 ~~~~iG~G--~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
+.++||+| +|++||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999875 4889999998652 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..+......
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234789999999999999999999987 999999999999999999999999876544221111
Q ss_pred -----cccceeeeeccccCccCC
Q 007120 599 -----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 -----~~~~~~~gt~~y~ape~~ 616 (617)
.......++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred ccccccccccccceecccChHHh
Confidence 011223467889999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=212.16 Aligned_cols=169 Identities=28% Similarity=0.388 Sum_probs=141.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 478999999865322 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 49999885432 35788999999999999999999987 99999999999999999999999999986532211
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 159 ~--~~~~~~~~~~~aPE~~ 175 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVL 175 (291)
T ss_pred c--ccccccccccCCcHHh
Confidence 1 1123467889999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=211.98 Aligned_cols=167 Identities=32% Similarity=0.422 Sum_probs=137.4
Q ss_pred cccceecccCcccEEEEEE-----cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEE
Q 007120 443 SINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (617)
+..+.||+|+||+||++.. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 346789999987532 23456788999999999999999999998764 357899
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999854 24899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccc-cceeeeeccccCccCC
Q 007120 595 DETEGN-TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~-~~~~~gt~~y~ape~~ 616 (617)
...... .....++..|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHh
Confidence 332111 1122345679999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=211.91 Aligned_cols=169 Identities=26% Similarity=0.322 Sum_probs=142.5
Q ss_pred CccccceecccCcccEEEEEEc----CCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (617)
+|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 57899999986522 22346788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 235788888889999999999999987 99999999999999999999999999988
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...... ......|+..|++||++
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIV 178 (290)
T ss_pred ccccccc-ccccccCCcccCChhhc
Confidence 6443221 12235688999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=207.83 Aligned_cols=170 Identities=25% Similarity=0.451 Sum_probs=143.2
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.+|++.+.||+|+||.||++...++..+|+|.++... .....|.+|+.++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999886532 234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999998542 235789999999999999999999987 9999999999999999999999999998764332211
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 158 -~~~~~~~~~~~aPe~~ 173 (256)
T cd05112 158 -STGTKFPVKWSSPEVF 173 (256)
T ss_pred -cCCCccchhhcCHhHh
Confidence 1122345789999975
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=215.95 Aligned_cols=166 Identities=30% Similarity=0.427 Sum_probs=142.1
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
|+....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999875 5889999998654444566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--
Confidence 999988733 34789999999999999999999987 999999999999999999999999999876433221
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||++
T Consensus 174 ~~~~~~~~~y~aPE~~ 189 (297)
T cd06659 174 RKSLVGTPYWMAPEVI 189 (297)
T ss_pred ccceecCccccCHHHH
Confidence 2335689999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=213.26 Aligned_cols=167 Identities=26% Similarity=0.437 Sum_probs=142.9
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.|+..+.||+|+||.||+|.... ++.||+|.++.. .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667889999999999998754 788999988643 2345568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998842 45788999999999999999999987 99999999999999999999999999987754322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
......|+..|+|||.+
T Consensus 157 -~~~~~~~~~~y~aPE~~ 173 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVI 173 (277)
T ss_pred -hhhcccCcccccCHHHh
Confidence 12234578899999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=208.09 Aligned_cols=166 Identities=29% Similarity=0.446 Sum_probs=134.4
Q ss_pred ceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeEEEEEecCC
Q 007120 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMP 519 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 519 (617)
+.||+|+||.||+|...+ ...||||++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 357999998543 33456788999999999999999999998764 445789999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc-
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE- 598 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~- 598 (617)
+++|.+++... ...+++...+.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999643 234677888999999999999999887 999999999999999999999999999876432211
Q ss_pred -cccceeeeeccccCccCC
Q 007120 599 -GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 -~~~~~~~gt~~y~ape~~ 616 (617)
.......++..|+|||.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~ 174 (262)
T cd05058 156 VHNHTGAKLPVKWMALESL 174 (262)
T ss_pred ecccccCcCCccccChhHh
Confidence 111233467789999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=209.82 Aligned_cols=168 Identities=27% Similarity=0.426 Sum_probs=145.9
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999975 47899999986532 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998532 6899999999999999999999987 99999999999999999999999999998864322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|++||++
T Consensus 154 ~--~~~~~~~~~y~~PE~~ 170 (274)
T cd06609 154 K--RNTFVGTPFWMAPEVI 170 (274)
T ss_pred c--cccccCCccccChhhh
Confidence 1 2235678899999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=206.62 Aligned_cols=170 Identities=34% Similarity=0.516 Sum_probs=143.5
Q ss_pred ccccceecccCcccEEEEEEcC-----CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+++.+.||+|+||.||++...+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999999754 378999999754332 5678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999864222 12799999999999999999999987 999999999999999999999999999987654
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ...++..|+|||.+
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~ 176 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESL 176 (258)
T ss_pred cccccc-cCCCcccccChHHh
Confidence 332211 23367899999965
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=214.22 Aligned_cols=150 Identities=26% Similarity=0.314 Sum_probs=133.1
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|+..+.||+|+||.||++...+ ++.+|||.+..... ...+.+..|+.+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999865 88999999865322 34567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||+++++|.+++... ....+++.....++.|+++||+|||+.+ ++|+||||+||+|+.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998642 2346889999999999999999999987 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=213.30 Aligned_cols=168 Identities=24% Similarity=0.296 Sum_probs=143.9
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999875 4788999987643 234567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+||++++++.++|+|||++..+....
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999998854 345789999999999999999999732 39999999999999999999999999987653222
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 159 ---~~~~~~~~~~~aPE~~ 174 (284)
T cd06620 159 ---ADTFVGTSTYMSPERI 174 (284)
T ss_pred ---cCccccCcccCCHHHH
Confidence 2235689999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=209.21 Aligned_cols=165 Identities=30% Similarity=0.460 Sum_probs=134.6
Q ss_pred ceecccCcccEEEEEEcC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999855 33 5788888642 334556889999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 521 KSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 521 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++...... .......+..|+|||++
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~ 183 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESL 183 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHH
Confidence 987432111 11112345679999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=202.26 Aligned_cols=180 Identities=25% Similarity=0.307 Sum_probs=150.0
Q ss_pred hhcCCccccceecccCcccEEEEE-EcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----e
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----E 510 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 510 (617)
...++|.+.++||+|||.-||.++ +.+++.+|+|++...+.+..+..++|++.-++++||||+++++++..+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345689999999999999999998 4568899999997766677889999999999999999999999876543 4
Q ss_pred EEEEEecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
.||+++|...|+|.+.+..... +..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999875444 447899999999999999999999985 57999999999999999999999999988
Q ss_pred eeeC----CCCcc---cccceeeeeccccCccCCC
Q 007120 590 RTFG----GDETE---GNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 590 ~~~~----~~~~~---~~~~~~~gt~~y~ape~~~ 617 (617)
.... +.... ........|.-|.|||+|+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 7542 11111 1122244678899999984
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=206.55 Aligned_cols=169 Identities=27% Similarity=0.338 Sum_probs=148.3
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|++|.||+++... ++.|+||++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999865 89999999876433 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++... ..++...++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999542 558999999999999999999999 77 9999999999999999999999999999875443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||.+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~ 172 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERI 172 (264)
T ss_pred Cc--ccceeecccccCHhhh
Confidence 32 2245688999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=214.64 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=141.2
Q ss_pred CccccceecccCcccEEEEEEcC---CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (617)
+|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999987632 33346778899999999999999999999988 7899
Q ss_pred EEEecCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC----CCCeEEeec
Q 007120 513 LIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 586 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~----~~~~ki~DF 586 (617)
+||||+++ +|.+++..... ...++......++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666643222 236788999999999999999999987 999999999999999 999999999
Q ss_pred CCceeeCCCCc-ccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDET-EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~-~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+..... ........+|..|+|||.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELL 187 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHH
Confidence 99997644322 1223345688999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=210.04 Aligned_cols=172 Identities=27% Similarity=0.431 Sum_probs=142.5
Q ss_pred CCccccceecccCcccEEEEEEc-----CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEe--CCeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 511 (617)
+.|++.+.||+|+||.||++.+. .++.+|||.++..... ..+.|.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999864 2678999999764332 56789999999999999999999999987 5578
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996432 35899999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCccc-ccceeeeeccccCccCC
Q 007120 592 FGGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
+....... ......++..|++||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~ 184 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECL 184 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHH
Confidence 76332211 11122345679999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=209.97 Aligned_cols=167 Identities=26% Similarity=0.359 Sum_probs=145.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
+|++.+.||+|+||.||++... .++.||+|.+.+.. ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 48899999986522 2456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998542 46789999999999999999999987 9999999999999999999999999998875432
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....|+..|+|||.+
T Consensus 155 ~---~~~~~~~~~y~~PE~~ 171 (258)
T cd05578 155 L---TTSTSGTPGYMAPEVL 171 (258)
T ss_pred c---ccccCCChhhcCHHHH
Confidence 2 2235578899999975
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=211.11 Aligned_cols=170 Identities=24% Similarity=0.351 Sum_probs=144.4
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||+|...+ ++.||||.++.. .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999764 789999988642 23345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++++.+..++.. ...+++.....++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777766532 344789999999999999999999987 9999999999999999999999999999876543
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......++..|+|||++
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~ 173 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELL 173 (288)
T ss_pred cc-cccCcccccCCcCCchh
Confidence 21 22335678899999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=220.08 Aligned_cols=165 Identities=22% Similarity=0.310 Sum_probs=141.2
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-C-----CCccceEEEEEeCCeEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 513 (617)
+|++.+.||+|.||.|.+|.... ++.||||+++.. .....+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 88999999999999999998654 899999999863 345667788999999997 4 479999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC--CCeEEeecCCcee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRT 591 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--~~~ki~DFGla~~ 591 (617)
|+|.++ .+|.++|.... ...++......|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 79999997643 455889999999999999999999887 9999999999999653 4799999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....- .+..-++.|.|||+|
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVI 360 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVI 360 (586)
T ss_pred cCCcc-----eeeeeccccccchhh
Confidence 64321 245678899999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=218.36 Aligned_cols=168 Identities=26% Similarity=0.336 Sum_probs=143.2
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccch--------hhHHHHHHHHHHHccCC---CCCccceEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE--------QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQ 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 507 (617)
.+|+.++.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-..-.|+++|+.++ |+||++++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999865 57899998865211 11223567999999998 9999999999999
Q ss_pred CCeEEEEEecC-CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 508 GEEKLLIYEFM-PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 508 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
++.+||+||-. ++-+|.+++. ....+++.+...|+.||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 4568888883 3456899999999999999999999998 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
|.|..... .+....+||.+|.|||+++
T Consensus 715 gsaa~~ks----gpfd~f~gtv~~aapevl~ 741 (772)
T KOG1152|consen 715 GSAAYTKS----GPFDVFVGTVDYAAPEVLG 741 (772)
T ss_pred cchhhhcC----CCcceeeeeccccchhhhC
Confidence 99887643 3456789999999999874
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=211.56 Aligned_cols=169 Identities=27% Similarity=0.467 Sum_probs=146.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468889999999999999999864 5789999998654445567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 34688899999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....|+..|++||++
T Consensus 171 ~--~~~~~~~~~y~~PE~~ 187 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVV 187 (293)
T ss_pred c--cccccCChhhcCchhh
Confidence 2 2234688899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=206.70 Aligned_cols=171 Identities=27% Similarity=0.414 Sum_probs=141.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (617)
.+|++.+.||+|+||.||+|+... ++.||+|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478889999999999999998754 889999987431 223456889999999999999999999998764 457
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999854 234788889999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......++..|+|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVI 181 (264)
T ss_pred cccccccCccccccCCcccccCHhhh
Confidence 6432111 112235688999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=210.24 Aligned_cols=179 Identities=28% Similarity=0.445 Sum_probs=147.1
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEe-
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 507 (617)
++.++..+.+.|++.+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344555567789999999999999999999754 788999988653 23456788899999988 79999999999863
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 508 -----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 508 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
....+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 456799999999999999986532 345788888999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+..... ......|+..|+|||++
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l 193 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVI 193 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhc
Confidence 999999987642221 12345689999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-23 Score=204.55 Aligned_cols=169 Identities=26% Similarity=0.432 Sum_probs=144.1
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 4788999998642 334567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++++ ..+||+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345789999999999999999999987 9999999999999865 468999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 157 ~---~~~~~~~~~y~aPE~~ 173 (256)
T cd08220 157 K---AYTVVGTPCYISPELC 173 (256)
T ss_pred c---ccccccCCcccCchhc
Confidence 2 2235688899999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.65 Aligned_cols=168 Identities=25% Similarity=0.389 Sum_probs=140.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.||+|... +|+.||+|.++.. .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 4889999998642 222345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5788777542 345899999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 155 ~--~~~~~~~~~y~aPE~~ 171 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVL 171 (284)
T ss_pred C--cCCCccccCCcChHHH
Confidence 1 1234578899999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=208.92 Aligned_cols=167 Identities=26% Similarity=0.435 Sum_probs=143.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 515 (617)
.|+..+.||+|+||.||+|... +++.||||.+... ......++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999974 5889999998653 3344567889999999886 999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 25889999999999999999999987 999999999999999999999999999987654
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....|+..|+|||++
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVI 173 (277)
T ss_pred ccc--cccccCCcceeCHHHh
Confidence 322 2234688899999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=207.64 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=138.4
Q ss_pred ccccceecccCcccEEEEEEc----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
|++.+.||+|+||.||+|.+. .++.||||.++.. .....+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999864 2678999988652 3345677899999999999999999999987543
Q ss_pred eEEEEEecCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 2235788999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+.............++..|++||.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHH
Confidence 999987543322222233456779999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=225.17 Aligned_cols=172 Identities=28% Similarity=0.433 Sum_probs=146.0
Q ss_pred CCccccceecccCcccEEEEEEcC--C--cEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~--~--~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+++.+.++||+|.||.|++|.+.. | ..||||.++..... ....|++|+.+|.+|+|+|+++|+|...+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 455667899999999999999854 3 36899999865443 67899999999999999999999999987 788999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+|.++.|+|.+.|++ .....+-......++.|||.||.||.++. +|||||+++|+||-....+||+||||.|.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 34556778888999999999999999987 99999999999999999999999999999987
Q ss_pred CCcccc-cceeeeeccccCccCC
Q 007120 595 DETEGN-TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~-~~~~~gt~~y~ape~~ 616 (617)
++..+. .....-.+.|-|||-+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsL 287 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESL 287 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHh
Confidence 766532 2222245778888865
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=211.12 Aligned_cols=169 Identities=28% Similarity=0.391 Sum_probs=142.1
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (617)
++|++.+.||+|+||.||+|.... ++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 478888999999999999999864 7899999986422 22234577899999999999999999999887 789999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||++ ++|.+++... ...+++.....++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5898888542 235899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....++..|+|||.+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~ 178 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELL 178 (293)
T ss_pred Cccc--cccccccccccCchhh
Confidence 3221 2234578899999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=208.24 Aligned_cols=174 Identities=28% Similarity=0.445 Sum_probs=146.5
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCC-----
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE----- 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 509 (617)
.++++|++.+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999985 47889999887533 3456789999999999 7999999999997654
Q ss_pred -eEEEEEecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 510 -EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999986422 2456889999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++..+...... .....|+..|+|||++
T Consensus 159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 159 VSAQLDSTLGR--RNTFIGTPYWMAPEVI 185 (275)
T ss_pred cceecccchhh--hcCccccccccCHhHh
Confidence 99876433222 2235688999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=207.23 Aligned_cols=167 Identities=28% Similarity=0.429 Sum_probs=142.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
-|+..+.||+|+||.||+|... ++..||||.+... .......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 4789999987642 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.. ..+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+......
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999999842 35789999999999999999999987 999999999999999999999999999877533211
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||.+
T Consensus 158 --~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 158 --RNTFVGTPFWMAPEVI 173 (277)
T ss_pred --hccccCCccccChhhh
Confidence 2234578899999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-23 Score=207.77 Aligned_cols=167 Identities=27% Similarity=0.432 Sum_probs=143.9
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.|+..+.||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 56777899999999999999754 789999988643 2345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+......
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999999843 34788899999999999999999887 999999999999999999999999999887543322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 158 --~~~~~~~~~y~apE~~ 173 (277)
T cd06640 158 --RNTFVGTPFWMAPEVI 173 (277)
T ss_pred --cccccCcccccCHhHh
Confidence 2234578899999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=210.27 Aligned_cols=168 Identities=36% Similarity=0.483 Sum_probs=138.4
Q ss_pred ceecccCcccEEEEEEcC-------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998743 2578999886532 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-----CeEEeecCC
Q 007120 518 MPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 588 (617)
Q Consensus 518 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-----~~ki~DFGl 588 (617)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999887 99999999999999877 899999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+.............++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESL 185 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHH
Confidence 9876443322222233456789999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=227.77 Aligned_cols=173 Identities=23% Similarity=0.348 Sum_probs=133.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC--CcEEEEE------------------EecccchhhHHHHHHHHHHHccCCCCC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHRN 497 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 497 (617)
..++|++.+.||+|+||+||++..+. +..+++| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987543 2222222 111 12233456889999999999999
Q ss_pred ccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE
Q 007120 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (617)
Q Consensus 498 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl 575 (617)
||++++++...+..++|+|++. ++|.+++..... ...........|+.||+.||+|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 577777643211 112335566789999999999999987 9999999999999
Q ss_pred cCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 576 DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 576 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.++.+||+|||+++.+...... ......||..|+|||++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~ 340 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEIL 340 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhh
Confidence 99999999999999987543322 22235799999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=209.75 Aligned_cols=171 Identities=26% Similarity=0.340 Sum_probs=140.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCe-----
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 510 (617)
++|++.+.||+|+||.||+|... +++.||||.++... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 48899999876432 223467888999999995 6999999999987665
Q ss_pred EEEEEecCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 587 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFG 587 (617)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888764322 346799999999999999999999987 999999999999998 8999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+...... .....+++.|+|||++
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~ 183 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVL 183 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHh
Confidence 99876432221 1223567889999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=204.28 Aligned_cols=170 Identities=24% Similarity=0.363 Sum_probs=144.7
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.+|++... +++.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999864 4789999998642 334456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2235789999999999999999999987 99999999999999999999999999987754322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....|+..|+|||++
T Consensus 157 ~--~~~~~~~~~~~~pe~~ 173 (256)
T cd08218 157 L--ARTCIGTPYYLSPEIC 173 (256)
T ss_pred h--hhhccCCccccCHHHh
Confidence 1 2234578889999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=204.26 Aligned_cols=164 Identities=32% Similarity=0.450 Sum_probs=134.9
Q ss_pred ceecccCcccEEEEEEcC-C---cEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
++||+|+||.||+|.... + ..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997533 2 6899999875332 35668999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999643 25789999999999999999999887 99999999999999999999999999998754332211
Q ss_pred -cceeeeeccccCccCC
Q 007120 601 -TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 -~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 154 ~~~~~~~~~~y~aPE~~ 170 (257)
T cd05060 154 ATTAGRWPLKWYAPECI 170 (257)
T ss_pred cccCccccccccCHHHh
Confidence 1112245679999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=225.64 Aligned_cols=169 Identities=22% Similarity=0.284 Sum_probs=133.3
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCC------CCccceEEEEEe
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQ 507 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~ 507 (617)
+....++|++.++||+|+||+||+|.... ++.||||+++... ...+++..|+.++..++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34456789999999999999999998754 7889999986532 233455666766666654 558889998876
Q ss_pred C-CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCC------
Q 007120 508 G-EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM------ 579 (617)
Q Consensus 508 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~------ 579 (617)
. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678999988 6788888854 34588999999999999999999974 5 99999999999998765
Q ss_pred ----------CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 ----------NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 ----------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||++..... ......||..|+|||++
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~ 317 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVV 317 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHh
Confidence 499999999865321 12346799999999975
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.90 Aligned_cols=167 Identities=28% Similarity=0.428 Sum_probs=141.5
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..+.|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+.+++.++||||+++.+++.+++..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999875 4889999988642 22344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|+||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 93 v~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 6777766432 335899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ...++..|+|||++
T Consensus 167 ~~~------~~~~~~~y~aPE~~ 183 (307)
T cd06607 167 PAN------SFVGTPYWMAPEVI 183 (307)
T ss_pred CCC------CccCCccccCceee
Confidence 322 24578889999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=209.46 Aligned_cols=169 Identities=28% Similarity=0.435 Sum_probs=141.8
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 48899999886422 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++.... ...+++.....++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988886532 345899999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|+|||++
T Consensus 156 ~--~~~~~~~~~y~aPE~~ 172 (284)
T cd07860 156 T--YTHEVVTLWYRAPEIL 172 (284)
T ss_pred c--cccccccccccCCeEE
Confidence 1 1223467889999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=204.78 Aligned_cols=164 Identities=30% Similarity=0.471 Sum_probs=137.7
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
++|++.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999975 6788999998642 2346789999999999999999999998654 4789999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999996532 335789999999999999999999887 9999999999999999999999999998753221
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....+..|+|||++
T Consensus 155 --~~~~~~~~y~~pe~~ 169 (254)
T cd05083 155 --DNSKLPVKWTAPEAL 169 (254)
T ss_pred --CCCCCCceecCHHHh
Confidence 122345679999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=205.60 Aligned_cols=171 Identities=23% Similarity=0.449 Sum_probs=141.8
Q ss_pred CccccceecccCcccEEEEEEcC--CcEEEEEEeccc----------chhhHHHHHHHHHHHcc-CCCCCccceEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI----------SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 507 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 507 (617)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 678999987531 22334567788888865 799999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 23446889999999999999999999632 3999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|++....... ......|+..|++||++
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~ 185 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIV 185 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhh
Confidence 9999865443 22345688999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=208.22 Aligned_cols=168 Identities=26% Similarity=0.328 Sum_probs=144.7
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|+..+.||+|+||.||++... +++.|++|.+.... ....+++.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999986 48899999986532 34556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986432 567889999999999999999998 66 9999999999999999999999999998764322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ...++..|+|||++
T Consensus 156 ~~----~~~~~~~y~~PE~~ 171 (265)
T cd06605 156 AK----TFVGTSSYMAPERI 171 (265)
T ss_pred hh----cccCChhccCHHHH
Confidence 21 25678899999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=205.02 Aligned_cols=160 Identities=26% Similarity=0.323 Sum_probs=138.5
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||.|+||.||++.... ++.+++|.+.+.. ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999864 8899999986522 23456799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999954 234788999999999999999999987 9999999999999999999999999999875432 1223
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
..++..|++||++
T Consensus 152 ~~~~~~~~~PE~~ 164 (262)
T cd05572 152 FCGTPEYVAPEII 164 (262)
T ss_pred ccCCcCccChhHh
Confidence 4678899999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=201.15 Aligned_cols=168 Identities=31% Similarity=0.482 Sum_probs=146.0
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999875 478999999876432 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998542 46899999999999999999999887 99999999999999999999999999998754332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....++..|++||.+
T Consensus 155 ~--~~~~~~~~~y~~pe~~ 171 (254)
T cd06627 155 D--DASVVGTPYWMAPEVI 171 (254)
T ss_pred c--ccccccchhhcCHhhh
Confidence 2 2235688899999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=200.48 Aligned_cols=168 Identities=34% Similarity=0.520 Sum_probs=147.6
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999986 588999999976554567789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 46899999999999999999999977 99999999999999999999999999988765432
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.....++..|++||++
T Consensus 154 -~~~~~~~~~~~~PE~~ 169 (253)
T cd05122 154 -RNTMVGTPYWMAPEVI 169 (253)
T ss_pred -ccceecCCcccCHHHH
Confidence 2346688999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=220.85 Aligned_cols=175 Identities=21% Similarity=0.285 Sum_probs=132.8
Q ss_pred hcCCccccceecccCcccEEEEEE-----------------cCCcEEEEEEecccchhhHHH--------------HHHH
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLKE--------------LKNE 486 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 486 (617)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 567899999999999999999964 234679999986533222223 3446
Q ss_pred HHHHccCCCCCc-----cceEEEEEe--------CCeEEEEEecCCCCCHHHHHhcCCC---------------------
Q 007120 487 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDSFIFDQTR--------------------- 532 (617)
Q Consensus 487 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 532 (617)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 678888754 3467999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccC
Q 007120 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTK 612 (617)
Q Consensus 533 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~a 612 (617)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123467788899999999999999987 999999999999999999999999999876432221 1112234789999
Q ss_pred ccCC
Q 007120 613 AFLY 616 (617)
Q Consensus 613 pe~~ 616 (617)
||.+
T Consensus 379 PE~l 382 (507)
T PLN03224 379 PEEL 382 (507)
T ss_pred hhhh
Confidence 9975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=211.35 Aligned_cols=169 Identities=24% Similarity=0.331 Sum_probs=145.1
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.-|.+.+.||+|.|..|-+|++ -.|..||||++.+. +......+..|++-|+.++|||||+|+.+.-....+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3467778999999999999975 46999999999764 33445678899999999999999999999988999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE-cCCCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl-~~~~~~ki~DFGla~~~~~~ 595 (617)
.-.+|+|.+||-+... -+.+....+++.||+.|+.|.|+.. +|||||||+||.+ .+-|-+||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999965443 3778888899999999999999876 9999999999876 66789999999999877554
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
+. .++.+|++.|.|||.+
T Consensus 173 ~k---L~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEIL 190 (864)
T ss_pred ch---hhcccchhhccCchhh
Confidence 43 5568999999999975
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=207.67 Aligned_cols=173 Identities=28% Similarity=0.472 Sum_probs=148.9
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
....+.|+..+.||+|++|.||++... +++.|++|.+..... ..+.+.+|+.+++.++|+|++++++.+...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677888899999999999999986 588999999876433 567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+..
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999996532 36899999999999999999999987 99999999999999999999999999887643
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......++..|++||++
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~ 188 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVI 188 (286)
T ss_pred chh--hhccccCCcccCCHhHh
Confidence 322 12234578899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=213.85 Aligned_cols=171 Identities=28% Similarity=0.459 Sum_probs=141.9
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC--CeE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 511 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 511 (617)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999975 4789999988542 233445677899999999 999999999998654 367
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 599888843 26789999999999999999999987 99999999999999999999999999997
Q ss_pred eCCCCcc---cccceeeeeccccCccCC
Q 007120 592 FGGDETE---GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~---~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......||..|+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred cccccccccCcchhcccccccccCceee
Confidence 7543322 123345689999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=206.50 Aligned_cols=162 Identities=29% Similarity=0.368 Sum_probs=137.0
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||+||++... +++.+|+|.+.... ......+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 48899999986422 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+..... ...
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence 999865332 35789999999999999999999987 99999999999999999999999999987643221 223
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
..++..|+|||++
T Consensus 154 ~~~~~~y~~PE~~ 166 (277)
T cd05577 154 RAGTPGYMAPEVL 166 (277)
T ss_pred ccCCCCcCCHHHh
Confidence 4578899999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=202.88 Aligned_cols=174 Identities=26% Similarity=0.420 Sum_probs=143.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 515 (617)
+|++.+.||.|+||.||++... +++.||+|.+.. ......+.+..|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 478899998864 234456678899999999999999999998764 34678999
Q ss_pred ecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||+++++|.+++... .....+++...+.++.+|+.||.|||..+ ..+|+|+||+|+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456899999999999999999999322 234999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....++..|+|||++
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~ 182 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQL 182 (265)
T ss_pred cCCccc--ccccccCCCccChhhh
Confidence 644321 2234688999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=200.93 Aligned_cols=170 Identities=31% Similarity=0.433 Sum_probs=147.1
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (617)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 58899999986533 24577899999999999999999999999988 8899999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986432 6899999999999999999999987 999999999999999999999999999988655
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
..........++..|++||.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred cccccccCCCCCccccCHhhh
Confidence 432112345688899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=207.39 Aligned_cols=162 Identities=29% Similarity=0.440 Sum_probs=140.5
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHH
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (617)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999875 58899999986544555677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccccccee
Q 007120 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (617)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 604 (617)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+...... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 98743 34788999999999999999999987 999999999999999999999999999876543221 2235
Q ss_pred eeeccccCccCC
Q 007120 605 VGTYCGTKAFLY 616 (617)
Q Consensus 605 ~gt~~y~ape~~ 616 (617)
.|+..|++||++
T Consensus 177 ~~~~~y~~pE~~ 188 (292)
T cd06657 177 VGTPYWMAPELI 188 (292)
T ss_pred ccCccccCHHHh
Confidence 688999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.99 Aligned_cols=172 Identities=27% Similarity=0.423 Sum_probs=139.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-----
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (617)
.++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999975 48899999886422 2223456789999999999999999999876543
Q ss_pred ---EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 511 ---KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 511 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
.++||||++ ++|.+++.. ....+++.+...++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999997 578887743 2235799999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcc--cccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
++..+...... .......++..|+|||++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHh
Confidence 99877433221 112234578899999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=202.70 Aligned_cols=166 Identities=28% Similarity=0.341 Sum_probs=140.9
Q ss_pred ceecccCcccEEEEE-EcCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
+.||+|+|+.|.-+. +..+.++|||++.+..........+|++++..-+ |+||++|+.+++++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999887 5679999999998877777788899999999885 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC---CeEEeecCCceeeC--CCCcc
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFG--GDETE 598 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~ki~DFGla~~~~--~~~~~ 598 (617)
...|.+ ...+++.+..++..+||.||.|||..+ |.||||||+|||-.+.. -+||+||.|+.-+. .+-+.
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999854 445788999999999999999999998 99999999999986544 38999998876442 22111
Q ss_pred ---cccceeeeeccccCccCCC
Q 007120 599 ---GNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 599 ---~~~~~~~gt~~y~ape~~~ 617 (617)
....+++|+-.|||||+.+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCccccCcccchhhcchhHHh
Confidence 1234577889999999864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=222.12 Aligned_cols=172 Identities=27% Similarity=0.407 Sum_probs=148.2
Q ss_pred hcCCccccceecccCcccEEEEEEcCCc-EEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..+.|.++..||.|+||.||+|..++.. ..|.|.+...++...+.|.-|+.+|+..+||+||+|++.+...+.++|+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4456778889999999999999876643 456677777777889999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
||.||..+..+.+. ...+...++..++++++.||.|||++. |||||||+-|||++-+|.++|+|||.+-.....
T Consensus 110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 99999999988653 445889999999999999999999987 999999999999999999999999987654322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
...-....||+.|||||+.
T Consensus 184 -~qkRDsFIGTPYWMAPEVv 202 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVV 202 (1187)
T ss_pred -HhhhccccCCcccccchhe
Confidence 2223457899999999974
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=208.51 Aligned_cols=173 Identities=28% Similarity=0.422 Sum_probs=142.0
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 509 (617)
...++|++.+.||+|+||.||+|.... ++.||||.++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345689999999999999999999864 7899999986532 223456788999999999999999999987655
Q ss_pred ------eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 510 ------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 510 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 677776432 345899999999999999999999987 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+...... ......++..|+|||++
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELL 189 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHh
Confidence 999999987543321 11223467889999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=206.03 Aligned_cols=160 Identities=28% Similarity=0.331 Sum_probs=130.4
Q ss_pred eecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHH---HHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI---LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.||+|+||.||++...+ ++.+|||.+.+.. ......+.+|.. ++...+||||+.+.+.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998754 7899999886421 122233344443 3444589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.....
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999999854 345899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
....||..|+|||++
T Consensus 153 --~~~~~~~~y~aPE~~ 167 (279)
T cd05633 153 --HASVGTHGYMAPEVL 167 (279)
T ss_pred --cCcCCCcCccCHHHh
Confidence 234589999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=205.69 Aligned_cols=170 Identities=26% Similarity=0.305 Sum_probs=141.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (617)
++|+..+.||.|++|.||++...+ ++.+|+|.+... .......+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 467888999999999999999854 788999998753 234567799999999999999999999998654 3689999
Q ss_pred ecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||+++++|.+++... .....++......++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23445788899999999999999999987 99999999999999999999999999886543
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ....++..|++||.+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~ 175 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERI 175 (287)
T ss_pred ccc----ccccCCccccCHHHh
Confidence 221 134577889999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=231.86 Aligned_cols=174 Identities=29% Similarity=0.466 Sum_probs=135.9
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 508 (617)
..+|+.++.||+||||.|||++. -||+.+|||++... +......+.+|+.++++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45788889999999999999985 37999999998643 344567788999999999999999876511000
Q ss_pred --------------------------------------------------------------------------------
Q 007120 509 -------------------------------------------------------------------------------- 508 (617)
Q Consensus 509 -------------------------------------------------------------------------------- 508 (617)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007120 509 -------------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557 (617)
Q Consensus 509 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 557 (617)
..+||=||||+.-.|+++++...... .....++++.+|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 11356789998888888885432211 456778899999999999999
Q ss_pred CCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC--------------C--CCcccccceeeeeccccCccCCC
Q 007120 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG--------------G--DETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 558 ~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~--------------~--~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
++ ||||||||.||+||++..|||+|||+|.... . .......+..+||.-|+|||+++
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 98 9999999999999999999999999999721 0 00111234578999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=205.83 Aligned_cols=170 Identities=26% Similarity=0.393 Sum_probs=139.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|++|.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999975 58899999886422 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~~ 595 (617)
|++ ++|.+++.... ...+++.....++.||+.||+|||+.+ ++||||+|+||++++ ++.+||+|||+++.+...
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57877774322 233577888899999999999999987 999999999999985 567999999999876433
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....++..|+|||++
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 157 VRT--FTHEVVTLWYRAPEIL 175 (294)
T ss_pred ccc--cccCceeecccCHHHH
Confidence 221 1234578899999965
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=217.52 Aligned_cols=179 Identities=29% Similarity=0.470 Sum_probs=152.9
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEe-
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 507 (617)
.+..+...++.|++.+.||+|.+|.||+++. ++++.+|||++... ....+++..|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445556778899999999999999999985 45888999988763 34566777888888877 69999999999875
Q ss_pred ----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 508 ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 508 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
++.++||||||.+|+..+++.... ...+.|.....|+.++++|+.+||... +||||||=.||||++++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 457899999999999999997644 667899999999999999999999886 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.|||++..+... ....++.+||+.+||||++
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEVi 195 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVI 195 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceee
Confidence 999999988543 3445567899999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=204.69 Aligned_cols=168 Identities=29% Similarity=0.436 Sum_probs=140.8
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
|++.+.||+|++|.||+|... ++..||||++.... ....+.+.+|+.+++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999875 58999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
+ ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.+......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68999885433 235899999999999999999999987 999999999999999999999999999876433221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 156 --~~~~~~~~~~~aPE~~ 171 (283)
T cd07835 156 --YTHEVVTLWYRAPEIL 171 (283)
T ss_pred --cCccccccCCCCCcee
Confidence 1223568899999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=208.18 Aligned_cols=173 Identities=29% Similarity=0.366 Sum_probs=141.6
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEec--c-----cchhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLS--K-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~--~-----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 510 (617)
++|-++.+||+|+|++||+|.. ...+-||||+-. + ..+...+...+|-++-+.|+||-||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4666788999999999999985 346778998742 2 122234556788999999999999999999865 456
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFG 587 (617)
.+-|+|||++.+|+-||.. ...+++.+...|+.||..||.||.+.. ++|||-||||.||||.. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999943 556899999999999999999999884 78999999999999954 4779999999
Q ss_pred CceeeCCCCcc-----cccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
|+|++.++... ..+...+||+.|+|||-|
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCccee
Confidence 99999765443 124456799999999965
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=203.85 Aligned_cols=163 Identities=27% Similarity=0.358 Sum_probs=138.6
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 89999999865322 4566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc-----
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE----- 598 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~----- 598 (617)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999642 25899999999999999999999987 999999999999999999999999998875433210
Q ss_pred -cccceeeeeccccCccCC
Q 007120 599 -GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 -~~~~~~~gt~~y~ape~~ 616 (617)
.......++..|++||++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~ 173 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVI 173 (265)
T ss_pred cccccCcccCccccCHHHh
Confidence 122335577889999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=188.37 Aligned_cols=177 Identities=24% Similarity=0.314 Sum_probs=143.6
Q ss_pred HHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecc-cchhhHHHHHHHHHHHc-cCCCCCccceEEEEEeCCeE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~ 511 (617)
++...+.+.-...||+|++|.|-+-++. +|...|+|++.. ...+..+...+|+.+.. ....|.+|.++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4445556666789999999999888864 589999999975 34556677778887654 45799999999999988999
Q ss_pred EEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 512 LLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
++.||.|. .||+.+..+. .+...+++...-+|+..|.+||.|||++ +.+||||+||+||||+.+|++||+|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 7888776432 3456688888999999999999999996 469999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
.+.+.- ..+...|...|||||.++
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERIN 221 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcC
Confidence 885332 122356888999999764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=202.43 Aligned_cols=170 Identities=25% Similarity=0.407 Sum_probs=143.6
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999865 788999998642 223456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986432 335789999999999999999999987 99999999999999886 56999999998875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....|++.|+|||++
T Consensus 157 ~~--~~~~~~~~~~~ape~~ 174 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEIC 174 (257)
T ss_pred cc--ccccCCCccccCHHHH
Confidence 22 2234588999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=204.61 Aligned_cols=166 Identities=28% Similarity=0.427 Sum_probs=142.4
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5789999998654445566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++..+......
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999999854 34788999999999999999999987 999999999999999999999999998876443221
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||++
T Consensus 172 ~~~~~~~~~y~aPE~~ 187 (285)
T cd06648 172 RKSLVGTPYWMAPEVI 187 (285)
T ss_pred cccccCCccccCHHHh
Confidence 2234588999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=207.37 Aligned_cols=171 Identities=32% Similarity=0.435 Sum_probs=140.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (617)
..++|++.+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34689999999999999999999754 8899999986422 12233567899999999999999999998765 4689
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||++ ++|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999997 5888888542 245899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....++..|+|||.+
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELL 180 (309)
T ss_pred CCccCC--CCcccccccccChhhh
Confidence 543221 1223457889999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=211.40 Aligned_cols=170 Identities=25% Similarity=0.387 Sum_probs=140.2
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 511 (617)
.++|++.+.||+|+||.||+|... +++.||||.++.. .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 4889999998642 2234567888999999999999999999876543 57
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+||++ ++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 47877773 235889999999999999999999987 99999999999999999999999999988
Q ss_pred eCCCCccc-ccceeeeeccccCccCC
Q 007120 592 FGGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
........ ......||..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIM 181 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHh
Confidence 65432211 12335688999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=204.11 Aligned_cols=168 Identities=28% Similarity=0.415 Sum_probs=141.4
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEEEe
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 516 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 516 (617)
|++.+.||+|+||.||+|...+ ++.+|+|++.... ......+.+|+.+++.++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999765 7899999997642 33456788999999999999999999999988 78999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++ ++|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 998 4888888542 246899999999999999999999987 9999999999999999999999999999875543
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....++..|+|||.+
T Consensus 155 ~~~-~~~~~~~~~y~~PE~~ 173 (287)
T cd07840 155 SAD-YTNRVITLWYRPPELL 173 (287)
T ss_pred ccc-ccccccccccCCceee
Confidence 211 2224567889999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=206.81 Aligned_cols=164 Identities=28% Similarity=0.450 Sum_probs=139.6
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|+..+.||+|+||.||++... ++..||+|.+... .......+..|+.++++++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999975 4789999998642 22345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++ |+|.+++.. ....+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 577777643 2345899999999999999999999987 999999999999999999999999998865432
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
....|++.|+|||++
T Consensus 179 -----~~~~~~~~y~aPE~~ 193 (317)
T cd06635 179 -----NSFVGTPYWMAPEVI 193 (317)
T ss_pred -----ccccCCccccChhhh
Confidence 234578899999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=206.18 Aligned_cols=171 Identities=32% Similarity=0.430 Sum_probs=146.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (617)
++|.+.+.||+|+||.||++... +++.||+|.+.+. .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 5889999988642 2344567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 236899999999999999999999987 99999999999999999999999999997754
Q ss_pred CCcc------------------cccceeeeeccccCccCC
Q 007120 595 DETE------------------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~------------------~~~~~~~gt~~y~ape~~ 616 (617)
.... .......++..|++||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 194 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence 3321 112234578899999964
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=203.41 Aligned_cols=160 Identities=27% Similarity=0.320 Sum_probs=130.8
Q ss_pred eecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHH---HHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.||+|+||.||++.... ++.||+|.+.+.. ......+..|. .+++...||||+++.+.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 7899999986421 11222233443 34455689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999998853 346899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
....|+..|+|||++
T Consensus 153 --~~~~~~~~y~aPE~~ 167 (278)
T cd05606 153 --HASVGTHGYMAPEVL 167 (278)
T ss_pred --cCcCCCcCCcCcHHh
Confidence 234689999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=211.20 Aligned_cols=167 Identities=29% Similarity=0.370 Sum_probs=139.1
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (617)
..++|+..+.||+|+||.||++... +++.||||.+.+. .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3468999999999999999999875 5889999998642 233456778899999999999999999998644
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...++||||++ ++|.+.+.. .++......++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999996 588877732 1788889999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++....... .....+|..|+|||++
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~ 189 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVI 189 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHH
Confidence 998754322 2234578899999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-24 Score=235.42 Aligned_cols=172 Identities=27% Similarity=0.392 Sum_probs=145.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+-+++....||.|.||.||.|... +|...|+|-++. ..........+|+.++..|+|||+|+.+|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345666789999999999999864 488889997754 23345677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|||++|+|.+.+.. ....++.....+..|++.|+.|||+++ ||||||||.||||+.+|.+|++|||.|+.+.+.
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999843 333566666668899999999999998 999999999999999999999999999988665
Q ss_pred Ccc--cccceeeeeccccCccCC
Q 007120 596 ETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~--~~~~~~~gt~~y~ape~~ 616 (617)
... ...+...||+-|||||.|
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhh
Confidence 321 224567899999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=197.50 Aligned_cols=171 Identities=26% Similarity=0.380 Sum_probs=147.2
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.||++... +++.+++|++.... ......+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 48899999987532 24567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 1356899999999999999999999987 9999999999999999999999999999875443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......|+..|+|||.+
T Consensus 158 ~--~~~~~~~~~~y~~pe~~ 175 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELC 175 (258)
T ss_pred c--eecceeeeecccChhHh
Confidence 1 22335688899999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=202.30 Aligned_cols=165 Identities=23% Similarity=0.318 Sum_probs=135.9
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCCccceEEEEEeC--CeEEEEEe
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 516 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 516 (617)
|++.+.||+|+||.||+|... +++.||+|+++.. .........+|+..+.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999875 4789999998653 2222334457888888885 99999999999987 88999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5888887542 246899999999999999999999987 999999999999999 999999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ....++..|+|||.+
T Consensus 154 ~~---~~~~~~~~y~aPE~~ 170 (282)
T cd07831 154 PY---TEYISTRWYRAPECL 170 (282)
T ss_pred Cc---CCCCCCcccCChhHh
Confidence 21 234578899999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=210.84 Aligned_cols=170 Identities=24% Similarity=0.379 Sum_probs=141.1
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (617)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68888999999999999999875 48899999986532 2345677889999999999999999998763 34679
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+|+||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 689888843 344899999999999999999999987 999999999999999999999999999877
Q ss_pred CCCCcc--cccceeeeeccccCccCC
Q 007120 593 GGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
...... .......|+..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred cccCcCCCcccccccccccccChHHh
Confidence 543321 112345688999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=209.31 Aligned_cols=167 Identities=27% Similarity=0.400 Sum_probs=139.8
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 509 (617)
...++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999864 5889999998642 2233456889999999999999999999987654
Q ss_pred --eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 510 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 6799888742 35789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+.... ....++..|++||++
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~ 187 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVI 187 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHH
Confidence 998764322 234578889999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=203.81 Aligned_cols=169 Identities=27% Similarity=0.335 Sum_probs=141.4
Q ss_pred CccccceecccCcccEEEEEEc----CCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (617)
+|++.+.||+|+||.||+++.. ++..||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999853 46789999986422 22345788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999853 245788899999999999999999887 99999999999999999999999999987
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+....... .....|+..|++||.+
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVI 178 (288)
T ss_pred cccccccc-cccccCCccccCHHHh
Confidence 65433211 2234588899999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=208.49 Aligned_cols=172 Identities=28% Similarity=0.399 Sum_probs=142.1
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
..++...+++|++.+.||+|+||.||++... +++.||||+++.. .....+.+.+|+.++++++||||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667889999999999999999999864 5889999998753 223356788899999999999999999988653
Q ss_pred ------CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 509 ------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 509 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2357888876 7899888743 34789999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++..... .....+|..|+|||.+
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~ 189 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIM 189 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHH
Confidence 9999999875322 1234678899999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=199.38 Aligned_cols=159 Identities=27% Similarity=0.316 Sum_probs=131.9
Q ss_pred ceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHH-HccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|... +++.||||.+++.. ......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 47899999986532 1223344455444 4556899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 999999854 235788999999999999999999987 999999999999999999999999999875431
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
....++..|++||++
T Consensus 151 -~~~~~~~~y~~pe~~ 165 (260)
T cd05611 151 -KKFVGTPDYLAPETI 165 (260)
T ss_pred -ccCCCCcCccChhhh
Confidence 234578889999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=198.50 Aligned_cols=162 Identities=23% Similarity=0.247 Sum_probs=131.3
Q ss_pred hcCCcccccee--cccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHc-cCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~i--G~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.+ |+|+||.||++... ++..+|+|.+........ |+.... ..+||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566776666 99999999999875 478899998864221111 121111 1279999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~ 592 (617)
||||+++++|.+++... ..+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.+
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999542 36899999999999999999999987 99999999999999998 9999999999876
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... ...++..|+|||++
T Consensus 161 ~~~~------~~~~~~~y~aPE~~ 178 (267)
T PHA03390 161 GTPS------CYDGTLDYFSPEKI 178 (267)
T ss_pred CCCc------cCCCCCcccChhhh
Confidence 4322 23578899999976
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=202.91 Aligned_cols=170 Identities=24% Similarity=0.356 Sum_probs=138.9
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||+|.... ++.||||.++... .....++..|+.++.+.. ||||+++++++.++...++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678888999999999999999865 8899999987532 234456667777666665 99999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|||++ ++|.+++... ...+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||+++.+.
T Consensus 93 ~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 5777766432 23689999999999999999999974 5 9999999999999999999999999998764
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ....++..|+|||++
T Consensus 167 ~~~~~---~~~~~~~~y~aPE~~ 186 (296)
T cd06618 167 DSKAK---TRSAGCAAYMAPERI 186 (296)
T ss_pred CCCcc---cCCCCCccccCHhhc
Confidence 43322 223577889999976
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=199.54 Aligned_cols=169 Identities=27% Similarity=0.457 Sum_probs=144.7
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|++.+.||+|+||.||++... +++.+++|.+... ......++.+|+.++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 4789999998652 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
+++++|.+++.... ....+++...+.++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 2355789999999999999999999987 9999999999999999999999999999875542
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|++||++
T Consensus 158 ----~~~~~~~~~~~~Pe~~ 173 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVW 173 (256)
T ss_pred ----cccccCCccccCHHHH
Confidence 2234578899999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=202.16 Aligned_cols=167 Identities=28% Similarity=0.385 Sum_probs=139.9
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccch-hhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecC
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
|++.+.||+|++|.||+|...+ ++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999865 78899999865322 22234557899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 789998886532 246799999999999999999999987 99999999999999999999999999987754322
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 155 --~~~~~~~~~~~aPE~~ 170 (283)
T cd07830 155 --YTDYVSTRWYRAPEIL 170 (283)
T ss_pred --cCCCCCcccccCceee
Confidence 1234578899999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=201.71 Aligned_cols=163 Identities=29% Similarity=0.456 Sum_probs=137.9
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
|...+.||+|+||+||+|+.. +++.|++|++... .....+.+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999874 4789999998642 223446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+. ++|.+++.. ....+++.++..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 677777743 2345899999999999999999999987 99999999999999999999999999875422
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....|+..|+|||++
T Consensus 174 ---~~~~~~~~~y~aPE~~ 189 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVI 189 (313)
T ss_pred ---CCCccccccccChhhc
Confidence 2235688899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=208.15 Aligned_cols=169 Identities=25% Similarity=0.394 Sum_probs=140.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----e
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----E 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 510 (617)
.++|.+.+.||+|+||.||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999999875 4889999998642 2334556778999999999999999999886543 4
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 788888843 345889999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....... ......++..|+|||++
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~ 180 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELL 180 (337)
T ss_pred ccCCCcc--cccccccccCccChHHH
Confidence 7754321 12234578899999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=207.55 Aligned_cols=171 Identities=25% Similarity=0.329 Sum_probs=149.2
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEec--ccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (617)
...|+++++||.||.+.||++...+.+.+|+|++. ..+.+....|..|+.+|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 45789999999999999999998888899999875 356677889999999999995 999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||- ..+|..+|..... ....| .+..+-.||+.++.++|.++ |||.||||.|+|+ -.|.+||+|||+|+.+..+
T Consensus 440 E~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 976 4799999965332 33445 55668899999999999998 9999999999998 4578999999999999999
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+.......+||+-||+||-|
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl 533 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEAL 533 (677)
T ss_pred ccceeeccccCcccccCHHHH
Confidence 888877888999999999965
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=203.63 Aligned_cols=170 Identities=27% Similarity=0.352 Sum_probs=137.1
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+|+..+.||+|+||.||++.... ++.||||.+... .......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 55667899999999999998754 789999998653 2344567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
++ ++|.++... ......+++.....++.+++.||+|||+.. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 455544321 112356899999999999999999999752 3999999999999999999999999999876433
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....|+..|+|||++
T Consensus 162 ~~---~~~~~~~~~y~aPE~~ 179 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERI 179 (288)
T ss_pred Cc---cccccCccCccCHHHh
Confidence 22 1234588899999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=204.50 Aligned_cols=168 Identities=21% Similarity=0.195 Sum_probs=135.9
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555655555554 5899999998653 3456678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc----
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---- 597 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~---- 597 (617)
+|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999996532 234788889999999999999999987 99999999999999999999999999987643222
Q ss_pred -ccccceeeeeccccCccCC
Q 007120 598 -EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 -~~~~~~~~gt~~y~ape~~ 616 (617)
........++..|+|||++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred cccccccccccccccCHHHh
Confidence 1112334577889999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=206.73 Aligned_cols=169 Identities=30% Similarity=0.444 Sum_probs=143.2
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (617)
+|++.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999765 8899999987633 344568899999999999999999999998875 789
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||++ ++|.+++.. ...+++..+..++.+++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 588888843 236899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcc-cccceeeeeccccCccCC
Q 007120 593 GGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
...... .......+|..|+|||++
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELL 178 (330)
T ss_pred cccccccccccccccccCcCCceee
Confidence 554311 112335678899999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=205.49 Aligned_cols=170 Identities=25% Similarity=0.357 Sum_probs=137.7
Q ss_pred CCcc-ccceecccCcccEEEEEEc-CCcEEEEEEecccchhh--------------HHHHHHHHHHHccCCCCCccceEE
Q 007120 440 DNFS-INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLLG 503 (617)
Q Consensus 440 ~~~~-~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 503 (617)
++|. +.+.||+|+||.||+|... .++.||||.++...... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3467999999999999975 48899999986422111 124778999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 504 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 689988843 345788999999999999999999987 999999999999999999999
Q ss_pred eecCCceeeCCCCc------------ccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDET------------EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+..... ........++..|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 205 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence 99999987752111 1111223467889999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=204.64 Aligned_cols=169 Identities=27% Similarity=0.403 Sum_probs=136.9
Q ss_pred CccccceecccCcccEEEEEEcC---CcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC----Ce
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 510 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 510 (617)
+|++.+.||+|+||.||++.... +..||||++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999753 678999998642 222355778899999999 599999999986543 34
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 689888843 345889999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcc--cccceeeeeccccCccCC
Q 007120 591 TFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||..|+|||++
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred ecccccccccccccCcccCccccCcHHH
Confidence 77533221 112345689999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=202.60 Aligned_cols=165 Identities=29% Similarity=0.451 Sum_probs=139.4
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+.|+..+.||+|+||.||+|+... +..+++|.+.. ......+.+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347777899999999999999754 78899998863 22334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..+...
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 6887777432 344788999999999999999999987 999999999999999999999999999876432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
....++..|+|||++
T Consensus 169 ------~~~~~~~~y~aPE~~ 183 (308)
T cd06634 169 ------NXFVGTPYWMAPEVI 183 (308)
T ss_pred ------ccccCCccccCHHHH
Confidence 234578899999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=220.85 Aligned_cols=179 Identities=29% Similarity=0.401 Sum_probs=146.6
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC--------CcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCCccceEE
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLG 503 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g 503 (617)
..+...+++++.+.||+|.||.|++|.... ...||||.++. ......+.+..|+.+|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 345556666777899999999999998531 34799999975 3345678899999999998 6999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhcCC---------C--C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCC
Q 007120 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQT---------R--R--TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (617)
Q Consensus 504 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp 570 (617)
+|..+...++|+||++.|+|.+||+... . . ..+.....+.++.|||.||+||++.. +|||||++
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997644 0 0 23888999999999999999999876 99999999
Q ss_pred CcEEEcCCCCeEEeecCCceeeCCCCcccccceeee--eccccCccCC
Q 007120 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG--TYCGTKAFLY 616 (617)
Q Consensus 571 ~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g--t~~y~ape~~ 616 (617)
|||||.++..+||+||||||.....+.... ....| ...+||||-+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl 493 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESL 493 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHh
Confidence 999999999999999999997655443321 11122 3459999965
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=204.82 Aligned_cols=164 Identities=27% Similarity=0.420 Sum_probs=136.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
.++|...+.||+|+||.||+|... +++.||||++.+. .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368889999999999999999964 5899999998652 2223456889999999999999999999987543
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++|+||+. .+|..++ ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4689999996 4776665 234788999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....+|..|+|||++
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~ 186 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVI 186 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhh
Confidence 875322 1234678899999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.46 Aligned_cols=168 Identities=27% Similarity=0.390 Sum_probs=139.6
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 511 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 511 (617)
...+++|++.+.||+|+||.||++... +++.||||++.+. .....+.+..|+.+++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346778999999999999999999865 5889999988542 22345678899999999999999999999876 5578
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+||+ +++|..++.. ..+++.....++.|+++||.|||+.+ |+||||+|+|||+++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 5689888742 34678888889999999999999987 99999999999999999999999999986
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ....++..|+|||.+
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~ 177 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIM 177 (328)
T ss_pred cCCCc-----CCCcccccccCceee
Confidence 53221 224567889999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-24 Score=198.18 Aligned_cols=170 Identities=29% Similarity=0.484 Sum_probs=134.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeC--------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 508 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 508 (617)
..|+...+||+|.||+||+|+.++ ++.||+|++-. ..+..-....+|+.++..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345566799999999999999755 77889887533 1222234557899999999999999999988642
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
...+||+++|+ .+|.-+|... ...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 24799999997 6888888542 345788899999999999999999876 99999999999999999999999999
Q ss_pred ceeeCCCCcc---cccceeeeeccccCccCC
Q 007120 589 VRTFGGDETE---GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~---~~~~~~~gt~~y~ape~~ 616 (617)
|+.+.-.+.. ..++ .+-|+.|.+||.+
T Consensus 171 ar~fs~~~n~~kprytn-rvvTLwYrppEll 200 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTN-RVVTLWYRPPELL 200 (376)
T ss_pred ccceecccccCCCCccc-ceeeeecCCHHHh
Confidence 9887543332 1233 3458999999965
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=202.50 Aligned_cols=172 Identities=29% Similarity=0.452 Sum_probs=139.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
.++|++.+.||+|+||.||+|... +++.+|||++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 47899999886422 222346778999999999999999999876543
Q ss_pred --eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 510 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
..++|+||++. +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999974 67766643 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCccc---------ccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEG---------NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~---------~~~~~~gt~~y~ape~~ 616 (617)
+++......... ......++..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL 198 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence 998765332211 11234678899999964
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=202.05 Aligned_cols=170 Identities=25% Similarity=0.282 Sum_probs=139.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (617)
..+|.++.+||+|+||+|.+|.-+. .+.+|||++++. .....+--+.|-++|+.. +-|.+++|..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3478888999999999999998765 567999999862 122344455667777665 56899999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+.+|+|-..+.... .+-+..+..+|.+||-||-+||+.+ ||.||||.+|||||.+|++||+|||++|.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999988875433 3455667789999999999999998 9999999999999999999999999999532
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
- ....+.+.+||+.|+|||.+
T Consensus 502 ~--~~~TTkTFCGTPdYiAPEIi 522 (683)
T KOG0696|consen 502 F--DGVTTKTFCGTPDYIAPEII 522 (683)
T ss_pred c--CCcceeeecCCCcccccceE
Confidence 1 22346678899999999975
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=198.91 Aligned_cols=167 Identities=31% Similarity=0.439 Sum_probs=141.3
Q ss_pred ccccceecccCcccEEEEEEc-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
|+..+.||+|++|.||++... +++.+++|.++.... .....+..|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456689999999999999875 588899999865322 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 888887542 246899999999999999999999987 999999999999999999999999999987654311
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 155 --~~~~~~~~~~~~PE~~ 170 (283)
T cd05118 155 --YTHYVVTRWYRAPELL 170 (283)
T ss_pred --ccCccCcccccCcHHH
Confidence 1224577889999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=196.39 Aligned_cols=167 Identities=28% Similarity=0.443 Sum_probs=136.4
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccC---CCCCccceEEEEEeCCe-----
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 510 (617)
|++.+.||+|+||.||+|+... ++.||||.++.. .......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999865 889999998642 122234566777766555 69999999999998776
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.+++|||++ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 58988885432 235899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... .....++..|+|||++
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~ 178 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVL 178 (287)
T ss_pred eccCCcc---cccccccccccChHHh
Confidence 8754322 2234578889999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=198.40 Aligned_cols=172 Identities=18% Similarity=0.225 Sum_probs=125.4
Q ss_pred hcCCccccceecccCcccEEEEEEcCC----cEEEEEEecccchhhH-----------HHHHHHHHHHccCCCCCccceE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVKLL 502 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~ 502 (617)
..++|++.++||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997553 4556664322111110 1122344556778999999999
Q ss_pred EEEEeCC----eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 503 GCCIQGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 503 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
+++.... ..++++|++. .++.+.+.. ....++.....++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876654 3478888774 466666532 223467888899999999999999987 9999999999999999
Q ss_pred CCeEEeecCCceeeCCCCcc-----cccceeeeeccccCccCC
Q 007120 579 MNPKISDFGLVRTFGGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 579 ~~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
+.+||+|||+|+.+..+... .......||+.|+|||.+
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence 99999999999987432211 112234699999999964
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=193.00 Aligned_cols=161 Identities=30% Similarity=0.377 Sum_probs=138.7
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
||+|+||.||++.... ++.+++|.+.... ......+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999754 8899999986532 23456889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccce
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 603 (617)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 9999542 35799999999999999999999977 99999999999999999999999999988754321 1234
Q ss_pred eeeeccccCccCC
Q 007120 604 VVGTYCGTKAFLY 616 (617)
Q Consensus 604 ~~gt~~y~ape~~ 616 (617)
..++..|++||++
T Consensus 153 ~~~~~~~~~Pe~~ 165 (250)
T cd05123 153 FCGTPEYLAPEVL 165 (250)
T ss_pred CcCCccccChHHh
Confidence 5678899999975
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=205.23 Aligned_cols=169 Identities=26% Similarity=0.386 Sum_probs=138.6
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC----------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG---------- 508 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 508 (617)
.+|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578899999999999999998754 789999998765555667889999999999999999999776543
Q ss_pred ----CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEE
Q 007120 509 ----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKI 583 (617)
Q Consensus 509 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki 583 (617)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588888742 34788999999999999999999987 99999999999997 4567899
Q ss_pred eecCCceeeCCCCcc-cccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+...... .......++..|+|||++
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHH
Confidence 999999876432221 112234578899999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=202.02 Aligned_cols=167 Identities=25% Similarity=0.298 Sum_probs=134.3
Q ss_pred ceeccc--CcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G--~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
..||+| +||+||++... .++.||||.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 89999999975 5899999998642 233457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc-
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG- 599 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~- 599 (617)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999986532 234788999999999999999999887 9999999999999999999999998654332211110
Q ss_pred ----ccceeeeeccccCccCC
Q 007120 600 ----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ----~~~~~~gt~~y~ape~~ 616 (617)
......++..|++||++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred ccccccccccCccCccChhhh
Confidence 01112345679999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=197.88 Aligned_cols=167 Identities=31% Similarity=0.434 Sum_probs=141.3
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
|+..+.||+|.+|.||+|+... ++.+|+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566889999999999999765 8999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999996432 45899999999999999999999987 999999999999999999999999999887543321
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....++..|+|||++
T Consensus 155 --~~~~~~~~~~~aPE~~ 170 (282)
T cd07829 155 --YTHEVVTLWYRAPEIL 170 (282)
T ss_pred --cCccccCcCcCChHHh
Confidence 1223457789999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=196.27 Aligned_cols=170 Identities=28% Similarity=0.372 Sum_probs=137.5
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998754 344555555431 222344677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456899999999999999999999987 999999999999975 569999999998875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....|+..|+|||.+
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~ 177 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEAL 177 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHH
Confidence 43321 2234578899999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=188.34 Aligned_cols=171 Identities=23% Similarity=0.345 Sum_probs=139.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++++.+..||.|..|.|++.+++. |..+|||.+.+. .....+.++..+.++.+-+ .|.||+.+|+|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455666889999999999999865 789999999763 4455667778888776665 899999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|.|. .-++.+|.. ...++++.-.-++...+.+||.||.++. .|||||+||+|||+|+.|++|++|||++-.+-..
T Consensus 171 elMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9884 334444432 2455888888899999999999998754 5999999999999999999999999999888654
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
.. .++.+|...|||||-++
T Consensus 246 kA---htrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 246 KA---HTRSAGCAAYMAPERID 264 (391)
T ss_pred cc---cccccCCccccCccccC
Confidence 43 34678999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-23 Score=193.78 Aligned_cols=172 Identities=29% Similarity=0.346 Sum_probs=138.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-chhhHHHHHHHHHHH-ccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++++.+..||.|+||+|+|-.++. |+..|||+++.. .+...++++.|.... +.-+.||||+++|.+......++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 355556789999999999998765 899999999753 335667788888765 45578999999999999899999999
Q ss_pred cCCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 517 FMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 517 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
.|. -||+.+... ......+++.-.-+|......||.||-.. +.|||||+||+|||||..|.+||+|||++-.+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 677655421 12234577777788888899999999875 4699999999999999999999999999988743
Q ss_pred CCcccccceeeeeccccCccCCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
....+..+|...|||||-++
T Consensus 221 ---SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred ---HHHhhhccCCccccChhccC
Confidence 22344577999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=213.29 Aligned_cols=171 Identities=20% Similarity=0.263 Sum_probs=120.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC-----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEE------EE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 506 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 506 (617)
..++|++.+.||+|+||.||+|.+.+ +..||||++..... .+....| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 58899998864221 1111111 1122222222222211 24
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccC
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTRR-----------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 569 (617)
.....++||||+++++|.+++...... ..........++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998643211 01122345578999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 570 ASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 570 p~NiLl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+||||++ ++.+||+|||+|+.+...... ......+|+.|+|||.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQY 329 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHh
Confidence 99999986 579999999999976443322 23346789999999954
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=202.36 Aligned_cols=166 Identities=28% Similarity=0.423 Sum_probs=140.0
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe----
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 510 (617)
..++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45689999999999999999999854 789999998642 22344667889999999999999999998776654
Q ss_pred --EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 511 --KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 511 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5799988843 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..+... .....+|..|+|||++
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~ 187 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIM 187 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHH
Confidence 9876432 2234578889999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=201.57 Aligned_cols=147 Identities=24% Similarity=0.377 Sum_probs=129.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..-|..++.||-|+||+|.++...+ ...+|+|.|.+. ........+.|..+|+..+.+-||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4567778999999999999998655 567899999763 345667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
|||+++|++-.+|- +...+++.....++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.=
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999999883 3455777777778889999999999887 99999999999999999999999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=209.90 Aligned_cols=168 Identities=28% Similarity=0.383 Sum_probs=133.6
Q ss_pred ccccceecccCccc-EEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCC
Q 007120 442 FSINNKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 442 ~~~~~~iG~G~fG~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
|...+.+|.|+-|+ ||+|.+ ++++||||++-. ....-..+|+.+++.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44457889998875 799998 688999999843 3445567899998887 69999999999888999999999995
Q ss_pred CCCHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---C--CCeEEeecCCceeeC
Q 007120 520 NKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLVRTFG 593 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~--~~~ki~DFGla~~~~ 593 (617)
.+|++++........ ..-.....+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||++|.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 799999965311111 111334567889999999999976 999999999999976 3 579999999999998
Q ss_pred CCCcccc-cceeeeeccccCccCCC
Q 007120 594 GDETEGN-TNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 594 ~~~~~~~-~~~~~gt~~y~ape~~~ 617 (617)
.++.... .....||-||+|||++.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHh
Confidence 7776532 45577999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-22 Score=188.52 Aligned_cols=168 Identities=24% Similarity=0.273 Sum_probs=134.7
Q ss_pred hcCCcccc-ceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHcc-CCCCCccceEEEEEe----CCe
Q 007120 438 ATDNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEE 510 (617)
Q Consensus 438 ~~~~~~~~-~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~ 510 (617)
.+++|++. ++||-|-.|+|..+..+. ++.+|+|.+... ...++|+++--. -.|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566664 689999999999998754 788999988542 234566665433 369999999998764 345
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFG 587 (617)
+++|||.|+||.|.+.+.++. ...+++++...|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 689999999999999997643 456899999999999999999999987 999999999999864 5679999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
+||.... .....+.+-|+.|.|||+++
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhC
Confidence 9997543 33455677889999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-22 Score=204.17 Aligned_cols=169 Identities=23% Similarity=0.280 Sum_probs=145.6
Q ss_pred cCCccccceecccCcccEEEEEEcCCc-EEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..+++.+..||-|+||.|-+....... .+|+|.+++ .+..+.++...|-.+|...+.|.||+|+-.+.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666788999999999998875533 378888865 4556678889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||-|-+|.|...|+++. .++......++..+.+|++|||.++ ||.|||||+|.|||.+|-+||.|||+||.++.
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997643 3566666678889999999999988 99999999999999999999999999999865
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .+-+.+||+.|.|||.+
T Consensus 573 g~---KTwTFcGTpEYVAPEII 591 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEII 591 (732)
T ss_pred CC---ceeeecCCcccccchhh
Confidence 43 36678999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=186.15 Aligned_cols=150 Identities=19% Similarity=0.100 Sum_probs=125.6
Q ss_pred cCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHhc
Q 007120 451 GGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (617)
Q Consensus 451 G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 529 (617)
|.+|.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 47899999987532 234455556667799999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeecc
Q 007120 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609 (617)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 609 (617)
. ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++..+.... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 34889999999999999999999987 9999999999999999999999999987764321 12345677
Q ss_pred ccCccCC
Q 007120 610 GTKAFLY 616 (617)
Q Consensus 610 y~ape~~ 616 (617)
|+|||++
T Consensus 148 y~aPE~~ 154 (237)
T cd05576 148 YCAPEVG 154 (237)
T ss_pred ccCCccc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=180.53 Aligned_cols=140 Identities=18% Similarity=0.166 Sum_probs=108.1
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchh--h-------H-----------------HHHHHHHHHHccCCCCCc
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--G-------L-----------------KELKNEVILFSKLQHRNL 498 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~ni 498 (617)
...||+|+||.||+|...+|+.||||+++..... . . .....|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999998653110 0 1 122348999999988776
Q ss_pred cceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecccCCCcEEEcC
Q 007120 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 577 (617)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlkp~NiLl~~ 577 (617)
.....+.. ...+|||||++++++...+.. ...++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 233899999998877654322 24578889999999999999999 6776 99999999999998
Q ss_pred CCCeEEeecCCceeeC
Q 007120 578 DMNPKISDFGLVRTFG 593 (617)
Q Consensus 578 ~~~~ki~DFGla~~~~ 593 (617)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-20 Score=179.32 Aligned_cols=169 Identities=32% Similarity=0.426 Sum_probs=145.1
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999876 789999999764443 57789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+++|.+++..... .+++.....++.+++.++.|||+.+ ++|+||+|.||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999854322 1789999999999999999999987 999999999999999999999999999988654311
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......++..|++||++
T Consensus 155 ~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 155 LLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccceeccCCcCCHhHh
Confidence 22345678889999975
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=175.71 Aligned_cols=142 Identities=19% Similarity=0.211 Sum_probs=111.9
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHccCCCCCc
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRNL 498 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 498 (617)
...||+|+||.||+|...+|+.||||.+...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753110 01224678999999999988
Q ss_pred cceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcC
Q 007120 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (617)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~ 577 (617)
.....+... ..+|||||++++++...... ...++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 24899999998865443211 2346778889999999999999999 77 99999999999999
Q ss_pred CCCeEEeecCCceeeCCC
Q 007120 578 DMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 578 ~~~~ki~DFGla~~~~~~ 595 (617)
++.++|+|||+|+.+...
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 899999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=183.55 Aligned_cols=172 Identities=23% Similarity=0.308 Sum_probs=141.2
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (617)
...++|.++.+||+|+|.+|..++++. .+.+|+|.+++. ..+...=.+.|-.++... +||.+|.|..++.....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 345689999999999999999999765 688999998762 222233455666666554 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|.||+++|+|--.+. +...+++.....+..+|..||.|||+.+ ||.||||.+|||||.+|++||+|+|++|.
T Consensus 327 ffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999976553 3344777777778899999999999998 99999999999999999999999999996
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
--.+ ...+.+.+||+-|+|||.+
T Consensus 401 ~l~~--gd~tstfcgtpnyiapeil 423 (593)
T KOG0695|consen 401 GLGP--GDTTSTFCGTPNYIAPEIL 423 (593)
T ss_pred CCCC--CcccccccCCCcccchhhh
Confidence 4322 2346678999999999976
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=183.88 Aligned_cols=182 Identities=23% Similarity=0.298 Sum_probs=150.2
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEE
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 504 (617)
.+++.....+++...++.+|.||.||.|.+.+ .+.|-||.++. .++-+...+..|..++..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34556666788888899999999999997643 45678888865 455667889999999999999999999999
Q ss_pred EEeCC-eEEEEEecCCCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 505 CIQGE-EKLLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 505 ~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
+.+.. ..+.+|.++.-|+|..||. +......+...+...++.|++.||+|||.++ +||.||+++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 98754 5688999999999999997 4444566788899999999999999999987 9999999999999999
Q ss_pred CCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 579 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.++||+|=.|+|.+-+.+.+--.........||+||-+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 99999999999988665554332223334578888865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-22 Score=186.13 Aligned_cols=164 Identities=29% Similarity=0.423 Sum_probs=133.2
Q ss_pred cceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eEEEEEe
Q 007120 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLIYE 516 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E 516 (617)
.+-||-|+||.||..+.+ +|+.||.|++...- -...+.+.+|+.++...+|.|++..++...... ++|.|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 368999999999999874 58999999986532 234567889999999999999999988865543 3467888
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
.|. .+|...+ .+...++.....-+..||++||+|||+.+ |.||||||.|.|+++|...||+||||||.-..++
T Consensus 138 LmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 884 5677666 34556777777778999999999999987 9999999999999999999999999999876665
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
....+ ..+-|..|.|||.+
T Consensus 211 ~~hMT-qEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 211 RLNMT-HEVVTQYYRAPELL 229 (449)
T ss_pred hhhhH-HHHHHHHhccHHHh
Confidence 54444 34567889999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=177.70 Aligned_cols=156 Identities=28% Similarity=0.394 Sum_probs=135.6
Q ss_pred CcccEEEEEEcC-CcEEEEEEecccchhh-HHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHhc
Q 007120 452 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (617)
Q Consensus 452 ~fG~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 529 (617)
+||.||+|...+ ++.+++|.+....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8899999997644333 68899999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeecc
Q 007120 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609 (617)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 609 (617)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||++..+.... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2789999999999999999999987 9999999999999999999999999999876542 2234557889
Q ss_pred ccCccCC
Q 007120 610 GTKAFLY 616 (617)
Q Consensus 610 y~ape~~ 616 (617)
|++||.+
T Consensus 152 ~~~pE~~ 158 (244)
T smart00220 152 YMAPEVL 158 (244)
T ss_pred CCCHHHH
Confidence 9999964
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-19 Score=168.70 Aligned_cols=162 Identities=35% Similarity=0.540 Sum_probs=138.3
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHH
Q 007120 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (617)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998764322 35789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCCCCccccccee
Q 007120 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRV 604 (617)
Q Consensus 526 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~ 604 (617)
++.... ..+++..+..++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985422 35789999999999999999999987 999999999999999 89999999999998754321 12234
Q ss_pred eeeccccCccCC
Q 007120 605 VGTYCGTKAFLY 616 (617)
Q Consensus 605 ~gt~~y~ape~~ 616 (617)
.+...|++||.+
T Consensus 154 ~~~~~~~~pe~~ 165 (215)
T cd00180 154 VGTPAYMAPEVL 165 (215)
T ss_pred cCCCCccChhHh
Confidence 567789999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-21 Score=198.73 Aligned_cols=171 Identities=25% Similarity=0.396 Sum_probs=150.0
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
...++|+....+|.|.||.|||++... ++..|||.++........-.+.|+.+++.-+|||||.++|-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 456789999999999999999999754 8889999998766667778889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+.+|+|++..+- -.++++.+...++++..+|++|||+.+ -+|||||=.|||+++.+.+|++|||.+-.++..
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999987643 356888889999999999999999998 799999999999999999999999998877532
Q ss_pred CcccccceeeeeccccCccC
Q 007120 596 ETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~ 615 (617)
- ..-....||+.+||||+
T Consensus 166 i--~KrksfiGtpywmapEv 183 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEV 183 (829)
T ss_pred h--hhhhcccCCccccchhH
Confidence 2 22344779999999996
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=171.00 Aligned_cols=163 Identities=25% Similarity=0.403 Sum_probs=134.5
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCe--EEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE--KLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~--~~lV 514 (617)
.++|++.+++|+|.+++||.|.. .+.+.++||.++.. ..+.+.+|+.+|..|. ||||++|++...+... ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46899999999999999999984 55788999999763 4567899999999998 9999999999887653 5799
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla~~~~ 593 (617)
+||+.+.+...+. ..+.-.....++.++++||.|+|+.| |+|||+||.|++||.. -..+|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999999887665 22455566778999999999999998 9999999999999865 579999999999987
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+... ..+.++-+--||++
T Consensus 185 p~~eYn---VRVASRyfKGPELL 204 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELL 204 (338)
T ss_pred CCceee---eeeehhhcCCchhe
Confidence 655432 23455666677764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=166.89 Aligned_cols=138 Identities=20% Similarity=0.317 Sum_probs=106.7
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-----CCCCccceEEEEEeCC---eEE-E
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-L 513 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~-l 513 (617)
+-.+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 444333478887654344567899999999999 6799999999998874 333 7
Q ss_pred EEec--CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeecccCCCcEEEcC----CCCeEEee-
Q 007120 514 IYEF--MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISD- 585 (617)
Q Consensus 514 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~iiHrDlkp~NiLl~~----~~~~ki~D- 585 (617)
|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999999541 24444 35677888887 9999988 999999999999974 34799999
Q ss_pred cCCcee
Q 007120 586 FGLVRT 591 (617)
Q Consensus 586 FGla~~ 591 (617)
||....
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 555444
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=153.36 Aligned_cols=76 Identities=49% Similarity=0.777 Sum_probs=65.4
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||.||++.|. ...+.|.|+.||+|+|.|.+|.++|+|++.+.....++ +|+|+|||||++.+ +.+||||||
T Consensus 41 ~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~~~~~~-~L~ddGnlvl~~~~----~~~~W~Sf~ 114 (116)
T cd00028 41 RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVL-VLLDDGNLVLYDSD----GNFLWQSFD 114 (116)
T ss_pred CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEecccCCCCceEE-EEeCCCCEEEECCC----CCEEEcCCC
Confidence 6899999999994 45588999999999999999999999998752234445 99999999999974 679999999
Q ss_pred CC
Q 007120 95 YP 96 (617)
Q Consensus 95 ~P 96 (617)
||
T Consensus 115 ~P 116 (116)
T cd00028 115 YP 116 (116)
T ss_pred CC
Confidence 99
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-19 Score=169.49 Aligned_cols=164 Identities=23% Similarity=0.356 Sum_probs=128.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEE-EEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 516 (617)
+.|.+.+.+|+|.||.+.+++++. ...+++|.+.+ .....++|.+|...--.| .|.||+.-+.. +...+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 578899999999999999999876 56889998865 344577899888765555 68999877654 556677889999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE-cC-CCCeEEeecCCceeeCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQ-DMNPKISDFGLVRTFGG 594 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl-~~-~~~~ki~DFGla~~~~~ 594 (617)
|+|.|+|.+-+.. .-+-+....+++.|++.||.|+|+.. +||||||.+|||| +. ...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999887733 33566667789999999999999987 9999999999999 33 45899999999887542
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.- ....-+.-|.+||..
T Consensus 176 tV-----~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELC 192 (378)
T ss_pred ee-----hhhhhhcccCCcHHH
Confidence 21 122345568888864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=183.86 Aligned_cols=163 Identities=25% Similarity=0.312 Sum_probs=133.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++.|.+...+|.|+|+.|-.+... .++..+||++.+.. ..-.+|+.++ ..-+||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888889999999999998864 47889999997642 2233455443 44479999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE-cCCCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl-~~~~~~ki~DFGla~~~~~~ 595 (617)
.+.++-|.+.+.... ... .++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.+...
T Consensus 397 ~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998877774322 222 777789999999999999988 9999999999999 58999999999999988654
Q ss_pred CcccccceeeeeccccCccCCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~~ 617 (617)
..+.+-|..|.|||++.
T Consensus 470 -----~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLA 486 (612)
T ss_pred -----hcccchhhcccChhhhc
Confidence 33456788999999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=169.41 Aligned_cols=168 Identities=20% Similarity=0.252 Sum_probs=138.4
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCC--CC----ccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RN----LVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~g~~~~~~~ 510 (617)
..++|.+...+|+|.||.|.++.... +..||||+++.. ....+..+-|+.++.+|.+ |+ +|++.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36789999999999999999998754 688999998764 2345566789999999943 22 7788888999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-------------
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 577 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~------------- 577 (617)
.+||+|.+ +-|+.++|.. +.-.+++......|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 4599999965 33456888999999999999999999987 999999999999732
Q ss_pred -------CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 -------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 -------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..+||+|||-|..-.... ..++.|+.|.|||+|
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVI 281 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchhe
Confidence 2358999999999754333 457889999999986
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=145.36 Aligned_cols=75 Identities=48% Similarity=0.788 Sum_probs=64.9
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||+|||+.|+... +.|.|+.||+|+|.|.+|.++|+|++....+..++ +|+|+|||||++.. +.+||||||
T Consensus 40 ~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~~~~~-~L~ddGnlvl~~~~----~~~~W~Sf~ 113 (114)
T smart00108 40 RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVL-VLLDDGNLVIYDSD----GNFLWQSFD 113 (114)
T ss_pred CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEecccCCCCceEE-EEeCCCCEEEECCC----CCEEeCCCC
Confidence 6899999999998764 88999999999999999999999998622344555 99999999999874 679999999
Q ss_pred C
Q 007120 95 Y 95 (617)
Q Consensus 95 ~ 95 (617)
|
T Consensus 114 ~ 114 (114)
T smart00108 114 Y 114 (114)
T ss_pred C
Confidence 7
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=160.04 Aligned_cols=135 Identities=19% Similarity=0.266 Sum_probs=114.2
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
+.||+|++|.||+|.. .+..|+||....... .....+.+|+.++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677889997643111 1224678899999999999998888888888888999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998431 12 77889999999999999987 99999999999999 789999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=161.74 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=112.4
Q ss_pred CCccccceecccCcccEEEEE--EcCCcEEEEEEecccchh------------------------hHHHHHHHHHHHccC
Q 007120 440 DNFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISEQ------------------------GLKELKNEVILFSKL 493 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 493 (617)
..|++.+.||+|+||.||+|. ..+|+.||||.+...... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 567999999998642110 112356899999999
Q ss_pred CCCC--ccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCC
Q 007120 494 QHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (617)
Q Consensus 494 ~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~ 571 (617)
.|.. +.+++++ ...++||||+++.+|..++.. ...++......++.||+.+|++||+.+ +|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7643 3444443 235899999999888765422 223455666789999999999999875 3999999999
Q ss_pred cEEEcCCCCeEEeecCCceeeCCC
Q 007120 572 NVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 572 NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++ ++.++|+|||+|......
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCc
Confidence 99999 889999999999976543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-18 Score=165.63 Aligned_cols=164 Identities=30% Similarity=0.359 Sum_probs=130.5
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------e
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------E 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 510 (617)
.+|.-++.+|.|.- .|..+.. -.+++||+|++.. ......+...+|..++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35655667777776 4444432 2478999998854 23344567788999999999999999999987654 3
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.|+|||||. .+|...+. ..++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 589999995 78888874 33677788899999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.-..+ ...+-.+.|+-|.|||.+
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevi 189 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVI 189 (369)
T ss_pred ccCcc---cccCchhheeeccCchhe
Confidence 74332 234456789999999975
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=158.21 Aligned_cols=141 Identities=13% Similarity=0.130 Sum_probs=114.7
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccch---hhHHH------HHHHHHHHccCCCCCccceEEEEEe
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE---QGLKE------LKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
...++|...+++|+|+||.||.... ++..+|||.+..... ..... +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999655 577899999964221 12122 6899999999999999999988664
Q ss_pred C--------CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 508 G--------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 508 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
. ...+|||||+++.+|.++.. ++. ....+++.+|..+|..+ ++||||+|.||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 24789999999999987741 222 24568999999999988 99999999999999988
Q ss_pred CeEEeecCCceeeC
Q 007120 580 NPKISDFGLVRTFG 593 (617)
Q Consensus 580 ~~ki~DFGla~~~~ 593 (617)
++|+|||..+...
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 9999999988764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=180.78 Aligned_cols=140 Identities=20% Similarity=0.283 Sum_probs=113.5
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEeccc-c------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-S------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
...|...+.||+|+||.||+|.+.+...++.+++.+. . ....+.+.+|+.++..++|++++....++.+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445567899999999999998755433332223221 1 12235688999999999999999988888887888
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999883 34678999999999999987 9999999999999 678999999999997
Q ss_pred eC
Q 007120 592 FG 593 (617)
Q Consensus 592 ~~ 593 (617)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=153.32 Aligned_cols=167 Identities=22% Similarity=0.339 Sum_probs=130.2
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 515 (617)
....|.+.++||.|+||.+|.|.. .+|.+||||.-+... .--++..|..+.+.|+| ..|..+..+..+...-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 346799999999999999999985 569999999765422 22356678888888876 67888888888999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DFGla~~~ 592 (617)
|.+ +-+|.+++.-.++ .++..+.+-++-|++.-++|+|..+ +|||||||+|+|+.-+ ..+.++||||||.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 6788887743333 3778899999999999999999988 9999999999998543 45889999999987
Q ss_pred CCCCcc--cc---cceeeeeccccC
Q 007120 593 GGDETE--GN---TNRVVGTYCGTK 612 (617)
Q Consensus 593 ~~~~~~--~~---~~~~~gt~~y~a 612 (617)
-...+. .+ .....||-.|.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred ccccccccCccccCCccceeeeehh
Confidence 544332 11 223456666653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=151.69 Aligned_cols=133 Identities=20% Similarity=0.216 Sum_probs=106.2
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEecccchh----hHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
....|++|+||+|+.+.- .+.+++.+.++....- ....|.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 447899999999997765 6788887777653221 1225889999999995 5889999886 4569999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeeccc-CCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
++.+|...+.. ....++.|++++|.++|+++ |+|||| ||.|||+++++.++|+|||+|+....
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99998654311 11347789999999999998 999999 79999999999999999999996543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=155.99 Aligned_cols=144 Identities=18% Similarity=0.177 Sum_probs=111.2
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccch----------------------hhHHHHHHHHHHHcc
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFSK 492 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~ 492 (617)
+......|.+.+.||+|+||.||++...+++.||||++..... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999998653210 011236778888988
Q ss_pred CCCCC--ccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCC
Q 007120 493 LQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (617)
Q Consensus 493 l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp 570 (617)
+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 88874 444444 2455899999999998765410 234568899999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeecCCceeeCC
Q 007120 571 SNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 571 ~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+||++++++.++|+|||++..+..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999977643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=155.61 Aligned_cols=132 Identities=22% Similarity=0.318 Sum_probs=108.6
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.||+|+||.||+|.+ ++..|++|...... ....+.+.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999854311 112356789999999999988766666666777789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
++++|.+++.... . .++.+++++|.+||+.+ ++|+|++|.||+++ ++.++|.|||+++...
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998874311 0 78999999999999987 99999999999999 8999999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.7e-16 Score=159.14 Aligned_cols=170 Identities=31% Similarity=0.451 Sum_probs=142.4
Q ss_pred ccccceecccCcccEEEEEEcCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCC-CccceEEEEEeCCeEEEEEec
Q 007120 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 517 (617)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 78899998753222 467899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~~~~ 596 (617)
+.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++... .+|+.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743221125788899999999999999999988 99999999999999988 79999999999775544
Q ss_pred ccc----ccceeeeeccccCccCC
Q 007120 597 TEG----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~----~~~~~~gt~~y~ape~~ 616 (617)
... ......||..|++||.+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred ccccccccccccccccccCCHHHh
Confidence 322 24567899999999965
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=164.01 Aligned_cols=169 Identities=25% Similarity=0.338 Sum_probs=131.2
Q ss_pred CccccceecccCcccEEEEEEcCC--cEEEEEEecccchhhHHHHHHHHHHHccCCC----CCccceEEEE-EeCCeEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 513 (617)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.+++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997553 4788887655322222267888888888873 5788888888 46778899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-----CCeEEeecCC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 588 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-----~~~ki~DFGl 588 (617)
||+.+ +-+|.++..... ...++..+.++|+.|++.+|++||+.+ +|||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 789999775444 466899999999999999999999988 9999999999999754 4699999999
Q ss_pred ce--eeCCCCcc----c-c-cceeeeeccccCcc
Q 007120 589 VR--TFGGDETE----G-N-TNRVVGTYCGTKAF 614 (617)
Q Consensus 589 a~--~~~~~~~~----~-~-~~~~~gt~~y~ape 614 (617)
|+ .+...... . . ....+||..|+++.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~ 207 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN 207 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHH
Confidence 99 43222211 1 1 12345898898764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=154.87 Aligned_cols=164 Identities=21% Similarity=0.355 Sum_probs=128.3
Q ss_pred CccccceecccCcccEEEEE-EcCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
+|.+.++||+|.||.++.|+ +-+++.||||.-...++ .-+++.|-+..+.| .-++|..++-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 78999999999999999997 56799999998654322 23455666666666 4589999998888888899999988
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-----CCeEEeecCCceeeC
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLVRTFG 593 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-----~~~ki~DFGla~~~~ 593 (617)
+-||.++..-.. ..++.++.+.+|.|++.-|+|+|++. +|.|||||+|+||... ..+.|+|||+||.+.
T Consensus 107 -GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 678888764333 34788999999999999999999987 9999999999999643 458999999999986
Q ss_pred CCCcc--cc---cceeeeeccccC
Q 007120 594 GDETE--GN---TNRVVGTYCGTK 612 (617)
Q Consensus 594 ~~~~~--~~---~~~~~gt~~y~a 612 (617)
...+. .+ .....||-.||+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred CccccccCccccccccccceeeeE
Confidence 54442 11 223446666664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=163.86 Aligned_cols=172 Identities=19% Similarity=0.212 Sum_probs=141.4
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCC------CCCccceEEEEEeC
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ------HRNLVKLLGCCIQG 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~ 508 (617)
+....+|.+....|+|-|++|.+|.... |+.||||++.. .+...+.=+.|+++|++|+ --++++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3345678888889999999999998754 88999999975 3334455578999999995 34789999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFG 587 (617)
++++||+|-+. .+|.+.|.......-|.......++.|+..||..|-..+ |+|.||||.||||++. ..+||+|||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 99999999884 789999987776666778888889999999999999877 9999999999999875 568999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.|...+.++... ..-+..|.|||.+
T Consensus 583 SA~~~~eneitP----YLVSRFYRaPEIi 607 (752)
T KOG0670|consen 583 SASFASENEITP----YLVSRFYRAPEII 607 (752)
T ss_pred cccccccccccH----HHHHHhccCccee
Confidence 999887665422 2345689999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.7e-16 Score=157.43 Aligned_cols=145 Identities=26% Similarity=0.498 Sum_probs=125.7
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcC----CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCC
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (617)
+....+.|...++||+|.|+.||++.+.. .+.||+|.+...+ .-..+.+|+++|..+. |.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34445678888999999999999998643 5789999987543 3345889999999984 899999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCC
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGL 588 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGl 588 (617)
...+|+||++.-...++++. ++..++..++..+..||+++|+++ ||||||||.|+|-+. .+.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999999854 567888889999999999999998 999999999999975 56789999999
Q ss_pred ce
Q 007120 589 VR 590 (617)
Q Consensus 589 a~ 590 (617)
|.
T Consensus 180 A~ 181 (418)
T KOG1167|consen 180 AQ 181 (418)
T ss_pred HH
Confidence 98
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=136.82 Aligned_cols=136 Identities=22% Similarity=0.178 Sum_probs=114.7
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--CCccceEEEEEeCCeEEEEEecCCCC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 521 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 521 (617)
+.+.||+|.++.||++...+ ..++||....... ...+..|+.++..++| ..+++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34789999999999999854 7899998865332 5678899999999977 58999999888888899999999987
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||+++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77533 55666778999999999999865456999999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=143.08 Aligned_cols=137 Identities=21% Similarity=0.231 Sum_probs=97.5
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchh--hHHH----------------------HHHHHHHHccCCCCC--c
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHRN--L 498 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 498 (617)
.+.||+|+||.||+|...+++.||||.+...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987642111 1111 134555555554432 4
Q ss_pred cceEEEEEeCCeEEEEEecCCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEc
Q 007120 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSF-IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~ 576 (617)
.+.+++ ...++||||++++.+... +... . .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 245899999998544321 1110 0 11 4567789999999999998 66 99999999999999
Q ss_pred CCCCeEEeecCCceeeCC
Q 007120 577 QDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 577 ~~~~~ki~DFGla~~~~~ 594 (617)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 99999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-14 Score=142.21 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=105.8
Q ss_pred ceec-ccCcccEEEEEEcCCcEEEEEEecccc-------------hhhHHHHHHHHHHHccCCCCCc--cceEEEEEeCC
Q 007120 446 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 509 (617)
Q Consensus 446 ~~iG-~G~fG~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 509 (617)
..|| .|+.|+||+.... +..++||++.... ......+.+|+.++..|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4787 8999999999874 6788998875310 1223467889999999998885 67777754432
Q ss_pred e----EEEEEecCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 510 E----KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 510 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
. .++|+||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 699988843 223432 3568999999999998 9999999999999999999999
Q ss_pred ecCCceeeC
Q 007120 585 DFGLVRTFG 593 (617)
Q Consensus 585 DFGla~~~~ 593 (617)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.7e-15 Score=116.18 Aligned_cols=66 Identities=44% Similarity=1.024 Sum_probs=57.5
Q ss_pred CCCCCceEEEeeccCCCCcccccccCCChHhHHHhhccCCceEEEEeeccCCCCceeeecccCcccc
Q 007120 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347 (617)
Q Consensus 281 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~~l~n~ 347 (617)
|+.+++|+++++|++|++....+..+.++++|++.||+||||+||+|.+.. ++++|.+|.+.|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445799999999999999877666678999999999999999999998654 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=147.45 Aligned_cols=134 Identities=26% Similarity=0.359 Sum_probs=111.3
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-----CC---CccceEEEEEe---
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HR---NLVKLLGCCIQ--- 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~g~~~~--- 507 (617)
.+|.+.++||=|.|++||++.... .+-||+|+.+. .+...+....|+.+|++++ |+ .||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 688899999999999999998754 67899999875 3455667889999999874 33 49999999975
Q ss_pred -CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 508 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
+.+++||+|++ +.+|..+|... .-.-++.....+|+.||+.||.|||.++ .|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 56788887542 3344788999999999999999999987 69999999999999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-14 Score=161.40 Aligned_cols=149 Identities=23% Similarity=0.364 Sum_probs=115.7
Q ss_pred HhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 512 (617)
+.....|.+.+.||+|+||+||+|...+++.||+|.-+....- +|.-=.+++.+|+ -+-|..+..+..-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445678888999999999999999888999999987653221 2222223333443 233444555555667778
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-------CCCeEEee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKISD 585 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-------~~~~ki~D 585 (617)
||+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||..+ |||+||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999994 4567899999999999999999999987 999999999999932 34699999
Q ss_pred cCCceeeC
Q 007120 586 FGLVRTFG 593 (617)
Q Consensus 586 FGla~~~~ 593 (617)
||-+..+.
T Consensus 845 fG~siDm~ 852 (974)
T KOG1166|consen 845 FGRSIDMK 852 (974)
T ss_pred cccceeee
Confidence 99987763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-14 Score=168.96 Aligned_cols=119 Identities=16% Similarity=0.137 Sum_probs=86.9
Q ss_pred cCCC-CCccceEEEE-------EeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007120 492 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (617)
Q Consensus 492 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (617)
.++| +||+++++++ .+.+..++++||+ .++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5888888877 3334567888987 56999999542 345899999999999999999999987 9
Q ss_pred eecccCCCcEEEcC-------------------CCCeEEeecCCceeeCCCCcc--------------cccceeeeeccc
Q 007120 564 IHRDLKASNVLLDQ-------------------DMNPKISDFGLVRTFGGDETE--------------GNTNRVVGTYCG 610 (617)
Q Consensus 564 iHrDlkp~NiLl~~-------------------~~~~ki~DFGla~~~~~~~~~--------------~~~~~~~gt~~y 610 (617)
|||||||+||||+. ++.+||+|||+++........ .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 455677777777643211000 001123578899
Q ss_pred cCccCC
Q 007120 611 TKAFLY 616 (617)
Q Consensus 611 ~ape~~ 616 (617)
+|||++
T Consensus 182 ~APE~~ 187 (793)
T PLN00181 182 TSPEED 187 (793)
T ss_pred EChhhh
Confidence 999986
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-13 Score=145.95 Aligned_cols=141 Identities=26% Similarity=0.301 Sum_probs=99.7
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhH----------------------------------------HHHHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL----------------------------------------KELKN 485 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 485 (617)
+.||.|++|+||+|++.+|+.||||.......... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864211100 02445
Q ss_pred HHHHHccC----CCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 007120 486 EVILFSKL----QHRNLVKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR-GLLYLHQDS 559 (617)
Q Consensus 486 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~~ 559 (617)
|+..+.++ +|.+-+.+-..+. .....+|||||+++++|.+++..... .. .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555444 2333233222222 23457999999999999887643111 12 23456666666 478889887
Q ss_pred CCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 560 ~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
++|+|++|.||++++++.++|.|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999998854
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.9e-14 Score=154.40 Aligned_cols=167 Identities=24% Similarity=0.265 Sum_probs=127.1
Q ss_pred ccceecccCcccEEEEEEcC-CcEEEEEEec----c-cch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS----K-ISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
....+|.|++|.|+...... ....+.|... . ..+ .....+..|..+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999777776432 3333333322 1 111 122236677888889999999888877777777666799
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++ +|..++.. ...+...++..++.|+..|+.|||+.+ |.|||||++|++++.++.+||+|||.+....-.-
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99988843 235677788889999999999999998 9999999999999999999999999998764433
Q ss_pred cc--cccceeeeeccccCccCCC
Q 007120 597 TE--GNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 597 ~~--~~~~~~~gt~~y~ape~~~ 617 (617)
.. .......|+-.|+|||.+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~ 497 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLT 497 (601)
T ss_pred chhhhhhcCcccCCcCcCccccc
Confidence 32 3445578999999999863
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-13 Score=129.75 Aligned_cols=166 Identities=22% Similarity=0.359 Sum_probs=126.1
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
++.+..+|.+...|+.|+|++. |..+++|++.- ......+.|..|.-.++-..||||+.++|.|.......+|..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3444567888999999999995 44556676643 33344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee-cccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH-RDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH-rDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+.|+|...|++.. .-..+-.+..+++.+||+||+|||+.. ++|- --|.++.|+||++.+++|+ .+-+|+-- +.
T Consensus 270 p~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsf--qe 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF--QE 343 (448)
T ss_pred cchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeee--ec
Confidence 9999999998744 345788899999999999999999975 3443 3689999999999999886 12222210 00
Q ss_pred ccccceeeeeccccCccCCC
Q 007120 598 EGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~~ 617 (617)
. ...-.+.+++||.++
T Consensus 344 ---~-gr~y~pawmspealq 359 (448)
T KOG0195|consen 344 ---V-GRAYSPAWMSPEALQ 359 (448)
T ss_pred ---c-ccccCcccCCHHHHh
Confidence 1 112346788888653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-13 Score=146.66 Aligned_cols=158 Identities=27% Similarity=0.288 Sum_probs=126.2
Q ss_pred eecccCcccEEEEEE----cCCcEEEEEEecccch--hhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecCC
Q 007120 447 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.+|+|.||.|+...- ..+..+|+|.+++... ........|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987752 2366788888865321 11225667888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCccc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~ 599 (617)
+|.|...+.+ ....+......+...+|-+++++|+.+ |+|||+|++||+++.+|++|+.|||++|..-..+.
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999776633 333455555566778999999999987 99999999999999999999999999998743332
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
.+||+.|||||.+
T Consensus 153 ----~cgt~eymApEI~ 165 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEII 165 (612)
T ss_pred ----cccchhhhhhHhh
Confidence 2799999999975
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.5e-12 Score=105.42 Aligned_cols=80 Identities=44% Similarity=0.982 Sum_probs=64.9
Q ss_pred CCCCCCC---CceEEEeeccCCCCcccccccCCChHhHHHhhccCCceEEEEeeccCCCCceeeecccCccccccCCCCc
Q 007120 278 PLNYSRQ---DGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354 (617)
Q Consensus 278 ~~~c~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~~l~n~~~~~~~~ 354 (617)
+++|... +.|+++.++++|+..... ..+++++|++.||+||+|+||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999876543 6679999999999999999999974 3567999999999877654456
Q ss_pred ceeeeeec
Q 007120 355 QDFYIRMS 362 (617)
Q Consensus 355 ~~~yvrvs 362 (617)
.++|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-13 Score=152.47 Aligned_cols=168 Identities=17% Similarity=0.200 Sum_probs=128.6
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecc-cchhhHHHHHHHHHH--HccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK-ISEQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~-~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++...+.||+++|=+|.+|+.++|. |+||.+-+ ......+.|.++++- +..++|||.+.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998777 78887744 334445555444433 5567999999888776666677888888
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee--CCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~--~~~ 595 (617)
.. .+|.+.| ..+..+...++.-|+.|++.||.-+|..+ |+|+|||.+||||++..-+.|+||.--|.. +.+
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 6888888 34556788888899999999999999987 999999999999999999999999877753 222
Q ss_pred Cc---ccccceeeeeccccCccCC
Q 007120 596 ET---EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~---~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....+...-.||+|||-|
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERF 199 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERF 199 (1431)
T ss_pred CcccceEEEecCCceeeecChHhh
Confidence 11 1223334445799999976
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.7e-12 Score=102.65 Aligned_cols=71 Identities=18% Similarity=0.257 Sum_probs=61.1
Q ss_pred CCCCCceEEEeeccCCCCcccccccCCChHhHHHhhcc---CCceEEEEeeccCCCCceeeecccCc-cccccCCCCcce
Q 007120 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE---NSSCMAYTNSDIRGGGSGCAMWFGEL-IDMRDFPGGGQD 356 (617)
Q Consensus 281 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~~~~~l-~n~~~~~~~~~~ 356 (617)
|...++|+++.++++|++.. .++++|++.|++ ||||.||+|.+ .+.||.+|.+.+ .+.+.+...+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~---~~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAK---ARKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccC---CCCCeEEecCcchhhHHhccCCCce
Confidence 33467899999999998765 579999999999 99999999975 245899999999 999888777899
Q ss_pred eeee
Q 007120 357 FYIR 360 (617)
Q Consensus 357 ~yvr 360 (617)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=116.21 Aligned_cols=130 Identities=23% Similarity=0.155 Sum_probs=97.0
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcc-ceEEEEEeCCeEEEEEecCCCCCHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLD 524 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (617)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57889999999999874 77899998754321 233567888888888665544 455443 33458999999998875
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
... . ....++.+++++|+.||+.. +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 0 11235678999999999876 23469999999999999 67899999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.4e-12 Score=136.11 Aligned_cols=147 Identities=20% Similarity=0.238 Sum_probs=93.6
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchh----------------------------------hHH---
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLK--- 481 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~--- 481 (617)
..|+. +.||+|++|+||+|++++ |+.||||.+.+.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999988 999999998642110 011
Q ss_pred ---HHHHHHHHHccCC----CCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHH-HHH
Q 007120 482 ---ELKNEVILFSKLQ----HRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGL 552 (617)
Q Consensus 482 ---~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia-~gl 552 (617)
.|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++-.-... ..+... ++...+ .-+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~~---la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMKL---LAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHHH---HHHHHHHHHH
Confidence 1344444444332 3333333333332 3456899999999999875321111 112111 221111 123
Q ss_pred HHHHhCCCCceeecccCCCcEEEcCCC----CeEEeecCCceeeCCC
Q 007120 553 LYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLVRTFGGD 595 (617)
Q Consensus 553 ~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DFGla~~~~~~ 595 (617)
..++..+ ++|+|++|.||+++.++ .+++.|||++..+...
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3344555 99999999999999988 9999999999988543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=116.84 Aligned_cols=166 Identities=23% Similarity=0.308 Sum_probs=107.2
Q ss_pred CccccceecccCcccEEEEEEcC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCC----------CCccceEEE--
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGC-- 504 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~-- 504 (617)
.+...+.||.|+++.||.+++.. ++++|||.... ......+++++|...+..+.+ -.++.-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45566899999999999999866 89999998743 233456788888877766543 111111111
Q ss_pred -------EEeCC--------eEEEEEecCCCCCHHHHHh---cCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 007120 505 -------CIQGE--------EKLLIYEFMPNKSLDSFIF---DQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565 (617)
Q Consensus 505 -------~~~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH 565 (617)
..... ..+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11111 135777777 478887753 2111 223445667778899999999999998 999
Q ss_pred cccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccC
Q 007120 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 566 rDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~ 615 (617)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~ 213 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPEL 213 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhh
Confidence 999999999999999999999988775432111 223467889885
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-11 Score=128.38 Aligned_cols=123 Identities=28% Similarity=0.424 Sum_probs=100.7
Q ss_pred HccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccC
Q 007120 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (617)
Q Consensus 490 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 569 (617)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++.+|++||+|||+.. . ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4678999999999999999999999999999999999965 3455899999999999999999999864 2 3999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 570 p~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++|+++|....+||+|||+..+..............-..-|+|||++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell 123 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL 123 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence 99999999999999999999887531111111112234568888875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.8e-10 Score=106.29 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=98.3
Q ss_pred ceecccCcccEEEEEEcC-------CcEEEEEEeccc-------------c---------hhhHHHHH----HHHHHHcc
Q 007120 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------S---------EQGLKELK----NEVILFSK 492 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~-------------~---------~~~~~~~~----~E~~~l~~ 492 (617)
..||.|..+.||.|.-.+ +..+|||..+.. . ....+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998543 478999976421 0 01122333 88888888
Q ss_pred CCC--CCccceEEEEEeCCeEEEEEecCCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeeccc
Q 007120 493 LQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDL 568 (617)
Q Consensus 493 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDl 568 (617)
+.. -++.+.+++ ...+|||||+.+..+.. .|.+ ..++..+...+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 854 456666654 45689999998654422 2211 2244455667789999999999 7766 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCceeeC
Q 007120 569 KASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 569 kp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
++.|||++ ++.+.|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.6e-10 Score=103.47 Aligned_cols=133 Identities=20% Similarity=0.289 Sum_probs=102.3
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEE-eccc------ch-hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI------SE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~-l~~~------~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..+++|+-..++.+.+.+ .++++|. +++. +. -..+...+|+.++++++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999997743 4455553 3331 11 1234567899999998776666556667788888999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
+++..|.+++... +..++..|-.-+.-||..+ |||+||.++||++..+. +.++||||++.-.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999999898442 2457778888889999998 99999999999997766 9999999999643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=109.20 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=109.8
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccch-hhHHHHHHHHHHHccCCC--CCccceEEEEEeCC---eEEEEEecCC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMP 519 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 519 (617)
+.|+.|..+.+|++...+|+.+++|....... .....+..|..++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987678999998754222 135678899999999876 45677888876543 5689999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS---------------------------------------- 559 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------------- 559 (617)
+.++.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 23567777788888888888888521
Q ss_pred -------------CCceeecccCCCcEEEcC--CCCeEEeecCCcee
Q 007120 560 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRT 591 (617)
Q Consensus 560 -------------~~~iiHrDlkp~NiLl~~--~~~~ki~DFGla~~ 591 (617)
+..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-09 Score=99.06 Aligned_cols=144 Identities=26% Similarity=0.302 Sum_probs=106.6
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEE-Eecccc-------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVK-RLSKIS-------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK-~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
....|.+|+-+.|+++.+ .|+...|| ++.+.- .-.....++|++++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999998 46665666 344321 112356788999999887666655555677777788999
Q ss_pred ecCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeecCCcee
Q 007120 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRT 591 (617)
Q Consensus 516 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DFGla~~ 591 (617)
||+++ -++.+++.........+. ....++..|-+.+.-||... |||+||..+||+|..++. +.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~-~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDE-GLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccch-hHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 478888865443332232 22578888999999999988 999999999999976553 58999999876
Q ss_pred e
Q 007120 592 F 592 (617)
Q Consensus 592 ~ 592 (617)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.9e-11 Score=131.71 Aligned_cols=174 Identities=25% Similarity=0.298 Sum_probs=135.9
Q ss_pred cCCccccceecccCcccEEEEEEcC--CcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 513 (617)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3466777889999999998887633 4556777665432 333445556777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecccCCCcEEEcCCC-CeEEeecCCcee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRT 591 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~ 591 (617)
+.||..++++.+.+... .....+....-.+..|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998777311 1112344555668899999999999 766 99999999999999999 999999999998
Q ss_pred eCC-CCcccccceeee-eccccCccCC
Q 007120 592 FGG-DETEGNTNRVVG-TYCGTKAFLY 616 (617)
Q Consensus 592 ~~~-~~~~~~~~~~~g-t~~y~ape~~ 616 (617)
+.. +..........| ++.|+|||.+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccc
Confidence 876 555555566778 9999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.2e-10 Score=103.85 Aligned_cols=76 Identities=20% Similarity=0.084 Sum_probs=64.9
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccc
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|+|.+++... ...+++.++..|+.||++||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999642 345899999999999999999999864 999999999999999 99999875422
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
..||..|+|||++
T Consensus 64 ---~~g~~~y~aPE~~ 76 (176)
T smart00750 64 ---SRVDPYFMAPEVI 76 (176)
T ss_pred ---CCCcccccChHHh
Confidence 2578999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.6e-09 Score=107.38 Aligned_cols=115 Identities=20% Similarity=0.302 Sum_probs=79.3
Q ss_pred CCCCccceEEEEEeC---------------------------CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHH
Q 007120 494 QHRNLVKLLGCCIQG---------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546 (617)
Q Consensus 494 ~H~niv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 546 (617)
+|||||++.++|.+. ...|+||.-.+ .+|.+||..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 699999988876432 23578887774 68999985422 34555666889
Q ss_pred HHHHHHHHHHhCCCCceeecccCCCcEEE--cCCC--CeEEeecCCceeeCC--CCccc--ccceeeeeccccCccCC
Q 007120 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGLVRTFGG--DETEG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 547 ~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--~~~~--~~ki~DFGla~~~~~--~~~~~--~~~~~~gt~~y~ape~~ 616 (617)
|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||-+-.-.. -+... ......|--+-||||.+
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999998 9999999999998 4444 468899996543211 11100 01112355677888864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-09 Score=122.45 Aligned_cols=136 Identities=22% Similarity=0.258 Sum_probs=92.1
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...+|..++.|..|++|.||..+++. .+.+|+|.-+.. . +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--l----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--L----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc--h----hhhc--cccccCCccee-----------------
Confidence 34688889999999999999998865 567787433221 0 0000 22333344443
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC-
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD- 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~- 595 (617)
|+-...+. ....++. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+.+.....
T Consensus 136 ----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 44444442 1222331 2278899999987 999999999999999999999999999864211
Q ss_pred ------------CcccccceeeeeccccCccCC
Q 007120 596 ------------ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ------------~~~~~~~~~~gt~~y~ape~~ 616 (617)
..+.....++||+.|.|||++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 111224456899999999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.7e-08 Score=97.32 Aligned_cols=140 Identities=17% Similarity=0.116 Sum_probs=100.0
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccch-----------hhHHHHHHHHHHHccCCCCC--ccceEEEEEeC-----
Q 007120 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-----------QGLKELKNEVILFSKLQHRN--LVKLLGCCIQG----- 508 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~----- 508 (617)
.+-+-....|++..+ +|+.+.||+...... .....+.+|...+.++...+ .+..+++....
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444333444667666 678899997643211 11124778999888885433 44556666542
Q ss_pred CeEEEEEecCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-------CCC
Q 007120 509 EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMN 580 (617)
Q Consensus 509 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-------~~~ 580 (617)
..-+||+|++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|+++.||||+. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2468999999986 8999884321 223455677789999999999999998 999999999999975 468
Q ss_pred eEEeecCCcee
Q 007120 581 PKISDFGLVRT 591 (617)
Q Consensus 581 ~ki~DFGla~~ 591 (617)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.3e-10 Score=115.33 Aligned_cols=101 Identities=26% Similarity=0.344 Sum_probs=87.1
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++.|+++...+|.+||.........++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666677889999999999999999 44 899999999999999999999999999
Q ss_pred eeeCCCC----cccccceeeeeccccCccCC
Q 007120 590 RTFGGDE----TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~----~~~~~~~~~gt~~y~ape~~ 616 (617)
-...... .....+...||..||+||.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi 434 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQI 434 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHH
Confidence 8876555 23445667899999999965
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.2e-08 Score=92.74 Aligned_cols=125 Identities=22% Similarity=0.254 Sum_probs=81.5
Q ss_pred EEEEEEcCCcEEEEEEeccc--------------ch------------hhHHHHHHHHHHHccCCCC--CccceEEEEEe
Q 007120 456 VYKGTLVDGQEIAVKRLSKI--------------SE------------QGLKELKNEVILFSKLQHR--NLVKLLGCCIQ 507 (617)
Q Consensus 456 Vy~~~~~~~~~vavK~l~~~--------------~~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~ 507 (617)
||.|...++..+|||+.+.. .. ......++|.+.|.++... ++.+.+.+.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 89999888999999976431 00 0123467899999999866 466666542
Q ss_pred CCeEEEEEecCC--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 508 GEEKLLIYEFMP--NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 508 ~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
...|||||++ +..+..+... . ++......++.+++..+.. +|..+ |||+||.+.|||++++ .+.|+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 5555443321 1 1122334566777776666 46666 9999999999999888 99999
Q ss_pred ecCCceeeC
Q 007120 585 DFGLVRTFG 593 (617)
Q Consensus 585 DFGla~~~~ 593 (617)
|||.|....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.7e-08 Score=102.85 Aligned_cols=122 Identities=16% Similarity=0.233 Sum_probs=101.0
Q ss_pred cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHH
Q 007120 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541 (617)
Q Consensus 462 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 541 (617)
.++.+|.|...+...........+-+..|+.++||||++++.........|||+|-+ ..|..++.... ....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHHH
Confidence 357888888887655444556778889999999999999999999999999999988 46777774422 4445
Q ss_pred HHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 542 ~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
...+.||+.||.|||+.+ .++|++|.-..|+|++.|..||++|.++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 556899999999999766 59999999999999999999999999886543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.2e-08 Score=103.91 Aligned_cols=171 Identities=23% Similarity=0.297 Sum_probs=129.4
Q ss_pred Cccccceecc--cCcccEEEEEE---cCCcEEEEEEecc--cchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 441 NFSINNKLGE--GGFGPVYKGTL---VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 441 ~~~~~~~iG~--G~fG~Vy~~~~---~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...+++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999986 3477899998433 2222233334566666666 4999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFG 587 (617)
+-+|++. .+|.++... ....++....+.+..+..+ |+.++|+.. |+|-|+||.||++.++ ..++++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 788877743 2333566677777788888 999999987 9999999999999999 899999999
Q ss_pred CceeeCCCCcccc---cceeeeeccccCccCCC
Q 007120 588 LVRTFGGDETEGN---TNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 588 la~~~~~~~~~~~---~~~~~gt~~y~ape~~~ 617 (617)
+...++....... ..+..|...|++||..+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 9999876553211 12234667899999753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.8e-07 Score=88.05 Aligned_cols=135 Identities=18% Similarity=0.207 Sum_probs=93.5
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccc----------------------hhhHHHHHHHHHHHccCCCC--Cc
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------------EQGLKELKNEVILFSKLQHR--NL 498 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--ni 498 (617)
.+.+.||.|.-+.||.|..+.|.++|||.=+... .......++|.+.|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568999999999999999999999999532210 00123456788888888655 66
Q ss_pred cceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
.+.+++ +...+||||+++-.|...-. ..-+... ++..|++-+.-+-..+ |||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666655 45689999999866643210 1122233 3334444444444444 9999999999999999
Q ss_pred CCeEEeecCCceee
Q 007120 579 MNPKISDFGLVRTF 592 (617)
Q Consensus 579 ~~~ki~DFGla~~~ 592 (617)
|.+.|+||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999766654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.2e-07 Score=94.42 Aligned_cols=141 Identities=22% Similarity=0.329 Sum_probs=109.8
Q ss_pred cccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEEEEEecCCC-CCHHHH
Q 007120 453 FGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMPN-KSLDSF 526 (617)
Q Consensus 453 fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~ 526 (617)
-.+.||+.. .+|..+++|++.....+.......-++.++++.|+|||++..++.. +..+++||+|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788875 4689999999943222222233345678899999999999998763 4467899999985 577776
Q ss_pred HhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 527 IFDQT------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 527 l~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
.+... .....++...+.++.|++.||.++|+.| +..+-|.|++||++.+.+++|+..|+-..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 64321 2234678899999999999999999998 88899999999999999999999999888865
Q ss_pred CC
Q 007120 595 DE 596 (617)
Q Consensus 595 ~~ 596 (617)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 55
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.1e-06 Score=80.65 Aligned_cols=140 Identities=16% Similarity=0.139 Sum_probs=103.0
Q ss_pred ecccCcccEEEEEEcCCcEEEEEEecc-c----c-hhhHHHHHHHHHHHccCCCC--CccceEEEEEeCC----eEEEEE
Q 007120 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK-I----S-EQGLKELKNEVILFSKLQHR--NLVKLLGCCIQGE----EKLLIY 515 (617)
Q Consensus 448 iG~G~fG~Vy~~~~~~~~~vavK~l~~-~----~-~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~ 515 (617)
-++||-+.|++-.+ +|+.+-+|+... . . +.....|.+|...|.++... .+.+.+....... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35688888998776 455788888652 1 1 33567899999999998543 3455553322222 257999
Q ss_pred ecCC-CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC--eEEeecCCceee
Q 007120 516 EFMP-NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~ki~DFGla~~~ 592 (617)
|-++ ..+|.+++.+.. ....+...+..+..+|++.+.-||+.+ +.|+|+-+.|||++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 9765 468998885422 234577778899999999999999998 999999999999986667 999999877653
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.9e-07 Score=77.27 Aligned_cols=86 Identities=24% Similarity=0.390 Sum_probs=60.3
Q ss_pred EEEecCCcEEEEcCC-CcEEEeeCCccCcCC-ceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceec
Q 007120 34 LMINKTGNLVLTSQS-NIVVWSAYLSKEVQT-PVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (617)
Q Consensus 34 l~l~~~G~L~l~~~~-~~~vWst~~~~~~~~-~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (617)
+....||+||+.+.. +.+||++++...... ..+ .|.++|||||++.+ +.++|+|=. .
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~S~t---~------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTL-TLQSDGNLVLYDGD----GRVVWSSNT---T------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEE-EEeCCCCEEEEeCC----CCEEEEecc---c-------------
Confidence 444578999999765 589999997543222 445 89999999999864 568998711 0
Q ss_pred cCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEe
Q 007120 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRT 156 (617)
Q Consensus 112 ~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~ 156 (617)
...+.+.+.|+++|+..++-- .+++.|.+
T Consensus 83 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S 111 (114)
T smart00108 83 ---------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111 (114)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence 134567889999999766532 24577865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=84.66 Aligned_cols=107 Identities=26% Similarity=0.282 Sum_probs=84.2
Q ss_pred HHHHHHHHHHccCCC--CCccceEEEEEeCC----eEEEEEecCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 007120 481 KELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553 (617)
Q Consensus 481 ~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~ 553 (617)
....+|...+..+.. -.+.+.+++..... ..+||+|++++. +|.+++..... .+...+..++.++++.+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 356777777777743 44567777776633 348999999874 89999854222 456677789999999999
Q ss_pred HHHhCCCCceeecccCCCcEEEcCCC---CeEEeecCCceeeC
Q 007120 554 YLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFG 593 (617)
Q Consensus 554 yLH~~~~~~iiHrDlkp~NiLl~~~~---~~ki~DFGla~~~~ 593 (617)
-||..+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999998 99999999999998887 89999999888754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=75.54 Aligned_cols=87 Identities=22% Similarity=0.308 Sum_probs=61.0
Q ss_pred EEec-CCcEEEEcCC-CcEEEeeCCccC-cCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceec
Q 007120 35 MINK-TGNLVLTSQS-NIVVWSAYLSKE-VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (617)
Q Consensus 35 ~l~~-~G~L~l~~~~-~~~vWst~~~~~-~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (617)
.... ||+||+.+.. ++++|++++... .....+ .|.++|||||++.+ +.++|||=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~S~~~---------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTL-TLQSDGNLVIYDGS----GTVVWSSNTT---------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEE-EEecCCCeEEEcCC----CcEEEEeccc----------------
Confidence 3444 8999998765 589999997642 233445 89999999999864 5688986421
Q ss_pred cCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 112 ~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
...+.+.+.|+++|+..++-.+ +.+.|.+..
T Consensus 84 ---------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ---------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 0245678899999997765332 467787643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.5e-06 Score=92.60 Aligned_cols=140 Identities=17% Similarity=0.257 Sum_probs=91.1
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhh------------------------------HH----------HHHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG------------------------------LK----------ELKN 485 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~----------~~~~ 485 (617)
+-|+.++-|+||+|++++|+.||||+..+.-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5788999999999999999999999876421110 01 1233
Q ss_pred HHHHHccC----C-CCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 007120 486 EVILFSKL----Q-HRNLVKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG-LLYLHQD 558 (617)
Q Consensus 486 E~~~l~~l----~-H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-l~yLH~~ 558 (617)
|+.-+.++ + .+++ ++=..+. -.....|+|||++|-.+.+...... ...+.+. ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc
Confidence 44433333 2 2332 2222332 3456789999999999988853222 2234333 33333332 3333334
Q ss_pred CCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 559 ~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
+ ++|.|..|-||+++.++.+-+.|||+...+..
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4 99999999999999999999999999988754
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.9e-06 Score=69.07 Aligned_cols=73 Identities=37% Similarity=0.773 Sum_probs=55.6
Q ss_pred CCceEEEeeccCCCCcccccccCCChHhHHHhhcc-CCceEEEEeeccCCCCceeeecc-cCccccccCCCCcceeeee
Q 007120 284 QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMWF-GELIDMRDFPGGGQDFYIR 360 (617)
Q Consensus 284 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~~~-~~l~n~~~~~~~~~~~yvr 360 (617)
...|..++++.+++..... ....++++|++.|+. +|+|.||.|.. ...+|.+|. +.+.+....+..+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3568899999998654432 345789999999999 99999999974 345799998 7777776445555666665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.7e-07 Score=88.89 Aligned_cols=96 Identities=24% Similarity=0.302 Sum_probs=79.4
Q ss_pred HHccCCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007120 489 LFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (617)
Q Consensus 489 ~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (617)
-|-.+.|.|||++..++.+.. ...++.|||+-|+|.++|++-.. ...+....-.+++-||..||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 345567999999999986643 46899999999999999975322 344566666789999999999999975 78
Q ss_pred eeecccCCCcEEEcCCCCeEEee
Q 007120 563 IIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
|+|+++..+.|++..++-+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred cccCCcchhheeecCCceEEecc
Confidence 99999999999999999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.6e-07 Score=96.79 Aligned_cols=149 Identities=24% Similarity=0.261 Sum_probs=115.6
Q ss_pred hcCCccccceecccCcccEEEEEEc--CCcEEEEEEecccchhhHH--HHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKISEQGLK--ELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
...+|..+..||.+.|+.|++...+ ++..+++|.+.+....... .-..|+.+...+ .|.++++....+.+....+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4457888899999999999988753 4678899987653222111 123455554444 5888888777788888888
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCcee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRT 591 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla~~ 591 (617)
+=.||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887665 23445778888999999999999999876 9999999999999886 8899999999874
Q ss_pred e
Q 007120 592 F 592 (617)
Q Consensus 592 ~ 592 (617)
+
T Consensus 417 ~ 417 (524)
T KOG0601|consen 417 L 417 (524)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-05 Score=77.83 Aligned_cols=139 Identities=17% Similarity=0.161 Sum_probs=85.1
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--ccceEEEEEeCCeEEEEEecCCCCC-
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 522 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 522 (617)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24567788775422 2345688999888886443 4677888878888889999999863
Q ss_pred HHHHH---------------------hcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCceeeccc
Q 007120 523 LDSFI---------------------FDQTRRTLLDWSQRFH-IIC----------GTAR-GLLYLHQD-SRLRIIHRDL 568 (617)
Q Consensus 523 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-gl~yLH~~-~~~~iiHrDl 568 (617)
+...+ +... ........+.. +-. .+.. ...+|... .+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 00011111000 000 0011 12222211 1335789999
Q ss_pred CCCcEEEcCCCCeEEeecCCcee
Q 007120 569 KASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 569 kp~NiLl~~~~~~ki~DFGla~~ 591 (617)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.1e-06 Score=78.81 Aligned_cols=105 Identities=24% Similarity=0.234 Sum_probs=82.7
Q ss_pred HHHHHHHccCCC-CCccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007120 484 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (617)
Q Consensus 484 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (617)
..|..++..+++ +++++++|.| ..++|.||...+++...-.....-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457788888877 6999999999 34789999987765421000011123589999999999999999999865445
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+.-.|++|+|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.7e-05 Score=72.37 Aligned_cols=140 Identities=14% Similarity=0.132 Sum_probs=90.6
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHH---------HHHHHHHHccCCC---CCccceEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE---------LKNEVILFSKLQH---RNLVKLLGC 504 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~g~ 504 (617)
....+|...+++-......|.+-.. +++..++|..+.......+. ..+++..+.+++. .....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888888877777776655 57888999876432222221 1233333333322 222222222
Q ss_pred EEe-----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 505 CIQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 505 ~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
... ....+|||||++|..|.++.. ++. .++..++++|.-||+.| +.|+|+.|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 222 234468999999988865531 221 24556778899999998 99999999999998655
Q ss_pred CeEEeecCCceee
Q 007120 580 NPKISDFGLVRTF 592 (617)
Q Consensus 580 ~~ki~DFGla~~~ 592 (617)
+++.||+..+..
T Consensus 173 -i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 -IRIIDTQGKRMS 184 (229)
T ss_pred -EEEEECcccccc
Confidence 999999887654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.7e-05 Score=75.42 Aligned_cols=144 Identities=20% Similarity=0.179 Sum_probs=86.3
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CccceEEEEEeC---CeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQG---EEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~Ey~~~ 520 (617)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++...... ...+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 678999999999999866 68999987653 4556777888888877533 356777755433 346899999999
Q ss_pred CCHHH----------------HH---hcC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 007120 521 KSLDS----------------FI---FDQ-TRRTLLDWSQ---------RFHI------------ICGTAR-GLLYLHQ- 557 (617)
Q Consensus 521 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~yLH~- 557 (617)
..+.. .+ +.. .......+.. .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 111 0111111110 0000 111222 2333332
Q ss_pred ---CCCCceeecccCCCcEEEc-CCCCeEEeecCCceee
Q 007120 558 ---DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTF 592 (617)
Q Consensus 558 ---~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~~ 592 (617)
..+..++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4e-05 Score=76.18 Aligned_cols=141 Identities=15% Similarity=0.144 Sum_probs=85.3
Q ss_pred eecccCc-ccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecCCCCCHH
Q 007120 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (617)
Q Consensus 447 ~iG~G~f-G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (617)
.|..|.. ..||+.... +..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 678988764 4678888775432 345667888877773 344667888877766789999999998776
Q ss_pred HHH-------------------hcCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 007120 525 SFI-------------------FDQTR-RTLLD--WSQRFHIIC--------------------GTARGLLYLHQ----D 558 (617)
Q Consensus 525 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gl~yLH~----~ 558 (617)
... +.... ..... ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00111 001110000 01111222211 1
Q ss_pred CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 559 ~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.2e-05 Score=82.92 Aligned_cols=141 Identities=14% Similarity=0.190 Sum_probs=88.8
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhh-------------------------------------HHHHHHHHH
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-------------------------------------LKELKNEVI 488 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 488 (617)
+-|+..+.|.|++|++++|+.||||..++.-+.. .-.|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999875421110 001344444
Q ss_pred HHcc----CCCCCc---cceEEEEE-eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007120 489 LFSK----LQHRNL---VKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560 (617)
Q Consensus 489 ~l~~----l~H~ni---v~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~ 560 (617)
-..+ +.|-++ |.+=.++. -...+.|+||||+|..+.+...-. ...++......-+.++..-+ |-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 3322 345551 11112222 234678999999999887664221 12244444433333333222 22334
Q ss_pred CceeecccCCCcEEEcC----CCCeEEeecCCceeeC
Q 007120 561 LRIIHRDLKASNVLLDQ----DMNPKISDFGLVRTFG 593 (617)
Q Consensus 561 ~~iiHrDlkp~NiLl~~----~~~~ki~DFGla~~~~ 593 (617)
++|+|-.|-||+++. +..+.+-|||+.+.+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999998774
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=70.53 Aligned_cols=150 Identities=18% Similarity=0.218 Sum_probs=90.8
Q ss_pred HhHHhhcCCccccc---eecccCcccEEEEEEcCCcEEEEEEecccchhhHH---------H---------------HHH
Q 007120 433 ATIANATDNFSINN---KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK---------E---------------LKN 485 (617)
Q Consensus 433 ~~~~~~~~~~~~~~---~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~---------~---------------~~~ 485 (617)
..+....+...+.. .|++|.-..||+|.-.++..+|||+.+.......+ . ..+
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 33333334444433 55677788899998878999999988642111100 0 123
Q ss_pred HHHHHccCC--CCCccceEEEEEeCCeEEEEEecCCCCC-HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007120 486 EVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKS-LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (617)
Q Consensus 486 E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (617)
|..-|.++. +-.+.+-+++ ..-.|||||+.... -.-.|.+ ..+...+...+..++++.|.-|-..+ +
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 444444442 2223333332 23369999996541 1111211 11222245556677777777777633 4
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
+||+||+.-|||+. ++.+.|+|||-|..+.
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8999999999888764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=84.93 Aligned_cols=78 Identities=15% Similarity=0.326 Sum_probs=57.1
Q ss_pred cceecccCcccEEEEEEcCC---cEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCc--cceEEEEEeC---CeEEEE
Q 007120 445 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 514 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 514 (617)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |.++ .+++++|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877553 467777764322 122356889999999985 6665 7888888764 356899
Q ss_pred EecCCCCC
Q 007120 515 YEFMPNKS 522 (617)
Q Consensus 515 ~Ey~~~gs 522 (617)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00025 Score=67.63 Aligned_cols=135 Identities=16% Similarity=0.263 Sum_probs=90.9
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccc----------------hhhHHHHHHHHHHHccCC------CCCccceE
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 502 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 502 (617)
...||+|+.-.||. +++....+||+..... ....+++.+|+.-...+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999885 4556677888876543 122445556655444443 88899999
Q ss_pred EEEEeCCeEEEEEecCCC------CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 503 GCCIQGEEKLLIYEFMPN------KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 503 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
|+...+...-+|+|.+.+ -+|.+++.+ ..++. ...+.+. +-..||-++. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999988899987633 367888833 23444 3333333 3456666655 99999999999995
Q ss_pred CC--C--CeEEee-cCCceee
Q 007120 577 QD--M--NPKISD-FGLVRTF 592 (617)
Q Consensus 577 ~~--~--~~ki~D-FGla~~~ 592 (617)
.. + .+.|+| ||-...+
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred ecCCCceEEEEEeCCCCcccc
Confidence 42 2 467777 6755543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00021 Score=67.69 Aligned_cols=125 Identities=28% Similarity=0.399 Sum_probs=90.7
Q ss_pred CCccccceecccCc-ccEEEEEEcCCcEEEEEEecc---c---------ch---------hhHHHHHHHHHHHccCC---
Q 007120 440 DNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK---I---------SE---------QGLKELKNEVILFSKLQ--- 494 (617)
Q Consensus 440 ~~~~~~~~iG~G~f-G~Vy~~~~~~~~~vavK~l~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 494 (617)
.+++.++.||.|.- |.||++++ +|+.+|+|.++. . .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68899999999999 99999998 678999999321 0 00 12345889999888875
Q ss_pred CCCc--cceEEEEEeCC------------------eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007120 495 HRNL--VKLLGCCIQGE------------------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554 (617)
Q Consensus 495 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y 554 (617)
+.++ |+.+||..-.. .+.||.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 89999874321 1357788776432 111 2345667788889
Q ss_pred HHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 555 LH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999987 3589999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00071 Score=69.30 Aligned_cols=78 Identities=13% Similarity=0.069 Sum_probs=56.9
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCC---CCccceEEEEEeC---CeEEEEEe
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIYE 516 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E 516 (617)
...+.||.|..+.||+....++ .+.+|..+. ......|..|...++.|.. ..+.+++++|... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346899999999999876555 456666432 1133578889999888853 4678889888653 56899999
Q ss_pred cCCCCCH
Q 007120 517 FMPNKSL 523 (617)
Q Consensus 517 y~~~gsL 523 (617)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00051 Score=67.88 Aligned_cols=73 Identities=16% Similarity=0.294 Sum_probs=44.6
Q ss_pred ceecccCcc-cEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC---CccceEEEEEeCC---eEEEEEecC
Q 007120 446 NKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEFM 518 (617)
Q Consensus 446 ~~iG~G~fG-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~Ey~ 518 (617)
+.|+.|+.. .||+. +..+++|..+. ......+.+|..++..+... -+.++++.....+ ..++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58864 23566776543 22345788899888777532 3445555443322 347899999
Q ss_pred CCCCHH
Q 007120 519 PNKSLD 524 (617)
Q Consensus 519 ~~gsL~ 524 (617)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0014 Score=64.71 Aligned_cols=141 Identities=18% Similarity=0.226 Sum_probs=79.9
Q ss_pred ceecccCcccEEEEEEcC--CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-ccceEEEEEeCCeEEEEEecCCCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
+.|..|-...+|+....+ ++.+++|....... ......+|+.++..+...+ ..++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467777788999988654 57888887654221 1123346777777774433 344444332 247999999876
Q ss_pred HHHH--------------H---hcCCCC--------CCCC-HHHHHHHHH----------------------HHH---HH
Q 007120 523 LDSF--------------I---FDQTRR--------TLLD-WSQRFHIIC----------------------GTA---RG 551 (617)
Q Consensus 523 L~~~--------------l---~~~~~~--------~~l~-~~~~~~i~~----------------------~ia---~g 551 (617)
+... | +..... .... +.....+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1 111111 0111 111111110 111 11
Q ss_pred H-HHHHhC-CCCceeecccCCCcEEEcC-CCCeEEeecCCcee
Q 007120 552 L-LYLHQD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (617)
Q Consensus 552 l-~yLH~~-~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~ 591 (617)
| +.+... .+..++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111111 2345899999999999998 57899999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0013 Score=56.98 Aligned_cols=74 Identities=27% Similarity=0.426 Sum_probs=47.7
Q ss_pred CceEEEc-cCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEec--CCCEEEeeCCCCCCCceeee
Q 007120 15 HEVVWVA-NRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD--SGNLVLRDEHDGDSETYFWQ 91 (617)
Q Consensus 15 ~t~VW~A-nr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~Lld--sGNlVl~~~~~~~~~~~lWQ 91 (617)
.++||.. +...+.. ..+.+.|..+|||||.|..+.++|+|... ...+.. ...+ .||++ .... ..+.|.
T Consensus 38 ~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~--ptdt~L-~~q~l~~~~~~-~~~~----~~~sw~ 108 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY--PTDTLL-PGQKLGDGNVT-GKND----SLTSWS 108 (114)
T ss_dssp TEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--SS-EEE-EEET--TSEEE-EEST----SSEEEE
T ss_pred CCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--CccEEE-eccCcccCCCc-cccc----eEEeEC
Confidence 4679999 4344432 45889999999999999999999999422 222333 5666 88888 5432 457898
Q ss_pred eccCCC
Q 007120 92 SFDYPS 97 (617)
Q Consensus 92 SFd~PT 97 (617)
|=+.|.
T Consensus 109 s~~dps 114 (114)
T PF01453_consen 109 SNTDPS 114 (114)
T ss_dssp SS----
T ss_pred CCCCCC
Confidence 876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0014 Score=65.68 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=77.8
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEecCCCCCHHH
Q 007120 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (617)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .++++... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 345677788998873 567788887644222211235678888887754433 34454432 368999999876542
Q ss_pred H-----------------HhcCCC-CCCCCHHHHH-HHHH---------HHHHHHHHHHhC-----CCCceeecccCCCc
Q 007120 526 F-----------------IFDQTR-RTLLDWSQRF-HIIC---------GTARGLLYLHQD-----SRLRIIHRDLKASN 572 (617)
Q Consensus 526 ~-----------------l~~~~~-~~~l~~~~~~-~i~~---------~ia~gl~yLH~~-----~~~~iiHrDlkp~N 572 (617)
- |+.... ...++...++ .+.. .+..-+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 1112222111 1110 111112222111 12358999999999
Q ss_pred EEEcCCCCeEEeecCCcee
Q 007120 573 VLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~ 591 (617)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.004 Score=65.94 Aligned_cols=75 Identities=15% Similarity=0.221 Sum_probs=53.7
Q ss_pred ceecccCcccEEEEEEcCC-cEEEEEEeccc-----c--hhhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEEEE
Q 007120 446 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI-----S--EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (617)
+.||.|.+..||+....+| +.|+||.-... . ....+.+..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999985321 1 123456677777777652 2457777777 44667899
Q ss_pred EecCCCCC
Q 007120 515 YEFMPNKS 522 (617)
Q Consensus 515 ~Ey~~~gs 522 (617)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0017 Score=66.49 Aligned_cols=143 Identities=20% Similarity=0.176 Sum_probs=84.5
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--ccceEEE------EEeCCeEEEEEe
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 516 (617)
.+.|..|....+|+.... +..+++|.... ........|+.++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 356777777889988754 45688888754 22345666777777764332 4444432 123445689999
Q ss_pred cCCCCCHHH----HH----------hcCCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 007120 517 FMPNKSLDS----FI----------FDQTR--------RTLLDWSQRF----------HIICGTARGLLYLHQ----DSR 560 (617)
Q Consensus 517 y~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~gl~yLH~----~~~ 560 (617)
|++|..+.. .+ +.... .....|.... .....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11 11000 0112222211 011123344555543 123
Q ss_pred CceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 561 ~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3589999999999999988789999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=5.3e-05 Score=85.83 Aligned_cols=148 Identities=18% Similarity=0.244 Sum_probs=101.6
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEec---ccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
...+.+.+.+-+.+|.++.++.+.-.. +...++|... +......+..+.+-.+.-..+||-+++...-+....+.+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 455678888888899999998776432 3223333322 222222333344444444456677776666666677889
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
|+++|..+++|...|+... ..+..-....+..+.++++|||+.. ++|||++|.|.|+..+++.+++|||+.+
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999986533 2232222334556778999999865 8999999999999999999999998444
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0032 Score=57.97 Aligned_cols=129 Identities=19% Similarity=0.261 Sum_probs=85.1
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcc-ceEEEEEeCCeEEEEEecCCCCC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
..+.|++|.+|.||++.+. +..+|+|.-.. ......+..|++++..++-.++- +++.+- ..++.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3468999999999999985 55888887654 23467788999999988866654 344442 2345699999888
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccC-CCcEEEcCCCCeEEeecCCceee
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk-p~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|.+.-.. .+..+.+. +++.---|-..+ |-|..|. |...+|-.+..+.|+||.-|..-
T Consensus 99 L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8765421 12333333 333322233223 7777763 55555556669999999998853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.06 E-value=8.4e-05 Score=80.13 Aligned_cols=161 Identities=16% Similarity=0.099 Sum_probs=109.4
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-ccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 516 (617)
.+.-+....-.+++++++++|.+-...+....+.+... .+..-++++|.+.+||| .++.++-+...+...++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33444455678899999999987544444445555331 45567889999999999 7777777777778889999
Q ss_pred cCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 517 FMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
++..+ +-.... ......+..-+...+...-+++++|||+.. -+||| ||+..+ ...|..||+....+.+.
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 211111 001111223333445566678999999864 48999 777755 77899999999988654
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......+|...++||..
T Consensus 385 ~---~~~t~~~~~~~~~pev~ 402 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVI 402 (829)
T ss_pred c---ccccCCCCCCCCCchhh
Confidence 3 23446688899999854
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0012 Score=52.14 Aligned_cols=49 Identities=18% Similarity=0.436 Sum_probs=34.8
Q ss_pred eeccCCCCcccccccCCChHhHHHhhccCCceEEEEeeccCCCCceeeecccC
Q 007120 291 TELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGE 343 (617)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~~ 343 (617)
.+++++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 4556655444323 2558999999999999999999974 23459876543
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0059 Score=62.69 Aligned_cols=141 Identities=26% Similarity=0.368 Sum_probs=81.3
Q ss_pred ceecccCcccEEEEEEcC-------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 517 (617)
+.+..|-.-.+|+....+ ++.+++|...... .......+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 355556666888887654 4788888865432 223445667777776643333 355655532 368999
Q ss_pred CCCCCHHHH-----------------HhcCCCCC------CCC--HHHHHH--------------------------HHH
Q 007120 518 MPNKSLDSF-----------------IFDQTRRT------LLD--WSQRFH--------------------------IIC 546 (617)
Q Consensus 518 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 546 (617)
++|..+... |+...... ..+ |..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111110 011 111100 111
Q ss_pred HHHHHHHHHHh------CCCCceeecccCCCcEEEcCC----CCeEEeecCCcee
Q 007120 547 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (617)
Q Consensus 547 ~ia~gl~yLH~------~~~~~iiHrDlkp~NiLl~~~----~~~ki~DFGla~~ 591 (617)
.+..-+..|.. ..+..++|+|+.|.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234568999999999999985 8899999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.043 Score=56.79 Aligned_cols=142 Identities=20% Similarity=0.202 Sum_probs=75.0
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CccceEE------EEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG------CCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~Ey 517 (617)
+.|..|....+|+....++ .+++|+..... .+....|..++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777778998876544 68888775212 22233344444444221 2333332 12234567899999
Q ss_pred CCCCCHH-----------HHH---hcCCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHHhC---
Q 007120 518 MPNKSLD-----------SFI---FDQTR--------RTLLDW-SQRFHI------------I-CGTARGLLYLHQD--- 558 (617)
Q Consensus 518 ~~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~i------------~-~~ia~gl~yLH~~--- 558 (617)
++|..+. ..| +.... ...+.| .....- . ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987431 111 11110 001112 111111 1 1111122333211
Q ss_pred -CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 559 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 559 -~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
-+..+||+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776678999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.014 Score=59.09 Aligned_cols=31 Identities=23% Similarity=0.502 Sum_probs=26.1
Q ss_pred CceeecccCCCcEEEcCCCC-eEEeecCCcee
Q 007120 561 LRIIHRDLKASNVLLDQDMN-PKISDFGLVRT 591 (617)
Q Consensus 561 ~~iiHrDlkp~NiLl~~~~~-~ki~DFGla~~ 591 (617)
..++|+|+.|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997554 57999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.015 Score=60.90 Aligned_cols=141 Identities=18% Similarity=0.270 Sum_probs=79.0
Q ss_pred ceecccCcccEEEEEEcC-----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcc-ceEEEEEeCCeEEEEEecCC
Q 007120 446 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~ 519 (617)
+.|-.|-.-.+|+....+ ++.|++|........ .-.-.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345456667888877533 357888877553322 22236677777777544443 556655332 5899998
Q ss_pred CCCHHHH-----------------HhcCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 007120 520 NKSLDSF-----------------IFDQT-R--RTLLDWSQRFHIICG-----------------TARGLLYL----HQ- 557 (617)
Q Consensus 520 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~-----------------ia~gl~yL----H~- 557 (617)
+.+|... ++... . .....|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 0 011112222222211 11112222 21
Q ss_pred CCCCceeecccCCCcEEEcC-CCCeEEeecCCcee
Q 007120 558 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (617)
Q Consensus 558 ~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~ 591 (617)
..+..++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 57899999998875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.059 Score=54.73 Aligned_cols=75 Identities=19% Similarity=0.246 Sum_probs=48.0
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEEEEEecCC
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
+..+.|+-|....+|+.. .+++.+.||.-.. .....|..|..-|+.|. -..+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678888889999877 5688899998752 33456777887777763 4557789999888888899999998
Q ss_pred CC
Q 007120 520 NK 521 (617)
Q Consensus 520 ~g 521 (617)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.087 Score=54.22 Aligned_cols=143 Identities=23% Similarity=0.216 Sum_probs=79.9
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CccceEEEE------EeCCeEEEEEe
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCC------IQGEEKLLIYE 516 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E 516 (617)
.+.++.|-...+|+....++ .+++|+..... ...+...|..++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35667777788998875444 57778764421 123344556666555322 234444321 22345689999
Q ss_pred cCCCCCHH-----------HH---HhcCCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 007120 517 FMPNKSLD-----------SF---IFDQTRR---------TLLDWSQRF------------HIICGTARGLLYLHQ---- 557 (617)
Q Consensus 517 y~~~gsL~-----------~~---l~~~~~~---------~~l~~~~~~------------~i~~~ia~gl~yLH~---- 557 (617)
|++|..+. .. ++..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 11 1111000 011222111 011223345555543
Q ss_pred CCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 558 ~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
..+..++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998877999999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0048 Score=62.07 Aligned_cols=134 Identities=16% Similarity=0.170 Sum_probs=89.7
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecc--c-------ch-------------hhHHHHHHHHHHHccCCC--C
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--I-------SE-------------QGLKELKNEVILFSKLQH--R 496 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~-------~~-------------~~~~~~~~E~~~l~~l~H--~ 496 (617)
-++..++||-|.-+-||.+-..+|.+.++|.=.. . .. ...-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567789999999999999998899988874211 0 00 001124567777777743 2
Q ss_pred CccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 497 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
-+.+.++ .+..++|||++.+-.|...- ...+..+. ...+..-+.-|..+| +||+|..-=||+|+
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 2334443 35568999999887775432 12233333 333344455666666 99999999999999
Q ss_pred CCCCeEEeecCCce
Q 007120 577 QDMNPKISDFGLVR 590 (617)
Q Consensus 577 ~~~~~ki~DFGla~ 590 (617)
++..++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.059 Score=56.08 Aligned_cols=163 Identities=14% Similarity=0.094 Sum_probs=96.3
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEE-------EeCCeEEEEE
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-------IQGEEKLLIY 515 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-------~~~~~~~lV~ 515 (617)
.....||+|+.+.+|-.--- +..| .|+...-......+.. ..+..--.||-+-.-+.+- ..+...-++|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk~--a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQKV--AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hchh-heeecCCCchHHHHHH--HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34578999999999854321 1223 3444332221111111 1122333565443312221 1112244667
Q ss_pred ecCCCCC-HHHHHhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 516 EFMPNKS-LDSFIFD---QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 516 Ey~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
..+++.. ...++.- +..-...+|...++.+..+|.+.+-||..+ .+-+|+.++|+|+++++.+.|.|=..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7666542 2333321 223345789999999999999999999998 88899999999999999999987543322
Q ss_pred eCCCCcccccceeeeeccccCccC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~ 615 (617)
-.++. ..--.+|...|++||.
T Consensus 167 ~~ng~---~~~cpVg~~eftPPEl 187 (637)
T COG4248 167 NANGT---LHLCPVGVSEFTPPEL 187 (637)
T ss_pred ccCCc---eEecccCccccCCHHH
Confidence 21111 1223568889999996
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.052 Score=55.79 Aligned_cols=141 Identities=22% Similarity=0.248 Sum_probs=92.2
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEeccc-----ch-----------------hhHHH----HHHHHHHHccCCCCC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-----SE-----------------QGLKE----LKNEVILFSKLQHRN 497 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~-----~~-----------------~~~~~----~~~E~~~l~~l~H~n 497 (617)
+...|..|.-.-||.+.-.+|..+|||+.+.. +. ...+. ...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34578889999999999989999999987531 00 00111 235666666666544
Q ss_pred ccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC
Q 007120 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (617)
Q Consensus 498 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~ 577 (617)
|.----... ....|||+|+..-.... -.-+...++...+..+-.+++.-|.-|-..+ ++||.||.--|+|+ .
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 431111111 12369999995322111 1112334556667777788888888888877 59999999999998 5
Q ss_pred CCCeEEeecCCceee
Q 007120 578 DMNPKISDFGLVRTF 592 (617)
Q Consensus 578 ~~~~ki~DFGla~~~ 592 (617)
+|.+.|+|.+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 678999998876643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.13 Score=52.70 Aligned_cols=145 Identities=15% Similarity=0.288 Sum_probs=80.6
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEec-ccchhhHHHHHHHHHHHccCCC--CCccceEEEEEeCC--eEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~ 520 (617)
+.+..|..-.+|..... +++.++.+-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 34433333334444332 6777777221 1222344556677777777643 33456778887776 56999999987
Q ss_pred CCHH------------------HHHhc---C--------C------CCCCCCHHHHHHHH--------HHHHHHHHHHHh
Q 007120 521 KSLD------------------SFIFD---Q--------T------RRTLLDWSQRFHII--------CGTARGLLYLHQ 557 (617)
Q Consensus 521 gsL~------------------~~l~~---~--------~------~~~~l~~~~~~~i~--------~~ia~gl~yLH~ 557 (617)
..+. ++|.. - . ..+...|....+.+ -....-..+|++
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 3221 11110 0 0 00111111111100 011223445544
Q ss_pred C-----CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 558 D-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 558 ~-----~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
. ++..++|+|+.+.|++++.+.-+-|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 3 235699999999999999988899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.15 Score=53.17 Aligned_cols=79 Identities=13% Similarity=0.143 Sum_probs=48.8
Q ss_pred eecccCcccEEEEEEcCC-cEEEEEEeccc----c---hhhHHHHHHHHHHHccCC--CC-CccceEEEEEeCCeEEEEE
Q 007120 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 515 (617)
.||.|-.-.||++..+++ +.|+||.-... . +...+....|...|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578899999999998654 68999975321 1 122344455666665442 23 35555544 566677999
Q ss_pred ecCCCC-CHHHHH
Q 007120 516 EFMPNK-SLDSFI 527 (617)
Q Consensus 516 Ey~~~g-sL~~~l 527 (617)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.49 Score=48.59 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.2
Q ss_pred CceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 561 ~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.3 Score=51.86 Aligned_cols=80 Identities=11% Similarity=0.086 Sum_probs=50.8
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEeccc----ch---hhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEEEE
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (617)
.+.||.|..-.||+... +++.++||.-... .. .....-..|...|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 36889999999999876 4567899976521 11 12223333455554442 357888888876 456788
Q ss_pred EecCCC--CCHHHHH
Q 007120 515 YEFMPN--KSLDSFI 527 (617)
Q Consensus 515 ~Ey~~~--gsL~~~l 527 (617)
|||+++ ..+.+-|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.12 Score=53.84 Aligned_cols=141 Identities=15% Similarity=0.236 Sum_probs=76.5
Q ss_pred ceecccCcccEEEEEEcC----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.|..|=.-.+|+....+ +..|++|....... ..-.-.+|..+++.+...++ .++++++.. . +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 344445566788876543 23788887754322 22233567777777765555 356666532 2 58999977
Q ss_pred CCHHH-------HH----------hcCC-C--CCCCCHHHHHHHHHH----------------------HHHHHH----H
Q 007120 521 KSLDS-------FI----------FDQT-R--RTLLDWSQRFHIICG----------------------TARGLL----Y 554 (617)
Q Consensus 521 gsL~~-------~l----------~~~~-~--~~~l~~~~~~~i~~~----------------------ia~gl~----y 554 (617)
..|.. .+ +... . ..+.-|....++..+ +.+-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 11 1111 0 011122222222111 111111 1
Q ss_pred HHh-CCCCceeecccCCCcEEEcC-CCCeEEeecCCcee
Q 007120 555 LHQ-DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (617)
Q Consensus 555 LH~-~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~ 591 (617)
+.+ ..+.-+.|.|+-+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12234789999999999975 57899999998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.52 Score=45.61 Aligned_cols=74 Identities=16% Similarity=0.255 Sum_probs=50.1
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC---CCCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 447 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
.+.-|.--+.|.... +..++.||+-.. .....|..|+.-|..| +-.++.+++.+-.+..+.|+|+||++-+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 444444334444332 457788887533 3456777787665555 445678888888899999999999998776
Q ss_pred H
Q 007120 524 D 524 (617)
Q Consensus 524 ~ 524 (617)
+
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.047 Score=52.80 Aligned_cols=30 Identities=30% Similarity=0.494 Sum_probs=21.7
Q ss_pred ceeecccCCCcEEE-cCCCCeEEeecCCcee
Q 007120 562 RIIHRDLKASNVLL-DQDMNPKISDFGLVRT 591 (617)
Q Consensus 562 ~iiHrDlkp~NiLl-~~~~~~ki~DFGla~~ 591 (617)
.+.|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.089 Score=54.06 Aligned_cols=71 Identities=20% Similarity=0.221 Sum_probs=55.8
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..|++|++. +++|. ......|.+.+.|+.+.+.-+.-|... .++=|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 456777766 44442 233457889999999888777777654 4689999999999999 999999999999
Q ss_pred ee
Q 007120 590 RT 591 (617)
Q Consensus 590 ~~ 591 (617)
|.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 95
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 617 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 3e-98
Identities = 74/203 (36%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 417 ENEDQNI-DLELPLFELATIANATDNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 469
EN+ + D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 470 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 586 FGLVRTFGGDETEGNTNRVVGTY 608
FGL R T+R+VGT
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTT 199
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-89
Identities = 79/181 (43%), Positives = 109/181 (60%), Gaps = 3/181 (1%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 488
F L + A+DNFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICG 547
+ S HRNL++L G C+ E+LL+Y +M N S+ S + ++ + LDW +R I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ARGL YLH +IIHRD+KA+N+LLD++ + DFGL + +T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 608 Y 608
Sbjct: 199 I 199
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 3e-83
Identities = 77/207 (37%), Positives = 118/207 (57%), Gaps = 10/207 (4%)
Query: 408 TENSRETDQENEDQNIDLELPL----FELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
++ S+ T+ N+ + +P L + AT+NF +G G FG VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G ++A+KR + S QG++E + E+ S +H +LV L+G C + E +LIY++M N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 524 DSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
++ T+ + W QR I G ARGL YLH + IIHRD+K+ N+LLD++ PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 583 ISDFGLVRTF-GGDETEGNTNRVVGTY 608
I+DFG+ + D+T +T V GT
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTL 205
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-64
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI 475
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ 58
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDSFIFDQT 531
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---- 113
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKIS 584
+ ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY 608
DFGL F ++ G+T+ VGT
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTR 197
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 2e-55
Identities = 56/188 (29%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
DN + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 498 LVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ + + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 553 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG------DETEGN 600
YLH + + I HRDL + NVL+ D ISDFGL G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 601 TNRVVGTY 608
VGT
Sbjct: 185 AISEVGTI 192
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+I + + +D +I +L +I K+G G FG V++
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWC----DL----------NIKEKIGAGSFGTVHRAE 57
Query: 461 LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
G ++AVK L + + E EV + +L+H N+V +G Q ++ E++
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
SL + R LD +R + A+G+ YLH I+HR+LK+ N+L+D+
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
K+ DFGL R T ++ GT
Sbjct: 176 YTVKVCDFGLSRLK--ASTFLSSKSAAGTPE 204
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 11/171 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL G C+ L+ E+ SL + + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 560 RLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+IHRDLK N+LL KI DFG + + + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAA 168
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 14/174 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 498 LVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ +LG C I +MP SL + + + T + D SQ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
H L I L + +V++D+DM +IS + +F + +
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPA 173
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 491
+ ++G+GGFG V+KG LV D +A+K L +G +E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ Y+ I+HRDL++ N+ L + K++DFGL + ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 607 TYC 609
+
Sbjct: 189 NFQ 191
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG+G FG K T G+ + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+K +G + + I E++ +L I + WSQR A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ IIHRDL + N L+ ++ N ++DFGL R ++T+ R
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 499
+ +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L G C++ L+ EF L+ + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 560 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ IIHRDLK+SN+L+ Q + KI+DFGL R + G Y
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYA 179
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 10/172 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG VYKG ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ +G + ++ ++ SL + T + + I TARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
IIHRDLK++N+ L +D KI DFGL ++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
E+ R+ ++++ LPL TIA + ++G+G +G V+ G G++
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEK 62
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKS 522
+AVK E + E+ ++H N++ + I+G LI ++ N S
Sbjct: 63 VAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQ 577
L ++ + T LD + + GL +LH + I HRDLK+ N+L+ +
Sbjct: 122 LYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 578 DMNPKISDFGLVRTF--GGDETEGNTNRVVGTYC 609
+ I+D GL F +E + N VGT
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 410 NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV 469
+ +T ++ +I E +L I +G+G FG VY G E+A+
Sbjct: 17 KASQTSIFLQEWDIPFE----QL----------EIGELIGKGRFGQVYHGRW--HGEVAI 60
Query: 470 KRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
+ + + +E LK K EV+ + + +H N+V +G C+ +I ++L S +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ + +LD ++ I +G+ YLH I+H+DLK+ NV D + I+DFG
Sbjct: 121 --RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 588 LVRTFGGDETEGNTNR---VVGTYC 609
L G + ++ G C
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLC 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--S 491
T+A + ++ +G+G +G V++G+ G+ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 492 KLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L+H N++ + + LI + SL ++ + T LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 548 TARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGN 600
A GL +LH + I HRDLK+ N+L+ ++ I+D GL + ++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 601 TNRVVGTYC 609
N VGT
Sbjct: 174 NNPRVGTKR 182
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 22/216 (10%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ ++ + LPL TIA + +G+G FG V++G G+
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGE 66
Query: 466 EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPN 520
E+AVK S E+ +E E+ L+H N++ + + L+ ++ +
Sbjct: 67 EVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLL 575
SL ++ R + + TA GL +LH + + I HRDLK+ N+L+
Sbjct: 125 GSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 576 DQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYC 609
++ I+D GL D + N VGT
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 12/180 (6%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ KLGEGGF V L DG A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 500 KLLGCCIQ----GEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLY 554
+L+ C++ E L+ F +L + I + + L Q ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---EGNTNRVVGTYCGT 611
+H HRDLK +N+LL + P + D G + + T + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 7/159 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 497
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+V+L+G C Q + ++ E + +F+ +T L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ + KISDFG+ R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------------IFDQTRRTLLDWSQR 541
QH+++V+ G C +G L+++E+M + L+ F + L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G++YL + L +HRDL N L+ Q + KI DFG+ R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+IHRDL A N L+ ++ K+SDFG+ R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQ 540
QH ++VK G C G+ ++++E+M + L+ F + + L SQ
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
HI A G++YL + +HRDL N L+ ++ KI DFG+ R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL R IHRDL N+L++ + KI DFGL + D+
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL R IHRDL N+L++ + KI DFGL + D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G C + ++ E++ N L +++ ++ L+ SQ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL A N L+D+D+ K+SDFG+ R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------IFDQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S+ + + S+ +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ +HRDL A N L++ K+SDFGL R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+VK G C + LI EF+P+ SL ++ + ++ Q+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ YL + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTA 549
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 51/165 (30%), Positives = 66/165 (40%), Gaps = 15/165 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H +++K GCC L+ E++P SL ++ R + +Q G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ YLH IHRDL A NVLLD D KI DFGL +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 493
+ + LGEG FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 494 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHII 545
H N+++LLG CI+ + ++I FM L +++ +T + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +HRDL A N +L DM ++DFGL +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 498
+ +G+G FG VY G +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 499 VKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L+G + E ++ +M + L FI ++ + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+VK G + L+ E++P+ L F+ Q R LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL R +HRDL A N+L++ + + KI+DFGL + D+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
I +G G G V G L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G +G +++ E+M N SLD+F+ +T Q ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S L +HRDL A NVL+D ++ K+SDFGL R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWS 539
LQH N+V LLG + + +I+ + + L F D+T ++ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+ + K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+ + ++ ++ L I Q + L Q L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+I+HRD+K+ N+ L +D ++ DFG+ R +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 491
++ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL H++LV G C+ G+E +L+ EF+ SLD+++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDE 596
+ +L +IH ++ A N+LL ++ + K+SD G+ T +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 494 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTL-----LDWSQRF 542
H ++ KL+G ++ K ++I FM + L +F+ R L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLV 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL S IHRDL A N +L +DM ++DFGL R
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 500 KLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L I E+M SL ++ + R++L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 23/192 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F LG GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 498 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+V+ + K+ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A + +LH ++HRDLK SN+ D K+ DFGLV DE E +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 606 G------TYCGT 611
GT
Sbjct: 182 PAYARHTGQVGT 193
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL A N L+ ++ K++DFGL R GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F + + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 53/187 (28%), Positives = 82/187 (43%), Gaps = 28/187 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+F +G GGFG V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 499 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF 542
V GC + L I EF +L+ +I ++ R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +G+ Y+H ++I+RDLK SN+ L KI DFGLV + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 603 RVVGTYC 609
R GT
Sbjct: 180 RSKGTLR 186
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
N SI+ +G G FG V G L +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + + +++ E+M N SLDSF+ + Q ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 11/163 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ + + Q ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL + + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++V+LLG C L+ +++P SL + + R L + A+G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL ++HR+L A NVLL +++DFG+ D+ +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVR 590
A G YL IHRD+ A N LL KI DFG+ R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---------------------IFDQT 531
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 35/181 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT---- 548
+ H +++KL G C Q LLI E+ SL F+ + R + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLD 140
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
++G+ YL + ++++HRDL A N+L+ + KISDFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 590 R 590
R
Sbjct: 198 R 198
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ ++ +LLG C+ LI + MP L ++ + + + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL R++HRDL A NVL+ + KI+DFGL + G +E E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVR 590
A G YL IHRD+ A N LL KI DFG+ R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L+G C Q E +L+ E L F+ +R + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFGL + G D++
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHR+L A N L+ ++ K++DFGL R GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 28/195 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+F LG+G FG V K +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 498 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+V+ ++K ++ E+ N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
L Y+H IIHRDLK N+ +D+ N KI DFGL + +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 605 VG--------TYCGT 611
+ GT
Sbjct: 179 NLPGSSDNLTSAIGT 193
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-30
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + E +I EFM SL F+ + + A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL+A+N+L+ + KI+DFGL R +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 507 QGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ I+ E +P SL + + + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 566 RDLKASNVLLDQDM-NPKISDFGLVRTFGGDETEGNTNRVVGT 607
RD+K NVL++ KISDFG + G T GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 49/186 (26%), Positives = 73/186 (39%), Gaps = 16/186 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 498
+ L EGGF VY+ + G+E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 499 VKLLGCCIQGEEK-------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG----- 606
+ ++H+ + IIHRDLK N+LL K+ DFG T + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 607 -TYCGT 611
T T
Sbjct: 208 ITRNTT 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 51/176 (28%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C G L+I E+ L +F+ + +R S+ I
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDEL 140
Query: 549 --------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + IHRDL A N+LL KI DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L R +HRD+ A NVL+ + K+ DFGL R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 495
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLL 553
N++K I+ + +L I E L I ++ L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
++H R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 54/172 (31%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L QH N+V LLG C G L+I E+ L +F+ + + +L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 549 ----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + IHRD+ A NVLL KI DFGL R
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K R + + E ++ L L L + +LG G FG V
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA---------DIELGCGNFGSVR 353
Query: 458 KGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513
+G + ++I A+K L + +E+ E + +L + +V+L+G C Q E +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 412
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E L F+ +R + S ++ + G+ YL +HR+L A NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 574 LLDQDMNPKISDFGLVRTFGGDETE 598
LL KISDFGL + G D++
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSY 492
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 22/184 (11%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQ 478
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----T 534
+ + EV L HRNL++L G + ++ E P SL + T
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L ++ A G+ YL R IHRDL A N+LL KI DFGL+R
Sbjct: 123 LSRYAV------QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 595 DETE 598
++
Sbjct: 174 NDDH 177
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 10/176 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H+ D ++HRDLK +NV LD N K+ DFGL R D + T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ + + + I +LG+G FG VYK G A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ H +VKLLG + ++ EF P ++D+ + L Q +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVVGT 607
L +LH RIIHRDLKA NVL+ + + +++DFG +T + +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 493 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF-------------IFDQTRRTLLD 537
+ H N+V LLG C + L +I EF +L ++ + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + + IHRDL A N+LL + KI DFGL R
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-L 461
+ TEN + L + + K+GEG G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALR--MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
G+++AVK + +Q + L NEV++ QH N+V++ + GEE ++ EF+
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
+L D + L+ Q + + L YLH +IHRD+K+ ++LL D
Sbjct: 128 ALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 582 KISDFGLVRTFGGDETEGNTNR--VVGT 607
K+SDFG F ++ R +VGT
Sbjct: 181 KLSDFG----FCAQISKDVPKRKSLVGT 204
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 494
++ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + E +I E P L ++ + + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L + +HRD+ N+L+ K+ DFGL R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
HQ I+H DLK +N L+ D K+ DFG+ D T+ V + GT
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT----TSVVKDSQVGT 191
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 45/182 (24%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
+ L +LH + ++IHRD+K+ N+LL D + K++DFG F + + +V
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMV 177
Query: 606 GT 607
GT
Sbjct: 178 GT 179
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 46/181 (25%), Positives = 71/181 (39%), Gaps = 35/181 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C LI+E+ L +++ +++R + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEE 162
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
A+G+ +L +HRDL A NVL+ KI DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 590 R 590
R
Sbjct: 220 R 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 70 KIIRLYD-YEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
HQ I+H DLK +N L+ D K+ DFG+ D T+ V + GT
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT----TSVVKDSQVGT 172
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
YLH+ R+IHRDLK N+ L++D+ KI DFGL E +G + CGT
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKK---VLCGT 204
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 16/175 (9%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 499 --VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++L ++ + + N L+S++ ++ +D +R + +H
Sbjct: 117 KIIRLYD-YEITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
Q I+H DLK +N L+ D K+ DFG+ D T+ V + G
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT----TSVVKDSQVGA 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L E + + F + KLGEG +G VYK GQ +A+K++ E L+E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+ + ++VK G + + ++ E+ S+ I + R L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
T +GL YLH R IHRD+KA N+LL+ + + K++DFG G +T N V+
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVI 186
Query: 606 GT 607
GT
Sbjct: 187 GT 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
YLH R R+IHRDLK N+ L++D+ KI DFGL E +G + CGT
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKK---VLCGT 178
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ ++ Q R + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHV-KDKNIIELVHQVSMGMKYL---EES 136
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFGL + DE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 20/184 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +L + I+HR++K N++ D K++DFG R DE +
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVS 174
Query: 608 YCGT 611
GT
Sbjct: 175 LYGT 178
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+ E +++ D E + + ++N + ++G G F VYKG
Sbjct: 1 QEERNQQQDDIEELETKAVG--------MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTV 52
Query: 466 EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI---QGEEKLLIY-EFMP 519
E+A + K+++ + K E + LQH N+V+ +G++ +++ E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QD 578
+ +L +++ R ++ +GL +LH + IIHRDLK N+ +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ KI D GL + V+GT
Sbjct: 169 GSVKIGDLGLATL----KRASFAKAVIGT 193
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELK 484
+ EL + FS ++G G FG VY + + + +A+K++S K S + +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
EV KL+H N ++ GC ++ L+ E+ + D + + L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G +GL YLH +IHRD+KA N+LL + K+ DFG N+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--F 210
Query: 605 VGT 607
VGT
Sbjct: 211 VGT 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L R +HRD+ A NVL+ + K+ DFGL R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K + + K + ++NE + +L + + ++G G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVH 75
Query: 458 KGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
+ G + AVK RL + E++ + L +V L G +G + I
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNI 127
Query: 515 Y-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E + SL I + L + + + GL YLH RI+H D+KA NV
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNV 181
Query: 574 LLDQDMNP-KISDFGL---VRTFGGDETEGNTNRVVGT 607
LL D + + DFG ++ G ++ + + GT
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 52/180 (28%), Positives = 96/180 (53%), Gaps = 23/180 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGL 552
++++L + + L+ E N ++ ++ ++ + + ++ F II G +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG----M 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTYCGT 611
LYLH I+HRDL SN+LL ++MN KI+DFGL + + + T CGT
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL----KMPHEKHY---TLCGT 175
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 20/184 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +L + I+HR++K N++ D K++DFG R DE +
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVS 174
Query: 608 YCGT 611
GT
Sbjct: 175 LYGT 178
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 15/186 (8%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVI 488
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 489 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
+ K HRN+ G I+ +++L L+ EF S+ + T+ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+I RGL +LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
Query: 602 NRVVGT 607
N +GT
Sbjct: 187 NTFIGT 192
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 19/174 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+NF K+GEG +G VYK + G+ +A+K++ +E ++E+ L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKE 58
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKLL I E KL L++EF+ + L F+ D + T + + +G
Sbjct: 59 LNHPNIVKLL-DVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQG 115
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H R++HRDLK N+L++ + K++DFGL R F G T+ VV
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 44/173 (25%), Positives = 67/173 (38%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QH 495
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+L + L + E SL + L +Q + + T L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH ++H D+K +N+ L K+ DFGL+ G T G G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILF 490
+++ F KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLDSFIFDQTRRTLLDWSQRFHIICG 547
+L+H N+V+L I E KL L++EFM N K L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+GL + H++ +I+HRDLK N+L+++ K+ DFGL R F G ++ VV
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ +A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V L+ I E L L++EFM K L + +T L SQ + RG+
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGV 132
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ HQ RI+HRDLK N+L++ D K++DFGL R F G T+ VV
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 493
A+ + F+ K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ K G ++ + +I E++ S D LD +Q I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH + + IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + LGEG F VYK Q +A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N++ LL + + L+++FM L+ I + +L S + T +GL
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLHQ I+HRDLK +N+LLD++ K++DFGL ++F G T++VV
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 32/187 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N+++L G ++ LI E+ P ++ + + ++ +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITEL 118
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A L Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRT---DL 167
Query: 609 CGTKAFL 615
CGT +L
Sbjct: 168 CGTLDYL 174
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 493
+ + +KLGEG + VYKG + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+V L I E+ L L++E++ +K L ++ +++ + RGL
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H+ +++HRDLK N+L+++ K++DFGL R T+ N VV
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-25
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 23/185 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 496
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 497 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH+ RIIHRDLK N++L Q + KI D G + E +
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------LCT 181
Query: 607 TYCGT 611
+ GT
Sbjct: 182 EFVGT 186
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L+H+N+V+L + ++KL L++EF + L + + LD + +G
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKG 113
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H ++HRDLK N+L++++ K+++FGL R F G + VV
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+VKL I +++L L++E + + L + L+ + G+
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H R++HRDLK N+L++++ KI+DFGL R F G T+ +V
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQ 494
D++ + +G G V +++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
GL YLH++ IHRD+KA N+LL +D + +I+DFG V F + N+V T+
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG-VSAFLATGGDITRNKVRKTFV 187
Query: 610 GT 611
GT
Sbjct: 188 GT 189
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 39/201 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 480
+++ I L +G F + L D + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRT 534
+ KNE+ + + +++ + G I +++ +IYE+M N S+ F D+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ II Y+H + I HRD+K SN+L+D++ K+SDFG
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 595 DETEGNTNRVVGTYCGTKAFL 615
+ + GT F+
Sbjct: 205 KKIK--------GSRGTYEFM 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 45/194 (23%), Positives = 72/194 (37%), Gaps = 35/194 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 494
T F K+G G FG V+K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 495 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGL 552
H ++V+ + + +LI E+ SL I + R + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLVRTFG 593
Y+H ++H D+K SN+ + + P KI D G V
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 594 GDETEGNTNRVVGT 607
+ E G
Sbjct: 186 SPQVE------EGD 193
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 28/181 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
V G + + + E M + SLD F + ++D Q I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVG 606
L +LH S+L +IHRD+K SNVL++ K+ DFG LV + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-------DIDAG 171
Query: 607 T 607
Sbjct: 172 C 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 31/161 (19%), Positives = 62/161 (38%), Gaps = 9/161 (5%)
Query: 432 LATIANATDNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNE 486
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ + H N+V I E ++ FM S + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
G + L Y+H +HR +KAS++L+ D +S
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR 173
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + K+GEG +G V+K GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + + +L L++E+ + ++ + + + I T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAV 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H+ IHRD+K N+L+ + K+ DFG R ++ + V
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 20/178 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 499
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ C + + + E +L ++ + + + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 559 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L I+HRDLK N+L+ + ISDFGL + + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS---GVPGT 189
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D + KLGEG +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGT 548
LQHRN+++L I +L LI+E+ + + +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 549 A---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN 600
G+ + H R +HRDLK N+LL KI DFGL R F G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 601 TNRVV 605
T+ ++
Sbjct: 195 THEII 199
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N++++ +++ L+ EF P L + + ++ RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEEL 123
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A L Y H ++IHRD+K N+L+ KI+DFG T
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--------TM 172
Query: 609 CGT 611
CGT
Sbjct: 173 CGT 175
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+V+ G + + + E M + S D F + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEG 599
L +L L+IIHRD+K SN+LLD+ N K+ DFG LV + G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG 187
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKELKN 485
+ ++GEG +G V+K G+ +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 486 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+H N+V+L E KL L++E + ++ L +++ D+ +
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
++ RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 601 TNRVV 605
T+ VV
Sbjct: 177 TSVVV 181
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 34/183 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 499 VKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHI----- 544
V L +K L+ E++P ++ + + +L I
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML------LIKLYMY 148
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H + I HRD+K N+LLD K+ DFG + E N +
Sbjct: 149 QLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 603 RVV 605
+
Sbjct: 201 YIC 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 35/189 (18%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------LK 481
AT + ++G G +G VYK G +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL 536
L+ +H N+V+L+ E K+ L++E + ++ L +++ D+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++ RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 597 TEGNTNRVV 605
T VV
Sbjct: 175 A--LTPVVV 181
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + +GEG +G V K G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + +++ L++EF+ + ++ + + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H IIHRD+K N+L+ Q K+ DFG RT E + V
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 32/195 (16%), Positives = 56/195 (28%), Gaps = 26/195 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 492
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTAR 550
+K + +L+ E +L + I + T ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLVRTFGGDETEG 599
+ +H IIH D+K N +L D + D G D
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ----SIDMKLF 236
Query: 600 NTNRVVGTYCGTKAF 614
+ C T F
Sbjct: 237 PKGTIFTAKCETSGF 251
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 29/191 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 498
+ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
++ C + L + E N +L + L ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLVRTFGGDETEGN 600
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 601 TNRVVGTYCGT 611
TN + GT
Sbjct: 187 TN--LNNPSGT 195
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 53/185 (28%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR---- 550
VKL Q +EKL + N L R+ F C R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETC--TRFYTA 137
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH IIHRDLK N+LL++DM+ +I+DFG + + + N
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN---- 190
Query: 607 TYCGT 611
++ GT
Sbjct: 191 SFVGT 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 52/242 (21%), Positives = 81/242 (33%), Gaps = 70/242 (28%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F +G GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 498 LVKLLGCCIQG----------------------------------EEKLL-------IYE 516
+V+ ++ + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 517 FMPNKSLDSFIFDQT----RRTLLDWSQR------------FHIICGTARGLLYLHQDSR 560
+ S +++ Q + L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE------TEGNTNRVVGTYCGTKAF 614
++HRDLK SN+ D K+ DFGLV DE T GTK
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK-- 240
Query: 615 LY 616
LY
Sbjct: 241 LY 242
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 22/177 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LGEG +G V + AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 503 GCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLLYLHQ 557
+ EEK +Y E+ + +R + + + +I G YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAF 614
I+H+D+K N+LL KIS G+ +T R T G+ AF
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFAADDTCR---TSQGSPAF 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 37/177 (20%), Positives = 67/177 (37%), Gaps = 19/177 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G G V+K G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V+ G I + + E M + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTYC 609
+ +IHRD+K SN+LLD+ K+ DFG LV +R G
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-------DRSAGCAA 189
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 34/187 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+G+G FG V+K GQ++A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 493 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN---KSLDSFIFDQTRRTLLDWSQR 541
L+H N+V L+ C L+++F + L + S+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEI 126
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN- 600
++ GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGL R F +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 601 --TNRVV 605
TNRVV
Sbjct: 184 RYTNRVV 190
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 24/233 (10%), Positives = 55/233 (23%), Gaps = 41/233 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLEL-----PLFELATIANATDNFSINNKLGEGGF 453
KR + + + + + + ++ + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 454 GPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC---- 505
V+ V+ ++ A+K + S L+ L ++L + +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 506 ------IQGEEK----------------LLIYEFMP---NKSLDSFIFDQTRRTLLDWSQ 540
+Q + LL+ + F R
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ R L ++H N+ + D + D + G
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 8/180 (4%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLV-DGQEIA 468
E + +E Q LE L + + D+F ++LG G G V+K + G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 469 VKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
K + +I ++ E+ + + +V G E + E M SLD +
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
R + + +GL YL + +I+HRD+K SN+L++ K+ DFG
Sbjct: 123 KKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 498 LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHI----- 544
+V+L EK L+ +++P +++ + + ++TL ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV----IYVKLYMY 163
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H I HRD+K N+LLD D K+ DFG + E N +
Sbjct: 164 QLF---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 603 RVV 605
+
Sbjct: 216 YIC 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 20/179 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYL 555
+VKL I+ E+ L LI E+ + ++ R + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAF 614
H + RI+HRDLKA N+LLD DMN KI+DFG F + +CG +
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-------LDAFCGAPPY 179
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 54/172 (31%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+ I HRD+K N+LLD+ N KISDFGL F N R++ CGT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGT 170
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 33/261 (12%), Positives = 70/261 (26%), Gaps = 48/261 (18%)
Query: 390 VLIAGYLIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKL 448
V+I R + N+ +E + D + P + + L
Sbjct: 22 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 81
Query: 449 GEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ---------- 494
G+ + T G+ V +K++K EV+ L+
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 495 ---------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSF--IFDQTR-RT 534
+ ++++ +Y M + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L R + R L LH ++H L+ +++LDQ ++ F + G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG- 257
Query: 595 DETEGNTNRVVGTYCGTKAFL 615
++ F
Sbjct: 258 ---------ARVVSSVSRGFE 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 54/172 (31%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+ I HRD+K N+LLD+ N KISDFGL F N R++ CGT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGT 170
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 15/207 (7%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+S + ++ +F + + ++ + KLG G +G V V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 466 EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
E A+K + K +S +L EV + L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMN 580
I + + +D + + G+ YLH+ I+HRDLK N+LL ++D
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDAL 177
Query: 581 PKISDFGLVRTFGGDETEGNTNRVVGT 607
KI DFGL F + +GT
Sbjct: 178 IKIVDFGLSAVFENQKK---MKERLGT 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 444 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 499 VKLLGCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+ L + + K+ L++++ L I + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFG 593
G+ YLH + ++HRDLK +N+L+ + KI+D G R F
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 27/183 (14%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 491
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFH-IICGT 548
+++H N++K+L + + L+ E + L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
YL IIHRD+K N+++ +D K+ DFG + + T+
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-------LFYTF 189
Query: 609 CGT 611
CGT
Sbjct: 190 CGT 192
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 5e-20
Identities = 30/194 (15%), Positives = 53/194 (27%), Gaps = 38/194 (19%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-------- 495
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 496 --------RNLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIF------DQTRR 533
+LVK + L + P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
L R + R L LH ++H L+ +++LDQ ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 594 GDETEGNTNRVVGT 607
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 18/215 (8%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLEL-PLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+ K + + D + ++I + P + D + I +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 461 -LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
G+ K ++ +KNE+ + ++L H L+ L E +LI EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 520 NKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
L D + + + + C GL ++H+ I+H D+K N++ +
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 579 MNP--KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
KI DFGL DE +V T
Sbjct: 186 KASSVKIIDFGLATKLNPDE-------IVKVTTAT 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH+ IIHRDLK NVLL ++D KI+DFG + G ++
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-------LMR 299
Query: 607 TYCGT 611
T CGT
Sbjct: 300 TLCGT 304
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 40/183 (21%), Positives = 68/183 (37%), Gaps = 23/183 (12%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+++L E+ IY E L + + D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---A 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ Y H+ L + HRDLK N L D K+ DFGL F + ++ T
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTK 168
Query: 609 CGT 611
GT
Sbjct: 169 VGT 171
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 57/222 (25%)
Query: 433 ATIANATDNFSINN-----KLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------ 474
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 475 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 517
++++ E+ + KL H N+VKL+ + + +Y E
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFEL 119
Query: 518 MPNKSLDSFIFDQTRRTLL--DWSQRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ + + L D ++ + +I G + YLH +IIHRD+K SN+
Sbjct: 120 VNQGPV----MEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNL 168
Query: 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
L+ +D + KI+DFG+ F G + ++ GT AF+
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGS------DALLSNTVGTPAFM 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 21/222 (9%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFS----INNKLGEGGF 453
R + K + T N D + + + D+ I+ +LG G F
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 454 GPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512
G V++ T G A K + E + ++ E+ S L+H LV L E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 513 LIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
+IYEFM L + + + + + + +C GL ++H+ +H DLK
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPE 284
Query: 572 NVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
N++ + K+ DFGL + V GT
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ-------SVKVTTGT 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 29/219 (13%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + + + Q++ E L + A + + +G G V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 465 QEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
E AVK + E+ + + E IL H +++ L+ E ++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMF 176
Query: 516 ---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572
+ M L ++ ++ + + + + +LH I+HRDLK N
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE---AVSFLHA---NNIVHRDLKPEN 230
Query: 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+LLD +M ++SDFG E + CGT
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGT 262
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 21/170 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I ++ E++ L +I R ++ + F I+ Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
++HRDLK NVLLD MN KI+DFGL E + T CG+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGS 173
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 56/193 (29%), Positives = 79/193 (40%), Gaps = 38/193 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMP---------NKSLDSFIFDQTRRTLLDWSQRF--- 542
R +V L + + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-------AIFYTA 296
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
I+ G L +LHQ II+RDLK NVLLD D N +ISD GL +T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT----- 344
Query: 603 RVVGTYCGTKAFL 615
Y GT F+
Sbjct: 345 -KTKGYAGTPGFM 356
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFS 491
D F + G+G FG V G G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 492 KLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQR 541
L H N+V+L GE ++ E++P ++ ++ Q +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI----- 129
Query: 542 FHI------ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGG 594
I + R + LH S + + HRD+K NVL+++ K+ DFG +
Sbjct: 130 -LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 595 DETEGNTNRVV 605
E N +
Sbjct: 185 SEP--NVAYIC 193
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + LG+G FG V + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N++KL + + L+ E L I + R + +D ++ + G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GIT 140
Query: 554 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ +I+HRDLK N+LL +D N +I DFGL F + +GT
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 13/180 (7%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 495
D + + LGEG V L+ QE AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
RN+++L+ + + L++E M S+ S I + L+ S + L +L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---ALDFL 127
Query: 556 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYCGT 611
H I HRDLK N+L +Q KI DF L + + + T CG+
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 26/185 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH IIHRDLK NVLL ++D KI+DFG + G ++
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-------LMR 174
Query: 607 TYCGT 611
T CGT
Sbjct: 175 TLCGT 179
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-19
Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 23/184 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGTARG 551
R +V L + ++ L L+ M L I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L LH R RI++RDLK N+LLD + +ISD GL +T + GT
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-------IKGRVGT 348
Query: 612 KAFL 615
++
Sbjct: 349 VGYM 352
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 46/182 (25%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LGEG FG V T Q++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFI---------FD---QTRRTLLDWSQRF--HIICGTA 549
Y+ + + D + FD + +R D +RF IIC
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
Y H R +I+HRDLK N+LLD ++N KI+DFGL + T C
Sbjct: 123 ----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-------FLKTSC 168
Query: 610 GT 611
G+
Sbjct: 169 GS 170
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 405 AEKTENSRETDQENEDQNIDLELP--LFELATI----ANATDNFSINNK--LGEGGFGPV 456
A+ TE + +D+ P F+ + ++++ LG G FG V
Sbjct: 46 ADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQV 105
Query: 457 YKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
+K G ++A K + + +E+KNE+ + ++L H NL++L + +L+
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165
Query: 516 EFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
E++ L D I + T LD IC G+ ++HQ + I+H DLK N+L
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ---MYILHLDLKPENIL 219
Query: 575 L-DQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
++D KI DFGL R + E + GT
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPRE-------KLKVNFGT 251
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 46/184 (25%), Positives = 68/184 (36%), Gaps = 24/184 (13%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKL 493
D F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRR----TLLDWSQRFHIIC 546
H N++K+ E+ +Y E L I R + ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNR 603
L Y H ++H+DLK N+L KI DFGL F DE +
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STN 185
Query: 604 VVGT 607
GT
Sbjct: 186 AAGT 189
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L +E+ Y + + L I + + D S I +
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SI 118
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
Y H I+HR+LK N+LL + K++DFGL E +
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-------AWHGFA 168
Query: 610 GT 611
GT
Sbjct: 169 GT 170
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 499
I +KLG GG VY + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+RI+HRD+K N+L+D + KI DFG+ + + + TN V+GT
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 42/223 (18%), Positives = 75/223 (33%), Gaps = 52/223 (23%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
+ + +G+G +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--------- 542
L H N+ +L + E+ + L+ E L + + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 543 ----------------------------HIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
+I+ L YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 575 L--DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
++ K+ DFGL + F + + T GT F+
Sbjct: 201 FSTNKSFEIKLVDFGLSKEF--YKLNNGEYYGMTTKAGTPYFV 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 43/184 (23%), Positives = 69/184 (37%), Gaps = 24/184 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 487
+N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
IL H N+++L L+++ M L ++ ++ + + + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ LH+ L I+HRDLK N+LLD DMN K++DFG E +
Sbjct: 136 ---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLRE 182
Query: 608 YCGT 611
CGT
Sbjct: 183 VCGT 186
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 24/187 (12%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKE-LKNEVI 488
+ D++ + +LG G F V K G+E A K RLS +E ++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++H N++ L + +LI E + L F+ ++ T + +Q I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH RI H DLK N++L + K+ DFG+
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-------E 167
Query: 605 VGTYCGT 611
GT
Sbjct: 168 FKNIFGT 174
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 21/170 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I + ++ E++ L +I R + + F I+ G Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
++HRDLK NVLLD MN KI+DFGL E + T CG+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGS 178
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 20/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
TD + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ L G+ ++ E M L I Q + + S I + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK---TVEYLHA 134
Query: 558 DSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
++HRDLK SN+L D+ NP +I DFG + + N ++ T C T
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE------NGLLMTPCYT 183
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 24/180 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
F LG G F V+ + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
+V L E Y + + L I ++ T D S + + Y
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---AVKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
LH+ I+HRDLK N+L +++ I+DFGL + ++ T CGT
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--------IMSTACGT 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 28/220 (12%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + Q I + ++ +++ KLG G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 465 QEIAVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
E A+K + K E+ +E+ NE+ L L H N++KL + ++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKY 120
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ EF L I ++ + D + I G+ YLH+ I+HRD+K
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---GICYLHK---HNIVHRDIKP 174
Query: 571 SNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
N+LL + +N KI DFGL F D +GT
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
R ++ +K S + + + +N++L + L ++FS++ +G GGFG VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCR 209
Query: 461 LVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKL- 512
D ++ A+K L K +QG NE I+ S + +V + +KL
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLK 569
I + M L + + RF+ II G L ++H +++RDLK
Sbjct: 269 FILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN---RFVVYRDLK 319
Query: 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+N+LLD+ + +ISD GL F + GT ++
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPH--------ASVGTHGYM 357
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 44/187 (23%), Positives = 68/187 (36%), Gaps = 24/187 (12%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L P K+ DFGL
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-------E 174
Query: 605 VGTYCGT 611
GT
Sbjct: 175 FKNIFGT 181
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 33/179 (18%), Positives = 62/179 (34%), Gaps = 18/179 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
RN++ L EE ++I+EF+ + + + H +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
LH I H D++ N++ + KI +FG R +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-------NFRLLFTA 166
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 32/175 (18%), Positives = 68/175 (38%), Gaps = 29/175 (16%)
Query: 444 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 501 LLGCCIQGEE-----KLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ E + Y E++ +SL +++ L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH + +++ DLK N++L ++ K+ D G V + GT
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 43/187 (22%), Positives = 68/187 (36%), Gaps = 24/187 (12%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L + K+ DFGL
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-------E 174
Query: 605 VGTYCGT 611
GT
Sbjct: 175 FKNIFGT 181
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 21/182 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
D + + +G+G F V + GQ+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL----DWSQRFHIICGT 548
L+H ++V+LL +++EFM L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H IIHRD+K VLL + K+ FG+ G V
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 606 GT 607
GT
Sbjct: 195 GT 196
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 45/186 (24%), Positives = 71/186 (38%), Gaps = 24/186 (12%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ T + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L KI DFGL
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-------EF 174
Query: 606 GTYCGT 611
GT
Sbjct: 175 KNIFGT 180
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 27/187 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSK 492
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 493 LQHR--NLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++LL + + LI E P + L FI T R L
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQV 158
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ + H ++HRD+K N+L+D + K+ DFG G + V
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS-----GALLKDT---VYTD 207
Query: 608 YCGTKAF 614
+ GT+ +
Sbjct: 208 FDGTRVY 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V+L IQ E L+++ + L I + + D S I + Y
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAY 143
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
H I+HR+LK N+LL + K++DFGL E + GT
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-------AWHGFAGT 193
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
D + I + +G G +G V + ++ + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 492 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L H ++VK+L I + + ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
G+ Y+H S I+HRDLK +N L++QD + K+ DFGL RT E +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 22/187 (11%)
Query: 432 LATI--ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNE 486
+ATI T+ + + +LG+G F V + ++ GQE A ++ +S + ++L+ E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
+ L+H N+V+L E+ Y + + L I + + D S
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGN 600
I +L+ HQ + ++HR+LK N+LL + K++DFGL G++
Sbjct: 118 QILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 601 TNRVVGT 607
GT
Sbjct: 172 G--FAGT 176
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 23/176 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTAR 550
N++ L + L++E + N +TL D+ RF++ I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---K 141
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H S I+HRD+K NV++D + ++ D+GL + RV
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA 192
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 48/206 (23%), Positives = 77/206 (37%), Gaps = 23/206 (11%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLS 473
+ +DL ++ N + + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 474 K--ISEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
K + E+ +E+ + + ++ L E +LI E+ + S +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 531 TRRTL--LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISD 585
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 586 FGLVRTFGGDETEGNTNRVVGTYCGT 611
FG+ R G + GT
Sbjct: 178 FGMSRKIGHAC-------ELREIMGT 196
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 31/187 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI------ICGT 548
LV L Q EE + ++ + + L R L + F IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL---------RYHLQQNVHFKEETVKLFICEL 124
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
L YL RIIHRD+K N+LLD+ + I+DF + + T
Sbjct: 125 VMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---IT----TM 174
Query: 609 CGTKAFL 615
GTK ++
Sbjct: 175 AGTKPYM 181
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 405 AEKTENSRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLVD 463
A K + +E+ +E + + L +E + A D F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 464 GQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFM 518
A+K L K LK++ NE + + LVKL + L ++ E++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYV 123
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR--------GLLYLHQDSRLRIIHRDLKA 570
+ F RR RF AR YLH L +I+RDLK
Sbjct: 124 AGGEM----FSHLRR-----IGRFSE--PHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
N+L+DQ +++DFG + +G T T CGT
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-----RVKGRTW----TLCGT 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 42/193 (21%), Positives = 77/193 (39%), Gaps = 37/193 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----I 488
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQTRRTLL--DWSQRF-- 542
+ + H +++LL + +E L+ E +P + L +I T + L S+ F
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFG 146
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNT 601
++ + + H ++HRD+K N+L+D K+ DFG G
Sbjct: 147 QVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDE- 193
Query: 602 NRVVGTYCGTKAF 614
+ GT+ +
Sbjct: 194 --PYTDFDGTRVY 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 25/180 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+D F + ++LG G VY+ + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
++KL E I E + L I ++ + D + I + Y
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAY 163
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
LH+ I+HRDLK N+L D KI+DFGL + ++ T CGT
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-------LMKTVCGT 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 17/171 (9%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 499
+ +G GG G VY+ V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+ GE +Y + L + + R+ L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
HRD+K N+L+ D + DFG+ DE VGT
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGT 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 20/170 (11%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 504
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E + L I + + + S + + ++H + ++
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSHMHD---VGVV 128
Query: 565 HRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
HRDLK N+L + ++ KI DFG R D N+ + T C T
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD------NQPLKTPCFT 172
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 31/174 (17%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
I L +I E+ L ++ R D ++ F ++ G + Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH--- 133
Query: 560 RLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
++I HRDLK N LLD KI DFG ++ + GT
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGT 180
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 23/177 (12%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG GG V+ L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 499 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V + GE + ++ E++ +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-TEGNTNRVVGT 607
L + H + IIHRD+K +N+++ K+ DFG+ R + T V+GT
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 39/189 (20%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
TD++ ++ + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V +L G+ L +I E M L F + R +++R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDI 137
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +LH I HRD+K N+L ++D K++DFG + +
Sbjct: 138 GT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA------ 185
Query: 603 RVVGTYCGT 611
+ T C T
Sbjct: 186 --LQTPCYT 192
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 41/187 (21%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 495
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH----------I 544
++++ G Q +++ +I +++ L F R+ SQRF +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----FSLLRK-----SQRFPNPVAKFYAAEV 115
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
L YLH II+RDLK N+LLD++ + KI+DFG + T
Sbjct: 116 CLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTY-- 161
Query: 605 VGTYCGT 611
T CGT
Sbjct: 162 --TLCGT 166
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 40/213 (18%), Positives = 82/213 (38%), Gaps = 57/213 (26%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 496 RNLVKLLGCCIQGEEKL--------------------------------------LIYEF 517
N++KL+ ++ +I E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 518 MPNKSLDSFI--FDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+P +L + F ++ R++ +I + R + ++H L I HRD+K N+
Sbjct: 120 VP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNL 172
Query: 574 LLDQDMNP-KISDFGLVRTFGGDETEGNTNRVV 605
L++ N K+ DFG + +E + +
Sbjct: 173 LVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 26/173 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+QH N++ LL + L+ FM L + + ++ ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LV 132
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+GL Y+H ++HRDLK N+ +++D KI DFGL R + T
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 30/184 (16%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 493
F + LG+G FG V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTA 549
H +VKL Q E KL LI +F+ L F + +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL--VRTFGGDETEGNTNRVVGT 607
L +LH L II+RDLK N+LLD++ + K++DFGL + +
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--------YS 185
Query: 608 YCGT 611
+CGT
Sbjct: 186 FCGT 189
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 23/225 (10%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANAT------DNFSINNKLGEGGFGP 455
+ +A+ + + + + E+ + F LG+G FG
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 456 VYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
V A+K L K +++ + E + +H L L Q ++
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L + E+ L F R + RF+ L YLH S +++RDLK
Sbjct: 223 LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVYRDLKL 277
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
N++LD+D + KI+DFGL + +G T + T+CGT +L
Sbjct: 278 ENLMLDKDGHIKITDFGLCKE---GIKDGATMK---TFCGTPEYL 316
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 36/221 (16%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
+R +NI E E ++ + + + ++F I +G G FG V
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHR--------------EDFEILKVIGRGAFGEVAV 92
Query: 459 GTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
L + ++ A+K L+K E + E + + + L Q + L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ ++ L + + R + + RF+ ++ + +HQ L +HRD+K
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA----IDSVHQ---LHYVHRDIKP 203
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
N+L+D + + +++DFG D T ++ GT
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSS-----VAVGT 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 38/189 (20%), Positives = 73/189 (38%), Gaps = 38/189 (20%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V+++ G + L ++ E + L F + R +++R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSI 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ YLH + I HRD+K N+L + K++DFG +
Sbjct: 171 GEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------ 218
Query: 603 RVVGTYCGT 611
+ T C T
Sbjct: 219 -SLTTPCYT 226
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 7e-15
Identities = 35/202 (17%), Positives = 62/202 (30%), Gaps = 52/202 (25%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 489
T+ K+GEG FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 490 FSKLQ---------HRNLVKLLGCCI-----------------------------QGEEK 511
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
L I +D +Q R L + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 572 NVLLDQDMNPKISDFGLVRTFG 593
NVLL + K+ ++
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 428 PLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 486
++ A D + LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 487 V-ILFSKLQHRNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQ 540
V + + Q ++V+++ G + L ++ E + L F + R +++
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTE 116
Query: 541 R-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGL 588
R I + YLH + I HRD+K N+L + K++DFG
Sbjct: 117 REASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
L +L C Q ++L + E++ L + Q R + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAE-IAIGLF 456
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETEGNTNRVVGTYCGT 611
+L II+RDLK NV+LD + + KI+DFG+ + + G T T+CGT
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--------KTFCGT 505
Query: 612 KAFL 615
++
Sbjct: 506 PDYI 509
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 42/224 (18%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY- 457
+ + +A+ + + ++ + D+F I +G G F V
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQR--------------DDFEILKVIGRGAFSEVAV 79
Query: 458 ---KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
K T GQ A+K ++K + + + E + R + +L Q E
Sbjct: 80 VKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENY 135
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRD 567
L L+ E+ L + + R + + RF+ I+ + +H+ L +HRD
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA----IDSVHR---LGYVHRD 187
Query: 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
+K N+LLD+ + +++DFG D T + GT
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-----VAVGT 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 23/177 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
DN+ I + +G G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 492 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L+ +++L I K ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
G ++H IIHRDLK +N LL+QD + K+ DFGL RT ++ N
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
L L Q ++L + E+ L F R + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETEGNTNRVVGTYCGTK 612
LH +++RD+K N++LD+D + KI+DFGL + G T+CGT
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--------KTFCGTP 169
Query: 613 AFL 615
+L
Sbjct: 170 EYL 172
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 30/178 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 483
+++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 484 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDW 538
+ L + H N++ L + E + L+ E M L I +R ++
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISP 133
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ + GL LH+ ++HRDL N+LL + + I DF L R D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ L+ E M L I + L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LL 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 54/230 (23%), Positives = 81/230 (35%), Gaps = 51/230 (22%)
Query: 404 IAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
I++ E ++ L + +F +G+G FG V
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 464 GQEI-AVKRLSK--ISEQGLKELKNEV--------ILFSKLQHRNLVKLLGCCIQGEEKL 512
+ AVK L K I + K E +L ++H LV L Q +KL
Sbjct: 62 EEVFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114
Query: 513 -LIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRF---HIICGTARGLLYLHQDSRLRI 563
+ +++ L F + R RF I L YLH L I
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPR-------ARFYAAEIASA----LGYLHS---LNI 160
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETEGNTNRVVGTYCGT 611
++RDLK N+LLD + ++DFGL + T T+CGT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--------STFCGT 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E++ ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVV 605
RGL Y+H S ++HRDLK SN+LL+ + KI DFGL R D T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
++F ++ LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H L + C Q +E L + E++ L Q+ F+ GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETEGNTNRVVGTYCGT 611
+LH I++RDLK N+LLD+D + KI+DFG+ + G +T T+CGT
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--------NTFCGT 181
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 41/189 (21%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
+F+ LG+G FG V E+ AVK L K + + ++V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRV 73
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---I 544
L + L +L C Q ++L + E++ L + Q R + F+ I
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAEI 130
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETEGNTN 602
G L +L II+RDLK NV+LD + + KI+DFG+ + + G T
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT----- 178
Query: 603 RVVGTYCGT 611
T+CGT
Sbjct: 179 ---KTFCGT 184
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
H LV L C Q E +L + E++ L Q +R L + RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTY 608
L YLH+ II+RDLK NVLLD + + K++D+G+ + GD T T+
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--------STF 170
Query: 609 CGTKAFL 615
CGT ++
Sbjct: 171 CGTPNYI 177
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 32/186 (17%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 491
+ F + LG+GG+G V+ K T + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICG 547
+++H +V L+ Q KL LI E++ L F+ + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL--VRTFGGDETEGNTNRVV 605
L +LHQ II+RDLK N++L+ + K++DFGL G T
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-------- 178
Query: 606 GTYCGT 611
T+CGT
Sbjct: 179 HTFCGT 184
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 33/224 (14%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 462
N+ + ++E E N + +F + +G G + V L
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVIGRGSYAKVLLVRLK 74
Query: 463 DGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQHRNLVKLLGCCIQGEEKL-LIYE 516
I A++ + K ++ + ++ E + H LV L C Q E +L + E
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIE 133
Query: 517 FMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
++ L Q +R L + RF+ I L YLH+ II+RDLK NV
Sbjct: 134 YVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE---RGIIYRDLKLDNV 184
Query: 574 LLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTYCGTKAFL 615
LLD + + K++D+G+ + GD T T+CGT ++
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTT--------STFCGTPNYI 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 45/221 (20%), Positives = 83/221 (37%), Gaps = 38/221 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
++ +NI ++T + D + +++ + +G G FG V
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--------------EDYEVVKVIGRGAFGEVQL 87
Query: 459 GTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
+++ A+K LSK I E + + +V+L Q + L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ E+MP L W+ RF+ ++ L +H + IHRD+K
Sbjct: 147 VMEYMPGGDL--VNLMSNYDVPEKWA-RFYTAEVVLA----LDAIHS---MGFIHRDVKP 196
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
N+LLD+ + K++DFG + + T GT
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVR-CD----TAVGT 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + L+ FM L + + L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLV 134
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+GL Y+H IIHRDLK N+ +++D KI DFGL R + T
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 35/190 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
DNF LG+G FG V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L H L +L CC Q ++L + EF+ L F ++RR + RF+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARA-RFYAAE- 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVV 605
L++LH II+RDLK NVLLD + + K++DFG+ + G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT-------- 181
Query: 606 GTYCGTKAFL 615
T+CGT ++
Sbjct: 182 ATFCGTPDYI 191
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 28/180 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ ++ E M +L I + L + ++
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LL 133
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 188
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 28/185 (15%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 490
+NF + LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IIC 546
Q LV L Q E KL LI +++ L F R + + + I+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L +LH+ L II+RD+K N+LLD + + ++DFGL + F DETE
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY---- 218
Query: 607 TYCGT 611
+CGT
Sbjct: 219 DFCGT 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 25/173 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + + +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + + L+ M L++ + Q L D +F +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK---LTDDHVQF-LI 138
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 23/175 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
+ +F + + LGEG +G V T G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E +I E M L I Q L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM---LSDDHIQY-FIYQ 120
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
T R + LH + +IHRDLK SN+L++ + + K+ DFGL R + +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 494
+ LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 495 HRNLVKLL----------GCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
H N+VK+ + +L ++ E+M L + + LL+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP---LLEEHA 122
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEG 599
R + RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGL R +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 600 N--TNRVV 605
+ +V
Sbjct: 179 GHLSEGLV 186
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 19/162 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 493 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ H N+V LLG C + G ++I EF +L +++ S+R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 9/87 (10%)
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
EEK L D + T L+ +S + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N+LL + KI DFGL R
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + KLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 492 KLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V LL + L++++M L + I L +++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI---LEPVHKQY-VVYQLI 119
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL R+F N
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + C +G+ +++ E + SL+ +F+ R + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKF-----SLKTVLLLADQMISRIE 119
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
Y+H + IHRD+K N L+ I DFGL + +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 17/148 (11%), Positives = 45/148 (30%), Gaps = 12/148 (8%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
G ++ +++A+ + + + L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
L++ E++ SL T + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ S V + D + ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ F + K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 499 V-KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + ++G+ +L+ + + SL+ +F+ R L + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKL-----SLKTVLMLADQMINRVE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
++H S +HRD+K N L+ I DFGL + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 35/166 (21%), Positives = 80/166 (48%), Gaps = 27/166 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL-- 553
+ + +G +L+ + + SL+ + D R +F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGR-------KFSVKTVAMAAKQMLAR 118
Query: 554 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
+H+ S +++RD+K N L+ + + + DFG+V+ +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 4e-08
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ W + Y
Sbjct: 92 DGNVVIYGSD-------IWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 25 NPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGD 84
++ ++ + NLVL + VW++ + L GN V+ D
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-- 70
Query: 85 SETYFWQS 92
W S
Sbjct: 71 --RSLWAS 76
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNL 498
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL--- 553
++ G+ ++ E + SL+ +FD R F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDR-------TFSLKTVLMIAIQLISRM 118
Query: 554 -YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
Y+H + +I+RD+K N L+ + N I DF L + +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 39/171 (22%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 494
D + I++ +G+G FG V K V+ + +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 495 HR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDW 538
+V L C+ E +L +Y+ + N + + TR+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFA--- 163
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFG 587
Q LL+L L IIH DLK N+LL KI DFG
Sbjct: 164 QQMC-------TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 32/181 (17%), Positives = 63/181 (34%), Gaps = 41/181 (22%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 498
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 499 V---------------KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWS 539
+ K G + + Y FM L I++ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAK------ 147
Query: 540 QRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRT 591
RF + + +L Y+H+ +H D+KASN+LL+ ++ D+GL
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 592 F 592
+
Sbjct: 204 Y 204
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 41/168 (24%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 496
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 497 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFG 587
+ L LH + RIIH DLK N+LL Q K+ DFG
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 40/184 (21%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 500 ---------KLLG-----CCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWSQR 541
LG E K Y FM L + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK---------ISGQNGT 147
Query: 542 FHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTFG 593
F + +L Y+H++ +H D+KA+N+LL ++ +D+GL +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 594 GDET 597
+
Sbjct: 205 PNGN 208
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW +N + L + GNLV+ QSN V+W + + + VL L
Sbjct: 35 YDSGKPVWASNTGGLGSGCRLTL--HNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQ 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ W +
Sbjct: 92 DRNVVIYG-------PVVWAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 35/170 (20%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 492
+ KLG G F V+ +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 493 LQHRNLVKLLGC-CIQGEEKL---LIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICG 547
+ +++KLL +G + +++E + ++L + I R + L + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI----- 136
Query: 548 TAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFG 587
++ GL Y+H R IIH D+K NVL++ +P KI+D G
Sbjct: 137 -SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + VL L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQP 101
Query: 72 SGNLVL 77
N+V+
Sbjct: 102 DRNVVI 107
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKT-GNLVLTSQSNIVVWSAYLSKE 60
++ K+P+ ++P +++ L + + + I +T NLVL +N +W+ +
Sbjct: 3 IIFSKQPDDNHP--QILHATESLEILFGTHVYRFIMQTDCNLVLY-DNNNPIWATN-TGG 58
Query: 61 VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92
+ L G LV+ + WQS
Sbjct: 59 LGNGCRAVLQPDGVLVVITNEN----VTVWQS 86
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 17/81 (20%), Positives = 25/81 (30%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y +W +N S L + GNLV+ +N VW + + L L
Sbjct: 35 YQNGRQIWASNTDR--RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQK 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
G V+ W
Sbjct: 92 DGRFVIYG-------PVLWSL 105
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 27/178 (15%), Positives = 63/178 (35%), Gaps = 35/178 (19%)
Query: 441 NFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELK------- 484
+ + + G +Y+ Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 485 -NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLL 536
+V + KL L+ +G + ++ Y F+ +SL S D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTF 592
+ C L +LH++ +H ++ A N+ +D + ++ + +G +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 44/184 (23%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR- 496
F + K+G+G FG V + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 497 ----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLDWS 539
N+VK G C+ E L +YE + + + F + + +L
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL--- 147
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
+ L YL ++ + H DLK N+LLD K T G
Sbjct: 148 ----------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 600 NTNR 603
T
Sbjct: 195 RTKS 198
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-06
Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S +W++ + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ D + W +
Sbjct: 90 DRNVVIYDNSN----NAIWAT 106
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 38/174 (21%), Positives = 62/174 (35%), Gaps = 46/174 (26%)
Query: 442 FSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR 496
+ I + LGEG FG V + G+ +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 497 ------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLD 537
V++L CI E LL Y+F+ F D R +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC- 128
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+ + +LH ++ H DLK N+L Q + + + R
Sbjct: 129 ------------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 37/189 (19%), Positives = 62/189 (32%), Gaps = 59/189 (31%)
Query: 439 TDNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 493
+ + I LGEG FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 494 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLD 537
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP---------------- 581
H+ L +LH ++ H DLK N+L
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 582 ---KISDFG 587
+++DFG
Sbjct: 179 TSIRVADFG 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 4e-05
Identities = 41/246 (16%), Positives = 79/246 (32%), Gaps = 60/246 (24%)
Query: 379 IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANA 438
I++S A+ + + L+ K+ + + E + + F ++ I
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------------FLMSPIKTE 101
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIA---VKRLSKISE--QGLKELK--------- 484
S+ ++ +Y D Q A V RL + Q L EL+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 485 ----------NEVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYEFMPNKSLDS 525
+V L K+Q + K+ L C E L L+Y+ PN + S
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ + R LL ++ +++ + +++ KI
Sbjct: 218 DHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI-- 268
Query: 586 FGLVRT 591
L+ T
Sbjct: 269 --LLTT 272
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-05
Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N D L + GNLV+ S N +W++ E V L
Sbjct: 34 YDVDKPIWATNTGG--LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQK 90
Query: 72 SGNLVLRDE 80
N+V+
Sbjct: 91 DRNVVIYGT 99
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-05
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
+ W +N N FL +N G L++ +WS+ S + Q VL L D G
Sbjct: 40 GGKYGWQSNTHG--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDG 96
Query: 74 NLVL 77
V+
Sbjct: 97 FGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNL 75
W +N N N L + G LV+ + VW + ++ V+ + G L
Sbjct: 37 NGNWQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRL 93
Query: 76 VLRDEHDGDSETY 88
V+ + +
Sbjct: 94 VVFGPSVFKIDPW 106
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 2e-04
Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ + V L
Sbjct: 165 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSG-NSRSAGRYVFVLQP 221
Query: 72 SGNLVL 77
NL +
Sbjct: 222 DRNLAI 227
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 19/149 (12%), Positives = 42/149 (28%), Gaps = 11/149 (7%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ VW +N + ++ G LV+ + N + WS+ VL L
Sbjct: 41 FDSDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQP 96
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+ + DS T S ++ + S
Sbjct: 97 DRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHP-------QTLHATQSLQL 149
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWN 160
+ + + + +V++ + + T
Sbjct: 150 SPYRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 494
+ + KLG G F V+ + + +A+K + K +E + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 495 -----HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHI 544
+V+LL I G +++E + L +I + L L ++ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575
I +GL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 38.3 bits (89), Expect = 9e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
+VW + F+ + +G L +T V+ + + + VL L +G V
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAV 102
Query: 77 L 77
+
Sbjct: 103 V 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 617 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.53 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.42 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.35 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.34 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.29 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.23 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.23 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.09 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.07 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.87 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.87 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.78 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.0 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.06 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 83.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.51 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.23 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.97 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.13 Aligned_cols=175 Identities=29% Similarity=0.487 Sum_probs=152.6
Q ss_pred cCCccccceecccCcccEEEEEEc------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 457888899999999999999874 36789999998777777889999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 513 LIYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
||||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 2356899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+|+.+.............||+.|||||++
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 9999999987554443334456799999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.80 Aligned_cols=175 Identities=27% Similarity=0.450 Sum_probs=144.5
Q ss_pred cCCccccceecccCcccEEEEEEc------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356788899999999999999874 36789999998777777889999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 513 LIYEFMPNKSLDSFIFDQT------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
|||||+++|+|.++|+... ....++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999997532 1346899999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+|+.+.............||+.|||||++
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 232 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 232 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhh
Confidence 999999999987655444444567799999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=322.13 Aligned_cols=174 Identities=28% Similarity=0.427 Sum_probs=150.0
Q ss_pred CCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999873 3678999999753 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
||||||++|+|.++|..... ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 246899999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++||+|||+|+.+.............||+.|||||++
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence 9999999999987655444445567899999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=318.18 Aligned_cols=172 Identities=27% Similarity=0.440 Sum_probs=143.0
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
...+++++.++||+|+||+||+|++. ..||||.++. ......++|.+|+.++++++|||||+++|+|.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34568888999999999999999874 3699999864 334567889999999999999999999999864 568999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||||++|+|.++|... ...++|.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.+..
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999653 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...........||+.|||||++
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l 206 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVI 206 (307)
T ss_dssp ---------CCCCTTSCCHHHH
T ss_pred CCcceeecccccCCCccCHHHh
Confidence 4444445567899999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.06 Aligned_cols=171 Identities=29% Similarity=0.393 Sum_probs=153.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||+|+.. +++.||||.+.+. .....+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 4899999999752 2344678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.++|.. ...+++.+...++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999964 345899999999999999999999998 999999999999999999999999999998765
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.........+||+.|||||++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELL 206 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHH
T ss_pred CCcccccCcccCcccCCHHHH
Confidence 555555667899999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.27 Aligned_cols=169 Identities=28% Similarity=0.410 Sum_probs=151.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999986 4899999999765555567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999854 34899999999999999999999998 99999999999999999999999999998864433
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....+||+.|||||++
T Consensus 226 --~~~~~~GTp~YmAPEvl 242 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELI 242 (346)
T ss_dssp --CBCCCCSCGGGCCHHHH
T ss_pred --cccccccCcCcCCHHHH
Confidence 23457899999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.29 Aligned_cols=171 Identities=22% Similarity=0.355 Sum_probs=144.8
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++++.||+|+||+||+|+.. +++.||||++.+. .....+.|.+|+.++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 4899999999652 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|.++|... ....+++.+...|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999653 3445789999999999999999999988 9999999999999999999999999999874322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
......+||+.|||||++
T Consensus 180 --~~~~~~~GT~~YmAPE~l 197 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEIC 197 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHH
T ss_pred --ccccccCCCccccCHHHH
Confidence 123346799999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=317.77 Aligned_cols=169 Identities=28% Similarity=0.410 Sum_probs=151.7
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+.|++.++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4579999999999999999999854 899999999765555567799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
|++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999954 34899999999999999999999998 99999999999999999999999999998864432
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....+||+.|||||++
T Consensus 303 --~~~~~~GTp~YmAPEvl 319 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELI 319 (423)
T ss_dssp --CBCCCEECTTTCCHHHH
T ss_pred --cccccccCcCcCCHHHH
Confidence 23457899999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=302.75 Aligned_cols=166 Identities=25% Similarity=0.378 Sum_probs=142.5
Q ss_pred cccceecccCcccEEEEEEcC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEEEEE
Q 007120 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 515 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 515 (617)
++.++||+|+||+||+|.... ++.||||++.. ......+.|.+|+.++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999854 78999999864 234456789999999999999999999999875 34579999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~ 594 (617)
||+++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999964 345899999999999999999999875 46999999999999984 79999999999986533
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....+||+.|||||++
T Consensus 185 ~----~~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp T----SBEESCSSCCCCCGGGG
T ss_pred C----ccCCcccCccccCHHHc
Confidence 2 23457899999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.01 Aligned_cols=183 Identities=25% Similarity=0.362 Sum_probs=156.7
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCC-CCccceE
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKLL 502 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H-~niv~l~ 502 (617)
+..+++...++|++.+.||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+.+|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445566778899999999999999999998753 358999999753 33456789999999999965 8999999
Q ss_pred EEEEeC-CeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeeccc
Q 007120 503 GCCIQG-EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (617)
Q Consensus 503 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 568 (617)
|+|.+. +..+||||||++|+|.++|+.... ...+++.+++.|+.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 568999999999999999975321 345899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 569 kp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+||||++++.+||+|||+|+.+..+..........||+.|||||++
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence 999999999999999999999988766555455567899999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.04 Aligned_cols=171 Identities=24% Similarity=0.340 Sum_probs=140.2
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----eEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 515 (617)
++|.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999998 68999999997532 22233456777778899999999999998754 579999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
||+++|+|.++|+. ..++|..+++|+.|+|+||+|||+++ .++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999964 34899999999999999999999862 3459999999999999999999999999999
Q ss_pred eeCCCCcc--cccceeeeeccccCccCC
Q 007120 591 TFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
........ .......||+.|||||++
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l 184 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHH
T ss_pred cccCCCCceeeecccccccccccCHHHh
Confidence 88654332 223346799999999976
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=304.36 Aligned_cols=174 Identities=26% Similarity=0.395 Sum_probs=138.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 509 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 509 (617)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 36889999999999999999975 4899999998653 3344567999999999999999999999987644
Q ss_pred ----eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 510 ----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 510 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
..++||||+++|+|.+++.........++...+.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976555455677888999999999999999998 99999999999999999999999
Q ss_pred cCCceeeCCCCccc----------ccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEG----------NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~----------~~~~~~gt~~y~ape~~ 616 (617)
||+|+.+..+.... .....+||+.|||||++
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~ 202 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHH
Confidence 99999886543321 12335799999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.12 Aligned_cols=167 Identities=26% Similarity=0.424 Sum_probs=134.0
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 4899999999652 2234567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+ +|+|.+++.. ...+++.+...++.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999864 345899999999999999999999998 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......||+.|+|||++
T Consensus 166 ~---~~~~~~GT~~Y~APE~~ 183 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVI 183 (275)
T ss_dssp ------------CTTSCHHHH
T ss_pred C---ccCCeeECcccCChhhh
Confidence 2 23357899999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.03 Aligned_cols=167 Identities=25% Similarity=0.309 Sum_probs=141.9
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+.|++.++||+|+||+||+|+... ++.||||+++... .+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4568888999999999999999754 8999999996522 224699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeCCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~~~~ 596 (617)
+++|+|.++|.. ...+++.++..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999964 345899999999999999999999987 99999999999999987 69999999999886543
Q ss_pred ccc---ccceeeeeccccCccCC
Q 007120 597 TEG---NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~---~~~~~~gt~~y~ape~~ 616 (617)
... .....+||+.|||||++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~ 228 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVV 228 (336)
T ss_dssp --------CCCCCCGGGCCHHHH
T ss_pred cccceecCCccccCccccCHHHH
Confidence 221 22346799999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=304.40 Aligned_cols=169 Identities=26% Similarity=0.291 Sum_probs=140.1
Q ss_pred CCccccceecccCcccEEEEEEc----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|++.+.||+|+||+||+|+.. .++.||||.+++. .......+.+|+.++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 3678999999652 22234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.++|.. ...+++.+...++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999964 345899999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....+||+.|||||++
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~ 198 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVV 198 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHH
T ss_pred CCCc--cccccccCcccCCHHHh
Confidence 4332 23346899999999975
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.66 Aligned_cols=192 Identities=16% Similarity=0.139 Sum_probs=143.7
Q ss_pred CCCceEEEccCCCCCCCC----ceeEEEecCCcEEE--EcCCCcEEEeeCCccC-----cCCceEEEEecCCCEEEeeCC
Q 007120 13 PPHEVVWVANRLNPINDS----FGFLMINKTGNLVL--TSQSNIVVWSAYLSKE-----VQTPVVLQLLDSGNLVLRDEH 81 (617)
Q Consensus 13 ~~~t~VW~Anr~~pv~~~----~~~l~l~~~G~L~l--~~~~~~~vWst~~~~~-----~~~~~~~~LldsGNlVl~~~~ 81 (617)
+.+ |||+|||++|+.++ +++|+|+.||+|+| .|++|++||+|+++.. .++++| +|+|+|||||++
T Consensus 51 ~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a-~L~d~GNlVl~~-- 126 (276)
T 3m7h_A 51 NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHL-VLQDDGNIVLVD-- 126 (276)
T ss_dssp TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEE-EECTTSCEEEEE--
T ss_pred CCC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEE-EEeCCCCEEecC--
Confidence 556 99999999999874 68999999999999 8888999999997531 123455 999999999997
Q ss_pred CCCCCceeeeeccCCCcccCCCCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEc-CCeEEEEeCCCC
Q 007120 82 DGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWN 160 (617)
Q Consensus 82 ~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~ 160 (617)
+.+|||| ||||||||||+|+.+.++|. .| ++.+||++|.|++.|+++|+. ++++ +..+||++++|+
T Consensus 127 ----~~~lWqS--~ptdtlLpg~~~~~~l~~g~--~L---~S~~dps~G~fsl~l~~dGnl--vLy~~~~~~yW~Sgt~~ 193 (276)
T 3m7h_A 127 ----SLALWNG--TPAIPLVPGAIDSLLLAPGS--EL---VQGVVYGAGASKLVFQGDGNL--VAYGPNGAATWNAGTQG 193 (276)
T ss_dssp ----EEEEEES--CTTSCCCCSCTTCEEECSSE--EE---CTTCEEEETTEEEEECTTSCE--EEECTTSSEEEECCCTT
T ss_pred ----CceeeCc--ccccccccccccccccccCc--cc---ccCCCCCCceEEEeecCCceE--EEEeCCCeEEEECCCCC
Confidence 4589999 99999999999999888874 36 678999999999999999863 4455 468999999996
Q ss_pred CccccCCCCCCCCceEEEEEecCc-eeEEEEEecCCceEEEEEEeeecceEEEEEEecCCCcEEEEeeecC
Q 007120 161 GLRFSAPSLRPNPIFSFSFVSNDV-ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPR 230 (617)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~r~~l~~~G~~l~~~~~~~~~~~w~~~~~~~~ 230 (617)
+... ...+... ..+.+.+++. ..+.++.. ....+|++|+.|| ++++|.| ...|..++.+|.
T Consensus 194 ~~~~-~l~l~~d--GnLvl~d~~~~~vWsS~t~--~~~~~rl~Ld~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 194 KGAV-RAVFQGD--GNLVVYGAGNAVLWHSHTG--GHASAVLRLQANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp TTCC-EEEECTT--SCEEEECTTSCEEEECSCT--TCTTCEEEECTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred CccE-EEEEcCC--CeEEEEeCCCcEEEEecCC--CCCCEEEEEcCCc-cEEEEcC---CCeEEccCccCC
Confidence 5321 1122222 2334444433 44444332 2234899999999 9999998 235665555543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=291.59 Aligned_cols=170 Identities=24% Similarity=0.405 Sum_probs=144.1
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------Ce
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 510 (617)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 4899999999753 234456788999999999999999999997643 56
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.||||||++ |+|.+++.. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 789999843 456899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCc--ccccceeeeeccccCccCC
Q 007120 591 TFGGDET--EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~--~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... .......+||+.|+|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHh
Confidence 8754322 2234457899999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=302.61 Aligned_cols=168 Identities=26% Similarity=0.334 Sum_probs=145.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhh---HHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQG---LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.++||+|+||+||+|+... ++.||||++++.. ... ..+.+.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999999865 8999999996521 111 22334457788899999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
||||||+++|+|.++|.. ...+++.....++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999964 345899999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.... ....+||+.|||||++
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl 362 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVL 362 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHH
T ss_pred cCCCC----CCCccCCcCccCHHHH
Confidence 86443 3346899999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=282.73 Aligned_cols=170 Identities=22% Similarity=0.324 Sum_probs=143.5
Q ss_pred HhhcCCccccceecccCcccEEEEEEc----CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (617)
....++|++.++||+|+||+||+|+.+ .++.||||++.+.. ....+.+|+.+++.+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 344578999999999999999999864 36789999986532 345678899999988 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCc
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla 589 (617)
.+|||||+++|+|.+++. .+++.+...++.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999982 3789999999999999999999998 9999999999999877 79999999999
Q ss_pred eeeCCCCcc--------------------------cccceeeeeccccCccCC
Q 007120 590 RTFGGDETE--------------------------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~--------------------------~~~~~~~gt~~y~ape~~ 616 (617)
+........ ......+||+.|+|||++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 976543211 112335799999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=296.86 Aligned_cols=170 Identities=25% Similarity=0.388 Sum_probs=151.2
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|+.+. |+.||||++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3589999999999999999999854 899999999776566677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC--CCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--~~~ki~DFGla~~~~~~ 595 (617)
|++|+|.++|.. ....+++.+...++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999854 2345899999999999999999999998 9999999999999854 89999999999998644
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ....+||+.|+|||++
T Consensus 311 ~~---~~~~~GT~~y~APEv~ 328 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVA 328 (573)
T ss_dssp SE---EEEECSSGGGCCHHHH
T ss_pred Cc---eeeeEECccccCHHHh
Confidence 32 3456799999999976
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=257.28 Aligned_cols=178 Identities=12% Similarity=0.171 Sum_probs=134.5
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||+|||+.| .++.|+|+.||+|||.|++|++||+|++.......++ +|+|+|||||++. ++|||||
T Consensus 44 ~~~vW~an~~~~---~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~-~l~d~Gnlvl~~~-------~~W~S~~ 112 (236)
T 1dlp_A 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL-VLQPDRTVTIYGP-------GLWDSGT 112 (236)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE-EECSSSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCC---CCeEEEEcCCCcEEEEcCCCcEEEeCCccccCCcEEE-EEeCCCCEEEecC-------CEEECCC
Confidence 689999999998 4589999999999999999999999997642233455 9999999999842 7999999
Q ss_pred CCCccc-CCCCccccee-ccCC-----cceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCCCCccccC-
Q 007120 95 YPSDTL-LPGMKLGWDL-KTGL-----ERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA- 166 (617)
Q Consensus 95 ~PTDTl-Lpgq~l~~~~-~~g~-----~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~- 166 (617)
|||||+ |||| +.+. .+|. +++|++ ..||++|.|++.++++| +++++++..+||++++|++. +..
T Consensus 113 ~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~ 184 (236)
T 1dlp_A 113 SNKGSVVVANN--GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCR 184 (236)
T ss_dssp CCSSCCCCSSC--CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCE
T ss_pred CCCcccccCCc--cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceE
Confidence 999877 5554 4444 4444 567874 78999999999999988 57778888899999999653 433
Q ss_pred CCCCCCCceEEEEEecCceeEEEEEecCCceEEEEEEeeecceEEEEE
Q 007120 167 PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFI 214 (617)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~l~~~~ 214 (617)
+.|..++.+ +.+..++.+.+.++..... ..+|++||+|| ++++|.
T Consensus 185 ~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~~rl~Ld~dG-~l~ly~ 229 (236)
T 1dlp_A 185 AVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GRYVFVLQPDR-NLAIYG 229 (236)
T ss_dssp EEEETTTEE-EEEETTTEEEEECCCCCSS-SCCEEEECSSS-CEEEEC
T ss_pred EEECCCCcE-EEEeCCCcEEEEeCCCCCC-CCEEEEEcCCC-cEEEeC
Confidence 556544422 2233344556665544333 35899999999 899884
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=265.33 Aligned_cols=183 Identities=38% Similarity=0.638 Sum_probs=159.8
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
...++...+++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455667889999999999999999999988899999999877666667889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865322 235899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...............||..|+|||++
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYF 213 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred cccccccccccccccCCCccccCHHHh
Confidence 986544333334456799999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=274.66 Aligned_cols=180 Identities=19% Similarity=0.231 Sum_probs=155.0
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEE
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 506 (617)
.+.++....++|++.++||+|+||+||+|+... ++.||||++++.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566677899999999999999999999865 7889999997522 222345899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999642 345899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|+.+....... .....||+.|+|||++
T Consensus 220 Gla~~~~~~~~~~-~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 220 GSCLKLMEDGTVQ-SSVAVGTPDYISPEIL 248 (437)
T ss_dssp TTCEECCTTSCEE-CCSCCSCGGGCCHHHH
T ss_pred hhhhhcccCCCcc-cccccCCcCeeChHHH
Confidence 9999875544322 2336799999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=257.16 Aligned_cols=173 Identities=28% Similarity=0.457 Sum_probs=150.3
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|.+.+.||+|+||.||++.... ++.||+|++........+.|.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4578899999999999999999854 889999998776677788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 345899999999999999999999988 99999999999999999999999999998754332
Q ss_pred ccc------------cceeeeeccccCccCC
Q 007120 598 EGN------------TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~------------~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHh
Confidence 211 1145699999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.33 Aligned_cols=180 Identities=20% Similarity=0.228 Sum_probs=154.7
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEE
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 506 (617)
.+.+.....++|++.+.||+|+||+||+++.. +++.||||++++. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999985 4899999999752 2233456899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999643 235899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+...... ......||+.|+|||++
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l 235 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEIL 235 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHH
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHH
Confidence 999987554322 12345799999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.93 Aligned_cols=189 Identities=42% Similarity=0.684 Sum_probs=161.5
Q ss_pred CCchhHHhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCccceEEEE
Q 007120 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCC 505 (617)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (617)
.+.++..++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999975322 2234689999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976432 4458999999999999999999999822239999999999999999999999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++.+...... ......||..|+|||++
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHH
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHh
Confidence 99999987544332 23345699999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-30 Score=271.00 Aligned_cols=177 Identities=20% Similarity=0.236 Sum_probs=152.7
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEe
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
+.++....++|++.+.||+|+||+||+++... ++.||||++++.. ....+.+.+|+.+++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44556677899999999999999999999865 7899999996521 2234468899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999854 24789999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|+.+...... ......||+.|+|||++
T Consensus 214 ~a~~~~~~~~~-~~~~~~gt~~Y~APE~l 241 (410)
T 3v8s_A 214 TCMKMNKEGMV-RCDTAVGTPDYISPEVL 241 (410)
T ss_dssp TCEECCTTSEE-ECCSCCSCGGGCCHHHH
T ss_pred eeEeeccCCcc-cccCCcCCccccCHHHh
Confidence 99987544321 23346799999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=254.69 Aligned_cols=170 Identities=25% Similarity=0.448 Sum_probs=150.7
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999986 4588999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999954 24889999999999999999999987 9999999999999999999999999999876544
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 171 ~~--~~~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVV 188 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHH
T ss_pred cc--cCCccCCcCccChhhh
Confidence 32 3346799999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=258.29 Aligned_cols=174 Identities=25% Similarity=0.390 Sum_probs=146.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 509 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 509 (617)
++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47889999999999999999986 5899999998643 3345678999999999999999999999987654
Q ss_pred -------------------------------------------------eEEEEEecCCCCCHHHHHhcCCCCCCCCHHH
Q 007120 510 -------------------------------------------------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540 (617)
Q Consensus 510 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 540 (617)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2799999999999999998765556677888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc----------cccceeeeeccc
Q 007120 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE----------GNTNRVVGTYCG 610 (617)
Q Consensus 541 ~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~y 610 (617)
++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .......||..|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999987 999999999999999999999999999988654321 112335699999
Q ss_pred cCccCC
Q 007120 611 TKAFLY 616 (617)
Q Consensus 611 ~ape~~ 616 (617)
+|||++
T Consensus 243 ~aPE~~ 248 (332)
T 3qd2_B 243 MSPEQI 248 (332)
T ss_dssp SCHHHH
T ss_pred cChHHh
Confidence 999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=259.61 Aligned_cols=170 Identities=22% Similarity=0.257 Sum_probs=148.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+++.. +++.||||.+++. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999986 4899999999753 233466789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999854 345889999999999999999999987 99999999999999999999999999997533
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~ 177 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVL 177 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGG
T ss_pred CCC--cccccccChhhCChhhh
Confidence 222 23456899999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=263.87 Aligned_cols=176 Identities=28% Similarity=0.428 Sum_probs=150.8
Q ss_pred hcCCccccceecccCcccEEEEEEc--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
..++|++.+.||+|+||.||+|+.. ++..||||.++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4568999999999999999999863 3457999999753 344567899999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999975331 235789999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+.++.+||+|||+++.+.............+|..|+|||++
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 277 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence 999999999999999987654443334445678899999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=256.03 Aligned_cols=180 Identities=27% Similarity=0.378 Sum_probs=153.8
Q ss_pred CchhHHhHHhhcC----------CccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCC
Q 007120 428 PLFELATIANATD----------NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR 496 (617)
Q Consensus 428 ~~~~~~~~~~~~~----------~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ 496 (617)
+.++.+++..+++ .|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3455555555443 2667789999999999999986 5899999999765555677899999999999999
Q ss_pred CccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 497 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999999843 35899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 577 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.++.+||+|||+++.+...... .....||..|+|||++
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVI 213 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHH
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhh
Confidence 9999999999999987644322 2346799999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=259.41 Aligned_cols=170 Identities=28% Similarity=0.428 Sum_probs=149.9
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999997 45899999998653 344567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999653 34889999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 167 ~~~---~~~~~gt~~y~aPE~~ 185 (328)
T 3fe3_A 167 GGK---LDAFCGAPPYAAPELF 185 (328)
T ss_dssp SCG---GGTTSSSGGGCCHHHH
T ss_pred CCc---cccccCCcceeCcccc
Confidence 332 3346799999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=257.95 Aligned_cols=170 Identities=31% Similarity=0.500 Sum_probs=147.0
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----eEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 513 (617)
..++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++++++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999875 789999999753 234455677999999999999999999998754 4699
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeecccCCCcEEEcCCCCeEE
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+||||+.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999954 2489999999999999999999987 5 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+|+.+.............||..|+|||++
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 205 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhc
Confidence 999999988765544444456799999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=261.81 Aligned_cols=169 Identities=24% Similarity=0.365 Sum_probs=149.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||++.... ++.||||.+.+. .....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4679999999999999999999765 789999998652 233457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999954 345899999999999999999999988 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~ 186 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMF 186 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGT
T ss_pred CCc---eeccCCCccccCCeee
Confidence 332 3456799999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.45 Aligned_cols=186 Identities=38% Similarity=0.613 Sum_probs=161.4
Q ss_pred CCchhHHhHHhhcCCcccc------ceecccCcccEEEEEEcCCcEEEEEEeccc----chhhHHHHHHHHHHHccCCCC
Q 007120 427 LPLFELATIANATDNFSIN------NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 496 (617)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~------~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~ 496 (617)
.+.+.+.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567788888888888776 8999999999999987 6889999998642 234467899999999999999
Q ss_pred CccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 497 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999975444566899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 577 QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 577 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+||+|||+++...............||..|+|||.+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 207 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHh
Confidence 9999999999999987654433334456799999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=257.50 Aligned_cols=172 Identities=28% Similarity=0.385 Sum_probs=147.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 58899999986432 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999843 345899999999999999999999987 9999999999999999999999999999875443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.........||..|+|||++
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELL 179 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHh
Confidence 33334456799999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=260.40 Aligned_cols=171 Identities=27% Similarity=0.358 Sum_probs=143.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+++... ++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 45789999999999999999999864 889999999753 233456788999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999642 45899999999999999999999987 999999999999999999999999999964
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .......||+.|+|||++
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEIL 196 (353)
T ss_dssp CC-----------CCGGGCCHHHH
T ss_pred ccCC--ccccccCCCcCeEChhhc
Confidence 3322 223456799999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=262.55 Aligned_cols=175 Identities=24% Similarity=0.377 Sum_probs=149.8
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
...++|++.+.||+|+||.||+|... +++.||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34568899999999999999999986 5889999998753 334456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999642 335889999999999999999999988 99999999999999999999999999997654
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...........+|..|+|||.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~ 287 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEAL 287 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHh
Confidence 3322222234568889999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.93 Aligned_cols=167 Identities=25% Similarity=0.345 Sum_probs=147.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+++.. +++.||||.+++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999985 48999999997532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999964 345889999999999999999999987 99999999999999999999999999998643
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||+.|+|||++
T Consensus 159 ~-----~~~~~gt~~y~aPE~~ 175 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVV 175 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHH
T ss_pred c-----cccccCCccccCHhHh
Confidence 2 2346799999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=255.86 Aligned_cols=170 Identities=26% Similarity=0.348 Sum_probs=148.3
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchh------hHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..+.|++.+.||+|+||.||++.... ++.||||.+++.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999864 889999998753221 35679999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC----CeEEeec
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 586 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DF 586 (617)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999943 346899999999999999999999987 99999999999998877 7999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+..... .....||+.|+|||++
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIV 190 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHH
T ss_pred CCceEcCCCCc---cccCCCCccEECchHH
Confidence 99998754332 3346799999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=262.94 Aligned_cols=176 Identities=16% Similarity=0.138 Sum_probs=147.3
Q ss_pred HHhhcCCccccceecccCcccEEEEE------EcCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCccceEEEE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCC 505 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~ 505 (617)
+....++|.+.+.||+|+||.||+|. ...++.||||+++... ..++..|+.++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456789999999999999999994 3457899999997543 446677777777776 99999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC------
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQT--RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------ 577 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~------ 577 (617)
...+..++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ ||||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999996422 3456899999999999999999999987 999999999999998
Q ss_pred -----CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 -----DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 -----~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+||+|||+|+.+.............||..|+|||++
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 257 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence 899999999999876533333334456799999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=256.03 Aligned_cols=180 Identities=27% Similarity=0.452 Sum_probs=143.0
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
.++....++|++.+.||+|+||.||+|+. .++.||||++... .....+++.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33445567899999999999999999987 6889999998653 33456789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999965433345899999999999999999999875 349999999999999999999999999998
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....... ......||..|+|||.+
T Consensus 188 ~~~~~~~--~~~~~~gt~~y~aPE~~ 211 (309)
T 3p86_A 188 LKASTFL--SSKSAAGTPEWMAPEVL 211 (309)
T ss_dssp ----------------CCTTSCHHHH
T ss_pred ccccccc--ccccCCCCccccChhhh
Confidence 7543322 23346799999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=262.75 Aligned_cols=171 Identities=22% Similarity=0.304 Sum_probs=145.9
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||+||+++... ++.||||++++. .....+.+..|..++.++ +|||||++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34689999999999999999999865 788999999753 223345688899998876 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999864 245899999999999999999999988 999999999999999999999999999964
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .......||+.|+|||++
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l 225 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEIL 225 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHH
T ss_pred ccCC--CccccccCCcccCCchhh
Confidence 3222 224457799999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=250.01 Aligned_cols=169 Identities=20% Similarity=0.256 Sum_probs=148.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||++.... ++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999864 788999998753 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC--CCCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--~~~~ki~DFGla~~~~~~ 595 (617)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999953 2345899999999999999999999987 999999999999987 789999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||+.|+|||++
T Consensus 158 ~~---~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CE---EEEEESCGGGSCHHHH
T ss_pred Cc---cccccCChhhcCcHHh
Confidence 32 3456799999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=256.69 Aligned_cols=173 Identities=26% Similarity=0.348 Sum_probs=147.6
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (617)
....++|++.+.||+|+||.||+|+... ++.||||.+++.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3456789999999999999999999864 8899999997532 23456778899988876 99999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999964 235899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....... ......||+.|+|||++
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~ 190 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEIL 190 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHH
T ss_pred hcccCCC--cccCCCCCcccCChhhh
Confidence 7533222 23456799999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.35 Aligned_cols=174 Identities=28% Similarity=0.424 Sum_probs=146.0
Q ss_pred hcCCccccceecccCcccEEEEEEc----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|... .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467889999999999999999984 3456999999753 4455678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 127 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999543 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCccc-ccceeeeeccccCccCC
Q 007120 593 GGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
....... ......+|..|+|||++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~ 226 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAI 226 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHh
Confidence 6543321 22234467789999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=250.38 Aligned_cols=171 Identities=26% Similarity=0.394 Sum_probs=143.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||++... .++.||||.+.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 488999999853 2334567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999642 35899999999999999999999987 99999999999999999999999999987754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .......||..|+|||.+
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~ 184 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQA 184 (294)
T ss_dssp ------------CCSSCCHHHH
T ss_pred ccc-cccCccccCccccCHhHh
Confidence 332 223346799999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=260.75 Aligned_cols=184 Identities=24% Similarity=0.372 Sum_probs=153.9
Q ss_pred hhHHhHHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccce
Q 007120 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL 501 (617)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l 501 (617)
+...+.....++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 345566677889999999999999999999842 3578999999763 334567899999999999 89999999
Q ss_pred EEEEEeCCe-EEEEEecCCCCCHHHHHhcCCC------------------------------------------------
Q 007120 502 LGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTR------------------------------------------------ 532 (617)
Q Consensus 502 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 532 (617)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999999975432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 533 ---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 533 ---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999987 99999999999999999999999999998755544
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
........||..|+|||++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp CEEC--CEECGGGCCHHHH
T ss_pred chhccccCCCceeEChhhh
Confidence 4444556789999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=255.81 Aligned_cols=170 Identities=24% Similarity=0.308 Sum_probs=147.5
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+++... ++.||||++++. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3578999999999999999999864 789999999753 334456788999999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999999642 35899999999999999999999987 9999999999999999999999999999743
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... ......||+.|+|||++
T Consensus 162 ~~~~--~~~~~~gt~~y~aPE~~ 182 (345)
T 3a8x_A 162 RPGD--TTSTFCGTPNYIAPEIL 182 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHH
T ss_pred CCCC--cccccCCCccccCcccc
Confidence 3222 23456799999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=248.83 Aligned_cols=169 Identities=27% Similarity=0.401 Sum_probs=141.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch--------------------------hhHHHHHHHHHHHc
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------------------------QGLKELKNEVILFS 491 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 491 (617)
.++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 478999999865321 12356889999999
Q ss_pred cCCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccC
Q 007120 492 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (617)
Q Consensus 492 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 569 (617)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 2346899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 570 p~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||++.++.+||+|||+++.+...... .....||..|+|||.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~ 209 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESL 209 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhh
Confidence 99999999999999999999987543322 2345799999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=255.35 Aligned_cols=167 Identities=24% Similarity=0.287 Sum_probs=148.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+++.. +++.||||.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 358999999999999999999986 4899999999653 223456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999642 34889999999999999999999988 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||+.|+|||++
T Consensus 194 ~-----~~~~~gt~~y~aPE~~ 210 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEII 210 (350)
T ss_dssp C-----BCCCEECGGGCCHHHH
T ss_pred C-----cccccCCccccCHHHh
Confidence 3 2346799999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-29 Score=257.20 Aligned_cols=182 Identities=26% Similarity=0.415 Sum_probs=153.2
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEE
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 504 (617)
...+....++|++.+.||+|+||.||+|+..+ ++.||||.++.. .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34445567899999999999999999999853 478999999753 33456789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007120 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (617)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (617)
+.+.+..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+.+ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999975321 256899999999999999999999987 9
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 564 iHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||||||+||||+.++.+||+|||+++.+.............+|..|+|||++
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 99999999999999999999999999887544333333445688999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=255.37 Aligned_cols=171 Identities=25% Similarity=0.282 Sum_probs=148.0
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45689999999999999999999865 788999999753 223456788999999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999642 34899999999999999999999987 999999999999999999999999999975
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ......||+.|+|||++
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~ 193 (353)
T 2i0e_A 172 IWDGV--TTKTFCGTPDYIAPEII 193 (353)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHH
T ss_pred ccCCc--ccccccCCccccChhhh
Confidence 33222 23456799999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=258.77 Aligned_cols=173 Identities=29% Similarity=0.450 Sum_probs=136.6
Q ss_pred cCCccccceecccCcccEEEEEEc----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999875 4678999999753 34456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999642 345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccc-ccceeeeeccccCccCC
Q 007120 594 GDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
...... ......+|..|+|||.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~ 222 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAI 222 (373)
T ss_dssp ---------------CTTSCHHHH
T ss_pred cCCccceeccCCCcCCCccChhhh
Confidence 543321 12223457789999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=250.39 Aligned_cols=172 Identities=27% Similarity=0.395 Sum_probs=149.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--eEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 514 (617)
.++|++.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4579999999999999999999865 8899999997533 334677889999999999999999999998765 67999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE----cCCCCeEEeecCCce
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~ki~DFGla~ 590 (617)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555899999999999999999999987 9999999999999 888889999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... .....||..|+|||++
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMY 187 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHh
Confidence 8765433 2235699999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=250.86 Aligned_cols=178 Identities=28% Similarity=0.401 Sum_probs=151.9
Q ss_pred HhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
....++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345578999999999999999999862 3478999999753 345567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecc
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 567 (617)
+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999975432 234789999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 568 lkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+|||+++++.+||+|||+++.+.............+|..|+|||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 224 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence 9999999999999999999999988655443334445678899999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=254.47 Aligned_cols=170 Identities=25% Similarity=0.336 Sum_probs=149.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999985 4889999999765555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC--CCCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--~~~~ki~DFGla~~~~~~ 595 (617)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999854 2345899999999999999999999987 999999999999974 578999999999987544
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 205 ~~---~~~~~gt~~y~aPE~~ 222 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIV 222 (387)
T ss_dssp SC---EEEECSSGGGCCHHHH
T ss_pred cc---eeeeccCCCccCchhc
Confidence 32 3345799999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=256.06 Aligned_cols=179 Identities=26% Similarity=0.381 Sum_probs=149.9
Q ss_pred HHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 506 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 506 (617)
.+...++|++.+.||+|+||.||+|... .+..||||.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999962 3568999999753 334457899999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTRR--------------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 566 (617)
..+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999653321 34789999999999999999999987 9999
Q ss_pred ccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 567 Dlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||||+||||+.++.+||+|||+++.+.............||+.|+|||.+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence 99999999999999999999999987655443334456788999999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=246.51 Aligned_cols=172 Identities=24% Similarity=0.436 Sum_probs=149.0
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346789999999999999999999888999999997532 2346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999964 3345899999999999999999999988 99999999999999999999999999997654332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. ......+|..|+|||.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~ 179 (269)
T 4hcu_A 162 T-SSTGTKFPVKWASPEVF 179 (269)
T ss_dssp H-STTSTTCCGGGCCHHHH
T ss_pred c-cccCcccccccCCHHHh
Confidence 2 22334577889999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=244.31 Aligned_cols=172 Identities=27% Similarity=0.393 Sum_probs=149.4
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||.||+|...++..||||.++... ...+++.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 456899999999999999999999888899999997532 3356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999653 335899999999999999999999987 99999999999999999999999999998755433
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....+|..|+|||.+
T Consensus 160 ~~-~~~~~~~~~y~aPE~~ 177 (268)
T 3sxs_A 160 VS-SVGTKFPVKWSAPEVF 177 (268)
T ss_dssp EE-CCSCCCCGGGCCHHHH
T ss_pred hc-ccCCCcCcccCCHHHH
Confidence 22 2234567789999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=249.47 Aligned_cols=171 Identities=31% Similarity=0.410 Sum_probs=145.5
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..++|++.+.||+|+||.||+|+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45689999999999999999999988999999998653 2233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9998 588888754 2345899999999999999999999987 999999999999999999999999999987533
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||++
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~ 191 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVL 191 (311)
T ss_dssp CC-----CCCCCCTTCCHHHH
T ss_pred ccc--ccCCcccCCcCCHHHh
Confidence 222 2335689999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=254.13 Aligned_cols=172 Identities=26% Similarity=0.335 Sum_probs=146.9
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
+.|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 47899999999999999999975 48999999986421 1235779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeecCCc
Q 007120 514 IYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLV 589 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DFGla 589 (617)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988875432 2345899999999999999999999987 999999999999987654 999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+...... .....||+.|+|||++
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~ 205 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVV 205 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHH
T ss_pred eEecCCCee--ecCCcCCcCccCHHHH
Confidence 987654321 2345799999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=249.85 Aligned_cols=168 Identities=25% Similarity=0.345 Sum_probs=147.1
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
+.|++.+.||+|+||.||++.... ++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468899999999999999999864 88999999865322 13577999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC----CeEEeecCC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 588 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DFGl 588 (617)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999953 345899999999999999999999987 99999999999999887 899999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+..... .....||+.|+|||++
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIV 189 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHH
T ss_pred CeECCCCCc---cccccCCcCcCCceee
Confidence 998754332 2345799999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=258.06 Aligned_cols=178 Identities=28% Similarity=0.396 Sum_probs=152.2
Q ss_pred HhhcCCccccceecccCcccEEEEEEc--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 505 (617)
....++|.+.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999999999999863 2357999999753 344567899999999999 999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999975431 235899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||++++.+||+|||+|+.+.............+|..|+|||++
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 265 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence 99999999999999999987654443334446688999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=244.66 Aligned_cols=169 Identities=25% Similarity=0.383 Sum_probs=144.4
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||+||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578999999999999999999854 889999998642 23345778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9985 55555543 2345899999999999999999999987 9999999999999999999999999999875332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 156 ~~--~~~~~~t~~y~aPE~~ 173 (292)
T 3o0g_A 156 RC--YSAEVVTLWYRPPDVL 173 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHH
T ss_pred cc--ccCCccccCCcChHHH
Confidence 22 2345689999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=266.89 Aligned_cols=172 Identities=27% Similarity=0.338 Sum_probs=150.2
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.+++.++|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999985 4899999999652 22345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999996533 334899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....||+.|+|||++
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl 357 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVV 357 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHH
T ss_pred cCcc---ccccCCCccccCHHHH
Confidence 4332 2335799999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=266.25 Aligned_cols=175 Identities=26% Similarity=0.410 Sum_probs=151.1
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
+...++|++.+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.++++++|||||+++++|.+.+..+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3445678899999999999999999876 7899999997532 3467899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999997533 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....+|..|+|||++
T Consensus 371 ~~~~~-~~~~~~~~~y~aPE~~ 391 (495)
T 1opk_A 371 DTYTA-HAGAKFPIKWTAPESL 391 (495)
T ss_dssp CCEEC-CTTCCCCGGGCCHHHH
T ss_pred Cceee-cCCCcCCcceeCHhHH
Confidence 43222 2234567899999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=253.17 Aligned_cols=169 Identities=27% Similarity=0.408 Sum_probs=147.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||++.... ++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4579999999999999999999754 889999998642 3345678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DFGla~~~ 592 (617)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.+
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999853 345899999999999999999999987 9999999999999865 45999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||++
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVL 202 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHH
T ss_pred cCCcc---cccCCCCccccCHHHH
Confidence 54332 2346799999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=252.90 Aligned_cols=170 Identities=26% Similarity=0.345 Sum_probs=137.2
Q ss_pred cCCccccceecccCcccEEEEEE----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 368899999997532 2345568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999954 235788999999999999999999987 9999999999999999999999999998
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....... ......||..|+|||++
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEIL 193 (327)
T ss_dssp -----------CTTSSCCTTSCHHHH
T ss_pred ccccCCc--cccccCCCcCccCHhhC
Confidence 7543322 12335689999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=247.22 Aligned_cols=168 Identities=26% Similarity=0.275 Sum_probs=139.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.++||+|+||+||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 5899999998642 223334455555555544 9999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67999888653 345899999999999999999999987 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 211 ~~---~~~~~gt~~y~aPE~~ 228 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELL 228 (311)
T ss_dssp -------CCCCCGGGCCGGGG
T ss_pred CC---CcccCCCccccCHhHh
Confidence 32 3345699999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=251.68 Aligned_cols=168 Identities=24% Similarity=0.382 Sum_probs=146.2
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|.+.+.||+|+||.||+|.. .+++.||||++.+.. ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 458899999986521 22345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+ +|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 68898888542 35899999999999999999999987 99999999999999999999999999997654
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~ 179 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVI 179 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGS
T ss_pred Ccc---cccccCCcCcCCHHHH
Confidence 332 3345799999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=253.60 Aligned_cols=165 Identities=27% Similarity=0.347 Sum_probs=139.7
Q ss_pred ccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 444 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
..+.||+|+||.||+|... +++.||||+++.......+++.+|+.++++++||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999975 488999999987555667789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE--cCCCCeEEeecCCceeeCCCCcccc
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--~~~~~~ki~DFGla~~~~~~~~~~~ 600 (617)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 99988642 345899999999999999999999988 9999999999999 6678999999999998754432
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 245 ~~~~~gt~~y~aPE~~ 260 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVV 260 (373)
T ss_dssp CCCCCSSCTTCCHHHH
T ss_pred cccccCCCcEeChhhc
Confidence 2235699999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=248.66 Aligned_cols=174 Identities=26% Similarity=0.450 Sum_probs=143.4
Q ss_pred hcCCccccceecccCcccEEEEEE-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC--Ce
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 510 (617)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346899999999999999999985 24789999999876666778899999999999999999999998654 45
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999653 234899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcc-cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......+|..|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESL 189 (295)
T ss_dssp -------------CTTCGGGGCCHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHh
Confidence 87544332 112233477789999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=251.57 Aligned_cols=179 Identities=25% Similarity=0.379 Sum_probs=133.7
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcCC----cEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
.....++|++.+.||+|+||.||+|..... ..||||.++.. .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345567899999999999999999987543 27999998653 345567899999999999999999999999887
Q ss_pred CeE------EEEEecCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 509 EEK------LLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 509 ~~~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
... ++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||||++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 99999999999999986432 1235899999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||+++.+.............+|..|+|||.+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhh
Confidence 9999999999987554443333445678899999964
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=258.70 Aligned_cols=175 Identities=28% Similarity=0.439 Sum_probs=147.5
Q ss_pred cCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||.||+|++. .++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999853 3568999999653 345566799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC---CeEEe
Q 007120 512 LLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 584 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~ki~ 584 (617)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 2245899999999999999999999988 99999999999999554 59999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+|+.+.............||+.|+|||++
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 258 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHh
Confidence 99999876433333333345688999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=259.75 Aligned_cols=169 Identities=26% Similarity=0.424 Sum_probs=149.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999986 58999999996532 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999953 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~ 187 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVI 187 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHH
T ss_pred ccc---ccccCCCcCeEChhhc
Confidence 332 3346799999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=253.11 Aligned_cols=180 Identities=29% Similarity=0.401 Sum_probs=152.4
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC-C-----cEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEE
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 505 (617)
......++|++.+.||+|+||.||+|.... + ..||||.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567899999999999999999999743 2 47999999753 334567899999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986432 1345799999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+.++.+||+|||+++.+.............||..|+|||.+
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence 999999999999999987554443334446688999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=266.46 Aligned_cols=175 Identities=27% Similarity=0.380 Sum_probs=149.1
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.+...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++|||||++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 445667899999999999999999999888999999997633 35678999999999999999999999986 6678999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999996422 235788999999999999999999987 99999999999999999999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....+|..|+|||.+
T Consensus 337 ~~~~~-~~~~~~~~~y~aPE~~ 357 (454)
T 1qcf_A 337 NEYTA-REGAKFPIKWTAPEAI 357 (454)
T ss_dssp HHHHT-TCSSSSCGGGSCHHHH
T ss_pred Cceec-cCCCcccccccCHHHh
Confidence 32211 2234467889999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=262.87 Aligned_cols=173 Identities=29% Similarity=0.369 Sum_probs=150.7
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|.+.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468899999999999999999986 48999999996532 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||++
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l 361 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELL 361 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHH
T ss_pred CCCcc--cccccCCccccChhhh
Confidence 44322 3345799999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=255.79 Aligned_cols=171 Identities=23% Similarity=0.262 Sum_probs=138.4
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHH-HccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+++... ++.||||++++.. ....+.+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34689999999999999999999865 7889999997532 2334566677776 57799999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999854 235788899999999999999999988 999999999999999999999999999874
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ......||+.|+|||++
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~ 211 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVL 211 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHH
T ss_pred ccCCC--ccccccCCccccCHHHh
Confidence 33222 23456799999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=264.20 Aligned_cols=171 Identities=23% Similarity=0.250 Sum_probs=137.7
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||++... +++.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 4889999999752 33445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999854 3458999999999999999999998 76 999999999999999999999999999865
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ......||+.|+|||++
T Consensus 300 ~~~~~--~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 300 IKDGA--TMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHH
T ss_pred cCCCc--ccccccCCccccCHhhc
Confidence 33322 23346799999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=249.60 Aligned_cols=178 Identities=28% Similarity=0.422 Sum_probs=150.5
Q ss_pred HhhcCCccccceecccCcccEEEEEEc--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 505 (617)
....++|++.+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 344578999999999999999999873 3678999999753 334567899999999999 999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999975332 234889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+.++.+||+|||+++.+.............+|..|+|||++
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence 99999999999999999988655433333445678899999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=245.45 Aligned_cols=169 Identities=25% Similarity=0.389 Sum_probs=142.8
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|+...++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999779999999986532 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 899888542 345889999999999999999999987 99999999999999999999999999987653322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||..|+|||++
T Consensus 156 ~--~~~~~~t~~y~aPE~~ 172 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVL 172 (288)
T ss_dssp --------CCCTTCCHHHH
T ss_pred c--cccccccccccCchhe
Confidence 1 2335689999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.61 Aligned_cols=169 Identities=22% Similarity=0.358 Sum_probs=149.5
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|.... +..||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4578999999999999999999865 678999999765555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceeeCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~~~ 594 (617)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999854 344899999999999999999999988 9999999999999 8889999999999998754
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||++
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~ 180 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVL 180 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHH
T ss_pred ccc---hhccCCCCCccChHHh
Confidence 432 2345699999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=251.15 Aligned_cols=181 Identities=25% Similarity=0.394 Sum_probs=152.8
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEE
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (617)
.+.....++|++.+.||+|+||.||+|... .++.||||.+... .......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556778999999999999999999864 2678999999753 334456799999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986421 1245789999999999999999999987 9999999999999999
Q ss_pred CCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 579 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+||+|||+++.+.............+|..|+|||++
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhh
Confidence 99999999999977544333333445678999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=243.19 Aligned_cols=168 Identities=27% Similarity=0.402 Sum_probs=138.9
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCccceEEEEEeC----CeE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEK 511 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~ 511 (617)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346899999999999999999988 6899999998653 23445555555554 8999999999997653 457
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+||||+.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999993 235899999999999999999999 655 999999999999999999999
Q ss_pred eecCCceeeCCCCccc--ccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~ape~~ 616 (617)
+|||+|+......... ......||..|+|||++
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHH
T ss_pred eeCCCeeecccccccccccccccccccceeChhhh
Confidence 9999999876543321 12334799999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=247.81 Aligned_cols=178 Identities=29% Similarity=0.376 Sum_probs=152.1
Q ss_pred HhhcCCccccceecccCcccEEEEEE------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
....++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34556899999999999999999985 236789999997533 34467899999999999 99999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTR---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999975432 124899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||++.++.+||+|||+++.+.............||..|+|||.+
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh
Confidence 99999999999999999988655443334446688999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=250.08 Aligned_cols=173 Identities=21% Similarity=0.328 Sum_probs=138.8
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe---
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 510 (617)
..++|++.+.||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999997 45889999999753 23445678999999999999999999999876543
Q ss_pred -EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999642 35899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcc-cccceeeeeccccCccCC
Q 007120 590 RTFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+.+...... .......||..|+|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 191 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQA 191 (311)
T ss_dssp ------------------CCTTCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHh
Confidence 987544322 223345699999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=258.37 Aligned_cols=170 Identities=26% Similarity=0.363 Sum_probs=146.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 457999999999999999999875 4889999998653 3344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc---CCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~ki~DFGla~~~ 592 (617)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999865 345899999999999999999999988 99999999999998 4678999999999887
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....||+.|+|||++
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVL 185 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHH
T ss_pred cCCCce--eecccCCcccCCHHHh
Confidence 544322 2346799999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=250.19 Aligned_cols=172 Identities=28% Similarity=0.464 Sum_probs=139.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|++.+.||+|+||.||+|+... ++ +||+|.+... .....++|.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3578999999999999999999643 33 4688887542 3345678999999999999999999999998765 78
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.............+|..|+|||++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHH
T ss_pred cCCcccccccCCCccccccChHHh
Confidence 655544444445678899999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=244.32 Aligned_cols=174 Identities=25% Similarity=0.364 Sum_probs=146.9
Q ss_pred HhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
....++|++.+.||+|+||.||++...++..||||++.... ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34556899999999999999999999888899999997532 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999652 345899999999999999999999987 999999999999999999999999999877543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......+|..|+|||.+
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~~ 193 (283)
T 3gen_A 174 EYT-SSVGSKFPVRWSPPEVL 193 (283)
T ss_dssp HHH-STTSTTSCGGGCCHHHH
T ss_pred ccc-cccCCccCcccCCHHHh
Confidence 222 12234567889999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=238.37 Aligned_cols=171 Identities=29% Similarity=0.390 Sum_probs=149.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57899999999999999999986 5889999998643 234457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999998843 345899999999999999999999987 99999999999999999999999999998754333
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
........||..|+|||++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~ 179 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELL 179 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGG
T ss_pred hhcccCCccccCccChHHH
Confidence 3333456789999999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=251.77 Aligned_cols=169 Identities=23% Similarity=0.281 Sum_probs=138.7
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4568999999999999999999986 5889999999753 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC--eEEeecCCceeeCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRTFGG 594 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~ki~DFGla~~~~~ 594 (617)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+|+....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999854 234899999999999999999999988 999999999999987765 99999999986432
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ......||+.|+|||.+
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~ 189 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVL 189 (361)
T ss_dssp -------------CTTSCHHHH
T ss_pred cC---CCCCCcCCCCcCChhhh
Confidence 22 22345799999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=251.59 Aligned_cols=175 Identities=18% Similarity=0.210 Sum_probs=149.5
Q ss_pred hcCCccccceeccc--CcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G--~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+| +||.||+++.. +++.||||++... .....+.+.+|+.+++.++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44689999999999 99999999986 4899999999653 2345677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999996532 345899999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCc-----ccccceeeeeccccCccCC
Q 007120 593 GGDET-----EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~-----~~~~~~~~gt~~y~ape~~ 616 (617)
..... ........||..|+|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred ccccccccccccccccccccccccCHHHH
Confidence 32211 1112234688999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=248.66 Aligned_cols=179 Identities=23% Similarity=0.269 Sum_probs=152.0
Q ss_pred CCchhHHhHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----CCCccc
Q 007120 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVK 500 (617)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 500 (617)
...+.+.+.....++|++.++||+|+||.||+|+.. +++.||||+++. .....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344455555666789999999999999999999984 488999999975 2345567788999998886 999999
Q ss_pred eEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---
Q 007120 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--- 577 (617)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--- 577 (617)
+++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 899999996533 335899999999999999999999987 999999999999975
Q ss_pred ----------------------CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 ----------------------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 ----------------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+||+|||+|+...... ....||..|+|||++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVI 231 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHH
Confidence 7899999999999754322 245789999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=250.77 Aligned_cols=163 Identities=22% Similarity=0.268 Sum_probs=137.5
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCC---------CCCccce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVKL 501 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 501 (617)
.++|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999998 68999999997532 223477888999888875 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 007120 502 LGCCI------------------------------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551 (617)
Q Consensus 502 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 551 (617)
.+.+. +....+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88754 26789999999999976666622 457999999999999999
Q ss_pred HHHHH-hCCCCceeecccCCCcEEEcCCC--------------------CeEEeecCCceeeCCCCcccccceeeeeccc
Q 007120 552 LLYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610 (617)
Q Consensus 552 l~yLH-~~~~~~iiHrDlkp~NiLl~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 610 (617)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.+... ...||..|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999987532 35799999
Q ss_pred cCccCC
Q 007120 611 TKAFLY 616 (617)
Q Consensus 611 ~ape~~ 616 (617)
+|||++
T Consensus 244 ~aPE~~ 249 (336)
T 2vuw_A 244 MDEDLF 249 (336)
T ss_dssp TCSGGG
T ss_pred cChhhh
Confidence 999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=245.47 Aligned_cols=172 Identities=28% Similarity=0.415 Sum_probs=133.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999875 48899999986532 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 517 FMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 517 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999986432 2245889999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||++
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~ 180 (317)
T 2pmi_A 160 IPVNT--FSSEVVTLWYRAPDVL 180 (317)
T ss_dssp SCCCC--CCCCCSCCTTCCHHHH
T ss_pred CCccc--CCCCcccccccCchHh
Confidence 33221 2335689999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=257.98 Aligned_cols=168 Identities=26% Similarity=0.407 Sum_probs=144.1
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-eEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~ 515 (617)
...++|++.+.||+|+||.||+|... ++.||||.++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44578899999999999999999984 7899999997532 5678999999999999999999999988766 789999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999997532 334789999999999999999999987 999999999999999999999999999975432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
. ....+|..|+|||.+
T Consensus 343 ~-----~~~~~~~~y~aPE~~ 358 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEAL 358 (450)
T ss_dssp ---------CCCTTTSCHHHH
T ss_pred c-----cCCCCCcceeCHHHh
Confidence 1 123578899999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=251.94 Aligned_cols=171 Identities=25% Similarity=0.316 Sum_probs=142.8
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCC--CCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4567999999999999999999988899999999864 334456789999999999987 999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 567899999965 345889999999999999999999987 99999999999997 6789999999999876
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............||+.|+|||++
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp -----------CCCCSSCCHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHH
Confidence 55444334456799999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=249.17 Aligned_cols=168 Identities=26% Similarity=0.350 Sum_probs=131.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||+|+... ++.||||.++.. ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 44679999999999999999999865 789999999753 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCCceeeC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFG 593 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGla~~~~ 593 (617)
|+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999954 345899999999999999999999987 999999999999975 8899999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~ 222 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEIL 222 (349)
T ss_dssp -------------CGGGSCHHHH
T ss_pred ccc---ccccccCCCCccCHHHh
Confidence 432 23346799999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=260.25 Aligned_cols=171 Identities=25% Similarity=0.401 Sum_probs=133.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC-----Ce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (617)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 4889999998652 334567899999999999999999999999543 46
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 789998854 345899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcc-------------------------cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-------------------------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-------------------------~~~~~~~gt~~y~ape~~ 616 (617)
.+...... ......+||+.|+|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 255 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence 87533211 123345789999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=249.93 Aligned_cols=179 Identities=22% Similarity=0.270 Sum_probs=144.8
Q ss_pred HHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
+....++|++.+.||+|+||.||+|.... ++.||||.+.+. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34455689999999999999999999754 789999998652 234567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------RTLLDWSQRFHIICGTARG 551 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~g 551 (617)
+..++||||+++|+|.+++..... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999842100 1123567788899999999
Q ss_pred HHHHHhCCCCceeecccCCCcEEEcCCC--CeEEeecCCceeeCCCCcc--cccceeeeeccccCccCC
Q 007120 552 LLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLVRTFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 552 l~yLH~~~~~~iiHrDlkp~NiLl~~~~--~~ki~DFGla~~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+.+ |+||||||+||||+.++ .+||+|||+++.+...... .......||+.|+|||++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 99999987 99999999999998776 8999999999987432221 123456799999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=248.33 Aligned_cols=170 Identities=25% Similarity=0.320 Sum_probs=147.3
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3468999999999999999999964 48899999987532 12345678899999999999999999999999
Q ss_pred CeEEEEEecCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 509 EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 509 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
+..++||||+..| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999854 335899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+..... .....||..|+|||++
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~ 201 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVL 201 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHH
T ss_pred cceECCCCCc---eeccCCCccccChhhh
Confidence 9998754432 3346799999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=246.36 Aligned_cols=170 Identities=21% Similarity=0.276 Sum_probs=146.0
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999997 458899999986532 234688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC-----eEEeecCCcee
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVRT 591 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~ki~DFGla~~ 591 (617)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346899999999999999999999987 999999999999999887 99999999998
Q ss_pred eCCCCccc-----ccceeeeeccccCccCC
Q 007120 592 FGGDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
+....... ......||..|+|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTH 189 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHH
Confidence 75443321 12356799999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=262.20 Aligned_cols=174 Identities=26% Similarity=0.398 Sum_probs=142.4
Q ss_pred HhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34556889999999999999999999888889999997533 345689999999999999999999999876 6789999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999542 2245899999999999999999999987 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......+|..|+|||.+
T Consensus 334 ~~~-~~~~~~~~~~y~aPE~~ 353 (452)
T 1fmk_A 334 EYT-ARQGAKFPIKWTAPEAA 353 (452)
T ss_dssp ----------CCGGGSCHHHH
T ss_pred cee-cccCCcccccccCHhHH
Confidence 322 12234577899999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=253.74 Aligned_cols=172 Identities=27% Similarity=0.395 Sum_probs=148.6
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--eEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 514 (617)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4579999999999999999999865 8999999997532 234577889999999999999999999998765 67999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE----cCCCCeEEeecCCce
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~ki~DFGla~ 590 (617)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976444445899999999999999999999987 9999999999999 788889999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... .....||..|+|||++
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMY 187 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHH
T ss_pred EccCCCc---cccccCCccccCHHHh
Confidence 8754432 2235699999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=255.93 Aligned_cols=171 Identities=26% Similarity=0.427 Sum_probs=143.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC-----Ce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (617)
.++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999754 788999999752 334567899999999999999999999999876 56
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 699999854 345899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCcc--------------------cccceeeeeccccCccCC
Q 007120 591 TFGGDETE--------------------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~--------------------~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||+.|+|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 87543321 123456799999999964
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=243.20 Aligned_cols=175 Identities=27% Similarity=0.410 Sum_probs=152.0
Q ss_pred HhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
....++|++.+.||+|+||.||+|.... +..||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456789999999999999999999865 788999999753 34567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999996533 345899999999999999999999987 99999999999999999999999999998764
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... ......+|..|+|||.+
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~ 184 (288)
T 3kfa_A 164 DTYT-AHAGAKFPIKWTAPESL 184 (288)
T ss_dssp SSSE-EETTEEECGGGCCHHHH
T ss_pred Cccc-cccCCccccCcCChhhh
Confidence 4332 23345678899999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=241.64 Aligned_cols=169 Identities=25% Similarity=0.347 Sum_probs=141.5
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578999999999999999999865 899999998643 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998853 345899999999999999999999987 9999999999999999999999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||.+
T Consensus 157 ~~--~~~~~~~~~y~aPE~~ 174 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELL 174 (311)
T ss_dssp -----------GGGCCHHHH
T ss_pred cc--cCCCcCCccccChHHH
Confidence 22 2345789999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=243.69 Aligned_cols=167 Identities=25% Similarity=0.411 Sum_probs=146.3
Q ss_pred cCCccccceecccCcccEEEEEEcC-C-------cEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
.++|++.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578899999999999999998754 3 4799999977666677889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC--------eE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK 582 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--------~k 582 (617)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 334899999999999999999999988 999999999999998887 99
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++..... ....||..|+|||++
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECI 189 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHh
Confidence 9999999765322 234588999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=245.66 Aligned_cols=183 Identities=25% Similarity=0.366 Sum_probs=153.2
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceE
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 502 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~ 502 (617)
.........++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34455566789999999999999999999852 3578999999753 334556899999999999 799999999
Q ss_pred EEEEeCC-eEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeeccc
Q 007120 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (617)
Q Consensus 503 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 568 (617)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9998755 48999999999999999965332 123789999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 569 kp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+||||+.++.+||+|||+++.+.............||+.|+|||++
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence 999999999999999999999987655444344456789999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=236.97 Aligned_cols=172 Identities=27% Similarity=0.473 Sum_probs=135.2
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467999999999999999999974 58999999986532 1234678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999642 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||++
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~ 184 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIA 184 (278)
T ss_dssp -----------------------
T ss_pred CCCCc--ceeccCCCCcCCcchh
Confidence 33222 2235689999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=249.14 Aligned_cols=172 Identities=24% Similarity=0.397 Sum_probs=142.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|++.+.||+|+||.||+|.... ++ +||+|.+... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3578899999999999999999754 43 3788877542 2234467788999999999999999999986 45688
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999643 345888999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.............||..|+|||.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHH
T ss_pred CcccccccccCCCCcccccChHHh
Confidence 665554444556788899999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=253.45 Aligned_cols=169 Identities=24% Similarity=0.337 Sum_probs=136.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
..++|.+.+.||+|+||.||+|.... ++.||||.+.+.. ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45789999999999999999999755 7899999986521 122335889999999999999999999974 5
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEee
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISD 585 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~D 585 (617)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 568999999999999998843 345899999999999999999999987 9999999999999754 4599999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|+.+.... ......||+.|+|||++
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~ 313 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVL 313 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTT
T ss_pred cccceecCCCc---cccccCCCCCccCceee
Confidence 99999875432 23356799999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=243.67 Aligned_cols=181 Identities=24% Similarity=0.400 Sum_probs=138.9
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEE
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 506 (617)
.++....++|.+.+.||+|+||.||+|.... ++.||||.++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4445566789999999999999999998743 458999998643 3445678999999999999999999999998
Q ss_pred eCCe-----EEEEEecCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC
Q 007120 507 QGEE-----KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (617)
Q Consensus 507 ~~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~ 578 (617)
+.+. .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7653 49999999999999998542 23456899999999999999999999987 9999999999999999
Q ss_pred CCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 579 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+||+|||+++.+.............++..|+|||.+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 99999999999987554433333445678899999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=238.58 Aligned_cols=169 Identities=26% Similarity=0.361 Sum_probs=145.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+|... +++.||||.+... ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 357899999999999999999986 5899999998752 334566788999999998 999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC----------------
Q 007120 515 YEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---------------- 577 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---------------- 577 (617)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999965322 255899999999999999999999987 999999999999984
Q ss_pred ---CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 ---DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 ---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...+||+|||+++...... ...||..|+|||++
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~ 202 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVL 202 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHh
Confidence 4479999999999875432 23589999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.74 Aligned_cols=172 Identities=23% Similarity=0.336 Sum_probs=134.3
Q ss_pred hcCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|.... +..||||.+... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 45689999999999999999998743 457999998753 334567899999999999999999999997 456789
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999643 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ......+|..|+|||.+
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~ 189 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESI 189 (281)
T ss_dssp -------------CCGGGCCHHHH
T ss_pred Cccccc-ccccCCCcccccChhhc
Confidence 543322 22334577899999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=250.45 Aligned_cols=171 Identities=25% Similarity=0.460 Sum_probs=135.6
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCC-CCCccceEEEEEeCC--eE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK 511 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 511 (617)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999999999999975 4889999998642 3445667889999999997 999999999998654 68
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 689998854 35889999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCCc-------------------ccccceeeeeccccCccCC
Q 007120 592 FGGDET-------------------EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~-------------------~~~~~~~~gt~~y~ape~~ 616 (617)
+..... ........||+.|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 643111 1122345799999999965
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=252.41 Aligned_cols=170 Identities=25% Similarity=0.310 Sum_probs=142.9
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCC--CCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 346999999999999999999988899999999864 23455678999999999996 59999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999999653 35788899999999999999999987 99999999999995 58899999999998765
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...........||+.|+|||++
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp -------CCSCCCGGGCCHHHH
T ss_pred CCccccCCCCCcCCCccChHHh
Confidence 4443334456799999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-28 Score=252.08 Aligned_cols=171 Identities=25% Similarity=0.309 Sum_probs=147.4
Q ss_pred cCCccccceecccCcccEEEEEE----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCccceEEEEEeCC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (617)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35899999999999999999997 358899999987522 23456678899999999 6999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999643 35889999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.+....... .....||..|+|||++
T Consensus 207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 207 KEFVADETER-AYDFCGTIEYMAPDIV 232 (355)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHH
T ss_pred eecccCCCCc-ccCcccCcCccChhhh
Confidence 9875433322 2345799999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=240.16 Aligned_cols=171 Identities=25% Similarity=0.381 Sum_probs=143.1
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|.+.+.||+|+||.||++.... +..||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 578899999999999999999754 8899999986532 33467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceeeC
Q 007120 518 MPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 518 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~~ 593 (617)
+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998543 22356899999999999999999999987 9999999999999 456889999999998775
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....||..|+|||++
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVF 198 (285)
T ss_dssp -----------CTTGGGCCHHHH
T ss_pred Cccc---CcCcccccCcCChHHh
Confidence 4332 2345689999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=267.68 Aligned_cols=171 Identities=25% Similarity=0.282 Sum_probs=148.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45689999999999999999999865 788999999752 233456788899999987 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999653 35899999999999999999999987 999999999999999999999999999975
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ......||+.|+|||++
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l 514 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEII 514 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHH
T ss_pred ccCCc--ccccccCCCcccCHhhh
Confidence 43322 24457799999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=243.72 Aligned_cols=173 Identities=24% Similarity=0.364 Sum_probs=148.9
Q ss_pred cCCccccceecccCcccEEEEEE-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 511 (617)
.++|++.+.||+|+||.||++++ ..++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35889999999999999999984 3478999999987666667889999999999999999999999874 4568
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999642 235899999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......||..|+|||++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred cccCCccceeeccCCccccccCHHHh
Confidence 7544332 223335588889999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=237.76 Aligned_cols=170 Identities=31% Similarity=0.516 Sum_probs=135.6
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+|... ++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3468999999999999999999974 8899999986532 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC--------CCCeEEee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISD 585 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--------~~~~ki~D 585 (617)
||||+++++|.+++. ...+++..+..++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999984 345899999999999999999999987556999999999999986 77899999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+++.+..... ....||..|+|||.+
T Consensus 160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~ 186 (271)
T 3dtc_A 160 FGLAREWHRTTK----MSAAGAYAWMAPEVI 186 (271)
T ss_dssp CCC-----------------CCGGGSCHHHH
T ss_pred CCcccccccccc----cCCCCccceeCHHHh
Confidence 999987654332 235689999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=241.09 Aligned_cols=173 Identities=28% Similarity=0.433 Sum_probs=144.9
Q ss_pred cCCccccceecccCcccEEEEEE-----cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--Ce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 510 (617)
.+.|++.+.||+|+||.||++++ .+++.||||++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34688899999999999999984 35789999999753 233457899999999999999999999999876 56
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999999543 345899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcc-cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||..|+|||.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeee
Confidence 87654432 223335588889999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=245.78 Aligned_cols=165 Identities=28% Similarity=0.445 Sum_probs=143.7
Q ss_pred CCccccceecccCcccEEEEEE-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+.|+..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999997 45889999998642 2334567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||++ |+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6888887532 345899999999999999999999987 999999999999999999999999999876432
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
....||+.|+|||++
T Consensus 208 ------~~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVI 222 (348)
T ss_dssp ------CCCCSCGGGCCHHHH
T ss_pred ------CcccCCcceeCHhhh
Confidence 235689999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=236.46 Aligned_cols=171 Identities=27% Similarity=0.363 Sum_probs=144.5
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
+|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4455569999999999999974 478999999976555567789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-CCCeEEeecCCceeeCCCCcc
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~ki~DFGla~~~~~~~~~ 598 (617)
+++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999976544455778999999999999999999987 999999999999987 899999999999987543221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 180 --~~~~~~~~~y~aPE~~ 195 (295)
T 2clq_A 180 --TETFTGTLQYMAPEII 195 (295)
T ss_dssp ---CCCCCCGGGCCHHHH
T ss_pred --ccccCCCccccChhhh
Confidence 2345689999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=242.64 Aligned_cols=169 Identities=26% Similarity=0.349 Sum_probs=147.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357899999999999999999986 488999999865321 1357799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC----CeEEeecC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DFG 587 (617)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999954 345789999999999999999999987 99999999999999888 79999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+..... .....||..|+|||++
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~ 190 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIV 190 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHH
T ss_pred cceecCcccc---ccccCCCCCccCcccc
Confidence 9998754332 2345699999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=240.78 Aligned_cols=173 Identities=29% Similarity=0.462 Sum_probs=135.0
Q ss_pred HhhcCCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
+...++|++.+.||+|+||.||+|... ..||||.++.. .....+.|.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 334568999999999999999999864 46999998642 345567899999999999999999999965 5566899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999954 3455899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............||..|+|||++
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~ 194 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVI 194 (289)
T ss_dssp ------------CCCTTCCHHHH
T ss_pred cccccccccccCCCccccCchhh
Confidence 43333334456799999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=239.52 Aligned_cols=173 Identities=28% Similarity=0.413 Sum_probs=146.8
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...++|++.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3456899999999999999999998888899999997532 34578999999999999999999999976 456899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999995321 225899999999999999999999988 9999999999999999999999999999875443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....+|..|+|||++
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~ 182 (279)
T 1qpc_A 164 YTA-REGAKFPIKWTAPEAI 182 (279)
T ss_dssp EEC-CTTCCCCTTTSCHHHH
T ss_pred ccc-ccCCCCccCccChhhh
Confidence 222 2234577889999964
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=243.68 Aligned_cols=172 Identities=26% Similarity=0.412 Sum_probs=138.3
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHc--cCCCCCccceEEEEEeC----Ce
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFS--KLQHRNLVKLLGCCIQG----EE 510 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~----~~ 510 (617)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++. .++||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34468999999999999999999985 8999999986422 233444445444 45999999999999987 68
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecccCCCcEEEcCCCCeEEee
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. +.+|+||||||+||||+.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999954 24899999999999999999999871 11399999999999999999999999
Q ss_pred cCCceeeCCCCccc--ccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~--~~~~~~gt~~y~ape~~ 616 (617)
||+|+.+....... ......||..|+|||++
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 218 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHH
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhc
Confidence 99998875443321 12345799999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=235.90 Aligned_cols=169 Identities=26% Similarity=0.404 Sum_probs=147.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4689999999999999999999754 889999998642 3345678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DFGla~~~ 592 (617)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888542 45899999999999999999999987 999999999999987655 999999999887
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||.+
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVL 179 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHH
T ss_pred ccCcc---ccCCCCCcCCcCchhh
Confidence 54332 2335689999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=242.86 Aligned_cols=160 Identities=25% Similarity=0.279 Sum_probs=124.9
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
+.||+|+||.||++.... ++.||||++.+ .....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 789999999999999854 88999999864 23467788999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC---CeEEeecCCceeeCCCCcccc
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFGGDETEGN 600 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~ki~DFGla~~~~~~~~~~~ 600 (617)
.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 999965 345899999999999999999999987 99999999999997765 8999999999976543322
Q ss_pred cceeeeeccccCccCC
Q 007120 601 TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 601 ~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||.+
T Consensus 166 ~~~~~~t~~y~aPE~~ 181 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELL 181 (325)
T ss_dssp ----------------
T ss_pred ccccCCCcCccCHHHh
Confidence 3346789999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=237.30 Aligned_cols=171 Identities=24% Similarity=0.344 Sum_probs=148.6
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|.+.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34578999999999999999999865 788999998652 23456788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998854 245899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||.+
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~ 187 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVL 187 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHH
T ss_pred cCccc--cccccCCCCcCCcchh
Confidence 33322 2345689999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=237.61 Aligned_cols=172 Identities=25% Similarity=0.425 Sum_probs=148.5
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||.||++...+++.||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346788999999999999999999888999999997632 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 9999999999653 345889999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. ......+|..|+|||.+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~ 177 (267)
T 3t9t_A 160 T-SSTGTKFPVKWASPEVF 177 (267)
T ss_dssp H-STTSTTCCGGGCCHHHH
T ss_pred c-ccccccccccccChhhh
Confidence 1 12234577889999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=241.43 Aligned_cols=172 Identities=24% Similarity=0.281 Sum_probs=140.7
Q ss_pred cCCcccc-ceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~-~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999864 5889999999765555567889999999884 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DFGla~~~ 592 (617)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999653 35889999999999999999999987 999999999999998776 999999999876
Q ss_pred CCCCcc-----cccceeeeeccccCccCC
Q 007120 593 GGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||..|+|||++
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVV 193 (316)
T ss_dssp -----------------CCSGGGCCHHHH
T ss_pred ccCCccccccccccccccCCcCccChHHh
Confidence 432211 112235599999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=242.37 Aligned_cols=171 Identities=24% Similarity=0.344 Sum_probs=149.0
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|.+.+.||+|+||.||++...+ ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999865 788999998652 33456788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999999854 245899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||++
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~ 213 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVL 213 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHH
T ss_pred cCccc--ccccCCCccccCHHHh
Confidence 33322 2345689999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=237.74 Aligned_cols=169 Identities=28% Similarity=0.375 Sum_probs=143.6
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+|.... ++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45689999999999999999998765 6789999986522 2235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998643 34899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||.+
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~ 179 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMI 179 (279)
T ss_dssp -----------CCCCTTCCHHHH
T ss_pred ccc----ccccCCCCCccCHhHh
Confidence 332 2345689999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=238.16 Aligned_cols=172 Identities=19% Similarity=0.243 Sum_probs=140.9
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3468999999999999999999975 5889999998753 22335789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999642 35899999999999999999999987 9999999999999999999999999998875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... ......||..|+|||++
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~ 207 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERF 207 (309)
T ss_dssp ------------CCGGGCCGGGT
T ss_pred ccccc-cccccCCCcCccCHHHH
Confidence 43322 22345699999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=244.59 Aligned_cols=173 Identities=21% Similarity=0.359 Sum_probs=149.5
Q ss_pred HHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--------hhhHHHHHHHHHHHccC-CCCCccceEEE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKLLGC 504 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 504 (617)
.....++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444568999999999999999999986 58999999986422 12245688999999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
+......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999964 245899999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++.+..... .....||+.|+|||++
T Consensus 243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~ 271 (365)
T 2y7j_A 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEIL 271 (365)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred ecCcccccCCCcc---cccCCCCCCccChhhc
Confidence 9999998764432 2346799999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=235.36 Aligned_cols=169 Identities=27% Similarity=0.429 Sum_probs=148.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.+.|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999875 4889999998653 23456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999842 45899999999999999999999987 9999999999999999999999999999876543
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 174 ~~--~~~~~~~~~y~aPE~~ 191 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVI 191 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHH
T ss_pred cc--cCccCCCcCccCHHHH
Confidence 22 2345789999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=245.99 Aligned_cols=173 Identities=20% Similarity=0.236 Sum_probs=140.6
Q ss_pred hcCCccccceecccCcccEEEEEEcC------CcEEEEEEecccchhh-----------HHHHHHHHHHHccCCCCCccc
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVK 500 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 500 (617)
..++|++.+.||+|+||.||+|.+.. ++.||||.+....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998865 3689999986533211 123455677788999999999
Q ss_pred eEEEEEeC----CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 501 LLGCCIQG----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 501 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
+++++... ...+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4579999999 99999999652 345899999999999999999999987 99999999999999
Q ss_pred --CCCCeEEeecCCceeeCCCCccc-----ccceeeeeccccCccCC
Q 007120 577 --QDMNPKISDFGLVRTFGGDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 577 --~~~~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
.++.+||+|||+|+.+....... ......||..|+|||++
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 233 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH 233 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence 88999999999999875433221 11334599999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=235.86 Aligned_cols=172 Identities=28% Similarity=0.454 Sum_probs=145.4
Q ss_pred cCCccccc-eecccCcccEEEEEEc---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~-~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|.+.+ .||+|+||.||+|... ++..||||.++.. .....+.+.+|+.++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999864 4778999999763 344567899999999999999999999999 5667899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999954 3445899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCcc-cccceeeeeccccCccCC
Q 007120 594 GDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
..... .......+|..|+|||++
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~ 185 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECI 185 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHH
T ss_pred cCcceeeccccccccccccCHHHh
Confidence 44332 122234568899999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-28 Score=265.28 Aligned_cols=174 Identities=26% Similarity=0.398 Sum_probs=147.3
Q ss_pred HhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 44566889999999999999999999888889999997633 345689999999999999999999999876 6789999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.++|... ....+++.+++.|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+++.+...
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999542 1245889999999999999999999987 999999999999999999999999999977533
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......+|..|+|||.+
T Consensus 417 ~~~-~~~~~~~~~~y~aPE~~ 436 (535)
T 2h8h_A 417 EYT-ARQGAKFPIKWTAPEAA 436 (535)
T ss_dssp HHH-TTCSTTSCGGGSCHHHH
T ss_pred cee-cccCCcCcccccCHHHh
Confidence 211 12223467889999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=237.27 Aligned_cols=168 Identities=29% Similarity=0.392 Sum_probs=143.0
Q ss_pred ccccceecccCcccEEEEEEc-----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEE
Q 007120 442 FSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (617)
|++.+.||+|+||.||++.+. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 4788999999753 334567899999999999999999999999984 57899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999954 23899999999999999999999988 9999999999999999999999999999886
Q ss_pred CCCcc-cccceeeeeccccCccCC
Q 007120 594 GDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
..... .......+|..|+|||.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHH
T ss_pred ccccccccccCCCCCceeeChHHh
Confidence 54322 223345588889999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=254.47 Aligned_cols=166 Identities=28% Similarity=0.363 Sum_probs=136.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------C
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 509 (617)
.++|++.+.||+|+||.||+|.... ++.||||++.+. .....+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4689999999999999999998754 889999999753 344567889999999999999999999999654 3
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999864 666662 23789999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...... ......||+.|+|||++
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~ 235 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVI 235 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHH
T ss_pred eecCCCc---ccCCCcccccccCHHHH
Confidence 9875432 23446799999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=245.93 Aligned_cols=165 Identities=22% Similarity=0.264 Sum_probs=131.8
Q ss_pred CCcccc-ceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCCccceEEEEEe----CCeEE
Q 007120 440 DNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEKL 512 (617)
Q Consensus 440 ~~~~~~-~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 512 (617)
++|.+. +.||+|+||+||++.... ++.||||++... ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 689999999999999754 889999998642 3456777776 45689999999999876 55689
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCCc
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLV 589 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGla 589 (617)
|||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996532 345899999999999999999999987 999999999999998 789999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...... ......||..|+|||++
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~ 235 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVL 235 (400)
T ss_dssp EECC--------------CTTCCGGGS
T ss_pred cccCCCC---ccccCCCCCCccCHhhc
Confidence 9865332 23356789999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=235.68 Aligned_cols=173 Identities=23% Similarity=0.351 Sum_probs=144.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCccceEEEEE--eCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 511 (617)
.++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 47899999997532 234578999999999999999999999985 34578
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||++++ |.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 777775432 346899999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.............||..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIA 183 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred cCccccccccccCCCCCCCcChhhc
Confidence 7644333333446699999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=233.60 Aligned_cols=169 Identities=29% Similarity=0.521 Sum_probs=142.4
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchh-------hHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3468999999999999999999985 5889999998642211 1267899999999999999999999986554
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC-----eEEe
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKIS 584 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~ki~ 584 (617)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998865 3346899999999999999999999875 34999999999999988776 9999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++..... .....||..|+|||++
T Consensus 172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 172 DFGLSQQSVHS-----VSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCTTCBCCSSC-----EECCCCCCTTSCGGGS
T ss_pred CCCcccccccc-----ccccCCCccccCchhh
Confidence 99999865432 2345689999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.76 Aligned_cols=168 Identities=24% Similarity=0.368 Sum_probs=143.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
++|++.+.||+|+||.||++... +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999986 489999999865321 13578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC----CeEEeecCC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 588 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DFGl 588 (617)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999954 345899999999999999999999987 99999999999998877 899999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+..... .....||..|+|||++
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~ 183 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIV 183 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHH
T ss_pred ceeccCCCc---ccccCCCcCccCccee
Confidence 998754332 2345689999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.87 Aligned_cols=171 Identities=26% Similarity=0.448 Sum_probs=140.2
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe-----------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----------- 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 507 (617)
++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 47889999999999999999975 589999999965 34556789999999999999999999999876
Q ss_pred --CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 34678999999999999999652 345688899999999999999999987 99999999999999999999999
Q ss_pred cCCceeeCCCCc------------ccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDET------------EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~------------~~~~~~~~gt~~y~ape~~ 616 (617)
||+++.+..... ........||..|+|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccc
Confidence 999987643211 1122345689999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=241.89 Aligned_cols=172 Identities=28% Similarity=0.464 Sum_probs=136.2
Q ss_pred cCCccccceecccCcccEEEEEEcC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.++|++.+.||+|+||.||+|.... ++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4689999999999999999999743 43 4677777542 3345678999999999999999999999998765 78
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.............+|..|+|||.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp ------------CCCGGGSCHHHH
T ss_pred cCccccccccCCCccccccCHHHH
Confidence 655444334445578899999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.98 Aligned_cols=170 Identities=28% Similarity=0.420 Sum_probs=141.5
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||+++... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3578999999999999999999865 889999998542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999888743 345899999999999999999999987 999999999999999999999999999877543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||++
T Consensus 178 ~~~--~~~~~~t~~y~aPE~~ 196 (331)
T 4aaa_A 178 GEV--YDDEVATRWYRAPELL 196 (331)
T ss_dssp --------CCCCCTTCCHHHH
T ss_pred ccc--cCCCcCCccccCcccc
Confidence 322 2345689999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=240.56 Aligned_cols=168 Identities=25% Similarity=0.399 Sum_probs=136.4
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.+.||+|+||.||++... ++.||||++.. ....+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999884 78899999864 344678999999999999999999999876 4479999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC-eEEeecCCceeeCCCCc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDET 597 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-~ki~DFGla~~~~~~~~ 597 (617)
++++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||||+.++. +||+|||+++.+...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976544445789999999999999999999943234999999999999998886 799999999876432
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.....||..|+|||++
T Consensus 160 ---~~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVF 175 (307)
T ss_dssp --------CCTTSSCHHHH
T ss_pred ---cccCCCCCceEChhhh
Confidence 2234689999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=235.16 Aligned_cols=166 Identities=30% Similarity=0.456 Sum_probs=143.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe-----------
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----------- 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 507 (617)
++|++.+.||+|+||.||+|... +++.||||++.... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 47889999999999999999986 58999999987532 356789999999999999999999865
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 508 -----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 508 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 345799999999999999996532 346899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+..... .....||..|+|||++
T Consensus 163 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQI 193 (284)
T ss_dssp ECCCTTCEESSCCSC---CCCCCSCCTTSCHHHH
T ss_pred ECcchhheecccccc---ccccCCcccccChhhh
Confidence 999999998765432 2235689999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=233.61 Aligned_cols=170 Identities=25% Similarity=0.398 Sum_probs=140.8
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999986 58999999986532 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999643 34789999999999999999999987 9999999999999999999999999998875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....||..|+|||.+
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~ 182 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVI 182 (276)
T ss_dssp C----------------CCTGGG
T ss_pred CCcc---eecccCCccccCHHHH
Confidence 4332 2345689999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.87 Aligned_cols=174 Identities=28% Similarity=0.405 Sum_probs=139.7
Q ss_pred hcCCccccceecccCcccEEEEEEcC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
..++|++.+.||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34578888999999999999998753 246999999753 334556799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999652 345899999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......+|..|+|||.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 222 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAI 222 (333)
T ss_dssp --------------CCCGGGSCHHHH
T ss_pred hccccccccccCCCCccccccCchhc
Confidence 7544322 112233467889999964
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=240.19 Aligned_cols=171 Identities=30% Similarity=0.476 Sum_probs=135.5
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHH--HHHHHHccCCCCCccceEEEEEe-----CCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK--NEVILFSKLQHRNLVKLLGCCIQ-----GEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~g~~~~-----~~~ 510 (617)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+. .|+..+..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456899999999999999999987 68999999986532 23333 44444566899999999987653 225
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceeecccCCCcEEEcCCCCeEEe
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------RLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
.++||||+++|+|.+++... ..++..+..++.||++||+|||+.. +.+|+||||||+||||+.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 68999999999999999542 2488999999999999999999881 0139999999999999999999999
Q ss_pred ecCCceeeCCCCcc------cccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETE------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~------~~~~~~~gt~~y~ape~~ 616 (617)
|||+++.+...... .......||..|+|||++
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhh
Confidence 99999987543221 112234699999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=246.89 Aligned_cols=171 Identities=28% Similarity=0.438 Sum_probs=132.8
Q ss_pred CccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeEEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 514 (617)
.|++.+.||+|+||.||+|.+.+ ...||||.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46777899999999999998743 246899998653 33556789999999999999999999999865 4577999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 3345789999999999999999999987 99999999999999999999999999997754
Q ss_pred CCcc--cccceeeeeccccCccCC
Q 007120 595 DETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
.... .......+|..|+|||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp -------------CCGGGSCHHHH
T ss_pred cccccccccCCCCCcccccChHHh
Confidence 3321 112334577899999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=260.93 Aligned_cols=172 Identities=27% Similarity=0.434 Sum_probs=139.0
Q ss_pred cCCccccc-eecccCcccEEEEEEc---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~-~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....++|.+|+.++++++|||||++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 7999999999999875 3567999999763 33456789999999999999999999999976 56899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+++.+.
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999954 3455899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCccc-ccceeeeeccccCccCC
Q 007120 594 GDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
...... ......+|..|+|||++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~ 511 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECI 511 (613)
T ss_dssp --------------CCTTSCHHHH
T ss_pred CCCceeeeccCCCCccceeCHhhh
Confidence 443221 12223456899999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=234.61 Aligned_cols=171 Identities=25% Similarity=0.332 Sum_probs=147.9
Q ss_pred hhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---------hhhHHHHHHHHHHHccCC-CCCccceEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCC 505 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~ 505 (617)
...++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999985 47899999986422 123467889999999996 99999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999964 245899999999999999999999987 99999999999999999999999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+++.+..... .....||..|+|||++
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 195 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEII 195 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHh
Confidence 999998754332 2345689999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=254.47 Aligned_cols=169 Identities=28% Similarity=0.368 Sum_probs=142.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||+|+.. ++..||||++.+.. ......+.+|+.+++.++|||||++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999986 47899999987532 334577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGla~~~ 592 (617)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988542 45889999999999999999999987 999999999999976 455999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||++
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 190 ENQKK---MKERLGTAYYIAPEVL 210 (494)
T ss_dssp BTTBC---BCCCCSCTTTCCHHHH
T ss_pred CCCcc---ccccCCCcCeeCHHHH
Confidence 64432 3345799999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=237.40 Aligned_cols=171 Identities=27% Similarity=0.411 Sum_probs=139.4
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccC---CCCCccceEEEEEeC
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG 508 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 508 (617)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999964 58899999986422 11234566777776666 599999999999886
Q ss_pred C-----eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEE
Q 007120 509 E-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (617)
Q Consensus 509 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki 583 (617)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 69999996533 234899999999999999999999998 999999999999999999999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+..... .....||..|+|||++
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 191 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVL 191 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHH
T ss_pred eeCccccccCCCcc---cCCccccccccCchHH
Confidence 99999987653322 2346789999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=241.93 Aligned_cols=169 Identities=24% Similarity=0.370 Sum_probs=147.7
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhh-----------------HHHHHHHHHHHccCCCCCccce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-----------------LKELKNEVILFSKLQHRNLVKL 501 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 501 (617)
.++|++.+.||+|+||.||+|.. +++.||||.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986522111 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCCHHHH------HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEE
Q 007120 502 LGCCIQGEEKLLIYEFMPNKSLDSF------IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVL 574 (617)
Q Consensus 502 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiL 574 (617)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 532 124668999999999999999999998 76 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.++.+||+|||+++.+.... .....||..|+|||.+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~ 222 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFF 222 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGG
T ss_pred EcCCCcEEEecccccccccccc----ccCCCCCcCccCchhh
Confidence 9999999999999999875432 2345689999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=239.72 Aligned_cols=176 Identities=26% Similarity=0.344 Sum_probs=146.3
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (617)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999997 4589999999876566677889999999999999999999999873 34678
Q ss_pred EEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 513 LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
+||||+++++|.+++... .....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998652 22456899999999999999999999987 99999999999999999999999999987
Q ss_pred eCCCCcc-------cccceeeeeccccCccCC
Q 007120 592 FGGDETE-------GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-------~~~~~~~gt~~y~ape~~ 616 (617)
....... .......||..|+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 215 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred cccccccccccccccccccccCCcccCCHhHh
Confidence 6321111 001224578999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=253.23 Aligned_cols=170 Identities=29% Similarity=0.399 Sum_probs=145.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccch-------------hhHHHHHHHHHHHccCCCCCccceEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLLG 503 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 503 (617)
..++|.+.+.||+|+||.||+|.... ++.||||.+.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45689999999999999999999865 78999999865221 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC---C
Q 007120 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---N 580 (617)
Q Consensus 504 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~ 580 (617)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999854 245899999999999999999999987 99999999999998776 6
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+++.+..... .....||+.|+|||++
T Consensus 188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 220 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVL 220 (504)
T ss_dssp EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHH
T ss_pred EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHh
Confidence 99999999998755432 2345699999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=243.07 Aligned_cols=172 Identities=28% Similarity=0.396 Sum_probs=136.4
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
....++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344568999999999999999999875 58899999996532 233457789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE-----cCCCCeEEeecC
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFG 587 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl-----~~~~~~ki~DFG 587 (617)
+||||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999998 5999998643 34899999999999999999999987 9999999999999 455569999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+...... .....||..|+|||++
T Consensus 183 ~a~~~~~~~~~--~~~~~~t~~y~aPE~~ 209 (329)
T 3gbz_A 183 LARAFGIPIRQ--FTHEIITLWYRPPEIL 209 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHH
T ss_pred CccccCCcccc--cCCCcCCccccCHHHh
Confidence 99887533222 2345689999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=232.33 Aligned_cols=168 Identities=25% Similarity=0.343 Sum_probs=144.7
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC--CeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (617)
.++|++.+.||+|+||.||+|+.. ++.||||.+... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457889999999999999999984 889999998753 344567899999999999999999999999887 678999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996532 335899999999999999999999864 4599999999999999999999999998765322
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
....||..|+|||.+
T Consensus 166 -------~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEAL 180 (271)
T ss_dssp -------TTCBSCGGGSCHHHH
T ss_pred -------cCccCCccccChhhh
Confidence 224688999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.59 Aligned_cols=173 Identities=27% Similarity=0.453 Sum_probs=147.2
Q ss_pred cCCccccceecccCcccEEEEEE-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC--eE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 511 (617)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45788999999999999999984 347899999998766666788999999999999999999999987654 67
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999653 345899999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......+|..|+|||.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESL 220 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred ccccccccccccCCCCceeEECchhh
Confidence 7654332 112234577889999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=241.98 Aligned_cols=169 Identities=27% Similarity=0.411 Sum_probs=137.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 5889999998653222 223566799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 6899888653 345899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||++
T Consensus 156 --~~~~~~~t~~y~aPE~~ 172 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDIL 172 (324)
T ss_dssp ---------CGGGCCHHHH
T ss_pred --ccccccCcccccChhhh
Confidence 12345689999999965
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=233.74 Aligned_cols=171 Identities=18% Similarity=0.296 Sum_probs=146.5
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..++|++.+.||+|+||.||+|.. .+++.||||.+... ...+.+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999996 45899999998643 2345688899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC-----eEEeecCCce
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVR 590 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~ki~DFGla~ 590 (617)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999653 335899999999999999999999987 999999999999987776 9999999999
Q ss_pred eeCCCCcc-----cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||..|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTH 190 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhh
Confidence 87654332 123456799999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=234.05 Aligned_cols=168 Identities=27% Similarity=0.359 Sum_probs=146.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+|.... ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 4679999999999999999999864 7789999986522 22346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999653 34889999999999999999999987 99999999999999999999999999987653
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||++
T Consensus 167 ~~----~~~~~~~~~y~aPE~~ 184 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMI 184 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHH
T ss_pred cc----cccccCCCCcCCHHHh
Confidence 22 2345689999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=236.38 Aligned_cols=173 Identities=28% Similarity=0.424 Sum_probs=142.6
Q ss_pred cCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe-CCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 512 (617)
..+|++.+.||+|+||.||+|...+ ...||||.+... .....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998643 236899998753 33456789999999999999999999999765 45779
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 3345789999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcc--cccceeeeeccccCccCC
Q 007120 593 GGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||..|+|||.+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESL 204 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHH
T ss_pred cccchhccccccCCCCCccccChHHh
Confidence 543321 123334577899999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=243.69 Aligned_cols=177 Identities=23% Similarity=0.350 Sum_probs=141.9
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccc-----------hhhHHHHHHHHHHHccCCCCCcc
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-----------EQGLKELKNEVILFSKLQHRNLV 499 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~H~niv 499 (617)
...++....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456777889999999999999999999998889999999985421 12247899999999999999999
Q ss_pred ceEEEEEeC-----CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 500 KLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 500 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 35799999998 688888864 3346899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+.++.+||+|||+++....... .....||..|+|||++
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~ 205 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELV 205 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHh
Confidence 99999999999999986544332 3346789999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=241.76 Aligned_cols=166 Identities=21% Similarity=0.335 Sum_probs=140.4
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||++.... ++.||||.+++... .+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4579999999999999999999864 88999999975322 345677777777 79999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC----CCeEEeecCCceee
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRTF 592 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~----~~~ki~DFGla~~~ 592 (617)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999854 345899999999999999999999988 9999999999998543 35999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....||..|+|||++
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVL 192 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHH
T ss_pred cCCCCc--eeccCCCccccCHHHh
Confidence 544322 3345789999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.80 Aligned_cols=179 Identities=28% Similarity=0.341 Sum_probs=136.3
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEe------
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ------ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~------ 507 (617)
.....+|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 334558999999999999999999975 58899999987655666778999999999996 9999999999953
Q ss_pred --CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
....++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 799999865444556899999999999999999999874 3599999999999999999999999
Q ss_pred cCCceeeCCCCccc----------ccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEG----------NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~----------~~~~~~gt~~y~ape~~ 616 (617)
||+++.+....... ......||..|+|||++
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CTTCBCCSSCC------------------------------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 99999875433211 11134589999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=245.16 Aligned_cols=168 Identities=24% Similarity=0.296 Sum_probs=145.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999986 4889999998753 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
|+++++|.+++... ..+++..+..++.+++.||.|||+. + |+||||||+||||+.++.+||+|||+++.+...
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999653 3488999999999999999999985 6 999999999999999999999999999876322
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||++
T Consensus 186 ----~~~~~~gt~~y~aPE~~ 202 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERL 202 (360)
T ss_dssp ----C----CCCCTTCCHHHH
T ss_pred ----cccCCCCCCCeECHHHH
Confidence 12345789999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=232.04 Aligned_cols=169 Identities=25% Similarity=0.358 Sum_probs=143.6
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (617)
+.|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457888899999999999999754 788999998642 34456789999999999999999999999876 35579
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEEeecCCcee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~ 591 (617)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+||||+ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999954 245889999999999999999999874 3599999999999998 789999999999986
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||.+
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMY 202 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGG
T ss_pred ccccc----cccccCCcCcCCHHHH
Confidence 54322 2345689999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=253.70 Aligned_cols=169 Identities=30% Similarity=0.420 Sum_probs=145.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
.++|++.+.||+|+||.||++... +++.||||++.+. .......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999985 5889999998642 2234678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc---CCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~ki~DFGla~~~ 592 (617)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999988543 35899999999999999999999988 99999999999995 4567999999999877
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||++
T Consensus 175 ~~~~~---~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 175 QQNTK---MKDRIGTAYYIAPEVL 195 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGG
T ss_pred CCCCc---cCCCcCCCCCCCHHHh
Confidence 54332 2345699999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=241.55 Aligned_cols=176 Identities=28% Similarity=0.439 Sum_probs=143.3
Q ss_pred hcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
..++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4468999999999999999999842 3678999999643 34556789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI 583 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki 583 (617)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 245889999999999999999999987 999999999999984 456999
Q ss_pred eecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 584 SDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|||+++.+.............||..|+|||++
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 217 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHh
Confidence 999999876544333333345678999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=236.58 Aligned_cols=172 Identities=26% Similarity=0.297 Sum_probs=134.1
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||++... +++.||||++... .....+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4568999999999999999999974 5889999998653 223334455666678999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
|||++ |+|.+++... .....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998 5888877532 2345689999999999999999999997 7 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||..|+|||++
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERI 181 (290)
T ss_dssp ------------CCCCCCSCHHHH
T ss_pred ccccc---ccccCCCccccChhhc
Confidence 54332 2234689999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.34 Aligned_cols=165 Identities=27% Similarity=0.399 Sum_probs=137.1
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
.++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999975 489999999854 23344677899999999999999999999998763
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899999854 34789999999999999999999988 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||+.|+|||++
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~ 197 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVI 197 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHH
Confidence 986432 2235689999999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.46 Aligned_cols=171 Identities=27% Similarity=0.382 Sum_probs=143.5
Q ss_pred CccccceecccCcccEEEEEEcC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE-EEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 514 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 514 (617)
.|...+.||+|+||.||+|...+ + ..||||.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45666899999999999998643 2 37999998753 334567899999999999999999999999877665 999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 3345789999999999999999999987 99999999999999999999999999987654
Q ss_pred CCc--ccccceeeeeccccCccCC
Q 007120 595 DET--EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~--~~~~~~~~gt~~y~ape~~ 616 (617)
... ........+|..|+|||.+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~ 200 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESL 200 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred CcccccccCcCCCCCccccChhhh
Confidence 332 1223345678999999965
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=243.30 Aligned_cols=172 Identities=31% Similarity=0.424 Sum_probs=139.8
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccch-----hhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
...++|++.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345689999999999999999999754 88999999864221 113468899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999985 88888854 2345788899999999999999999988 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .....||..|+|||++
T Consensus 161 ~~~~~~~~--~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 161 SFGSPNRA--YTHQVVTRWYRAPELL 184 (346)
T ss_dssp TTTSCCCC--CCCSCCCCTTCCHHHH
T ss_pred eccCCccc--CCcccccccccCchHh
Confidence 87533222 2345689999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=250.13 Aligned_cols=169 Identities=18% Similarity=0.182 Sum_probs=137.5
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecc---cchhhHHHHHHHH---HHHccCCCCCccceE-------E
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL-------G 503 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g 503 (617)
..++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+ .++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999996 4589999999864 2334567899999 566667899999998 6
Q ss_pred EEEeCC-----------------eEEEEEecCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007120 504 CCIQGE-----------------EKLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (617)
Q Consensus 504 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (617)
++.+.+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666553 278999999 6899999965321 123446888899999999999999988
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+||||||+||||+.++.+||+|||+|+.... ......| ..|+|||++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELE 274 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhh
Confidence 99999999999999999999999999997432 1234567 999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=235.38 Aligned_cols=174 Identities=25% Similarity=0.410 Sum_probs=137.6
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
..++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999974 589999999864 234456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 514 IYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998642 12456899999999999999999999987 999999999999999999999999999887
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... .....||..|+|||++
T Consensus 187 ~~~~~~--~~~~~~~~~y~aPE~~ 208 (310)
T 2wqm_A 187 SSKTTA--AHSLVGTPYYMSPERI 208 (310)
T ss_dssp --------------CCSSCCHHHH
T ss_pred cCCCcc--ccccCCCeeEeChHHh
Confidence 543322 2345689999999965
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=238.27 Aligned_cols=178 Identities=25% Similarity=0.391 Sum_probs=131.1
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
....++|++.+.||+|+||.||+|... +++.||||.+.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999864 58899999986532 3345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 514 IYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
||||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998631 12455899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCc---ccccceeeeeccccCccCC
Q 007120 589 VRTFGGDET---EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~---~~~~~~~~gt~~y~ape~~ 616 (617)
++.+..... ........||..|+|||++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHh
Confidence 987643321 1112345689999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=238.79 Aligned_cols=172 Identities=27% Similarity=0.409 Sum_probs=143.3
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
..++|++.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34689999999999999999999864 88999999976555667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998642 345899999999999999999999987 9999999999999999999999999986542111
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.......||..|+|||++
T Consensus 172 --~~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp --HC-----CCGGGCCHHHH
T ss_pred --cccccccCChhhcCCeee
Confidence 112235689999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.92 Aligned_cols=168 Identities=24% Similarity=0.342 Sum_probs=143.9
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|.+.+.||+|+||.||+++.. +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357889999999999999999975 5889999999765444556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceeeCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~~~ 594 (617)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998542 35889999999999999999999987 9999999999999 7889999999999987543
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......||..|+|||.+
T Consensus 162 ~----~~~~~~~~~~y~aPE~~ 179 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVL 179 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTB
T ss_pred C----ccccccCCCCccChHHh
Confidence 2 12335689999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=234.89 Aligned_cols=172 Identities=26% Similarity=0.370 Sum_probs=142.4
Q ss_pred hcCCccccc-eecccCcccEEEEEEc---CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 438 ATDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 438 ~~~~~~~~~-~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
..++|.+.+ .||+|+||.||+|... .++.||||.++... ....+++.+|+.+++.++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446788877 9999999999999653 36789999987532 23467899999999999999999999999 66778
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999965 234889999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCccc-ccceeeeeccccCccCC
Q 007120 592 FGGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
+....... ......+|..|+|||.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 192 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECI 192 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHh
Confidence 76544321 12233467889999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=239.53 Aligned_cols=172 Identities=27% Similarity=0.433 Sum_probs=143.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeC-------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 508 (617)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 358999999999999999999984 58999999986432 23345788999999999999999999999874
Q ss_pred -CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 509 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
+..++||||+++ +|.+.+... ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999984 777777542 345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcc--cccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
+|+.+...... .......||..|+|||++
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhh
Confidence 99987533221 223345689999999965
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.32 Aligned_cols=179 Identities=29% Similarity=0.447 Sum_probs=145.5
Q ss_pred hHHhHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEe-
Q 007120 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (617)
Q Consensus 431 ~~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 507 (617)
...++....++|++.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34445556789999999999999999999984 5889999998653 23456788999999998 89999999999987
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeE
Q 007120 508 -----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 508 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999996532 346889999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+..... ......||..|+|||++
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~ 201 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVI 201 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHH
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhh
Confidence 999999988753322 12345689999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=238.71 Aligned_cols=169 Identities=24% Similarity=0.378 Sum_probs=144.0
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCccceEEEEEeCC----e
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----E 510 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~ 510 (617)
...++|++.+.||+|+||.||+|.. +++.||||.+... ....+.+|++++.. ++||||+++++++.... .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3456899999999999999999998 5899999998642 34567778888776 79999999999998876 7
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecccCCCcEEEcCCCCeE
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPK 582 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiHrDlkp~NiLl~~~~~~k 582 (617)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||||+.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 8999999999999999954 24789999999999999999999 555 99999999999999999999
Q ss_pred EeecCCceeeCCCCccc--ccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~--~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+....... ......||..|+|||++
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhh
Confidence 99999999876543221 22345799999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=237.31 Aligned_cols=171 Identities=29% Similarity=0.450 Sum_probs=140.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcE--EEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE--IAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (617)
++|++.+.||+|+||.||+|+... +.. ||||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578899999999999999999754 554 599988652 334456789999999999 999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCe
Q 007120 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ 581 (617)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+++..... .......+|..|+|||.+
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~ 213 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESL 213 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhh
Confidence 99999999854321 112234578899999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=253.07 Aligned_cols=169 Identities=31% Similarity=0.414 Sum_probs=147.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||++... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357899999999999999999986 5899999998642 234567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCcee
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRT 591 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~ 591 (617)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999854 345899999999999999999999987 9999999999999 5678999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||+.|+|||++
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~ 200 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVL 200 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHH
T ss_pred cccccc---cccCCCCccccCceee
Confidence 754332 2345699999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=232.71 Aligned_cols=172 Identities=24% Similarity=0.359 Sum_probs=141.9
Q ss_pred hcCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|.... +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998653 346999998753 33456789999999999999999999999764 4568
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999652 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ......+|..|+|||.+
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~ 186 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESI 186 (281)
T ss_dssp ----------CCCCCGGGCCHHHH
T ss_pred cccccc-ccccCCCCcceeCchhh
Confidence 543322 22334578899999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=238.35 Aligned_cols=168 Identities=24% Similarity=0.341 Sum_probs=140.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (617)
.++|++.+.||+|+||.||+|.... ++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3579999999999999999999754 7899999986421 122346889999999999999999999987655
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeec
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 586 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DF 586 (617)
.++||||+++++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999843 345899999999999999999999987 999999999999987664 999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+..... .....||..|+|||++
T Consensus 162 g~~~~~~~~~~---~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 162 GHSKILGETSL---MRTLCGTPTYLAPEVL 188 (322)
T ss_dssp TTCEECCCCHH---HHHHHSCCTTCCHHHH
T ss_pred ccceecccccc---cccccCCcCccCchhh
Confidence 99998754321 2335689999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=233.64 Aligned_cols=171 Identities=29% Similarity=0.464 Sum_probs=143.4
Q ss_pred hhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
...++|++.+.||+|+||.||+|.... ++.||||.+... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345689999999999999999999864 889999998653 24567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999853 2345899999999999999999999987 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||..|+|||++
T Consensus 179 ~~~--~~~~~~~~~y~aPE~~ 197 (314)
T 3com_A 179 MAK--RNTVIGTPFWMAPEVI 197 (314)
T ss_dssp BSC--BCCCCSCGGGCCHHHH
T ss_pred ccc--cCccCCCCCccChhhc
Confidence 322 2345689999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=237.51 Aligned_cols=175 Identities=25% Similarity=0.358 Sum_probs=144.2
Q ss_pred HHhhcCCcccc-ceecccCcccEEEEEEcC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCCccceEEEEEeCC
Q 007120 435 IANATDNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (617)
Q Consensus 435 ~~~~~~~~~~~-~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (617)
.....+.|.+. +.||+|+||.||+|.... ++.||||+++... .....++.+|+.++..++ ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445567776 889999999999999764 8999999987532 234678899999999994 699999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeec
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDF 586 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DF 586 (617)
..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999998542 2356899999999999999999999987 999999999999988 789999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++.+..... .....||..|+|||++
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~ 205 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEIL 205 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHH
T ss_pred ccccccCCccc---cccccCCcCccCCeee
Confidence 99998754332 2346799999999975
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=232.45 Aligned_cols=170 Identities=29% Similarity=0.440 Sum_probs=143.9
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57899999999999999999986 58999999986532 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 998 69999986532 245789999999999999999999987 9999999999999999999999999998875432
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||..|+|||.+
T Consensus 158 ~~--~~~~~~~~~y~aPE~~ 175 (299)
T 2r3i_A 158 RT--YTHEVVTLWYRAPEIL 175 (299)
T ss_dssp BC--TTSCBCCCTTCCHHHH
T ss_pred cc--cCcccccccccCcHHh
Confidence 22 2235689999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=234.66 Aligned_cols=170 Identities=25% Similarity=0.384 Sum_probs=137.1
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEE-----------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------- 506 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 506 (617)
.++|++.+.||+|+||.||+|.... ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8899999997766667788999999999999999999999873
Q ss_pred ---eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeE
Q 007120 507 ---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 582 (617)
Q Consensus 507 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~k 582 (617)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699999842 45889999999999999999999987 99999999999997 567999
Q ss_pred EeecCCceeeCCCCcc-cccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+...... .......+|..|+|||.+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHh
Confidence 9999999987533221 122334578899999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=242.07 Aligned_cols=170 Identities=22% Similarity=0.332 Sum_probs=138.2
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC------
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (617)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999874 58999999986532 2234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 007120 509 --------------------------------EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYL 555 (617)
Q Consensus 509 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yL 555 (617)
...++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5887777532 2345689999999999999999999
Q ss_pred HhCCCCceeecccCCCcEEEc-CCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 556 H~~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+.+ |+||||||+||||+ .++.+||+|||+|+.+..... .....||..|+|||.+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELM 213 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHh
Confidence 9987 99999999999998 688999999999998754433 2235689999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=239.64 Aligned_cols=171 Identities=19% Similarity=0.238 Sum_probs=137.2
Q ss_pred cCCccccceecccCcccEEEEEEc----CCcEEEEEEecccchh-----------hHHHHHHHHHHHccCCCCCccceEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 503 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 503 (617)
.++|++.+.||+|+||.||+|... .+..||||.+...... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999985 4678999998653221 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC
Q 007120 504 CCIQ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (617)
Q Consensus 504 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~ 579 (617)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77889999999 99999998542 26899999999999999999999987 99999999999999887
Q ss_pred --CeEEeecCCceeeCCCCcc-----cccceeeeeccccCccCC
Q 007120 580 --NPKISDFGLVRTFGGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 580 --~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
.+||+|||+|+.+...... .......||..|+|||++
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence 9999999999987533221 112345799999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=234.23 Aligned_cols=163 Identities=22% Similarity=0.385 Sum_probs=142.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEe--CCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 514 (617)
.++|++.+.||+|+||.||+|... +++.||||.++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367999999999999999999874 5889999998753 3467889999999997 9999999999998 5678999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~ 593 (617)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 2788999999999999999999988 99999999999999776 89999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....||..|+|||.+
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELL 202 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHH
T ss_pred CCCc---cccccccccccChhhh
Confidence 4433 2335689999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=243.90 Aligned_cols=168 Identities=22% Similarity=0.315 Sum_probs=137.7
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe------EE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 512 (617)
..+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 347999999999999999999998877899998854221 22369999999999999999999976443 78
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEEeecCCcee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~ 591 (617)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655444322233456899999999999999999999987 99999999999999 799999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||+.|+|||++
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~ 213 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELI 213 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHH
Confidence 754433 2235689999999965
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=259.11 Aligned_cols=164 Identities=27% Similarity=0.373 Sum_probs=134.7
Q ss_pred ceecccCcccEEEEEEc---CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999763 35789999997532 334678999999999999999999999996 4568899999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc-c
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-G 599 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~-~ 599 (617)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999954 345899999999999999999999987 999999999999999999999999999987554332 2
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......+|..|+|||++
T Consensus 528 ~~~~~~~t~~y~APE~~ 544 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECI 544 (635)
T ss_dssp -------CGGGSCHHHH
T ss_pred cccCCCCceeeeChhhh
Confidence 22334577899999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.16 Aligned_cols=166 Identities=27% Similarity=0.353 Sum_probs=133.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 4889999998652 3345677899999999999999999999997765
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999997 57888874 23789999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+...... ......||..|+|||++
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~ 198 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVI 198 (371)
T ss_dssp ------------------CTTCCHHHH
T ss_pred ccccccc---ccCCceecCCccCHHHh
Confidence 9765332 12346799999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=239.68 Aligned_cols=170 Identities=22% Similarity=0.349 Sum_probs=144.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-----eE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 511 (617)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999975 4788999999753 3344578899999999999999999999997653 67
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 599998854 34899999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCCccc-ccceeeeeccccCccCC
Q 007120 592 FGGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
........ ......||+.|+|||++
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHh
Confidence 75433221 23446799999999963
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=257.23 Aligned_cols=160 Identities=19% Similarity=0.230 Sum_probs=124.9
Q ss_pred ceecccCcccEEEEEE-cCCcEEEEEEeccc----------chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEE
Q 007120 446 NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (617)
..++.|++|.+..++. .-|+.++||.+.+. .+...++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3456666666665542 23788999998642 223456799999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||++|++|.++|.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999964 3446654 48899999999999998 9999999999999999999999999999875
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+... ....+||++|+|||++
T Consensus 391 ~~~~~--~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 391 QDCSW--PTNLVQSFFVFVNELF 411 (569)
T ss_dssp ---CC--SHHHHHHHHHHHHHHC
T ss_pred CCCcc--ccCceechhhccHHHh
Confidence 54332 3456799999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=259.08 Aligned_cols=163 Identities=18% Similarity=0.294 Sum_probs=140.3
Q ss_pred cCCccccceecccCcccEEEEEEc--CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-----
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (617)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999985 4789999998643 33456688999999999999999999999987665
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.+|||||+++++|.+++.. .+++.+++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887732 5899999999999999999999988 9999999999999886 89999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+... ....||+.|+|||++
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIV 249 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHH
T ss_pred hcccC------CccCCCccccCHHHH
Confidence 87543 245699999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=232.52 Aligned_cols=176 Identities=28% Similarity=0.382 Sum_probs=144.7
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 513 (617)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999985 4889999998642 34456789999999999999999999998865 567899
Q ss_pred EEecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 514 IYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996532 2345899999999999999999999865 1239999999999999999999999999998
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .....||..|+|||.+
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~ 188 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQM 188 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHH
T ss_pred eecccccc--ccccCCCccccChHHh
Confidence 87543221 2234689999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=236.95 Aligned_cols=171 Identities=25% Similarity=0.402 Sum_probs=142.7
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC-----Ce
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (617)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999986 4889999999653 334456788999999999999999999998764 57
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 689998854 35899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCccc--------ccceeeeeccccCccCC
Q 007120 591 TFGGDETEG--------NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~--------~~~~~~gt~~y~ape~~ 616 (617)
.+....... ......||..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeee
Confidence 875432211 12234689999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=230.84 Aligned_cols=172 Identities=27% Similarity=0.373 Sum_probs=135.7
Q ss_pred cCCccccceecccCcccEEEEEEcC--C--cEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||.||+|++.. + ..||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4589999999999999999998642 3 36899998653 2345678999999999999999999999988765 8
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999653 245889999999999999999999987 99999999999999999999999999998
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......+|+.|+|||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESL 196 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHH
T ss_pred ccccccchhhhccCCCCceeeCchhh
Confidence 7654332 223345678899999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=240.86 Aligned_cols=165 Identities=28% Similarity=0.416 Sum_probs=125.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC------C
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 509 (617)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999864 4889999998652 334567888999999999999999999998764 4
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899888843 45899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||..|+|||++
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~ 201 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIM 201 (367)
T ss_dssp ----------------CCCTTCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHH
Confidence 976432 2345789999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=235.94 Aligned_cols=177 Identities=24% Similarity=0.302 Sum_probs=143.8
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCC--CCCccceEEEEEe
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQ 507 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~ 507 (617)
.+.+....++|++.+.||+|+||.||++...+++.||||.+.. ......+.+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3344555678999999999999999999988899999999864 23455678999999999997 5999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
.+..++||| +.+++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 6688999999652 45789999999999999999999987 999999999999964 899999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+.............||..|+|||.+
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAI 200 (313)
T ss_dssp SSCC--------------CCGGGCCHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHH
Confidence 99987655443334456799999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=240.66 Aligned_cols=168 Identities=20% Similarity=0.232 Sum_probs=142.2
Q ss_pred hcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccC------CCCCccceEEEEEeCCe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 510 (617)
...+|++.+.||+|+||.||+|.... ++.||||++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999998755 789999999753 33455677788777766 67899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC--eEEeecCC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGL 588 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~ki~DFGl 588 (617)
.++||||++ ++|.+++.... ...+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 68999886533 334899999999999999999999987 999999999999999887 99999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+..... .....||+.|+|||++
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVI 271 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHH
T ss_pred ceecCCc-----ccccCCCCCccChHHH
Confidence 9875432 2235789999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=254.61 Aligned_cols=176 Identities=22% Similarity=0.321 Sum_probs=144.1
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeC
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (617)
+.....++|++.+.||+|+||.||+|.+.. +..||||+++.. .....+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344456789999999999999999998743 457999998753 3344578999999999999999999999984 4
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 5689999999999999999643 345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+...... ......+|..|+|||++
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~ 564 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESI 564 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHH
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHh
Confidence 9987543322 22335577899999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=243.99 Aligned_cols=166 Identities=25% Similarity=0.362 Sum_probs=134.9
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC----C--eEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----E--EKL 512 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 512 (617)
.+|++.+.||+|+||.||+|+... ++.||||++.... +.+.+|+.++++++|||||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468889999999999999999864 8999999986532 2334799999999999999999998642 2 357
Q ss_pred EEEecCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCCce
Q 007120 513 LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVR 590 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGla~ 590 (617)
+||||+++ +|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999985 566555321 23456899999999999999999999987 9999999999999965 578999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... .....||+.|+|||++
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELI 228 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHH
Confidence 8754332 2235689999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=230.82 Aligned_cols=167 Identities=26% Similarity=0.417 Sum_probs=135.5
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC-eEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 516 (617)
..++|++.+.||+|+||.||++.. .++.||||.++.. ...+.+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346899999999999999999987 4889999998753 24567899999999999999999999976554 6899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 999999999996422 223788999999999999999999987 9999999999999999999999999998764322
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
....+|..|+|||.+
T Consensus 172 -----~~~~~~~~y~aPE~~ 186 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEAL 186 (278)
T ss_dssp ---------CCTTTSCHHHH
T ss_pred -----cCCCccccccCHHHh
Confidence 224578899999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=238.20 Aligned_cols=175 Identities=22% Similarity=0.277 Sum_probs=131.4
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe--
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 510 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 510 (617)
......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556689999999999999999999985 4889999998653 2333456778888899999999999999976443
Q ss_pred -----EEEEEecCCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecccCCCcEEEcC-CCCe
Q 007120 511 -----KLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDQ-DMNP 581 (617)
Q Consensus 511 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~iiHrDlkp~NiLl~~-~~~~ 581 (617)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999986 44444332 234556889999999999999999999 766 999999999999997 8999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+++.+..... .....||..|+|||++
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELI 203 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHH
Confidence 9999999998764433 2235689999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=239.99 Aligned_cols=168 Identities=16% Similarity=0.249 Sum_probs=141.5
Q ss_pred cCCccccceecccCcccEEEEEEcC---------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccc---------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 500 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 500 (617)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999764 788999998653 46889999999999999998
Q ss_pred ------eEEEEEe-CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcE
Q 007120 501 ------LLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (617)
Q Consensus 501 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni 573 (617)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6788877 67889999999 999999997532 356899999999999999999999987 99999999999
Q ss_pred EEcCCC--CeEEeecCCceeeCCCCccc-----ccceeeeeccccCccCC
Q 007120 574 LLDQDM--NPKISDFGLVRTFGGDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 574 Ll~~~~--~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
||+.++ .+||+|||+++.+....... ......||..|+|||.+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence 999998 99999999999875432211 11234799999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=225.88 Aligned_cols=171 Identities=22% Similarity=0.367 Sum_probs=139.8
Q ss_pred hcCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEE-EeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 515 (617)
..++|++.+.||+|+||.||+|+. .+++.||||.+... .....+.+|+.+++.++|++++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999997 45889999987542 2234688899999999998877777666 5677889999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~ 592 (617)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||| ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999999642 335899999999999999999999988 9999999999999 78999999999999987
Q ss_pred CCCCccc-----ccceeeeeccccCccCC
Q 007120 593 GGDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
....... ......||..|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 187 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTH 187 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHh
Confidence 6543321 22346799999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-26 Score=239.19 Aligned_cols=166 Identities=11% Similarity=0.076 Sum_probs=124.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHH---HHHccCCCCCccceE-------EE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLL-------GC 504 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 504 (617)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+++|+ .+++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 446889999999999999999975 58899999997632 24456777884 45555 799988755 45
Q ss_pred EEeC-----------------CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 007120 505 CIQG-----------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR------FHIICGTARGLLYLHQDSRL 561 (617)
Q Consensus 505 ~~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~ 561 (617)
+... ...+|||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 4433 33799999999 89999996532 23455556 788899999999999988
Q ss_pred ceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 562 ~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+||||||+||||+.++.+||+|||+|+...... ....+|..|+|||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~ 263 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFL 263 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhc
Confidence 9999999999999999999999999999764321 134567999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=228.12 Aligned_cols=170 Identities=29% Similarity=0.402 Sum_probs=146.2
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999986 5889999998653 233467899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC---CCeEEeecCCcee
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~ki~DFGla~~ 591 (617)
+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999988542 35899999999999999999999987 9999999999999764 4799999999987
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||..|+|||.+
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVL 195 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHH
T ss_pred ecCCCc---cccccCcccccChHHh
Confidence 754332 2234589999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=237.11 Aligned_cols=164 Identities=26% Similarity=0.416 Sum_probs=138.1
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE----
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK---- 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 511 (617)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999975 4889999999752 334467889999999999999999999999887655
Q ss_pred --EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 512 --LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 512 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68888772 23899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||..|+|||++
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~ 213 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVI 213 (371)
T ss_dssp -------------CTTCCCTTSCHHHH
T ss_pred cccccC-----cCCcccCccccCHHHh
Confidence 976432 2235689999999965
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=229.57 Aligned_cols=167 Identities=21% Similarity=0.332 Sum_probs=143.0
Q ss_pred cCCccccceecccCcccEEEEEE-c-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC------ccceEEEEEeCCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-V-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 510 (617)
.++|++.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 5789999999753 345677889999998887664 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-------------
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 577 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~------------- 577 (617)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 899999986532 345889999999999999999999987 999999999999987
Q ss_pred ------CCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 578 ------DMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 578 ------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++.+||+|||+++..... .....||..|+|||++
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~ 206 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVI 206 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHh
Confidence 678999999999975432 2235689999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=229.42 Aligned_cols=172 Identities=25% Similarity=0.327 Sum_probs=127.6
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHH-HHccCCCCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3468899999999999999999985 5889999999753 2334445556665 78889999999999999999999999
Q ss_pred EecCCCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 515 YEFMPNKSLDSFIFDQ--TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 887777431 1245689999999999999999999997 7 99999999999999999999999999988
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||..|+|||++
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERI 197 (327)
T ss_dssp -------------------------
T ss_pred cccccc---cccCCCCccccCceee
Confidence 754322 2234699999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=231.13 Aligned_cols=171 Identities=26% Similarity=0.424 Sum_probs=141.0
Q ss_pred hcCCccccceecccCcccEEEEEEc--CCcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCccceEEEEE----
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI---- 506 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 506 (617)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4568999999999999999999983 57899999986422 22234566777776665 8999999999997
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEee
Q 007120 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (617)
Q Consensus 507 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~D 585 (617)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4556899999998 69999986533 334889999999999999999999987 99999999999999999999999
Q ss_pred cCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 586 FGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+++.+.... ......||..|+|||++
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 191 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVL 191 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHH
T ss_pred CcccccccCCC---CccccccccceeCHHHH
Confidence 99998764322 23346689999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=236.65 Aligned_cols=167 Identities=23% Similarity=0.293 Sum_probs=139.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC--------CCCccceEEEEE---
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 506 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 506 (617)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999875 4789999999753 345677889999999885 788999999988
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCC-----
Q 007120 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM----- 579 (617)
Q Consensus 507 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~----- 579 (617)
.....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 56666666442 234589999999999999999999997 6 99999999999999775
Q ss_pred --------------------------------------------CeEEeecCCceeeCCCCcccccceeeeeccccCccC
Q 007120 580 --------------------------------------------NPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615 (617)
Q Consensus 580 --------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~ 615 (617)
.+||+|||+|+.+... .....||..|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999987532 223568999999997
Q ss_pred C
Q 007120 616 Y 616 (617)
Q Consensus 616 ~ 616 (617)
+
T Consensus 265 ~ 265 (397)
T 1wak_A 265 L 265 (397)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=240.95 Aligned_cols=170 Identities=25% Similarity=0.390 Sum_probs=125.8
Q ss_pred Cccc-cceecccCcccEEEEEEc---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEEE
Q 007120 441 NFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 514 (617)
Q Consensus 441 ~~~~-~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 514 (617)
.|++ .++||+|+||.||+|+.. +++.||||++... .....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 458999999999999975 4688999999753 223568899999999999999999999965 6688999
Q ss_pred EecCCCCCHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE----cCCCCeEEe
Q 007120 515 YEFMPNKSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKIS 584 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~ki~ 584 (617)
|||++ ++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 5787777421 12234899999999999999999999988 9999999999999 778999999
Q ss_pred ecCCceeeCCCCcc-cccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
|||+|+.+...... .......||+.|+|||++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhh
Confidence 99999987543221 223456799999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=235.43 Aligned_cols=176 Identities=28% Similarity=0.474 Sum_probs=142.2
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (617)
.+.....++|++.+.||+|+||.||+|...+ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344556789999999999999999998754 5999998642 22344678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999954 2345889999999999999999999987 99999999999998 6799999999988
Q ss_pred eeCCCCc---ccccceeeeeccccCccCC
Q 007120 591 TFGGDET---EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~---~~~~~~~~gt~~y~ape~~ 616 (617)
....... ........||..|+|||.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 206 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEII 206 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHH
T ss_pred ccccccccccccccccCCCcccccChHHh
Confidence 7642221 1222334589999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=224.34 Aligned_cols=170 Identities=22% Similarity=0.371 Sum_probs=142.4
Q ss_pred cCCccccceecccCcccEEEEEE-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEE-EeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 458999999986532 234688999999999998877666665 56778899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceeeC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~~ 593 (617)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 89999999642 345899999999999999999999987 9999999999999 588999999999999876
Q ss_pred CCCccc-----ccceeeeeccccCccCC
Q 007120 594 GDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
...... ......||..|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 187 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTH 187 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHH
T ss_pred ccccccccccccccccccccccCChhhh
Confidence 544321 12446799999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=233.37 Aligned_cols=164 Identities=26% Similarity=0.413 Sum_probs=137.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCe-----
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (617)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 4889999998652 33446788999999999999999999999987654
Q ss_pred -EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 68887762 23899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||..|+|||++
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~ 195 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVI 195 (353)
T ss_dssp TC-------------CCSBCCSCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHH
Confidence 876432 2235689999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=238.87 Aligned_cols=169 Identities=24% Similarity=0.268 Sum_probs=129.2
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEEecCC
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 519 (617)
.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|+.+++++ +|||||++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998776667999999998642 345678899999876 89999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-------------CCeE
Q 007120 520 NKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------MNPK 582 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-------------~~~k 582 (617)
|+|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996532211 1133345789999999999999987 9999999999999754 4899
Q ss_pred EeecCCceeeCCCCccc--ccceeeeeccccCccCC
Q 007120 583 ISDFGLVRTFGGDETEG--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 583 i~DFGla~~~~~~~~~~--~~~~~~gt~~y~ape~~ 616 (617)
|+|||+++.+....... ......||..|+|||++
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence 99999999886543321 23346799999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=232.12 Aligned_cols=172 Identities=23% Similarity=0.334 Sum_probs=136.5
Q ss_pred HHhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch------hhHHHHHHHHHHHccC----CCCCccceEE
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLLG 503 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g 503 (617)
.....++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999874 588999999965321 1233466788888888 8999999999
Q ss_pred EEEeCCeEEEEEec-CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCe
Q 007120 504 CCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNP 581 (617)
Q Consensus 504 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ 581 (617)
++...+..++|+|| +++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999965 235899999999999999999999987 99999999999999 88999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+++.+.... .....||..|+|||++
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~ 210 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWI 210 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHH
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceee
Confidence 999999999875433 2345689999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=239.35 Aligned_cols=171 Identities=23% Similarity=0.329 Sum_probs=134.0
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (617)
....+|++.+.||+|+||+|+.....+++.||||++.... ...+.+|+.+++.+ +|||||++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445788899999999999765555678999999986522 23466899999998 8999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-----CCCeEEeecCCce
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVR 590 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-----~~~~ki~DFGla~ 590 (617)
||++ |+|.+++.... .......+..++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+|+
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 69999996533 22344456789999999999999988 999999999999943 3468899999999
Q ss_pred eeCCCCcc-cccceeeeeccccCccCC
Q 007120 591 TFGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||+.|+|||++
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l 198 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEML 198 (432)
T ss_dssp CC------------CCSCTTSCCGGGT
T ss_pred eccCCCcceeeccccCCCcCccChhhh
Confidence 87644321 223446799999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=230.63 Aligned_cols=171 Identities=25% Similarity=0.332 Sum_probs=145.1
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccch------hhHHHHHHHHHHHccCC--CCCccceEEEEE
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCI 506 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~ 506 (617)
....++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445678999999999999999999864 588999999865321 12356778999999996 599999999999
Q ss_pred eCCeEEEEEecCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEEe
Q 007120 507 QGEEKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKIS 584 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki~ 584 (617)
..+..++|+||+.. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999964 345889999999999999999999987 99999999999999 78999999
Q ss_pred ecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 585 DFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||+++.+.... .....||..|+|||++
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~ 220 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWI 220 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHH
T ss_pred eCcccccccccc----ccCCCCCccCCChHHh
Confidence 999999875432 2235689999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=237.82 Aligned_cols=170 Identities=22% Similarity=0.365 Sum_probs=142.2
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.++||+|+||.||+|+.. +++.||||++.... ...++..|+.+++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999974 58999999876432 23468889999999987 556666777788889999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---cCCCCeEEeecCCceeeC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~ki~DFGla~~~~ 593 (617)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ ||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999642 345899999999999999999999987 9999999999999 688999999999999876
Q ss_pred CCCccc-----ccceeeeeccccCccCC
Q 007120 594 GDETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
...... ......||..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 185 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTH 185 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred CCccccccccccccccCCCccccCHHHh
Confidence 544321 12356799999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=225.33 Aligned_cols=167 Identities=22% Similarity=0.247 Sum_probs=121.4
Q ss_pred hcCCccccc-eecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeE
Q 007120 438 ATDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 511 (617)
Q Consensus 438 ~~~~~~~~~-~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 511 (617)
..++|.+.+ .||+|+||.||+|... +++.||||++... .... .+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 345788854 6999999999999986 4899999998652 2222 223334567799999999999976 4457
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGl 588 (617)
++||||+++|+|.+++.... ...+++.++..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999997532 346899999999999999999999987 999999999999976 45599999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
++...... .....||..|+|||++
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~ 201 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVL 201 (336)
T ss_dssp CEEC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhh
Confidence 99865332 2345689999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=229.15 Aligned_cols=172 Identities=23% Similarity=0.302 Sum_probs=142.3
Q ss_pred HhhcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CC-----CccceEEEEEeC
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQG 508 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~ 508 (617)
....++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345679999999999999999999975 4788999999753 344567788888888775 44 499999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc--CCCCeEEeec
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDF 586 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~ki~DF 586 (617)
+..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++ ..+||||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 59999986533 24589999999999999999999963 13499999999999994 5788999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+|+.+... .....||..|+|||++
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~ 230 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVL 230 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHH
T ss_pred cCceecccc-----cccccCCccccChHHH
Confidence 999987532 2235689999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=224.38 Aligned_cols=170 Identities=22% Similarity=0.343 Sum_probs=126.4
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
..++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467889999999999999999985 58999999996532 22334455666678899999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
|||+ ++.+..++.. ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4555555432 134589999999999999999999984 6 9999999999999999999999999998775
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.... .....||..|+|||++
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~ 196 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERI 196 (318)
T ss_dssp -------------CCTTCCHHHH
T ss_pred CCcc---ccccCCCccccChhhc
Confidence 4332 2345699999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=225.86 Aligned_cols=167 Identities=19% Similarity=0.305 Sum_probs=141.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-C-cEEEEEEecccchhhHHHHHHHHHHHccCCCCC------ccceEEEEEeCCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-G-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 510 (617)
.++|++.+.||+|+||.||+|.... + +.||||.++.. ....+.+.+|+.+++.++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4689999999999999999999753 4 68999999753 345667888999999987766 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEE---------------
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--------------- 575 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--------------- 575 (617)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 56777776543 2345899999999999999999999987 9999999999999
Q ss_pred ----cCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 576 ----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 576 ----~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.++.+||+|||+++...... ....||..|+|||++
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~ 211 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVI 211 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeee
Confidence 678899999999999754322 235689999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-25 Score=247.43 Aligned_cols=172 Identities=26% Similarity=0.366 Sum_probs=145.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe------CCe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 510 (617)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 4889999998653 44556789999999999999999999999765 667
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC---eEEeecC
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFG 587 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~ki~DFG 587 (617)
.++||||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555556889999999999999999999987 999999999999997665 9999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+++.+..... .....||..|+|||.+
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l 195 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELL 195 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSS
T ss_pred cccccccccc---cccccCCcccCChHHh
Confidence 9998754332 2346799999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=229.03 Aligned_cols=167 Identities=20% Similarity=0.294 Sum_probs=140.7
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCCccceEEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 506 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 506 (617)
.++|++.+.||+|+||.||+|+.. +++.||||.+.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 458999999999999999999974 588999999975 3344567888999988876 899999999998
Q ss_pred eCC----eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEc-----
Q 007120 507 QGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 576 (617)
Q Consensus 507 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~----- 576 (617)
... ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 899999996533 34489999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 577 -QDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 577 -~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..+.+||+|||+++.+... .....||..|+|||++
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL 207 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHH
Confidence 4458999999999987432 2235689999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=212.25 Aligned_cols=143 Identities=10% Similarity=0.068 Sum_probs=127.0
Q ss_pred cCCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+|.... ++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999865 899999999753 234457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
|||+++++|.+++.. . ....+..+|+.||+.||+|||+++ |+||||||+||||+.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999942 2 245578889999999999999988 999999999999999999999987754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-25 Score=240.49 Aligned_cols=156 Identities=18% Similarity=0.225 Sum_probs=122.8
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..+.||+|+||.||++.. .++.+++|+..... ....+.+.+|+.++++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 57888998764311 112456899999999999999997777777888889999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4579999999999999988 999999999999998 9999999999998654
Q ss_pred Cccc-----ccceeeeeccccCccCC
Q 007120 596 ETEG-----NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~-----~~~~~~gt~~y~ape~~ 616 (617)
+... ......||+.|+|||++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIW 508 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cccccchhhhhhhhcCCCCcCCHHHH
Confidence 3221 12356799999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-23 Score=210.13 Aligned_cols=148 Identities=24% Similarity=0.340 Sum_probs=127.5
Q ss_pred cCCcccc-ceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCCccceEEEEEe----CCeE
Q 007120 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEK 511 (617)
Q Consensus 439 ~~~~~~~-~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 511 (617)
.++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3467776 78999999999999974 4889999998642 3466788777 66799999999999987 6678
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGl 588 (617)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997632 345899999999999999999999987 999999999999998 78999999999
Q ss_pred ceeeCCC
Q 007120 589 VRTFGGD 595 (617)
Q Consensus 589 a~~~~~~ 595 (617)
++.+...
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=221.18 Aligned_cols=169 Identities=17% Similarity=0.199 Sum_probs=127.1
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC-CCccc------------
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH-RNLVK------------ 500 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~niv~------------ 500 (617)
...+|...+.||+|+||.||+|+.. +++.||||++.... ....+.|++|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456788899999999999999964 48999999987422 2336789999999999987 32111
Q ss_pred ---------eEEEEEe-----CCeEEEEEecCCCCCHHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007120 501 ---------LLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (617)
Q Consensus 501 ---------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (617)
+..+... ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346777765 6899988842 122445788899999999999999999987
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||||||||+||||+.++.+||+|||+++..... .....| ..|+|||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhh
Confidence 999999999999999999999999999976432 234567 999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=204.25 Aligned_cols=143 Identities=20% Similarity=0.176 Sum_probs=114.8
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccch------------------hhHHHHHHHHHHHccCC
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQ 494 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~ 494 (617)
..+......|++.+.||+|+||.||+|...+++.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566778899999999999999996789999999864221 13457899999999999
Q ss_pred CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEE
Q 007120 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (617)
Q Consensus 495 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL 574 (617)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 55699999999999987 411 123469999999999999988 999999999999
Q ss_pred EcCCCCeEEeecCCceeeC
Q 007120 575 LDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 575 l~~~~~~ki~DFGla~~~~ 593 (617)
|+ ++.+||+|||+|+.+.
T Consensus 226 l~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp EE-TTEEEECCCTTCEETT
T ss_pred EE-CCcEEEEECCCCeECC
Confidence 99 9999999999998653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=178.91 Aligned_cols=139 Identities=16% Similarity=0.170 Sum_probs=107.9
Q ss_pred CccccceecccCcccEEEEEE-cCCcE--EEEEEecccch------------------------hhHHHHHHHHHHHccC
Q 007120 441 NFSINNKLGEGGFGPVYKGTL-VDGQE--IAVKRLSKISE------------------------QGLKELKNEVILFSKL 493 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l 493 (617)
-|++.+.||+|+||.||+|.. .+|+. ||||.++.... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366788999999999999998 67888 99998753211 1123678999999999
Q ss_pred CCCCc--cceEEEEEeCCeEEEEEecCCC-C----CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceee
Q 007120 494 QHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIH 565 (617)
Q Consensus 494 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiH 565 (617)
+|+++ ..++.. ...+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88864 444442 356899999942 4 67666422 123456789999999999999 877 999
Q ss_pred cccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 566 RDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 566 rDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||||+|||++. .++|+|||+|..+..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999998643
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=136.50 Aligned_cols=98 Identities=22% Similarity=0.404 Sum_probs=78.4
Q ss_pred CCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCC
Q 007120 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (617)
Q Consensus 24 ~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 103 (617)
+.|+.+...+|.|..||+|+|.+. +++||++++.+......+ +|+|+|||||++ . +.++||||+
T Consensus 13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l-~l~~~GNLvl~d-~----~~~~W~S~~--------- 76 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVL-KMQNDGNLVIYS-G----SRAIWASNT--------- 76 (112)
T ss_dssp TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEE-EECTTSCEEEEE-T----TEEEEECCC---------
T ss_pred CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEE-EEeCCCCEEEEc-C----CEEEEECCc---------
Confidence 345555568899999999999987 899999997643233455 999999999998 3 579999994
Q ss_pred CcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEc-CCeEEEEeCCCCC
Q 007120 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNG 161 (617)
Q Consensus 104 q~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~~ 161 (617)
+|++|.|++.|+++|+ +++++ ...+||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4467889999999998 44555 4679999999976
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-16 Score=134.23 Aligned_cols=101 Identities=21% Similarity=0.368 Sum_probs=77.3
Q ss_pred ceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccC
Q 007120 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDY 95 (617)
Q Consensus 16 t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~ 95 (617)
..+|..++-. . +...+|.+..||+|||.+ .+++||++++.+......+ +|+|+|||||++.+ +.++||||
T Consensus 8 ~~L~~g~~l~-~-~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l-~l~~dGNLVl~~~~----~~~~W~S~-- 77 (110)
T 3a0c_A 8 NSLFTGHSLE-V-GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRL-TLHNNGNLVIYDQS----NRVIWQTK-- 77 (110)
T ss_dssp CEECTTCEEE-E-TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECC--
T ss_pred CEECCCCEEE-E-CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEE-EEeCCCCEEEECCC----CcEEEecC--
Confidence 3455544433 1 345889999999999998 5899999998643333456 99999999999864 67999999
Q ss_pred CCcccCCCCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007120 96 PSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (617)
Q Consensus 96 PTDTlLpgq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (617)
.+|++|.|++.|+++|+ +++++. .||+++++
T Consensus 78 -----------------------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------------------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999998 455665 89999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.9e-16 Score=129.88 Aligned_cols=70 Identities=17% Similarity=0.334 Sum_probs=59.5
Q ss_pred CCceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
..++||+|||+.|... .+.|+|+.||+|||.|+++++||+|++.+.....++ +|+|+|||||++. .||||
T Consensus 36 ~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l-~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 36 HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYIL-ILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTCCEEEECCCCCCSSCEEE-EECTTSCEEEEES-------EEEEC
T ss_pred CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCcEEEEEecCCCCCCCEEE-EEeCCCeEEEECC-------cEecC
Confidence 3589999999999864 478999999999999999999999998653344455 9999999999964 59998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=8.2e-17 Score=167.34 Aligned_cols=140 Identities=13% Similarity=0.174 Sum_probs=99.7
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccch--------------hhHHH--------HHHHHHHHccCCCC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------------QGLKE--------LKNEVILFSKLQHR 496 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l~~l~H~ 496 (617)
..-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 345889999999999999999998899999998753100 00111 23455566666544
Q ss_pred CccceEEEEEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc
Q 007120 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (617)
Q Consensus 497 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~ 576 (617)
++.-..-+... ..+|||||+++++|..+.. . .....++.||+.+|.|||..+ ||||||||.||||+
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 43221111111 2379999999988865431 1 123457899999999999987 99999999999998
Q ss_pred CCC----------CeEEeecCCceee
Q 007120 577 QDM----------NPKISDFGLVRTF 592 (617)
Q Consensus 577 ~~~----------~~ki~DFGla~~~ 592 (617)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999987764
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.1e-15 Score=128.86 Aligned_cols=86 Identities=21% Similarity=0.315 Sum_probs=70.3
Q ss_pred eeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceec
Q 007120 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (617)
Q Consensus 32 ~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (617)
.+|.|..||+|+|.+. +++||++++.+......+ +|+|+|||||++.+ +.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l-~l~~dGNLVl~d~~----~~~lW~S~------------------ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRA-VLQPDGVLVVITNE----NVTVWQSP------------------ 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECS------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEE-EEccCCEEEEEeCC----CcEEEcCC------------------
Confidence 5689999999999987 899999997643233456 99999999999864 67999999
Q ss_pred cCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 112 ~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
.+|++|.|++.++++|+ +++++ .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34678899999999998 44555 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.1e-15 Score=126.50 Aligned_cols=91 Identities=21% Similarity=0.358 Sum_probs=73.5
Q ss_pred ceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCccccee
Q 007120 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (617)
Q Consensus 31 ~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (617)
...|.+..||+|+|.+ .+++||++++.+......+ +|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l-~l~~~GnLvl~d~~----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRL-TLLSDGNLVIYDHN----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEE-EECCCCcEEEECCC----ceEEEEcCCC---------------
Confidence 4789999999999998 5889999997643233456 99999999999863 5799999997
Q ss_pred ccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCCCCc
Q 007120 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGL 162 (617)
Q Consensus 111 ~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~ 162 (617)
|++|.|++.++++|+ +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356788999999998 455654 89999999653
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.9e-14 Score=121.81 Aligned_cols=73 Identities=27% Similarity=0.371 Sum_probs=60.5
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||.||++.|. .++.++|..||||||.|.+|.++|+|.+....+..++ +|+|+|||||++. ++||||+
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~~g~~~l-~l~~dGnlvl~~~-------~~W~S~~ 107 (110)
T 3a0c_A 38 GKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVL-VLQQDRNVVIYGP-------VVWATGS 107 (110)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCCC--CcEEEEEeCCCCEEEECCCCcEEEecCCCCCCCCEEE-EEeCCccEEEECC-------CEecCCC
Confidence 5899999998763 3478999999999999999999999987643333355 9999999999862 6999999
Q ss_pred CCC
Q 007120 95 YPS 97 (617)
Q Consensus 95 ~PT 97 (617)
||.
T Consensus 108 ~~~ 110 (110)
T 3a0c_A 108 GPA 110 (110)
T ss_dssp CC-
T ss_pred cCC
Confidence 984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=119.27 Aligned_cols=74 Identities=20% Similarity=0.242 Sum_probs=61.7
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||+||++.|. .++.|+|..+|+|||.|.++.++|+|.+....+..++ +|+|+|||||++. ++||||.
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l-~l~~dGnlvl~~~-------~~W~S~~ 107 (115)
T 2dpf_A 38 GRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYAL-VLQKDGRFVIYGP-------VLWSLGP 107 (115)
T ss_dssp TEEEEECSCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEECSST
T ss_pred CEEEEeCCCCCCC--CceEEEECCCCcEEEECCCceEEEEcCCCCCCCCEEE-EEeCCCeEEEECC-------CEEECCC
Confidence 6899999999884 3578999999999999999999999987632333455 9999999999852 7999999
Q ss_pred CCCc
Q 007120 95 YPSD 98 (617)
Q Consensus 95 ~PTD 98 (617)
++..
T Consensus 108 ~~~~ 111 (115)
T 2dpf_A 108 NGCR 111 (115)
T ss_dssp TCBC
T ss_pred CCCc
Confidence 8765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.42 E-value=5.1e-13 Score=114.63 Aligned_cols=74 Identities=20% Similarity=0.376 Sum_probs=60.1
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||+||++.+ +.++.|+|..+|||||.| ++.++|+|.+....+..++ +|+++|||||++.. +.++||||+
T Consensus 37 ~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~~g~~~l-~l~~dGnlvl~~~~----~~~~W~S~~ 108 (112)
T 1xd5_A 37 NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYL-ILQRDRNVVIYDNS----NNAIWATHT 108 (112)
T ss_dssp TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-TTEEEEECCCCCSCCCCEE-EECTTSCEEEECTT----SCEEEECCC
T ss_pred CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-CCEEEEECCccCCCCCEEE-EEeCCCcEEEECCC----CceEEECCC
Confidence 589999999864 345789999999999999 8899999987542333455 99999999999743 568999999
Q ss_pred CC
Q 007120 95 YP 96 (617)
Q Consensus 95 ~P 96 (617)
+.
T Consensus 109 ~~ 110 (112)
T 1xd5_A 109 NV 110 (112)
T ss_dssp CC
T ss_pred cc
Confidence 84
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-12 Score=110.96 Aligned_cols=68 Identities=19% Similarity=0.390 Sum_probs=56.7
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
.++||+|||+.| +.++.|+|..||||||.|.++.++|+|.+....+..++ +|+|+|||||++. ++|||
T Consensus 48 ~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l-~l~~~Gnlvl~~~-------~~W~S 115 (119)
T 1b2p_A 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVL-VLQPDRNVVIYGD-------ALWAT 115 (119)
T ss_dssp TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEE-EECTTSCEEEEES-------EEEEC
T ss_pred CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEcCCCCCCCCCEEE-EEECCCcEEEECc-------cEeCC
Confidence 689999999877 33578999999999999999999999987642333455 9999999999872 79998
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=110.03 Aligned_cols=69 Identities=25% Similarity=0.349 Sum_probs=56.7
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeec
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSF 93 (617)
.++||++|++.+ +.++.|+|..||+|||.|.++.++|+|++.+.....++ +|+|+|||||++. ++|||=
T Consensus 37 ~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~-~L~ddGNlvly~~-------~~W~s~ 105 (109)
T 3dzw_A 37 DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVC-VLQKDRNVVIYGT-------ARWATG 105 (109)
T ss_dssp TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCEEE-EECTTSCEEEEES-------CCCCCC
T ss_pred CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECCCCCCCCCEEE-EEeCCCEEEEECC-------CEEeCC
Confidence 479999999876 34578999999999999999999999997643323345 9999999999974 589984
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.32 E-value=7e-12 Score=107.48 Aligned_cols=96 Identities=21% Similarity=0.241 Sum_probs=72.8
Q ss_pred CCCCCCCCceeEEEecCCcEEEEcC-CCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccC
Q 007120 23 RLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLL 101 (617)
Q Consensus 23 r~~pv~~~~~~l~l~~~G~L~l~~~-~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlL 101 (617)
.+.|+.+....|.+..||+|||.+. .++++|++++.+......+ +|+++|||||++.+ +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l-~l~~dGNLVl~d~~----~~~iW~S~t~------ 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFM-RLGHSGELDITDDR----LNTVFVSNTV------ 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----SCEEEECSCC------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEE-EEeCCCcEEEECCC----CCEEEECCCc------
Confidence 4677776668899999999999998 5899999998643233456 99999999999864 5689998431
Q ss_pred CCCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 102 PGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 102 pgq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
-..|.|.+.++.+|+..++ + .+.|.+++
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124578899999997665 3 58898874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=6.7e-12 Score=124.83 Aligned_cols=145 Identities=15% Similarity=0.057 Sum_probs=113.9
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 516 (617)
....|++...++.|+.+.||+... .++.+++|............+.+|+.+++.+. |..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345688778888888899999975 46899999986532223446888999998884 6788899999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-------------------------------------- 558 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------------------------------------- 558 (617)
|+++.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999987641 1122346888999999999981
Q ss_pred ------------------CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 559 ------------------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 559 ------------------~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998776678999998865
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=9.7e-12 Score=106.58 Aligned_cols=68 Identities=18% Similarity=0.289 Sum_probs=56.3
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
.++||.+|+..+- .++.|.|..+|+|||.|.+++++|++++....+..++ +|+|+|||||++ ..+|+|
T Consensus 44 ~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~-~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 44 TNIVWESGTSGRG--QHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVL-ILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTSCEEEECSCCCSSSCCEE-EECTTSCEEEEC-------SEEEES
T ss_pred CEEEEECCcccCC--cCEEEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEE-EEcCCceEEEec-------CCEecC
Confidence 5799999998762 3478999999999999999999999998643333455 999999999996 269997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=3.3e-11 Score=102.82 Aligned_cols=96 Identities=13% Similarity=0.173 Sum_probs=71.3
Q ss_pred CCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCC
Q 007120 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (617)
Q Consensus 24 ~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 103 (617)
+.++......|.+..||+|||.+.++ +|++++.+......+ +|+|+|||||++.++ +.++|||..+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l-~l~~dGNLVl~~~~~---~~~vW~S~t~-------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTL-RLNNRGQLEIHSANS---NTPVWVYPRS-------- 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEE-EECTTSCEEEECSSC---SSCSEEESSS--------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEE-EEcCCCcEEEEeCCC---CEEEEEeccc--------
Confidence 45555455789999999999999877 999998643233456 999999999998641 3369999731
Q ss_pred CcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 104 q~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
.....|.|.+.++.+|+..++ . .++|.+++
T Consensus 80 ---------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ---------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ---------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011346789999999997665 3 68998875
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.1e-11 Score=103.84 Aligned_cols=67 Identities=22% Similarity=0.374 Sum_probs=54.3
Q ss_pred ceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 16 t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
.+||.+|++.. +.++.|+|..+|+|||.|.++.++|++++....+..++ +|+|+|||||++. .+|+|
T Consensus 42 ~~vW~snt~~~--~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~-~L~~dGNlvly~~-------~~W~t 108 (110)
T 3r0e_B 42 KYGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVL-ILQDDGFGVIYGP-------AIFET 108 (110)
T ss_dssp SSCEECCCTTS--SSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEEES
T ss_pred eEEEECCCcCC--CcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEE-EEcCCccEEEecC-------CEecC
Confidence 47999999863 33478999999999999999999999987542333455 9999999999963 69987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.16 E-value=8.7e-11 Score=99.87 Aligned_cols=71 Identities=20% Similarity=0.285 Sum_probs=56.2
Q ss_pred EEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCC
Q 007120 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPS 97 (617)
Q Consensus 18 VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PT 97 (617)
+|.+|+..+ +.++.|+|..||+|||.|.++.++|++++.+......+ +|+|+|||||++ ..+|+|
T Consensus 39 ~Wssnt~~~--~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~-~L~~dGNlvly~-------~~~W~s----- 103 (109)
T 3r0e_A 39 NWQSNTANN--GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAA-VVHPDGRLVVFG-------PSVFKI----- 103 (109)
T ss_dssp TEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEE-EEETTTEEEEEC-------SEEEEE-----
T ss_pred eEEcCCCCC--CCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEE-EEcCCCeEEEEe-------cCEECC-----
Confidence 699998865 23578999999999999999999999987642233455 999999999996 269998
Q ss_pred cccCCC
Q 007120 98 DTLLPG 103 (617)
Q Consensus 98 DTlLpg 103 (617)
.|.+||
T Consensus 104 ~t~~~~ 109 (109)
T 3r0e_A 104 DPWVRG 109 (109)
T ss_dssp CTTSCC
T ss_pred CCccCC
Confidence 555543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=4.7e-11 Score=118.14 Aligned_cols=139 Identities=17% Similarity=0.133 Sum_probs=102.6
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--ccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey 517 (617)
..+.+....+.|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345543333456669999998766788999987543 2356788999888886544 56789988887888999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-------------------------------------- 559 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-------------------------------------- 559 (617)
+++.+|. .. . .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 21 1 11 2256777888888888642
Q ss_pred -----------------CCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 560 -----------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 560 -----------------~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+..++|+|++|.|||++++..++|+||+.+..-
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999988777789999998764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.2e-10 Score=96.50 Aligned_cols=92 Identities=15% Similarity=0.289 Sum_probs=67.0
Q ss_pred CCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCC
Q 007120 25 NPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGM 104 (617)
Q Consensus 25 ~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq 104 (617)
.++......|.+..||+|||.+. .++|++++.+......+ +|+|+|||||++.+ +.++|||-.+-
T Consensus 19 ~~L~sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l-~l~~dGNLvl~d~~----~~~iW~S~t~~-------- 83 (110)
T 3r0e_B 19 GRLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFL-RLNHKGELIIKDDD----FKTIWSSRSSS-------- 83 (110)
T ss_dssp EEEECSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEE-EECTTSCEEEECTT----CCEEEECCCCC--------
T ss_pred CEEEeCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEE-EEeCCCcEEEEeCC----CCEEEEcCCcC--------
Confidence 34433447899999999999877 58999998642223455 99999999999864 56899986410
Q ss_pred cccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 105 KLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 105 ~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
..|.|.+.++.+|+..++ + .+.|.+|+
T Consensus 84 -----------------------~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -----------------------KQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -----------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -----------------------CCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 123478889999987665 3 37888763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=5e-10 Score=95.25 Aligned_cols=87 Identities=17% Similarity=0.301 Sum_probs=64.5
Q ss_pred ceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCccccee
Q 007120 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (617)
Q Consensus 31 ~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (617)
...|.+..||+|||.+. ++++|++++.+......+ +|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l-~l~~dGNLvl~~~~----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHL-SMQSDGNLVVYSPR----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEE-EECTTSCEEEECTT----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEE-EEeCCCCEEEECCC----CCEEEECCCCC--------------
Confidence 47899999999999987 789999998643233455 99999999999864 56899986421
Q ss_pred ccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 111 ~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
..+.|.+.++.+|+..++ +. +.|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124578889999987654 32 5566553
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.05 E-value=6.3e-10 Score=94.51 Aligned_cols=93 Identities=18% Similarity=0.337 Sum_probs=69.3
Q ss_pred CCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCC
Q 007120 23 RLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLP 102 (617)
Q Consensus 23 r~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLp 102 (617)
.+.|+.+....|.+..||||||.++ +|++++.+......+ +|.++|||||++.+ +.++|+|-..
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l-~l~~dGnLvl~d~~----~~~vWss~t~------- 77 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKL-TLTDYGELVIKNGD----GSTVWKSGAQ------- 77 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEE-EECTTSCEEEECTT----SCEEEECCCC-------
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEE-EEcCCCeEEEEeCC----CCEEEcCCCc-------
Confidence 4566655567899999999999985 799998753233455 99999999999864 5689976210
Q ss_pred CCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007120 103 GMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (617)
Q Consensus 103 gq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (617)
...+.|.+.++++|+..++ + .+.|.+++|
T Consensus 78 ------------------------~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 ------------------------SVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ------------------------CSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ------------------------CCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 0235678899999887665 3 589999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.4e-09 Score=113.36 Aligned_cols=142 Identities=17% Similarity=0.214 Sum_probs=106.7
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEec--ccc-hhhHHHHHHHHHHHccCC--CCCccceEEEEEeC---CeEEEEE
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIY 515 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 515 (617)
..+.|+.|.+..||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.++++++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3478899999999998874 4678888775 321 123457888999998887 45688999998776 3479999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------ 559 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------ 559 (617)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123677888889999999999999731
Q ss_pred -------------------CCceeecccCCCcEEEcCCCC--eEEeecCCcee
Q 007120 560 -------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (617)
Q Consensus 560 -------------------~~~iiHrDlkp~NiLl~~~~~--~ki~DFGla~~ 591 (617)
+..++|+|++|.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 69999999885
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.87 E-value=1.4e-08 Score=85.56 Aligned_cols=77 Identities=19% Similarity=0.348 Sum_probs=58.4
Q ss_pred eeEEEecCCcEEEEcCCCcEEEeeCCccCc-CCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCccccee
Q 007120 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (617)
Q Consensus 32 ~~l~l~~~G~L~l~~~~~~~vWst~~~~~~-~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (617)
-+|.+..||||||.+. +++||++++.+.. ....+ +|.++|||||+|.+ +.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L-~l~~dGnLvL~d~~----~~~vWss~t---------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSA-VLQSDGNFVVYDSS----GRSLWASHS---------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEE-EECTTSCEEEECTT----CCEEEECCC----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEE-EEeCCccEEEECCC----cEEEEEecC----------------
Confidence 5799999999999985 5799999976432 23445 89999999999875 678998621
Q ss_pred ccCCcceEEEeecCCCCCCcceEEEEecCCCceEE
Q 007120 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVV 145 (617)
Q Consensus 111 ~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~ 145 (617)
....+.|.+.++++|+..++
T Consensus 79 ---------------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ---------------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ---------------CCCSSCEEEEECTTSCEEEE
T ss_pred ---------------CCCCCCEEEEEeCCCeEEEE
Confidence 11345688999999987654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.87 E-value=3.7e-09 Score=90.03 Aligned_cols=65 Identities=17% Similarity=0.155 Sum_probs=51.5
Q ss_pred EEEccCCCCCCCCceeEEEecCCcEEEEcCCCc-EEEeeCCccC--cCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNI-VVWSAYLSKE--VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 18 VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~-~vWst~~~~~--~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
||.+|+..+. ..+.|+|..+|+|||.|.++. ++|+|++... .....+ .|+++|||||++ ..+|+|
T Consensus 40 vW~snt~~~~--~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l-~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 40 GFQSNTHGRG--VDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAA-TLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CEECCCTTSC--SSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEE-EECTTSCEEEEC-------SEEEEC
T ss_pred EEECCcccCC--cCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEE-EECCCCeEEEec-------cCEEcc
Confidence 9999998762 347899999999999999876 5999986321 223345 999999999996 369997
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.78 E-value=3.3e-08 Score=96.41 Aligned_cols=88 Identities=19% Similarity=0.278 Sum_probs=67.1
Q ss_pred ceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCccccee
Q 007120 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (617)
Q Consensus 31 ~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (617)
.-.|.|..+|+|+|.+. +++||.+++.+. ....+ +|.++|||||+|.+ +.++|+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l-~l~~dGnLvl~d~~----~~~vW~s~~~--------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRA-VLQSDGLLVILTAQ----NTIRWSSGTK--------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBC-CBCSSSCBCCBCTT----TCCSCCCCCC---------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEE-EEcCCCcEEEEcCC----CcEEEeCCcc---------------
Confidence 36788889999999886 789999997643 44455 89999999999864 6789999874
Q ss_pred ccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCCC
Q 007120 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWN 160 (617)
Q Consensus 111 ~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 160 (617)
.++|.|.+.++.+|+..++ +. .+|.+..+.
T Consensus 85 ----------------~~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p 114 (236)
T 1dlp_A 85 ----------------GSIGNYVLVLQPDRTVTIY--GP--GLWDSGTSN 114 (236)
T ss_dssp ----------------CCSSCCEEEECSSSCEEEE--CS--EEEECSCCC
T ss_pred ----------------ccCCcEEEEEeCCCCEEEe--cC--CEEECCCCC
Confidence 0245677888888886553 22 789887653
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.8e-08 Score=100.19 Aligned_cols=70 Identities=23% Similarity=0.438 Sum_probs=58.7
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.+++|.+++..+- . ..|.+..+|+|++.|.++.++|++++.+ .....+ +|+++|||||++. .++|||||
T Consensus 183 ~~~yW~Sgt~~~~--~-~~l~l~~dGnLvl~d~~~~~vWsS~t~~-~~~~rl-~Ld~dGnLvly~~------~~~Wqsf~ 251 (276)
T 3m7h_A 183 GAATWNAGTQGKG--A-VRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVL-RLQANGSIAILDE------KPVWARFG 251 (276)
T ss_dssp SSEEEECCCTTTT--C-CEEEECTTSCEEEECTTSCEEEECSCTT-CTTCEE-EECTTSCEEEEEE------EEEEESSS
T ss_pred CeEEEECCCCCCc--c-EEEEEcCCCeEEEEeCCCcEEEEecCCC-CCCEEE-EEcCCccEEEEcC------CCeEEccC
Confidence 5789999998762 2 6899999999999999889999998764 234455 9999999999973 47999999
Q ss_pred C
Q 007120 95 Y 95 (617)
Q Consensus 95 ~ 95 (617)
|
T Consensus 252 ~ 252 (276)
T 3m7h_A 252 F 252 (276)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=2e-07 Score=94.49 Aligned_cols=136 Identities=20% Similarity=0.209 Sum_probs=98.9
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCC--ccceEEEEEeCC---eEEEEEecCC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRN--LVKLLGCCIQGE---EKLLIYEFMP 519 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~~ 519 (617)
+.++.|....||+.. ..+++|+... ......+.+|..+++.+ .+.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999998753 5688887653 23456788999999887 3333 445655544333 3479999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 007120 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD----------------------------------------- 558 (617)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------------- 558 (617)
+.+|..... ..++..++..++.++++.|..||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865432 2256677778888888888888861
Q ss_pred --------------CCCceeecccCCCcEEEcC--CCCeEEeecCCceee
Q 007120 559 --------------SRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTF 592 (617)
Q Consensus 559 --------------~~~~iiHrDlkp~NiLl~~--~~~~ki~DFGla~~~ 592 (617)
.+..++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 566899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.5e-06 Score=86.54 Aligned_cols=137 Identities=20% Similarity=0.141 Sum_probs=94.1
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC---CccceEEEEE-eCCeEEEEEecCCC
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPN 520 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 520 (617)
.+.++.|....||+. +..+++|+... ......+..|..+++.+.+. .+.+.+.++. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888889887 56788887532 23456789999999998753 3667777775 34457899999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------------------------------------------ 558 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------------ 558 (617)
..|...... .++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 123344444555555555555532
Q ss_pred ---------------CCCceeecccCCCcEEEcC---CCC-eEEeecCCceee
Q 007120 559 ---------------SRLRIIHRDLKASNVLLDQ---DMN-PKISDFGLVRTF 592 (617)
Q Consensus 559 ---------------~~~~iiHrDlkp~NiLl~~---~~~-~ki~DFGla~~~ 592 (617)
.+..++|+|+.|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 589999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=4.6e-06 Score=82.63 Aligned_cols=136 Identities=17% Similarity=0.142 Sum_probs=96.9
Q ss_pred ceecccCcc-cEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 446 NKLGEGGFG-PVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 446 ~~iG~G~fG-~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
+.+..|..+ .||+..... +..+++|+-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 355556665 589877643 56788887653 23456788888887774 4447789999999999999999999988
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 007120 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------------- 559 (617)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------------- 559 (617)
+.+..... ......++.+++..|.-||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87654221 1122345556666666666421
Q ss_pred ------------CCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 560 ------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 560 ------------~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887788999999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=2.7e-06 Score=88.05 Aligned_cols=80 Identities=6% Similarity=0.000 Sum_probs=55.3
Q ss_pred ccee-cccCcccEEEEEEc-------CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC---CCccceEEEEEeC--
Q 007120 445 NNKL-GEGGFGPVYKGTLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG-- 508 (617)
Q Consensus 445 ~~~i-G~G~fG~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~-- 508 (617)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999988764 26678888765422 0012457788888887742 3577888887655
Q ss_pred -CeEEEEEecCCCCCHH
Q 007120 509 -EEKLLIYEFMPNKSLD 524 (617)
Q Consensus 509 -~~~~lV~Ey~~~gsL~ 524 (617)
...++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 2468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.7e-05 Score=79.96 Aligned_cols=75 Identities=9% Similarity=0.139 Sum_probs=49.2
Q ss_pred cceecccCcccEEEEEEc-CCcEEEEEEecccch-------hhHHHHHHHHHHHccCCC--C-CccceEEEEEeCCeEEE
Q 007120 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQH--R-NLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~l 513 (617)
.+.||.|.++.||++... +++.++||....... .....+..|..+++.+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999764 467899998643211 123456778888876632 3 34466654 4556789
Q ss_pred EEecCCCC
Q 007120 514 IYEFMPNK 521 (617)
Q Consensus 514 V~Ey~~~g 521 (617)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00011 Score=75.09 Aligned_cols=141 Identities=17% Similarity=0.248 Sum_probs=78.9
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccC-----CCCCccceE-E--EEEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLL-G--CCIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~Ey 517 (617)
+.|+.|....||+....++ .+++|+.... . ..+..|..++..| ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4565667889999887544 5889988652 1 2223344444333 334444310 1 12346678999999
Q ss_pred CCCCCHH-----------HH---HhcCCC----C-------CCCCHHHHH------------------------------
Q 007120 518 MPNKSLD-----------SF---IFDQTR----R-------TLLDWSQRF------------------------------ 542 (617)
Q Consensus 518 ~~~gsL~-----------~~---l~~~~~----~-------~~l~~~~~~------------------------------ 542 (617)
+++..+. .. ++.... . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11 111100 0 112332211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 543 -HIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 543 -~i~~~ia~gl~yLH~----------~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
.+...+..++.+|++ ..+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011223446667763 1234699999999999998888999999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00023 Score=71.10 Aligned_cols=79 Identities=16% Similarity=0.206 Sum_probs=57.2
Q ss_pred CccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCC---CCccceEEEEEeCCeEEEEEec
Q 007120 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+.-.+.+|.|..+.||+.++.+|+.|.||+...........|..|...|+.|.. --+.+++++ + ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 4455678999999999999999999999998754333334467889888887742 234556654 2 24789999
Q ss_pred CCCCCH
Q 007120 518 MPNKSL 523 (617)
Q Consensus 518 ~~~gsL 523 (617)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0011 Score=66.96 Aligned_cols=139 Identities=15% Similarity=0.105 Sum_probs=92.9
Q ss_pred ccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCccceEEEEEeCCeEEEEEecCCC
Q 007120 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
..+.|+.|....+|+... +++.+++|..... ....+..|...|+.|. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999875 5678888887542 3567888988888774 35688999998888889999999998
Q ss_pred CCHH--------HH---HhcCCC-C------------------CCCCHHHHH---HHH--H--------------HHHHH
Q 007120 521 KSLD--------SF---IFDQTR-R------------------TLLDWSQRF---HII--C--------------GTARG 551 (617)
Q Consensus 521 gsL~--------~~---l~~~~~-~------------------~~l~~~~~~---~i~--~--------------~ia~g 551 (617)
..+. .. |+.... . -.-+|...+ ++. . .+..-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 11 222111 0 012454322 111 1 11111
Q ss_pred -HHHHHh-CCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 552 -LLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 552 -l~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
...|.. ..++.+||+|+.+.||+++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00057 Score=72.26 Aligned_cols=73 Identities=11% Similarity=0.161 Sum_probs=45.0
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEeccc----chh-----hHHHHHHHHHHHc-cCCCCCccceEEEEEeCCeEEEE
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQ-----GLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~----~~~-----~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.+.||.|....||+... +++.++||..... ... ....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999864 4678999943210 110 1223333433322 22234566777765 5667999
Q ss_pred EecC-CC
Q 007120 515 YEFM-PN 520 (617)
Q Consensus 515 ~Ey~-~~ 520 (617)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0035 Score=63.76 Aligned_cols=142 Identities=14% Similarity=0.054 Sum_probs=72.3
Q ss_pred ceecccCccc-EEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--CCccceEEEEEeCCeEEEEEecCCCCC
Q 007120 446 NKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (617)
Q Consensus 446 ~~iG~G~fG~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 522 (617)
+.|+.|.... +|+....+++.+++|...... ...+..|+.++..+.. -.+.+++.+..+. -++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3455554433 667665446677777654321 1234455666555532 3356677764333 378999998766
Q ss_pred HHHHHhcC---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 007120 523 LDSFIFDQ---------------------TRR--TLLDWSQRF-------H-------------IICGTARGLLYLH--- 556 (617)
Q Consensus 523 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~~ia~gl~yLH--- 556 (617)
+.+++... ... ...+..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 000 111111000 0 0001111222221
Q ss_pred hCCCCceeecccCCCcEEEcCC----CCeEEeecCCceee
Q 007120 557 QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRTF 592 (617)
Q Consensus 557 ~~~~~~iiHrDlkp~NiLl~~~----~~~ki~DFGla~~~ 592 (617)
...+..++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999875 68999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0034 Score=63.40 Aligned_cols=143 Identities=15% Similarity=0.107 Sum_probs=78.1
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--ccceEEE------EEeCCeEEEEEec
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYEF 517 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~Ey 517 (617)
+.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+...+ +.+++.. ....+..++|+||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999887555 6788887642 11234455666665553211 2333321 1234567899999
Q ss_pred CCCCCHHH-----H---------HhcCCC----C--C---CCCHHHHHHH------------HHHHHHHHHHHHhC----
Q 007120 518 MPNKSLDS-----F---------IFDQTR----R--T---LLDWSQRFHI------------ICGTARGLLYLHQD---- 558 (617)
Q Consensus 518 ~~~gsL~~-----~---------l~~~~~----~--~---~l~~~~~~~i------------~~~ia~gl~yLH~~---- 558 (617)
+++..+.. + ++.... . . ...|...+.- ...+.+.++.++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865321 0 111100 0 0 0123221110 11234455555532
Q ss_pred CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 559 ~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
.+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234589999999999999876678999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0013 Score=69.73 Aligned_cols=72 Identities=19% Similarity=0.319 Sum_probs=48.0
Q ss_pred ceecccCcccEEEEEEcC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEe
Q 007120 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 516 (617)
+.|+.|-...+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 577888888999998753 468888887431 111445578888877743333 56776543 2 38999
Q ss_pred cCCCCCH
Q 007120 517 FMPNKSL 523 (617)
Q Consensus 517 y~~~gsL 523 (617)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0023 Score=64.09 Aligned_cols=138 Identities=12% Similarity=0.097 Sum_probs=74.4
Q ss_pred cceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEecC-CCCC
Q 007120 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKS 522 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 522 (617)
.+.|+.|....+|+. +.+++|+....... .....+|..+++.+...++ .++++. +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578888999999998 55788877542111 1223456666666543222 456554 344457899999 6554
Q ss_pred HHHH------------------HhcCCC--CCCCCHHH-HHHHHH--------------HHHHHH----HHHHh-CCCCc
Q 007120 523 LDSF------------------IFDQTR--RTLLDWSQ-RFHIIC--------------GTARGL----LYLHQ-DSRLR 562 (617)
Q Consensus 523 L~~~------------------l~~~~~--~~~l~~~~-~~~i~~--------------~ia~gl----~yLH~-~~~~~ 562 (617)
|... |+.... ....+... ...+.. .+.+.+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4310 111110 00011111 111100 011111 11111 22345
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 563 IIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 563 iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0088 Score=60.48 Aligned_cols=142 Identities=14% Similarity=0.145 Sum_probs=79.0
Q ss_pred ceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CccceEEE-----EEeCCeEEEEEecC
Q 007120 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFM 518 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~Ey~ 518 (617)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 77788998877667789999886321 1234556677766665321 23444432 22345668899999
Q ss_pred CCCCHH-----HH---------HhcC----C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 007120 519 PNKSLD-----SF---------IFDQ----T--RRTLLDWSQR----FHI---------------ICGTARGLLYLHQ-- 557 (617)
Q Consensus 519 ~~gsL~-----~~---------l~~~----~--~~~~l~~~~~----~~i---------------~~~ia~gl~yLH~-- 557 (617)
++..+. .+ ++.. . .....++... ..+ ...+.+.++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 1110 0 0111222111 000 0111122233321
Q ss_pred --CCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 558 --DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 558 --~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999988765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0098 Score=63.33 Aligned_cols=73 Identities=15% Similarity=0.122 Sum_probs=46.4
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEecCCCCCH
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
+.|+.|-...+|+....+ +..+++|+....... .-....|..+++.|...++ .++++.+ .+ .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 578888888999998765 477888876432211 1122578888887765444 5677766 23 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0037 Score=64.82 Aligned_cols=141 Identities=18% Similarity=0.251 Sum_probs=81.0
Q ss_pred ceecccCcccEEEEEEcC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-ccceEEEEEeCCeEEEEEe
Q 007120 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 516 (617)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|..+++.+.-.+ ..++++.+.+ . +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence 567778788899988642 468888886332 123455668888887774222 3567766543 2 9999
Q ss_pred cCCCCCHHHH-----------------HhcCC--CCCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 007120 517 FMPNKSLDSF-----------------IFDQT--RRTLLD--WSQRFHIICGTA-------------------RGLLYL- 555 (617)
Q Consensus 517 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~gl~yL- 555 (617)
|+++..|..- |+... -..... |.+..++..++. ..+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 11110 011122 344444443332 122333
Q ss_pred ---Hh-CCCCceeecccCCCcEEEcCC----CCeEEeecCCcee
Q 007120 556 ---HQ-DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (617)
Q Consensus 556 ---H~-~~~~~iiHrDlkp~NiLl~~~----~~~ki~DFGla~~ 591 (617)
.. ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123458999999999999876 7899999998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0056 Score=63.22 Aligned_cols=73 Identities=14% Similarity=0.169 Sum_probs=43.1
Q ss_pred ceecccCcccEEEEEEcC---------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-ccceEEEEEeCCeEEEEE
Q 007120 446 NKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 515 (617)
+.|+.|..-.+|+....+ ++.+++|+...... .......|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467778788899988654 26788887654221 1223456777777764333 34666543 2 36899
Q ss_pred ecCCCCCH
Q 007120 516 EFMPNKSL 523 (617)
Q Consensus 516 Ey~~~gsL 523 (617)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.085 Score=53.61 Aligned_cols=33 Identities=24% Similarity=0.310 Sum_probs=28.8
Q ss_pred CCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 560 ~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+..++|+|+.+.||+++.++.+.|.||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 345999999999999998888999999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.00 E-value=0.34 Score=50.78 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=81.4
Q ss_pred ceecccCcccEEEEEEcC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-ccceEEEEEeCCeEEEEEe
Q 007120 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 516 (617)
+.+..|-.-.+|+....+ ++.+++|+...... ..-...+|..+++.+...+ ..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567777788899988753 57788888644221 1223356777776664222 34566533 2 278999
Q ss_pred cCCCCCHHH-------H-------H---hc--C-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 007120 517 FMPNKSLDS-------F-------I---FD--Q-----T---RRTLLDWSQRFHIICGT-------------------AR 550 (617)
Q Consensus 517 y~~~gsL~~-------~-------l---~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a~ 550 (617)
|+++..|.. . | +. . . ...+.-|.+..++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865421 0 1 10 0 0 11111243333332221 22
Q ss_pred HHHHHHh---------------------CCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 551 GLLYLHQ---------------------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 551 gl~yLH~---------------------~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
.+..|.+ ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 12345899999999999 8888999999998874
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.06 E-value=0.79 Score=35.61 Aligned_cols=35 Identities=29% Similarity=0.530 Sum_probs=28.0
Q ss_pred cCCChHhHHHhhccCCceEEEEeeccCCCCceeeeccc
Q 007120 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342 (617)
Q Consensus 305 ~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~ 342 (617)
..+++++|+..|+.+=.|.+|.|.. ....|+++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 3468999999999999999999973 2345987654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=83.83 E-value=18 Score=34.74 Aligned_cols=66 Identities=14% Similarity=0.242 Sum_probs=40.3
Q ss_pred CCceEEEccCCCC--CC----CCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeC
Q 007120 14 PHEVVWVANRLNP--IN----DSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDE 80 (617)
Q Consensus 14 ~~t~VW~Anr~~p--v~----~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~ 80 (617)
...++|...+..+ +. ...+.+-++.++.+...|++|.++|.-..........+ +.+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~-~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTA-RILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEE-EECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCcccccc-EECCCCCEEEEec
Confidence 4568899887642 11 11234444555666667888999999875421122334 6778888888654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.51 E-value=3.3 Score=38.76 Aligned_cols=87 Identities=7% Similarity=0.042 Sum_probs=62.2
Q ss_pred CCCCccceEEEEEeCCeEEEEEecCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceeecccCCC
Q 007120 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLL-YLHQDSRLRIIHRDLKAS 571 (617)
Q Consensus 494 ~H~niv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~-yLH~~~~~~iiHrDlkp~ 571 (617)
.||.+ -...-.+.+...+.++--+++ ++. .+ ..++...+++++..|+.-.. +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 333445667777777765433 333 23 23678899999888887776 5554 478889999
Q ss_pred cEEEcCCCCeEEeecCCceeeCC
Q 007120 572 NVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 572 NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|+++|.++.++|.-.|+-..+.+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSS
T ss_pred eEEEeCCCcEEEEEcCCcccCCC
Confidence 99999999999999998665543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.23 E-value=0.16 Score=53.93 Aligned_cols=61 Identities=15% Similarity=0.189 Sum_probs=18.3
Q ss_pred ccceecccCcccEEEEEEcC-CcEEEE------EEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEe
Q 007120 444 INNKLGEGGFGPVYKGTLVD-GQEIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~~-~~~vav------K~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
+.+.|| ||.||+|.+.. ..+||| |..+. ........|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999864 357888 66543 222344578889999999999999999887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.97 E-value=2.7 Score=39.23 Aligned_cols=89 Identities=10% Similarity=0.072 Sum_probs=64.4
Q ss_pred CCCCCccceEEEEEeCCeEEEEEecCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCC
Q 007120 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (617)
Q Consensus 493 l~H~niv~l~g~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~ 571 (617)
..||+++.. .+-.+.+.+.+.|+.-+. -++.. + ..++...+++++..|+.-..+++. =+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 367888766 455566666666665442 22222 2 336888999999999988866664 378889999
Q ss_pred cEEEcCCCCeEEeecCCceeeCC
Q 007120 572 NVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 572 NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|++++.++.++|.--|+-..+.+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC
T ss_pred eEEEcCCCCEEEEEccCccCCCC
Confidence 99999999999999998665543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 617 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 9e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-49
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 6/170 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+G + ++ ++ SL + T + + I TA+G+ YLH S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
IIHRDLK++N+ L +D+ KI DFGL ++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-46
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 6/174 (3%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK + A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL ++ EF ++D+ + + R L SQ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
H +IIHRDLKA N+L D + K++DFG+ ++ +
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 15/180 (8%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 495
D+F ++LG G G V+K + G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+ +I+HRD+K SN+L++ K+ DFG+ ++ GT++++
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYM 170
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-44
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 7/170 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIK 175
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 4e-44
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNE 486
EL + FS ++G G FG VY + + + +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
V KL+H N ++ GC ++ L+ E+ + D + L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G +GL YLH +IHRD+KA N+LL + K+ DFG N VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 607 TY 608
T
Sbjct: 174 TP 175
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-44
Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 7/169 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L++EFM + L ++ Q + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+IHRDL A N L+ ++ K+SDFG+ R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPV 166
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 8/171 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 497
+++ + LGEG +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-43
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 8/178 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
H+ D ++HRDLK +NV LD N K+ DFGL R D + Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 1e-42
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 20/200 (10%)
Query: 430 FELATIANATDNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 475
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL 535
+E+ ++ +E + + H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
Q ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 596 ETEGNTNRVVGTYCGTKAFL 615
++ +G +
Sbjct: 182 TSDPTYTSALG-GKIPIRWT 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-42
Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 6/170 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ +HRDL A N L++ K+SDFGL R DE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 14/183 (7%)
Query: 438 ATDNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
DN I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTK 612
YL + +HRDL A NVLL KISDFGL + G D++
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPL 176
Query: 613 AFL 615
+
Sbjct: 177 KWY 179
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 2e-42
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 31/207 (14%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKEL 483
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------- 535
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ + T+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 536 -------------LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGTYC 609
I+DFGL R +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIR 207
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 3e-42
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 6/171 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ IHRDL A N L+ ++ K++DFGL R GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 9e-42
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 8/163 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+HRDL A NVL+ +D K+SDFGL + + G
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 6/170 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ +T + L Q + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 17/181 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 500 KLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+ + L+ ++ + SL ++ R + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 556 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTY 608
H + + I HRDLK+ N+L+ ++ I+D GL D + N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 609 C 609
Sbjct: 177 R 177
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 51/191 (26%), Positives = 70/191 (36%), Gaps = 26/191 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+ S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL---------------L 536
L H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D A+G+ +L IHRDL A N+LL KI DFGL R D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 597 TEGNTNRVVGT 607
Sbjct: 200 NYVVKGNARLP 210
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 41/180 (22%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ ++ N+V L + G+E ++ E++ SL + + D Q +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 181
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-40
Identities = 48/174 (27%), Positives = 72/174 (41%), Gaps = 14/174 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+++L G LI E+ P ++ + ++ D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
H R+IHRD+K N+LL KI+DFG + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLD 169
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 31/197 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+N LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR------------------ 533
L H N+V LLG C LI+E+ L +++ + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 534 --TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+L + A+G+ +L +HRDL A NVL+ KI DFGL R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 592 FGGDETEGNTNRVVGTY 608
D
Sbjct: 214 IMSDSNYVVRGNARLPV 230
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 24/187 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------------FDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F+ + + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 602 NRVVGTY 608
Sbjct: 184 TMGRLPV 190
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 15/176 (8%)
Query: 445 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFL 615
+HRDL A NVLL KISDFGL + DE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWY 177
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 47/175 (26%), Positives = 66/175 (37%), Gaps = 13/175 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L HRNL++L G + K+ + E P SL + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YL R IHRDL A N+LL KI DFGL+R ++
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 13/180 (7%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVI 488
I T+ F LG G FG VYKG + E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ + + + ++ +LLG C+ LI + MP L ++ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 10/171 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
VKL E+ + N L +I D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
H IIHRDLK N+LL++DM+ +I+DFG + + + N VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S++ + S+ +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 606 GTY 608
Sbjct: 197 LPV 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 16/175 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 499 VKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+ + +L+ E M + +L +++ R ++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 555 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
LH + IIHRDLK N+ + + KI D GL V+GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTP 177
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (357), Expect = 6e-38
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDET 597
+H DLK N++ + K+ DFGL ++
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQG-LKELKNEVILFSKLQH 495
+F N +G G FG VY GTL+D AVK L++I++ G + + E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 496 RNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N++ LLG C++ E L++ +M + L +FI ++T + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGTY 608
+ + + +HRDL A N +LD+ K++DFGL R E + N+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-37
Identities = 45/191 (23%), Positives = 68/191 (35%), Gaps = 25/191 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 491
D + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 492 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQ-------------TRRTLLD 537
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
A+G+ +L + IHRDL A N+LL + KI DFGL R D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 598 EGNTNRVVGTY 608
Sbjct: 190 YVRKGDARLPL 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-37
Identities = 37/182 (20%), Positives = 75/182 (41%), Gaps = 5/182 (2%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 491
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
+ +H N++ + + + ++ + + ++ + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGT 611
L Y+H ++HRDLK SN+LL+ + KI DFGL R D
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 612 KA 613
+A
Sbjct: 179 RA 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (349), Expect = 8e-37
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 11/173 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L E +LI EF+ L I + + + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYC 609
I+H D+K N++ + KI DFGL DE T
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAE 193
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-36
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 12/174 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
L R +HRD+ A NVL+ + K+ DFGL R + D T ++
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 173
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (346), Expect = 2e-36
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 492
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+V + ++ I + M L + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
++H +++RDLK +N+LLD+ + +ISD GL F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-35
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 11/177 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ ++ Q ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610
YL + +HRDL A N+L++ ++ K+SDFGL R D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 8e-34
Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 20/181 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVIL 489
+N+ LG G V + +E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 490 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
K+ H N+++L L+++ M L ++ T + L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ LH +L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 609 C 609
Sbjct: 174 S 174
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 9e-34
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 9/173 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYC 609
I H D++ N++ + KI +FG R + Y
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 1e-33
Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++++ G ++ +I +++ L S + R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
II+RDLK N+LLD++ + KI+DFG +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------------L 536
+ +H+N++ LLG C Q +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
ARG+ YL + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 597 TEGNTNRVVGTY 608
T
Sbjct: 190 YYKKTTNGRLPV 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 7e-33
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 8/164 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
+ + K+GEG +G VYK G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
R++HRDLK N+L++++ KI+DFGL R FG +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-32
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 8/172 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+NF K+GEG +G VYK + G+ +A+K++ +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLL + L++EF+ D + T + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
R++HRDLK N+L++ + K++DFGL R FG V Y
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 3e-32
Identities = 40/181 (22%), Positives = 70/181 (38%), Gaps = 12/181 (6%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQ 494
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L G LI + + L I + +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAF 614
LH + + LD+D ISDFGL + + V+ T CGT +
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-------DPGSVLSTACGTPGY 175
Query: 615 L 615
+
Sbjct: 176 V 176
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 15/170 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 499 VKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
V+L EK L+ +++P + L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNT 601
Y+H I HRD+K N+LLD D K+ DFG + E +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 13/175 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 494
++F ++ LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H L + E + E++ L I + D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPD 168
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (300), Expect = 6e-31
Identities = 38/185 (20%), Positives = 71/185 (38%), Gaps = 17/185 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 495 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCG 610
L + H + IIHRD+K +N+++ K+ DFG+ R GN+ G
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIG 176
Query: 611 TKAFL 615
T +L
Sbjct: 177 TAQYL 181
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 19/187 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 497 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
N+V L+ C L+++F + + TL + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
L L+ R +I+HRD+KA+NVL+ +D K++DFGL R F +
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNR 181
Query: 609 CGTKAFL 615
T +
Sbjct: 182 VVTLWYR 188
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 14/170 (8%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 499
+ LGEG F VYK Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L+++FM + +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
I+HRDLK +N+LLD++ K++DFGL ++FG V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRW 165
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-29
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 20/188 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
A + ++GEG +G V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 494 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS---FIFDQTRRTLLDWSQRFHIICG 547
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL +LH R++HRDLK N+L+ K++DFGL R + + + +
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTS 174
Query: 608 YCGTKAFL 615
T +
Sbjct: 175 VVVTLWYR 182
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 12/173 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
L L + + E+ L + +R + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+++RD+K N++LD+D + KI+DFGL + D GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 3e-28
Identities = 45/200 (22%), Positives = 71/200 (35%), Gaps = 14/200 (7%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT- 460
+ +E+ + ED E P A + D F LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 461 LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517
G A+K L K + + ++ NE + + LVKL ++ E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
+ + S + R YLH L +I+RDLK N+L+DQ
Sbjct: 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 578 DMNPKISDFGLVRTFGGDET 597
+++DFG + G
Sbjct: 177 QGYIQVTDFGFAKRVKGRTW 196
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 4e-28
Identities = 32/183 (17%), Positives = 77/183 (42%), Gaps = 14/183 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + Q ++ + SL+ + R+ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 559 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGNTNRVV-GTYCGTK 612
+++RD+K N L+ + + + DFG+V+ + T+ + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 613 AFL 615
++
Sbjct: 178 RYM 180
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 9/172 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+GEG +G V+K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
++HRDLK N+L++++ K+++FGL R FG + V Y
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 7/168 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 497 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N++ LL E +F + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
H IIHRDLK N+ +++D KI DFGL R + T R
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 5e-27
Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 23/186 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 492
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 493 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ +++LL + + +LI E T R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+ + H ++HRD+K N+L+D + K+ DFG +
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--------TDFD 170
Query: 610 GTKAFL 615
GT+ +
Sbjct: 171 GTRVYS 176
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-27
Identities = 34/168 (20%), Positives = 67/168 (39%), Gaps = 19/168 (11%)
Query: 440 DNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 496
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 497 NLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
++V+++ L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLVRTFGGDET 597
YLH + I HRD+K N+L K++DFG + +
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 8e-27
Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 12/181 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + C + ++ + SL+ +R+ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 559 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLVRTFGGDETEGNTNRVV-GTYCGTKAF 614
IHRD+K N L + I DFGL + + T + GT +
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 615 L 615
Sbjct: 180 A 180
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 45/184 (24%), Positives = 71/184 (38%), Gaps = 20/184 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L P KI DFGL +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 606 GTYC 609
GT
Sbjct: 178 GTPE 181
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 15/179 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 491
+NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 492 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
++ LV L + LI +++ L + + + R T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
+L L +L II+RD+K N+LLD + + ++DFGL + F DETE +
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 4e-24
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 497
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 498 LVKLLGCCIQGEEKL--LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ L + L++E + N L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H + I+HRD+K NV++D + ++ D+GL + + N V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 8e-24
Identities = 31/161 (19%), Positives = 53/161 (32%), Gaps = 20/161 (12%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 492
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ R L KL G + +Y + N L I + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ I+H DL NVL+ + I DF G
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 21/179 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 497 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYC 609
G+ +LH IIHRDLK SN+++ D KI DFGL RT G V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 3e-23
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 7/175 (4%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 491 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++H N++ LL + ++ + + + + + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T R
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 3e-18
Identities = 32/186 (17%), Positives = 62/186 (33%), Gaps = 17/186 (9%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+ + KLG G F V+ +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 501 LLGCCIQGEEKLLIY-------------EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
KLL + F + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
GL Y+H+ R IIH D+K NVL++ +P+ + G
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 608 YCGTKA 613
++
Sbjct: 192 TREYRS 197
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 65.7 bits (160), Expect = 9e-14
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ + W + Y
Sbjct: 92 DGNVVIYG-------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.9 bits (132), Expect = 6e-10
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 13/102 (12%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEV 61
+L + N ++P + + S L + NLVL + + V + K
Sbjct: 12 ILYSTQGNDNHP-----QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK-- 64
Query: 62 QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD--YPSDTLL 101
T L +G + + + W S + +
Sbjct: 65 GTGCRAVLQPNGRMDVLT----NQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.3 bits (94), Expect = 9e-05
Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ S+ V L
Sbjct: 50 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQP 106
Query: 72 SGNLVLRD 79
NL +
Sbjct: 107 DRNLAIYG 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 52.1 bits (124), Expect = 5e-09
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S + S + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSD 98
N+V+ D +S W + +
Sbjct: 90 DRNVVIYD----NSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 51.6 bits (123), Expect = 8e-09
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N F L + GNLV+ + SN +W++ + V L
Sbjct: 34 YDVDKPIWATNTGGLSRSCF--LSMQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQK 90
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W + +
Sbjct: 91 DRNVVIYGTD-------RWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.2 bits (117), Expect = 6e-08
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + V L L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYV-LVLQP 101
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W +
Sbjct: 102 DRNVVIYG-------DALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.4 bits (102), Expect = 6e-06
Identities = 16/75 (21%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 19 WVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLR 78
+ + S + NLVL S++ VW++ + T L G LV+
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG--ATGCRAVLQSDGLLVIL 71
Query: 79 DEHDGDSETYFWQSF 93
T W S
Sbjct: 72 T----AQNTIRWSSG 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 617 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.98 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.55 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.54 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.54 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.24 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.96 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.92 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.9 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.74 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.33 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.26 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.25 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.85 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 88.96 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.42 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 83.22 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.47 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 82.37 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.22 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.33 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 80.92 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-36 Score=302.11 Aligned_cols=172 Identities=28% Similarity=0.385 Sum_probs=149.4
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999985 48999999986532 2345679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999843 446899999999999999999999988 9999999999999999999999999999886554
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
........+||+.|+|||++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~ 177 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELL 177 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHH
T ss_pred ccccccceeeCcCccCHhHh
Confidence 44444557899999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-36 Score=303.08 Aligned_cols=177 Identities=27% Similarity=0.403 Sum_probs=154.0
Q ss_pred hHHhhcCCccccceecccCcccEEEEEEcC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 434 ~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
+++...++|++.+.||+|+||+||+|++.. ++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 344556789999999999999999999865 889999998753 334678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++... ....+++..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.+
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999653 3456899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..+.... .....||..|+|||.+
T Consensus 166 ~~~~~~~-~~~~~g~~~y~aPE~~ 188 (287)
T d1opja_ 166 TGDTYTA-HAGAKFPIKWTAPESL 188 (287)
T ss_dssp CSSSSEE-ETTEEECGGGCCHHHH
T ss_pred CCCCcee-eccccccccccChHHH
Confidence 6544332 3345689999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-36 Score=300.38 Aligned_cols=172 Identities=29% Similarity=0.448 Sum_probs=142.8
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
...++|++.+.||+|+||+||+|+++ ..||||+++. ......+.|++|+.++++++|||||+++|++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34578999999999999999999864 4699999864 244567889999999999999999999999754 568999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.++|... ...+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999643 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...........||+.|+|||++
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l 178 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVI 178 (276)
T ss_dssp ---------CCCCGGGCCHHHH
T ss_pred cCCcccccccccCcccCCHHHH
Confidence 5444445567899999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-36 Score=296.34 Aligned_cols=171 Identities=25% Similarity=0.436 Sum_probs=140.8
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4578999999999999999999988899999999763 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.+++.. ....+++..++.|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999864 3456899999999999999999999987 999999999999999999999999999987554332
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
. .....||..|+|||.+
T Consensus 158 ~-~~~~~gt~~y~aPE~l 174 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVF 174 (263)
T ss_dssp --------CTTSCCHHHH
T ss_pred e-ecceecCcccCChHHh
Confidence 2 3346789999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-36 Score=298.29 Aligned_cols=173 Identities=28% Similarity=0.416 Sum_probs=149.1
Q ss_pred hhcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
...++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 345688999999999999999999988889999999753 3345789999999999999999999998754 56789999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|.+++.... ...+++..++.|+.|||+||.|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999875422 235899999999999999999999987 9999999999999999999999999999986544
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||.+
T Consensus 164 ~~~-~~~~~gt~~y~APE~~ 182 (272)
T d1qpca_ 164 YTA-REGAKFPIKWTAPEAI 182 (272)
T ss_dssp EEC-CTTCCCCTTTSCHHHH
T ss_pred ccc-ccccCCcccccChHHH
Confidence 332 3346789999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-35 Score=295.92 Aligned_cols=169 Identities=25% Similarity=0.457 Sum_probs=150.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999974 4899999999765555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++|+|.+++.. ..+++.++..++.||+.||+|||+.+ ||||||||+||||+.++++||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999998854 34899999999999999999999988 99999999999999999999999999998854433
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||+.|+|||++
T Consensus 172 ~--~~~~~gt~~Y~aPE~~ 188 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVV 188 (293)
T ss_dssp C--BCCCCSCGGGCCHHHH
T ss_pred c--ccccccCCCccChhhh
Confidence 2 3446799999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-35 Score=290.30 Aligned_cols=167 Identities=28% Similarity=0.376 Sum_probs=148.0
Q ss_pred CCccccceecccCcccEEEEEEcC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||+|+.+. ++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999854 889999998652 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999964 345899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||+.|+|||++
T Consensus 160 ~----~~~~~Gt~~Y~APE~~ 176 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMI 176 (263)
T ss_dssp C----CEETTEEGGGCCHHHH
T ss_pred c----ccccCCCCcccCHHHH
Confidence 2 2346799999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-35 Score=296.50 Aligned_cols=170 Identities=29% Similarity=0.404 Sum_probs=150.9
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 48899999998766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.+++.+. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 999999998542 345899999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
......||+.|+|||++
T Consensus 166 -~~~~~~Gt~~y~APE~l 182 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVV 182 (288)
T ss_dssp -HHTCCCSCCTTCCHHHH
T ss_pred -cccccccccccCCHHHH
Confidence 23346799999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-35 Score=294.80 Aligned_cols=171 Identities=29% Similarity=0.393 Sum_probs=146.8
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5899999998652 2334577999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999999998655
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
..........||+.|+|||++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~ 182 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELL 182 (288)
T ss_dssp --------CCCCGGGCCHHHH
T ss_pred CcccccccccCCccccCceee
Confidence 444444557799999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=291.09 Aligned_cols=175 Identities=28% Similarity=0.384 Sum_probs=137.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe--CCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 514 (617)
++|++.+.||+|+||+||+|+.. +++.||||.+... .+...+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 4889999998653 34456779999999999999999999999975 4457999
Q ss_pred EecCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 515 YEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 2456899999999999999999999854 13499999999999999999999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..+.. ......||+.|+|||++
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l 186 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQM 186 (269)
T ss_dssp C-------------CCCSCCCHHHH
T ss_pred cccCCC--ccccCCCCcccCCHHHH
Confidence 754332 23457799999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=285.07 Aligned_cols=171 Identities=25% Similarity=0.373 Sum_probs=151.3
Q ss_pred cCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
.++|++.++||+|+||+||+|++++++.||||.+++. ....++|++|+.++++++|||||+++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3689999999999999999999988889999999763 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|..++... ...+++..+++++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999997543 345889999999999999999999987 999999999999999999999999999987654333
Q ss_pred cccceeeeeccccCccCC
Q 007120 599 GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~~~~~~~gt~~y~ape~~ 616 (617)
......||..|+|||.+
T Consensus 157 -~~~~~~~t~~y~aPE~~ 173 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVL 173 (258)
T ss_dssp -CCCCSCCCGGGCCHHHH
T ss_pred -eecccCCCCCcCCcHHh
Confidence 23346799999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=300.99 Aligned_cols=169 Identities=24% Similarity=0.294 Sum_probs=147.5
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999975 4889999998653 3344578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+. + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999642 3589999999999999999999974 6 99999999999999999999999999997643
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. ....+||+.|+|||++
T Consensus 158 ~~----~~~~~GT~~Y~APEvl 175 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERL 175 (322)
T ss_dssp HT----C---CCSSCCCCHHHH
T ss_pred Cc----cccccCCccccCchHH
Confidence 22 2346899999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-34 Score=293.01 Aligned_cols=173 Identities=29% Similarity=0.425 Sum_probs=136.5
Q ss_pred cCCccccceecccCcccEEEEEEcC-C---cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|++.++||+|+||+||+|++.. + ..||||++.. ......++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999999753 2 3689999865 344556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++.. ....+++.+++.|+.|||+||+|||+.+ ||||||||+||||++++++||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998864 2345899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCcccc---cceeeeeccccCccCC
Q 007120 594 GDETEGN---TNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~---~~~~~gt~~y~ape~~ 616 (617)
....... .....||+.|+|||++
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 205 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAI 205 (299)
T ss_dssp ----------------CGGGSCHHHH
T ss_pred CCCCcceeeecccccCCccccCHHHH
Confidence 5443221 2224578999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=294.97 Aligned_cols=177 Identities=27% Similarity=0.385 Sum_probs=148.9
Q ss_pred hhcCCccccceecccCcccEEEEEEcC------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeC
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (617)
...++|++.++||+|+||+||+|+... ...||||.+... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 455789999999999999999999754 236999998653 334556899999999998 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeeccc
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTR--------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 568 (617)
+..++||||+++|+|.++|..... ...+++..++.|+.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965321 235899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 569 kp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||++.++.+||+|||+|+...............||+.|+|||++
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 999999999999999999999987665544444457799999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-34 Score=283.15 Aligned_cols=167 Identities=25% Similarity=0.369 Sum_probs=142.2
Q ss_pred ccccceecccCcccEEEEEEcC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe----CCeEEEE
Q 007120 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 514 (617)
Q Consensus 442 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 514 (617)
|++.++||+|+||+||+|+... ++.||||++... .....+.|.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3566789999999999999864 789999998652 34456789999999999999999999999875 3457999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc-CCCCeEEeecCCceeeC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFG 593 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~ki~DFGla~~~~ 593 (617)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+||||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999964 345899999999999999999999875 4599999999999996 57899999999998754
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||++
T Consensus 167 ~~~----~~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 167 ASF----AKAVIGTPEFMAPEMY 185 (270)
T ss_dssp TTS----BEESCSSCCCCCGGGG
T ss_pred CCc----cCCcccCccccCHHHh
Confidence 322 3356799999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=287.47 Aligned_cols=172 Identities=28% Similarity=0.437 Sum_probs=145.3
Q ss_pred cCCccccc-eecccCcccEEEEEEcC---CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 439 TDNFSINN-KLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 439 ~~~~~~~~-~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
.++|.+.+ +||+|+||+||+|.++. +..||||.++.. .....++|.+|+.++++++|||||+++|+|.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45677777 49999999999998643 457999999753 34456789999999999999999999999864 56899
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
||||+++|+|.+++.. ....+++..++.++.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999843 3356899999999999999999999987 9999999999999999999999999999986
Q ss_pred CCCcc-cccceeeeeccccCccCC
Q 007120 594 GDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
..... .......||+.|+|||++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~ 184 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECI 184 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHH
T ss_pred ccccccccccccccCccccChHHH
Confidence 54432 223345689999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=287.74 Aligned_cols=173 Identities=28% Similarity=0.417 Sum_probs=140.2
Q ss_pred cCCccccceecccCcccEEEEEEcCC-----cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
.+.|++.++||+|+||+||+|.++.. ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45788889999999999999997642 47999998653 3445567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++++|.+++... ...+++.+++.++.|||.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999988653 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCccc-ccceeeeeccccCccCC
Q 007120 593 GGDETEG-NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~-~~~~~~gt~~y~ape~~ 616 (617)
....... ......||..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l 185 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAI 185 (283)
T ss_dssp -------------CCCGGGSCHHHH
T ss_pred cCCCccceEeccCCCCccccCHHHH
Confidence 6543322 23345689999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-33 Score=292.00 Aligned_cols=170 Identities=25% Similarity=0.392 Sum_probs=150.9
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999975 4899999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc--CCCCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~ki~DFGla~~~~~~ 595 (617)
+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999854 2345899999999999999999999988 99999999999995 4678999999999988644
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||+.|+|||++
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~ 197 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVA 197 (350)
T ss_dssp SC---EEEECSCTTTCCHHHH
T ss_pred cc---cceecCcccccCHHHH
Confidence 32 3456799999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-34 Score=290.29 Aligned_cols=164 Identities=29% Similarity=0.462 Sum_probs=144.9
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
.|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5889999999999999999975 4889999998653 23445679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|..++.. ...+++.++..++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999877643 345899999999999999999999988 999999999999999999999999999976432
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
....||+.|+|||++
T Consensus 169 -----~~~~GT~~Y~APE~~ 183 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVI 183 (309)
T ss_dssp -----CCCCSCGGGCCHHHH
T ss_pred -----CccccCccccCHHHH
Confidence 235799999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=290.20 Aligned_cols=172 Identities=27% Similarity=0.407 Sum_probs=142.2
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
..++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|. .+..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 34689999999999999999999988889999999753 344578999999999999999999999985 4567899999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+++|+|..++.... ...++|.+++.|+.|||.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 93 ~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999986432 345899999999999999999999987 99999999999999999999999999998754443
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||+.|+|||.+
T Consensus 169 ~~-~~~~~gt~~y~aPE~~ 186 (285)
T d1fmka3 169 TA-RQGAKFPIKWTAPEAA 186 (285)
T ss_dssp --------CCGGGSCHHHH
T ss_pred ee-eccccccccccChHHH
Confidence 22 3346799999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=289.42 Aligned_cols=170 Identities=22% Similarity=0.257 Sum_probs=150.0
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (617)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999974 5899999999752 233467789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.. ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999864 345788899999999999999999998 99999999999999999999999999997654
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....+||+.|+|||++
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~ 177 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVL 177 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGG
T ss_pred CCc--ccccceeCHHHhhhhhc
Confidence 332 23457899999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=283.30 Aligned_cols=164 Identities=27% Similarity=0.370 Sum_probs=137.5
Q ss_pred ceecccCcccEEEEEEcC---CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEecCCC
Q 007120 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 520 (617)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 468999998642 33345789999999999999999999999864 567899999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc-c
Q 007120 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-G 599 (617)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~-~ 599 (617)
|+|.+++.. ...+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999964 345899999999999999999999987 999999999999999999999999999988654433 2
Q ss_pred ccceeeeeccccCccCC
Q 007120 600 NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 600 ~~~~~~gt~~y~ape~~ 616 (617)
......||+.|+|||.+
T Consensus 166 ~~~~~~gt~~y~APE~l 182 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECI 182 (277)
T ss_dssp C----CCCGGGCCHHHH
T ss_pred cccccCCCceecCchhh
Confidence 23345689999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-33 Score=288.94 Aligned_cols=170 Identities=25% Similarity=0.339 Sum_probs=150.5
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||.||+|+.. +++.||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 5899999999765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc--CCCCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~ki~DFGla~~~~~~ 595 (617)
+++|+|.+++.. ....+++.++..|+.||+.||+|||+.+ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988743 3345899999999999999999999988 99999999999998 6789999999999998654
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||+.|+|||++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~ 200 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIV 200 (352)
T ss_dssp SC---EEEECSSGGGCCHHHH
T ss_pred Cc---eeeccCcccccCHHHH
Confidence 32 3456799999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-33 Score=287.51 Aligned_cols=166 Identities=25% Similarity=0.353 Sum_probs=147.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++.+.||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 4899999999652 2334678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+++|+|..++.. ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998854 344788888899999999999999987 999999999999999999999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 158 -----~~~~~Gt~~Y~APE~l 173 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVV 173 (316)
T ss_dssp -----BCCCCSCTTTCCHHHH
T ss_pred -----cccccCcccccCHHHH
Confidence 2346799999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-34 Score=289.31 Aligned_cols=170 Identities=25% Similarity=0.339 Sum_probs=132.0
Q ss_pred hcCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
..+.|++.+.||+|+||+||+|+.. +++.||||.+.+.. ....+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999985 48899999987532 233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEc---CCCCeEEeecCCceee
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF 592 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~ki~DFGla~~~ 592 (617)
||+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ ||||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999954 346899999999999999999999988 99999999999994 5789999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||++
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~ 181 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVL 181 (307)
T ss_dssp ---------------CTTSCHHHH
T ss_pred cCCCe---eeeeeeCccccCcHHH
Confidence 54332 3346799999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-34 Score=288.39 Aligned_cols=182 Identities=26% Similarity=0.414 Sum_probs=154.4
Q ss_pred HHhHHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEE
Q 007120 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (617)
Q Consensus 432 ~~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 504 (617)
+.+++..+++|++.+.||+|+||+||+|+.+ +++.||||+++.. .....++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556667889999999999999999999874 2578999999753 33456789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007120 505 CIQGEEKLLIYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (617)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (617)
|.+.+..++||||+++|+|.++|.... ....+++..++.|+.|||.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999996422 1234889999999999999999999987 9
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 564 iHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|||||||+||||+.++.+||+|||+|+.+.............||+.|+|||++
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 99999999999999999999999999987655444445556789999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.1e-33 Score=279.22 Aligned_cols=169 Identities=25% Similarity=0.338 Sum_probs=147.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999985 58999999986421 12357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC----CeEEeecC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~ki~DFG 587 (617)
+|||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999652 45899999999999999999999988 99999999999998876 49999999
Q ss_pred CceeeCCCCcccccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+|+.+..... .....||+.|+|||++
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIV 188 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHH
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHH
Confidence 9998754332 2345789999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=1.2e-32 Score=284.77 Aligned_cols=166 Identities=24% Similarity=0.292 Sum_probs=148.2
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (617)
++|++++.||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 5899999998642 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~ 595 (617)
||+.+|+|..++... ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998543 35899999999999999999999988 999999999999999999999999999987533
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.....||+.|+|||++
T Consensus 195 -----~~~~~Gt~~Y~APE~~ 210 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEII 210 (350)
T ss_dssp -----BCCCEECGGGCCHHHH
T ss_pred -----cccccCccccCCHHHH
Confidence 2346799999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.9e-33 Score=281.58 Aligned_cols=181 Identities=25% Similarity=0.374 Sum_probs=143.3
Q ss_pred HhHHhhcCCccccceecccCcccEEEEEEcC------CcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCCccceEEE
Q 007120 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGC 504 (617)
Q Consensus 433 ~~~~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 504 (617)
.+.+...++|++.++||+|+||.||+|+... ++.||||+++. ......+++.+|...+.++ +|+|||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3444556789999999999999999998643 46899999975 3334566788888877776 78999999999
Q ss_pred EEeCC-eEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCC
Q 007120 505 CIQGE-EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (617)
Q Consensus 505 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp 570 (617)
+.+.+ ..++||||+++|+|.++|+.... ...+++.+++.++.|||+||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 68999999999999999965321 245889999999999999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 571 ~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||||++++++||+|||+|+...............||+.|+|||++
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence 9999999999999999999987666555555567899999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.4e-33 Score=282.63 Aligned_cols=171 Identities=28% Similarity=0.467 Sum_probs=141.3
Q ss_pred CCccccceecccCcccEEEEEEcC-Cc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (617)
++|++.++||+|+||+||+|.+.. ++ +||||+++. ......++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998753 33 689998865 3344577899999999999999999999999865 5678
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeC
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~ 593 (617)
++||+.+|+|.+++.. ....+++..++.++.|||+||+|||+++ ||||||||+||||+.++++||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999998865 3456899999999999999999999987 9999999999999999999999999999887
Q ss_pred CCCcccccceeeeeccccCccCC
Q 007120 594 GDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 594 ~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
............||+.|+|||.+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l 185 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESI 185 (317)
T ss_dssp TTCC--------CCTTTSCHHHH
T ss_pred cccccccccccccCccccChHHH
Confidence 65555555556799999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.98 E-value=2.2e-32 Score=273.50 Aligned_cols=168 Identities=26% Similarity=0.345 Sum_probs=147.7
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---------hhhHHHHHHHHHHHccCC-CCCccceEEEEEeC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 508 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 508 (617)
++|++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 58899999986521 112346889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCC
Q 007120 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (617)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGl 588 (617)
+..+|||||+++|+|.++|.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999964 345899999999999999999999988 99999999999999999999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+.+..... .....||..|+|||++
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEII 181 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHh
Confidence 998865432 2346799999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=2.1e-32 Score=284.35 Aligned_cols=168 Identities=25% Similarity=0.322 Sum_probs=144.1
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc---hhhHHHH---HHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+ ..|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999975 48999999986421 1122223 4457788889999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++|+|.++|.. ...+++..+..++.||+.||.|||+.+ ||||||||+||||++++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999964 345788999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCCcccccceeeeeccccCccCC
Q 007120 592 FGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+.... .....||+.|+|||++
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~ 177 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVL 177 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHH
T ss_pred cCCCc----ccccccccccchhHHh
Confidence 76443 3346799999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-32 Score=274.90 Aligned_cols=172 Identities=23% Similarity=0.341 Sum_probs=135.3
Q ss_pred hcCCccccceecccCcccEEEEEEcC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEE
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (617)
..++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++|||||+++|++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 45689999999999999999998743 356899998653 3444678999999999999999999999985 46789
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ ||||||||+|||+++++.+||+|||+|+.+
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998754 3345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...... ......||+.|+|||++
T Consensus 159 ~~~~~~-~~~~~~gt~~y~apE~l 181 (273)
T d1mp8a_ 159 EDSTYY-KASKGKLPIKWMAPESI 181 (273)
T ss_dssp -------------CCGGGCCHHHH
T ss_pred cCCcce-eccceecCcccchhhHh
Confidence 544332 23456789999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=278.58 Aligned_cols=179 Identities=25% Similarity=0.399 Sum_probs=153.7
Q ss_pred HHhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCccceEEEEEe
Q 007120 435 IANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (617)
Q Consensus 435 ~~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (617)
++...++|++.+.||+|+||+||+|.+. ++..||||+++.. .......|.+|+.++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578999999999999999999874 2578999999753 33455679999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCC
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~ 580 (617)
.+..++||||+++|+|.+++... .....+++..++.++.|+|+||.|||+.+ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999998532 22345789999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||+|+.+.............||+.|+|||.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHH
Confidence 999999999988665554445556799999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4e-32 Score=275.60 Aligned_cols=171 Identities=24% Similarity=0.340 Sum_probs=139.6
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----eEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 515 (617)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .....+..|+..+..++|||||+++|+|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677889999999999999997 68899999986532 22223345666677899999999999998754 578999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
||+++|+|.++|++ ..++|..++.++.|+|.||+|||+.. ..+||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999964 24899999999999999999999741 2459999999999999999999999999999
Q ss_pred eeCCCCcc--cccceeeeeccccCccCC
Q 007120 591 TFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
.+...... .......||+.|+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 184 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHH
T ss_pred cccCCCcceeccccceecccCcCChhhc
Confidence 88654332 233456799999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=273.06 Aligned_cols=169 Identities=20% Similarity=0.257 Sum_probs=147.2
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+.+++.++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999985 48899999997643 3445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC--CCeEEeecCCceeeCCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--~~~ki~DFGla~~~~~~ 595 (617)
+++|+|.+++.. ....+++.+...|+.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999954 2345899999999999999999999988 9999999999999854 58999999999987543
Q ss_pred CcccccceeeeeccccCccCC
Q 007120 596 ETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 596 ~~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....||+.|+|||.+
T Consensus 158 ~~---~~~~~~t~~y~ape~~ 175 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CE---EEEEESCGGGSCHHHH
T ss_pred Cc---ccccccccccccchhc
Confidence 32 3456789999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.5e-32 Score=275.80 Aligned_cols=169 Identities=27% Similarity=0.367 Sum_probs=145.5
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHc-cCCCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 514 (617)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999985 4889999999752 2234456667776654 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCC
Q 007120 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~ 594 (617)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999964 334788999999999999999999987 99999999999999999999999999997654
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... ......||+.|+|||++
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~ 175 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEIL 175 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHH
T ss_pred ccc--cccccCCCCCcCCHHHH
Confidence 332 23446799999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9e-32 Score=273.90 Aligned_cols=171 Identities=29% Similarity=0.461 Sum_probs=142.9
Q ss_pred CCccccceecccCcccEEEEEEcC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEeCCeEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (617)
++|++.++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|+.+++++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999865 33 5788888643 334566899999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCe
Q 007120 515 YEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (617)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ 581 (617)
|||+++|+|.++|+.. .....+++..+++++.|||+||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 582 KISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 582 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||+|||+|+...... ......||..|+|||.+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l 198 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL 198 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHh
Confidence 999999998764322 22345689999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-32 Score=276.35 Aligned_cols=178 Identities=29% Similarity=0.377 Sum_probs=153.5
Q ss_pred HhhcCCccccceecccCcccEEEEEEc------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEEe
Q 007120 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (617)
Q Consensus 436 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (617)
+...++|++.++||+|+||.||+|++. .++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345578999999999999999999863 3568999999753 334566899999999999 69999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCc
Q 007120 508 GEEKLLIYEFMPNKSLDSFIFDQT---------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (617)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (617)
++..++||||+++|+|.++|+... ....+++..++.++.|||+||+|||+++ ||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999997532 2235899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 573 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
||++.++.+||+|||+++.+.............||+.|+|||.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 219 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence 99999999999999999988765555445567899999999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.1e-31 Score=269.02 Aligned_cols=172 Identities=21% Similarity=0.312 Sum_probs=139.8
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----e
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----E 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 510 (617)
.++|++.+.||+|+||+||+|+.. +++.||||.+++. .....+.|.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 5899999999652 2344567999999999999999999999998654 3
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.+|||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998854 345899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCCCCc-ccccceeeeeccccCccCC
Q 007120 591 TFGGDET-EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~-~~~~~~~~gt~~y~ape~~ 616 (617)
.+..... ........||+.|+|||++
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 186 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQA 186 (277)
T ss_dssp ECC----------------TTCCHHHH
T ss_pred hhccccccccccccccCcccccCHHHH
Confidence 7654332 2234456799999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-32 Score=269.61 Aligned_cols=172 Identities=27% Similarity=0.375 Sum_probs=136.4
Q ss_pred cCCccccceecccCcccEEEEEEcC--C--cEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (617)
.++|++.+.||+|+||.||+|++.. + ..||||++++. .....++|.+|+.++++++|||||+++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998643 2 37899998652 33456789999999999999999999999965 567
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
++||||+++|+|.+++... ...+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999988653 345899999999999999999999987 99999999999999999999999999999
Q ss_pred eCCCCcc-cccceeeeeccccCccCC
Q 007120 592 FGGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 592 ~~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
+...... .......||+.|+|||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~ 186 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESL 186 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHH
Confidence 8655443 223345688999999965
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=270.35 Aligned_cols=167 Identities=28% Similarity=0.452 Sum_probs=142.3
Q ss_pred cceecccCcccEEEEEEcCC----cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCccceEEEEEeC-CeEEEEEecC
Q 007120 445 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 518 (617)
Q Consensus 445 ~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 518 (617)
.++||+|+||+||+|++.++ ..||||++++ ......++|.+|+.++++++|||||+++|+|.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 3689999975 3455668899999999999999999999999875 5789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCcc
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~~ 598 (617)
++|+|.+++.. ....+++..++.++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999865 3445788999999999999999999987 999999999999999999999999999987654332
Q ss_pred c--ccceeeeeccccCccCC
Q 007120 599 G--NTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 599 ~--~~~~~~gt~~y~ape~~ 616 (617)
. ......||..|+|||.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~ 206 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESL 206 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHH
T ss_pred cceecccccccccccChHHH
Confidence 2 23345689999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-32 Score=270.37 Aligned_cols=167 Identities=26% Similarity=0.413 Sum_probs=136.7
Q ss_pred hcCCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeC-CeEEEEEe
Q 007120 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYE 516 (617)
Q Consensus 438 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 516 (617)
..++|++.+.||+|+||.||+|.+ .+..||||+++.. ...++|.+|+.++++++|||||+++|+|.+. +..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 345788899999999999999998 5788999999753 3457899999999999999999999999764 56799999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+++|+|.++|.... ...+++..++.|+.|||.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999999999996532 235899999999999999999999987 9999999999999999999999999999764332
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
....+|..|+|||++
T Consensus 158 -----~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEAL 172 (262)
T ss_dssp ---------CCTTTSCHHHH
T ss_pred -----ccccccccCCChHHH
Confidence 234678999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-31 Score=270.54 Aligned_cols=170 Identities=29% Similarity=0.440 Sum_probs=143.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.++||+|+||+||+|+.. +++.||||+++... +...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 58999999996532 2345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
|+.++ +.+++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99755 4444433 23455899999999999999999999988 9999999999999999999999999999875433
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
. ......||+.|+|||++
T Consensus 157 ~--~~~~~~gt~~y~apE~~ 174 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEIL 174 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHH
T ss_pred c--cceeecccceeeehhhh
Confidence 2 23345799999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-31 Score=270.60 Aligned_cols=177 Identities=28% Similarity=0.399 Sum_probs=148.2
Q ss_pred hhcCCccccceecccCcccEEEEEEcC--------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCccceEEEEE
Q 007120 437 NATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 506 (617)
Q Consensus 437 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 506 (617)
...++|++.+.||+|+||.||+|+... +..||||++++. ......++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345689999999999999999998643 247999999763 344567889999999888 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcE
Q 007120 507 QGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (617)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni 573 (617)
+++..++||||+++|+|.++|..... ...+++.+++.++.|||.||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999965431 245899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 574 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|++.++.+||+|||+++...............||+.|+|||.+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 209 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence 9999999999999999988766555555567799999999965
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=271.30 Aligned_cols=165 Identities=30% Similarity=0.371 Sum_probs=137.8
Q ss_pred ccceecccCcccEEEEEEc-CCcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 444 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 444 ~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
.+++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999975 4899999998653221 234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
++++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887766652 3455788899999999999999999988 99999999999999999999999999998754432
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
. .....||+.|+|||++
T Consensus 156 ~--~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELL 172 (299)
T ss_dssp C--CCCSCCCCTTCCHHHH
T ss_pred c--ccceecChhhccHHHH
Confidence 2 2345799999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.9e-31 Score=269.86 Aligned_cols=167 Identities=22% Similarity=0.262 Sum_probs=140.1
Q ss_pred cCCccccc-eecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHcc-CCCCCccceEEEEEe----CCeE
Q 007120 439 TDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 511 (617)
Q Consensus 439 ~~~~~~~~-~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~ 511 (617)
.++|.+.+ .||+|+||+||+|+.. +++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 5999999999999974 5899999998642 356778887654 589999999999876 3568
Q ss_pred EEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCC
Q 007120 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (617)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGl 588 (617)
+|||||+++|+|.++|.... ...+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 345899999999999999999999988 999999999999985 56799999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLYD 617 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~~ 617 (617)
|+.+..... .....||+.|+|||++.
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCC
T ss_pred eeeccCCCc---cccccCCcccCCcHHHc
Confidence 998765433 33467999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=4.9e-31 Score=265.57 Aligned_cols=169 Identities=25% Similarity=0.370 Sum_probs=144.1
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.++||+|+||+||+|+.++++.||||+++.. .....+.+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999988999999999653 233467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCCc
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~~ 597 (617)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877776653 3456899999999999999999999987 99999999999999999999999999998754332
Q ss_pred ccccceeeeeccccCccCC
Q 007120 598 EGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 598 ~~~~~~~~gt~~y~ape~~ 616 (617)
......||+.|+|||.+
T Consensus 156 --~~~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVL 172 (286)
T ss_dssp --------CCCTTCCHHHH
T ss_pred --ccceecccchhhhHHHH
Confidence 23345689999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-31 Score=263.48 Aligned_cols=167 Identities=25% Similarity=0.345 Sum_probs=141.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccch------hhHHHHHHHHHHHccCC--CCCccceEEEEEeCCe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEE 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 510 (617)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 589999999864211 12345778999999986 8999999999999999
Q ss_pred EEEEEecCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCC-CCeEEeecCC
Q 007120 511 KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (617)
Q Consensus 511 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~ki~DFGl 588 (617)
.++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+.+ ||||||||+||||+.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 678787754 345899999999999999999999988 9999999999999854 7999999999
Q ss_pred ceeeCCCCcccccceeeeeccccCccCC
Q 007120 589 VRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 589 a~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+...... .....||+.|+|||++
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWI 181 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHH
T ss_pred ceeccccc----ccccccCCCcCCHHHH
Confidence 99764322 2346799999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=262.51 Aligned_cols=171 Identities=22% Similarity=0.346 Sum_probs=141.7
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCccceEEEEEeCC----eEE
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKL 512 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 512 (617)
.++|++++.||+|+||+||+|... +++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999874 58999999997533 344678899999999999999999999997654 235
Q ss_pred EEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceee
Q 007120 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (617)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~ 592 (617)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667779999999954 24899999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCcc-cccceeeeeccccCccCC
Q 007120 593 GGDETE-GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~-~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||+.|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred cCCCccceeeccccccceechHHHh
Confidence 544332 234556799999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=262.64 Aligned_cols=166 Identities=24% Similarity=0.338 Sum_probs=136.3
Q ss_pred CccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------eEEE
Q 007120 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKLL 513 (617)
Q Consensus 441 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 513 (617)
+|+..++||+|+||+||+|+.. +++.||||++.+... .+.+|+.++++++|||||++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999985 489999999965322 2347999999999999999999986532 4689
Q ss_pred EEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceee
Q 007120 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (617)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~ 592 (617)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444332234556899999999999999999999987 99999999999999775 8999999999987
Q ss_pred CCCCcccccceeeeeccccCccCC
Q 007120 593 GGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
...+. .....||..|+|||.+
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~ 194 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELI 194 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHH
T ss_pred cCCcc---cccccccccccChHHh
Confidence 55433 2235799999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-29 Score=260.81 Aligned_cols=165 Identities=27% Similarity=0.399 Sum_probs=136.6
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCccceEEEEEeCC------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (617)
.++|++.++||+|+||+||+|+.. +++.||||++++ ......+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 489999999975 23345678899999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5677777643 35899999999999999999999988 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+..... .....||+.|+|||.+
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~ 190 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVI 190 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHH
T ss_pred eccCCc-----cccccccccccCHHHH
Confidence 987432 2345799999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=2.9e-29 Score=257.64 Aligned_cols=162 Identities=22% Similarity=0.389 Sum_probs=139.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeC--CeEEEEE
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 515 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 515 (617)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 5899999998753 3457889999999995 99999999999854 4589999
Q ss_pred ecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCC-CeEEeecCCceeeCC
Q 007120 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (617)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~ki~DFGla~~~~~ 594 (617)
||+++++|..+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 34889999999999999999999998 99999999999998655 699999999998765
Q ss_pred CCcccccceeeeeccccCccCC
Q 007120 595 DETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~~~~~~~~gt~~y~ape~~ 616 (617)
... .....||+.|+|||.+
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELL 201 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHH
T ss_pred CCc---ccccccCccccCcccc
Confidence 433 3346789999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-29 Score=256.30 Aligned_cols=172 Identities=27% Similarity=0.406 Sum_probs=140.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC-------
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 508 (617)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999975 5899999998542 334457789999999999999999999998653
Q ss_pred -CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecC
Q 007120 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (617)
Q Consensus 509 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFG 587 (617)
...++||||++++.+..+. .....++......++.||+.||.|||+.+ |+||||||+||||++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 3578999999988776554 23445788899999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCCCcc--cccceeeeeccccCccCC
Q 007120 588 LVRTFGGDETE--GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 588 la~~~~~~~~~--~~~~~~~gt~~y~ape~~ 616 (617)
+|+.+...... .......||+.|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 193 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHH
Confidence 99987644322 223335699999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-29 Score=256.65 Aligned_cols=170 Identities=25% Similarity=0.375 Sum_probs=137.6
Q ss_pred cCCccccceecccCcccEEEEEEc-C-CcEEEEEEeccc--chhhHHHHHHHHHHHccC---CCCCccceEEEEEeC---
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG--- 508 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~--- 508 (617)
.++|+++++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.| +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 567999998642 222234566677766655 899999999998642
Q ss_pred --CeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeec
Q 007120 509 --EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (617)
Q Consensus 509 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DF 586 (617)
...+++|||++++.+...... ....+++.....++.||+.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 357899999998877655432 3455889999999999999999999988 999999999999999999999999
Q ss_pred CCceeeCCCCcccccceeeeeccccCccCC
Q 007120 587 GLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
|+++...... ......||+.|+|||++
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~ 187 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVL 187 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHH
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchh
Confidence 9998764332 23456799999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.5e-29 Score=250.14 Aligned_cols=169 Identities=25% Similarity=0.352 Sum_probs=146.6
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeCCeEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (617)
++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+++.++|||||++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 5889999998642 33456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCceeeCCCC
Q 007120 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (617)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~~~~~~ 596 (617)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345789999999999999999999987 9999999999999999999999999999876443
Q ss_pred cccccceeeeeccccCccCC
Q 007120 597 TEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 597 ~~~~~~~~~gt~~y~ape~~ 616 (617)
.. .....++..|+|||.+
T Consensus 156 ~~--~~~~~~~~~~~~pe~~ 173 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVL 173 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHH
T ss_pred cc--ceeeccccchhhhhHh
Confidence 32 2234577889999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=9.6e-29 Score=249.37 Aligned_cols=169 Identities=19% Similarity=0.302 Sum_probs=142.4
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCccceEEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||+||+|+.. +++.||||.++... ....+++|++.++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999975 48899999886432 23457788889988876 8999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC-----CCCeEEeecCCceee
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTF 592 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-----~~~~ki~DFGla~~~ 592 (617)
+ +++|.+++... ...+++.++..++.|++.||+|||+.+ ||||||||+||||+. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 68999988543 345899999999999999999999988 999999999999974 578999999999987
Q ss_pred CCCCcc-----cccceeeeeccccCccCC
Q 007120 593 GGDETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 593 ~~~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
...... .......||+.|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~ 185 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTH 185 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHh
Confidence 543221 123346799999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.9e-29 Score=255.38 Aligned_cols=170 Identities=25% Similarity=0.322 Sum_probs=145.8
Q ss_pred CCccccceecccCcccEEEEEEc----CCcEEEEEEeccc----chhhHHHHHHHHHHHccCCC-CCccceEEEEEeCCe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 510 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 510 (617)
++|++.+.||+|+||+||+|+.. +|+.||||.+++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999862 3789999998652 22345678899999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++||||+.+|+|.+++... ..++......++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998643 34577888899999999999999987 9999999999999999999999999999
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
.+....... .....||+.|++||.+
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIV 202 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHH
T ss_pred hhccccccc-ccccccccccchhHHh
Confidence 875444332 3346799999999965
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=4.5e-28 Score=245.28 Aligned_cols=169 Identities=22% Similarity=0.354 Sum_probs=136.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccce-EEEEEeCCeEEEEEec
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL-LGCCIQGEEKLLIYEF 517 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey 517 (617)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ...++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 48899999886532 23468899999999987775555 5555778888999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcC---CCCeEEeecCCceeeCC
Q 007120 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFGG 594 (617)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~ki~DFGla~~~~~ 594 (617)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 566666543 2345899999999999999999999988 999999999999854 55799999999998865
Q ss_pred CCcc-----cccceeeeeccccCccCC
Q 007120 595 DETE-----GNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 595 ~~~~-----~~~~~~~gt~~y~ape~~ 616 (617)
.... .......||+.|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 185 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTH 185 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHH
Confidence 4332 123446799999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.6e-28 Score=251.45 Aligned_cols=166 Identities=27% Similarity=0.387 Sum_probs=138.1
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEeC-----Ce
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (617)
.++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999974 5899999999753 334456789999999999999999999998643 33
Q ss_pred EEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCce
Q 007120 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (617)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~ 590 (617)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677788889999999843 34899999999999999999999988 9999999999999999999999999998
Q ss_pred eeCCCCcccccceeeeeccccCccCC
Q 007120 591 TFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 591 ~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
..... .....||+.|+|||.+
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~ 190 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIM 190 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHH
T ss_pred ccCcc-----cccccccccccCchhh
Confidence 76322 2346789999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-27 Score=248.26 Aligned_cols=166 Identities=27% Similarity=0.348 Sum_probs=130.3
Q ss_pred cCCccccceecccCcccEEEEEEc-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCccceEEEEEe------CC
Q 007120 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 509 (617)
Q Consensus 439 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 509 (617)
.++|++.++||+|+||+||+|... +++.||||++++. .......+.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 4899999999652 34455678999999999999999999999964 35
Q ss_pred eEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEeecCCc
Q 007120 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (617)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla 589 (617)
..++||||+.++.+. .+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999765554 441 24789999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCcccccceeeeeccccCccCC
Q 007120 590 RTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 590 ~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+....... .....||+.|+|||++
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~l 190 (355)
T d2b1pa1 167 RTAGTSFM---MTPYVVTRYYRAPEVI 190 (355)
T ss_dssp -----------------CCTTCCHHHH
T ss_pred hccccccc---cccccccccccChhhh
Confidence 98754332 3346799999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=1.8e-23 Score=216.93 Aligned_cols=168 Identities=19% Similarity=0.203 Sum_probs=132.3
Q ss_pred CCccccceecccCcccEEEEEEc-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCCccceEEEEEe
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 507 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 507 (617)
.+|++.++||+|+||+||+|+.. +++.||||++++. ....+.+.+|+.+++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 5899999999763 233567788888888775 5789999988865
Q ss_pred --CCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecccCCCcEEEcCCCC----
Q 007120 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 580 (617)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~---- 580 (617)
....+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34567777776655443333333445667889999999999999999998 55 999999999999987654
Q ss_pred --eEEeecCCceeeCCCCcccccceeeeeccccCccCC
Q 007120 581 --PKISDFGLVRTFGGDETEGNTNRVVGTYCGTKAFLY 616 (617)
Q Consensus 581 --~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ape~~ 616 (617)
+||+|||.|+..... .....||+.|+|||++
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~ 201 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL 201 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhc
Confidence 999999999876432 2346799999999964
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.1e-21 Score=184.35 Aligned_cols=133 Identities=21% Similarity=0.198 Sum_probs=105.8
Q ss_pred cccceecccCcccEEEEEEcCCcEEEEEEecccc------------------hhhHHHHHHHHHHHccCCCCCccceEEE
Q 007120 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------------------EQGLKELKNEVILFSKLQHRNLVKLLGC 504 (617)
Q Consensus 443 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~ 504 (617)
.+.++||+|+||.||+|+..+|+.||||.++... ......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999999889999999864210 0112345678889999999999988765
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecccCCCcEEEcCCCCeEEe
Q 007120 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (617)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~ki~ 584 (617)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 2 2379999999765533 223334578999999999999988 99999999999998654 8999
Q ss_pred ecCCceeeC
Q 007120 585 DFGLVRTFG 593 (617)
Q Consensus 585 DFGla~~~~ 593 (617)
|||+|+...
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999998874
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=1.5e-16 Score=135.58 Aligned_cols=100 Identities=16% Similarity=0.185 Sum_probs=81.6
Q ss_pred CCCCCCCceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCce
Q 007120 9 NKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETY 88 (617)
Q Consensus 9 ~~~~~~~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~ 88 (617)
|++++..+.+|++|++.|+....-+|.+..||+|+|.+. +.++|++++.+......+ +|+++|||||++.+ +.+
T Consensus 14 ~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~-~l~~~GnLvl~d~~----~~~ 87 (120)
T d1dlpa2 14 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA-VLQPNGRMDVLTNQ----NIA 87 (120)
T ss_dssp CCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEE-EEETTTEEEEEETT----TEE
T ss_pred EcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEE-EEeCCeeEEEEcCC----CCE
Confidence 567888899999999999987767899999999999986 678999987753344556 99999999999874 679
Q ss_pred eeeeccCCCcccCCCCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEE
Q 007120 89 FWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVV 145 (617)
Q Consensus 89 lWQSFd~PTDTlLpgq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~ 145 (617)
|||||. +.++|.|.+.|+++|+..++
T Consensus 88 lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 999984 23567899999999997654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.58 E-value=2.2e-15 Score=126.23 Aligned_cols=73 Identities=19% Similarity=0.302 Sum_probs=61.6
Q ss_pred CCceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeec
Q 007120 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (617)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSF 93 (617)
..++||+||++.|+.. .+.|.|+.||+|||.|++|++||+|++....+..++ .|+|+|||||++. .+|||+
T Consensus 36 ~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l-~L~ddGNlvly~~-------~~W~S~ 106 (109)
T d1kj1a_ 36 HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVL-VLQEDGNVVIYGS-------DIWSTG 106 (109)
T ss_dssp TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEE-EECTTSCEEEECC-------EEEECC
T ss_pred CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCCcEEEEEeeECCCCCEEE-EEeCCCcEEEECC-------CEecCC
Confidence 3578999999999875 378999999999999999999999987643444456 9999999999963 499999
Q ss_pred cC
Q 007120 94 DY 95 (617)
Q Consensus 94 d~ 95 (617)
.|
T Consensus 107 t~ 108 (109)
T d1kj1a_ 107 TY 108 (109)
T ss_dssp CC
T ss_pred Cc
Confidence 75
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=2.4e-15 Score=126.72 Aligned_cols=103 Identities=17% Similarity=0.229 Sum_probs=83.9
Q ss_pred CCceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeec
Q 007120 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (617)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSF 93 (617)
+.+..|+.+.+.++.....+|.+..||||||.+. +.++|++++.+ .....+ .|+|+|||||++.. +.+||||+
T Consensus 10 ~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l-~l~~dGNLvl~d~~----~~~vWsS~ 82 (115)
T d1dlpa1 10 EGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRA-VLQSDGLLVILTAQ----NTIRWSSG 82 (115)
T ss_dssp SSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBC-CBCSSSCBCCBCTT----TCCSCCCC
T ss_pred CCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEE-EEeccCCEEEEccC----CCEEEEcC
Confidence 3455689999999987778899999999999884 67899999875 455666 99999999999864 67899987
Q ss_pred cCCCcccCCCCcccceeccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 94 DYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 94 d~PTDTlLpgq~l~~~~~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
. +.++|.|.+.|+++|+..++ +.++|.+|.
T Consensus 83 t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 83 T-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp C-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred C-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 3 23678999999999996554 348999876
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.54 E-value=1e-14 Score=123.05 Aligned_cols=77 Identities=18% Similarity=0.355 Sum_probs=62.4
Q ss_pred CCceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeec
Q 007120 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (617)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSF 93 (617)
..++||.||++.|.. ++.|.|+.||+|+|.|. +.++|++++.+..+...+ +|+|+|||||++.+ +.++|||+
T Consensus 36 ~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~-~~~~w~s~t~~~~~~~~l-~L~ddGNlvly~~~----~~~~W~S~ 107 (112)
T d1xd5a_ 36 NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYL-ILQRDRNVVIYDNS----NNAIWATH 107 (112)
T ss_dssp TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-TEEEEECCCCCSCCCCEE-EECTTSCEEEECTT----SCEEEECC
T ss_pred CCcEEEEccCccCCC--CcEEEEeccccEEEEec-CCeEEEEeeccCCCceEE-EEcCCCCEEEECCC----CcEEecCC
Confidence 357999999998854 46899999999999997 467787776543344455 99999999999864 67899999
Q ss_pred cCCCc
Q 007120 94 DYPSD 98 (617)
Q Consensus 94 d~PTD 98 (617)
.+|++
T Consensus 108 t~~~n 112 (112)
T d1xd5a_ 108 TNVGN 112 (112)
T ss_dssp CCCCC
T ss_pred CccCC
Confidence 99986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.54 E-value=8.3e-15 Score=122.56 Aligned_cols=71 Identities=23% Similarity=0.329 Sum_probs=59.3
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||.||++.|- ..+.|.|..+|+|+|.|++|.+||+|++.......++ +|+|+|||||++. .+||||+
T Consensus 37 ~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l-~L~ddGNlVly~~-------~~W~S~t 106 (108)
T d1jpca_ 37 DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVC-ILQKDRNVVIYGT-------DRWATGT 106 (108)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEE-EECTTSCEEEEEC-------CCCCCCC
T ss_pred CceeeEeCCCCCC--CccEEEEeccceEEEECCCccceEEccccCCCCcEEE-EEcCCCCEEEeCC-------CcccCCC
Confidence 5789999999884 3468999999999999999999999987653333344 9999999999964 3899998
Q ss_pred C
Q 007120 95 Y 95 (617)
Q Consensus 95 ~ 95 (617)
|
T Consensus 107 ~ 107 (108)
T d1jpca_ 107 H 107 (108)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=1.5e-11 Score=103.84 Aligned_cols=70 Identities=20% Similarity=0.358 Sum_probs=57.7
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
.++||.||+..|.. ...|.|..||+|+|.|++|.+||++++.+.....++ +|+|+|||||++. ++|||-.
T Consensus 48 ~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~~l-~Lq~DGNlvlYg~-------~~W~S~T 117 (119)
T d1b2pa_ 48 NNPIWATNTGGLGN--GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVL-VLQPDRNVVIYGD-------ALWATQT 117 (119)
T ss_dssp TEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEE-EECTTSCEEEEES-------EEEECCC
T ss_pred CeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCCcEEEECCCcCCCCceEE-EEcCCCCEEEECC-------CEeccCC
Confidence 57899999987743 368999999999999999999999988753333345 9999999999963 6999965
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.96 E-value=2.4e-09 Score=90.06 Aligned_cols=85 Identities=19% Similarity=0.281 Sum_probs=65.1
Q ss_pred eEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceecc
Q 007120 33 FLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (617)
Q Consensus 33 ~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~ 112 (617)
.|.+..||||||.++ +.++|++++.+......+ .|.++|||||++.+ +.++|+|..
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l-~l~~dGnLvL~d~~----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRA-VLQPDGVLVVITNE----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEE-EEEeCCCEEEECCC----CcEEEECCC------------------
Confidence 578889999999876 568999998654344556 99999999999875 678997632
Q ss_pred CCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCC
Q 007120 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (617)
Q Consensus 113 g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (617)
.-+.|.|.+.|+++|+..++ +.+.|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11456788999999997664 347898875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.92 E-value=4.5e-09 Score=87.02 Aligned_cols=87 Identities=20% Similarity=0.372 Sum_probs=64.9
Q ss_pred eeEEEecCCcEEEEcCCCcEEEeeCCccCc-CCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCccccee
Q 007120 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (617)
Q Consensus 32 ~~l~l~~~G~L~l~~~~~~~vWst~~~~~~-~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (617)
-.|.+..||+|||.+ .+.+||++++.... ....+ .|.++|||||++.+ +.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~s~----------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKA-VLQSDGNFVVYDAE----GRSLWASH----------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEE-EECTTSCEEEECSS----SCEEEECC-----------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEE-EEcCCceEEEEeCC----CcEEEEEe-----------------
Confidence 578889999999986 56799999876432 23455 89999999999874 67899871
Q ss_pred ccCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007120 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (617)
Q Consensus 111 ~~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (617)
.....|.|.+.|+++|+..++ + .+.|.++.+
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 --------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred --------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 111356788999999997654 3 468987754
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.90 E-value=2.8e-09 Score=88.30 Aligned_cols=85 Identities=18% Similarity=0.357 Sum_probs=62.7
Q ss_pred eeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceec
Q 007120 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (617)
Q Consensus 32 ~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (617)
-+|.+..||||||.+. +.+||++++.+......+ .|.++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l-~l~~~Gnlvl~~~~----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFL-SMQTDGNLVVYNPS----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEE-EEeccceEEEECCC----ccceEEc-------------------
Confidence 5789999999999874 579999998753334456 99999999999875 6789986
Q ss_pred cCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeC
Q 007120 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (617)
Q Consensus 112 ~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 157 (617)
......+.|.+.|+++|+..++ . .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1112456788899999997654 2 2355554
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.79 E-value=1.1e-09 Score=91.49 Aligned_cols=69 Identities=19% Similarity=0.294 Sum_probs=55.1
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeecc
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 94 (617)
..+||.+|...+ ..+.+.|..+|+|||.|.++.+||++.+....+.-++ +|.++|||||++. .+|+|-.
T Consensus 44 ~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l-~Lq~DGNlvlY~~-------~~Wssgt 112 (115)
T d1dlpa1 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL-VLQPDRTVTIYGP-------GLWDSGT 112 (115)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE-EECSSSCEEEECS-------EEEECSC
T ss_pred CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEE-EECCCCcEEEeCC-------CeecCCC
Confidence 468999997542 3478999999999999999999999987653333445 9999999999953 6999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.74 E-value=7.4e-09 Score=87.21 Aligned_cols=68 Identities=21% Similarity=0.355 Sum_probs=52.8
Q ss_pred CceEEEccCCCCCCCCceeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeee
Q 007120 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (617)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 92 (617)
..+||.+|- +.......+.|..+|+|||.|.++.++|+|++........+ .|.++|||||++. .+|.|
T Consensus 53 ~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l-~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 53 DDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVF-VLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp TBCCSCCCC--CSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEE-EECSSSCEEEECC-------CCCBC
T ss_pred CcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEE-EECCCCcEEEeCC-------CcccC
Confidence 356898874 33344568999999999999999999999998653344445 8999999999953 48876
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.59 E-value=2.3e-07 Score=77.07 Aligned_cols=89 Identities=21% Similarity=0.376 Sum_probs=64.4
Q ss_pred eeEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCEEEeeCCCCCCCceeeeeccCCCcccCCCCcccceec
Q 007120 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (617)
Q Consensus 32 ~~l~l~~~G~L~l~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (617)
-.|.+..||||||.+ .+.+||++++.+....+.+ .|..+|||||++. +..+|-|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l-~l~~dGnLvl~~~-----~~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVL-KMQNDGNLVIYSG-----SRAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEE-EECTTSCEEEEET-----TEEEEEC-------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEE-EEeccccEEEEec-----CCeEEEE-------------------
Confidence 578999999999987 5679999987653344455 9999999999985 3456643
Q ss_pred cCCcceEEEeecCCCCCCcceEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007120 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (617)
Q Consensus 112 ~g~~~~l~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (617)
...-..|.|.+.|+.+|+..++- ....+.|.++.-
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHTN 109 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCCC
T ss_pred ------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCCc
Confidence 22224567889999999976542 235688988753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=7.6e-07 Score=85.49 Aligned_cols=143 Identities=15% Similarity=0.073 Sum_probs=97.6
Q ss_pred CCccccceecccCcccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCccceEEEEEeCCeEEEEEecC
Q 007120 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (617)
Q Consensus 440 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 518 (617)
..|+..+..+-++...||+... +++.+.||+...........+.+|...+..+. +--+.+++.+..+++..++|||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 4555544433344468998764 56677888886544444556777888776653 444678888888899999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007120 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--------------------------------------- 559 (617)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------------------- 559 (617)
++..+.+..... .. ...++.++++.+..||+..
T Consensus 93 ~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 93 DGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred cccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 998886544210 11 2234555566666666421
Q ss_pred -----------------CCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 560 -----------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 560 -----------------~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
...++|+|+.|.|||++++..+-|.||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999877778999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=4.4e-05 Score=72.31 Aligned_cols=131 Identities=18% Similarity=0.148 Sum_probs=84.6
Q ss_pred eecccCc-ccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCC--CCCccceEEEEEeCCeEEEEEecCCCCCH
Q 007120 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (617)
Q Consensus 447 ~iG~G~f-G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (617)
.+..|.. ..||+....++..+.+|...... ...+..|...++.+. ...+.+++++..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 57899888777778888765432 234666777766553 33467788888888889999999988665
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHH---------------------------------------------------H
Q 007120 524 DSFIFDQTRRTLLDWSQRFHIICGTARG---------------------------------------------------L 552 (617)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------------------l 552 (617)
.+.. ... ..++.++++. +
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 000 0111122222 2
Q ss_pred HHHHhC----CCCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 553 LYLHQD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 553 ~yLH~~----~~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
..+... .++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 222221 122379999999999999887788999998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.11 E-value=0.00061 Score=68.79 Aligned_cols=75 Identities=9% Similarity=0.139 Sum_probs=46.8
Q ss_pred ceecccCcccEEEEEEcC-CcEEEEEEeccc---c----hhhHHHHHHHHHHHccC---CCCCccceEEEEEeCCeEEEE
Q 007120 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---S----EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLI 514 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~---~----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV 514 (617)
+.||.|..-.||+....+ ++.|+||.-... . .........|...++.+ -...+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998654 678999975321 0 11122344566666544 22345666654 56667899
Q ss_pred EecCCCCC
Q 007120 515 YEFMPNKS 522 (617)
Q Consensus 515 ~Ey~~~gs 522 (617)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.33 E-value=0.007 Score=58.93 Aligned_cols=135 Identities=13% Similarity=0.146 Sum_probs=75.7
Q ss_pred ccEEEEEEcCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcc-----ce--EEEEEeCCeEEEEEecCCCCCHH--
Q 007120 454 GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-----KL--LGCCIQGEEKLLIYEFMPNKSLD-- 524 (617)
Q Consensus 454 G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-----~l--~g~~~~~~~~~lV~Ey~~~gsL~-- 524 (617)
=.||+....+|..+++|..... ....+++..|...+..|...++. .. -.........+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999988999999987643 22345677787777666432221 11 01223456678999999864331
Q ss_pred ---HH------H---hc------CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHH----hCCCCce
Q 007120 525 ---SF------I---FD------QTRRTLLDWS-------------------QRFHIICGTARGLLYLH----QDSRLRI 563 (617)
Q Consensus 525 ---~~------l---~~------~~~~~~l~~~-------------------~~~~i~~~ia~gl~yLH----~~~~~~i 563 (617)
.+ + +. .......++. .+-.+...+.+.++.+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 1 10 0011111211 11112222222333332 2223458
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 564 iHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
||+|+.+.|||++++ ..|.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.91 E-value=0.0055 Score=61.52 Aligned_cols=72 Identities=19% Similarity=0.311 Sum_probs=46.6
Q ss_pred ceecccCcccEEEEEEcCC--------cEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-cceEEEEEeCCeEEEEEe
Q 007120 446 NKLGEGGFGPVYKGTLVDG--------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 516 (617)
Q Consensus 446 ~~iG~G~fG~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 516 (617)
+.|+-|-.=.+|+....++ +.|.++..... .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5777777788999987542 45666665422 223345578888877743344 477777642 68999
Q ss_pred cCCCCCH
Q 007120 517 FMPNKSL 523 (617)
Q Consensus 517 y~~~gsL 523 (617)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.26 E-value=0.27 Score=46.58 Aligned_cols=32 Identities=28% Similarity=0.308 Sum_probs=28.0
Q ss_pred CCceeecccCCCcEEEcCCCCeEEeecCCcee
Q 007120 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (617)
Q Consensus 560 ~~~iiHrDlkp~NiLl~~~~~~ki~DFGla~~ 591 (617)
+..+||+|+.+.||+++.+...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34589999999999999988889999998764
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.25 E-value=0.037 Score=33.33 Aligned_cols=31 Identities=35% Similarity=0.817 Sum_probs=25.2
Q ss_pred CCCCcccCCCCceeeccC-CCCcccccCCceeC
Q 007120 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPK 262 (617)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 262 (617)
|+|.+-..||. |-|+.- ..-.|.|-.||+|.
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCC
Confidence 78999999996 889653 34469999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.85 E-value=0.054 Score=34.88 Aligned_cols=30 Identities=40% Similarity=0.830 Sum_probs=24.3
Q ss_pred CCCCc-ccCCCCceeeccCC-CCcccccCCce
Q 007120 231 DQCDT-YGLCGAYGICIIGQ-SPVCQCLKGFK 260 (617)
Q Consensus 231 ~~C~~-~~~CG~~g~C~~~~-~~~C~C~~gf~ 260 (617)
|+|.. ...|..+|.|.... .-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 67876 57899999997643 45799999998
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.96 E-value=0.13 Score=32.43 Aligned_cols=30 Identities=40% Similarity=0.894 Sum_probs=23.1
Q ss_pred CCCCcccCCCCceeeccC-CCCcccccCCcee
Q 007120 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKP 261 (617)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 261 (617)
|+|. +..|...|.|... ..-.|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 5789999999754 3567999999983
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.42 E-value=0.16 Score=31.91 Aligned_cols=30 Identities=20% Similarity=0.600 Sum_probs=23.0
Q ss_pred CCCCcccCCCCceeeccC-CCCcccccCCcee
Q 007120 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKP 261 (617)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 261 (617)
|+|. +..|...|.|... ..-.|.|++||+-
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 5664 4679999999754 4567999999983
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.22 E-value=0.21 Score=31.32 Aligned_cols=30 Identities=37% Similarity=0.639 Sum_probs=24.0
Q ss_pred CCCCCcccCCCCceeeccC-CCCcccccCCce
Q 007120 230 RDQCDTYGLCGAYGICIIG-QSPVCQCLKGFK 260 (617)
Q Consensus 230 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~ 260 (617)
.|+|. +..|-..|.|... ..-.|.|++||+
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence 47786 5789999999654 456799999997
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.47 E-value=0.31 Score=29.70 Aligned_cols=30 Identities=30% Similarity=0.695 Sum_probs=22.4
Q ss_pred CCCCcccCCCCceeeccC-CCCcccccCCcee
Q 007120 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKP 261 (617)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 261 (617)
|+|. +..|...|.|... ..-.|.|++||+-
T Consensus 1 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 1 DECA-SSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp CTTT-TCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCCC-CCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 3553 5779999999654 3567999999983
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.37 E-value=0.41 Score=30.28 Aligned_cols=30 Identities=30% Similarity=0.781 Sum_probs=23.1
Q ss_pred CCCCcccCCCCceeeccCC-CCcccccCCceeC
Q 007120 231 DQCDTYGLCGAYGICIIGQ-SPVCQCLKGFKPK 262 (617)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~~ 262 (617)
|+|..++.|. .+|.... +-.|.|++||+..
T Consensus 2 dEC~~~~~C~--~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTCS--QLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSCS--SCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCCC--CEeECCCCCEEeECCCCCeEC
Confidence 6888777774 5897553 5579999999974
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.22 E-value=0.45 Score=30.47 Aligned_cols=31 Identities=29% Similarity=0.535 Sum_probs=23.7
Q ss_pred CCCCCcccCCCCceeeccCC-CCcccccCCcee
Q 007120 230 RDQCDTYGLCGAYGICIIGQ-SPVCQCLKGFKP 261 (617)
Q Consensus 230 ~~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~ 261 (617)
.|+|..+. |+.++.|.... +=.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47898665 55789997654 457999999986
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.33 E-value=0.32 Score=31.37 Aligned_cols=34 Identities=26% Similarity=0.617 Sum_probs=24.2
Q ss_pred CCCCCccc-CCCCceeeccCC-CCcccccCCceeCCC
Q 007120 230 RDQCDTYG-LCGAYGICIIGQ-SPVCQCLKGFKPKSG 264 (617)
Q Consensus 230 ~~~C~~~~-~CG~~g~C~~~~-~~~C~C~~gf~~~~~ 264 (617)
-|+|.... .| .++.|.... +-.|.|++||+...+
T Consensus 3 idEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 3 IDECRISPDLC-GRGQCVNTPGDFECKCDEGYESGFM 38 (44)
T ss_dssp CCTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECTT
T ss_pred ccccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCCC
Confidence 37887744 56 479997653 457999999996533
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.92 E-value=0.52 Score=31.69 Aligned_cols=27 Identities=30% Similarity=0.684 Sum_probs=21.7
Q ss_pred cccCCCCceeecc---CCCCcccccCCcee
Q 007120 235 TYGLCGAYGICII---GQSPVCQCLKGFKP 261 (617)
Q Consensus 235 ~~~~CG~~g~C~~---~~~~~C~C~~gf~~ 261 (617)
..+.|...|.|.. .....|.|++||.-
T Consensus 10 ~~~~C~NgG~C~~~~~~~~~~C~C~~gy~G 39 (53)
T d3egfa_ 10 YDGYCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp SSCCSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred CCCCCCCCcEeeccCCCCCeEeECCCCCcC
Confidence 4689999999963 24678999999983
|